---
title: "OncoSimulR: forward genetic simulation in asexual populations with arbitrary epistatic interactions and a focus on modeling tumor progression."
author: "

Ramon Diaz-Uriarte, Sergio Sanchez-Carrillo, Juan Antonio Miguel-Gonzalez\\

Investigaciones Biomédicas 'Alberto Sols' (UAM-CSIC), Madrid,
Spain.\\

<ramon.diaz@iib.uam.es>, <https://ligarto.org/rdiaz>
"
date: "r paste0(Sys.Date(),'. OncoSimulR version ', packageVersion('OncoSimulR'), suppressWarnings(ifelse(length(try(system('git rev-parse --short HEAD', ignore.stderr = TRUE, intern = TRUE))), paste0('. Revision: ', system('git rev-parse --short HEAD', intern = TRUE)), '')))"
- \input{preamble.tex}
output:
bookdown::html_document2:
css: custom4.css
toc: yes
toc_float: true
fig_retina: null
classoption: a4paper
geometry: margin=3cm
fontsize: 12pt
bibliography: OncoSimulR.bib
biblio-style: "apalike"
vignette: >
%\VignetteIndexEntry{OncoSimulR: forward genetic simulation in asexual populations with arbitrary epistatic interactions and a focus on modeling tumor progression.}
%\VignetteEngine{knitr::rmarkdown}
%\VignettePackage{OncoSimulR}
%\VignetteEngine{knitr::rmarkdown}
%\VignetteEncoding{UTF-8}
%\VignetteKeywords{OncoSimulR simulation cancer oncogenetic trees}
%\VignetteDepends{OncoSimulR}
---

<!-- Fomr https://github.com/rstudio/bookdown/issues/153 -->
<script type="text/x-mathjax-config">
MathJax.Hub.Config({
TeX: { equationNumbers: { autoNumber: "AMS" } }
});
</script>

{r setup, include=FALSE}
## use collapse for bookdown, to collapse all the source and output
## blocks from one code chunk into a single block
time0 <- Sys.time()
knitr::opts_chunk$set(echo = TRUE, collapse = TRUE) options(width = 70) require(BiocStyle) require(pander) ## ## https://bookdown.org/yihui/rmarkdown-cookbook/time-chunk.html ## all_times <- list() # store the time for each chunk ## knitr::knit_hooks$set(time_it = local({
##   now <- NULL
##   function(before, options) {
##     if (before) {
##       now <<- Sys.time()
##     } else {
##       res <- difftime(Sys.time(), now, units = "secs")
##       all_times[[options$label]] <<- as.double(res) ## } ## } ## })) ## knitr::opts_chunk$set(time_it = TRUE)


\clearpage

# Introduction {#introdd}

OncoSimulR is an individual- or clone-based forward-time genetic
simulator for biallelic markers (wildtype vs. mutated) in asexually
reproducing populations without spatial structure (perfect
mixing). Its design emphasizes flexible specification of fitness and
mutator effects.

OncoSimulR was originally developed to simulate tumor progression with
emphasis on allowing users to set restrictions in the accumulation of
mutations as specified, for example, by Oncogenetic Trees
[OT: @Desper1999JCB; @Szabo2008] or Conjunctive Bayesian Networks
[CBN: @Beerenwinkel2007; @Gerstung2009; @Gerstung2011], with the
possibility of adding passenger mutations to the simulations and allowing
for several types of sampling.

Since then, OncoSimulR has been vastly extended to allow you to specify
other types of restrictions in the accumulation of genes, such as the XOR
models of @Korsunsky2014 or the "semimonotone" model of
@Farahani2013. Moreover, different fitness effects related to the order in
which mutations appear can also be incorporated, involving arbitrary numbers
of genes. This is *very* different from "restrictions in the order of
accumulation of mutations". With order effects, described in a recent cancer
paper by Ortmann and collaborators [@Ortmann2015], the effect of having both
mutations "A" and "B" differs depending on whether "A" appeared before or
after "B" (the actual case involves genes JAK2 and TET2).

More generally, OncoSimulR now also allows you to specify arbitrary
epistatic interactions between arbitrary collections of genes and to model,
for example, synthetic mortality or synthetic viability (again, involving an
arbitrary number of genes, some of which might also depend on other genes,
or show order effects with other genes). Moreover, it is possible to specify
the above interactions in terms of modules, not genes. This idea is
discussed in, for example, @Raphael2014a and @Gerstung2011: the restrictions
encoded in, say, CBNs or OT can be considered to apply not to genes, but to
modules, where each module is a set of genes (and the intersection between
modules is the empty set) that performs a specific biological
function. Modules, then, play the role of a "union operation" over the set
of genes in a module. In addition, arbitrary numbers of genes without
interactions (and with fitness effects coming from any distribution you
might want) are also possible.

You can also directly specify the mapping between genotypes and
fitness and, thus, you can simulate on fitness landscapes of
arbitrary complexity.

It is now (released initially in this repo as the freq-dep-fitness
branch on February 2019) also possible to simulate scenarios with
frequency-dependent fitness, where the fitness of one or more
genotypes depends on the relative or absolute frequencies of other
genotypes, as in game theory and adaptive dynamics. This makes it
possible to model predation and parasitism, cooperation and
mutualism, and commensalism. It also allows to model therapeutic
interventions (where fitness changes at specified time points or as
a function of the total populations size).

Simulations can start from arbitrary initial population compositions
and it is also possible to simulate multiple species. Thus, simulations
that involve both ecological and evolutionary processes are possible.

Mutator/antimutator genes, genes that alter the mutation rate of
other genes [@gerrish_complete_2007; @tomlinson_mutation_1996], can
also be simulated with OncoSimulR and specified with most of the
mechanisms above (you can have, for instance, interactions between
mutator genes). And, regardless of the presence or not of other
mutator/antimutator genes, different genes can have different
mutation rates.

Simulations can be stopped as a function of total population size, number
of mutated driver genes, or number of time periods. Simulations can also
be stopped with a stochastic detection mechanism where the probability of
detecting a tumor increases with total population size. Simulations return
the number of cells of every genotype/clone at each of the sampling
periods and we can take samples from the former with single-cell or whole-
tumor resolution, adding noise if we want. If we ask for them, simulations
also store and return the genealogical relationships of all clones
generated during the simulation.

The models so far implemented are all continuous time models, which are
simulated using the BNB algorithm of @Mather2012. The core of the code is
implemented in C++, providing for fast execution.  To help with simulation
studies, code to simulate random graphs of the kind often seen in CBNs, OTs,
etc, is also available. Finally, OncoSimulR also allows for the generation
of random fitness landscapes and the representation of fitness landscapes
and provides statistics of evolutionary predictability.

## Key features of OncoSimulR {#key}

As mentioned above, OncoSimulR is now a very general package for forward
genetic simulation, with applicability well beyond tumor progression. This
is a summary of some of its key features:

<!-- FIXME: add the tables of the poster -->

* You can specify arbitrary interactions between genes, with
arbitrary fitness effects, with explicit support for:
- Restrictions in the accumulations of mutations, as specified by
Oncogenetic Trees (OTs), Conjunctive Bayesian Networks (CBNs),
semimonotone progression networks, and XOR relationships.

- Epistatic interactions including, but not limited to, synthetic
viability and synthetic lethality.
- Order effects.

* You can add passenger mutations.
* You can add mutator/antimutator effects.
* Fitness and mutation rates can be gene-specific.
* You can add arbitrary numbers of non-interacting
genes with arbitrary fitness effects.

* you can allow for deviations from the OT, CBN, semimonotone, and
XOR models, specifying a penalty for such deviations (the $s_h$
parameter).

* You can conduct multiple simulations, and sample from them with
different temporal schemes and using both whole tumor or single cell
sampling.

* You can stop the simulations using a flexible combination of
conditions: final time, number of drivers, population
size, fixation of certain genotypes, and a stochastic
stopping mechanism that depends on population size.

* Right now, three different models are available, two that lead
to exponential growth, one of them loosely based on @Bozic2010, and
another that leads to logistic-like growth, based on @McFarland2013.

<!-- * Code in C++ is available (though not yet callable from R) for -->
<!--       using several other models, including the one from @Beerenwinkel2007b. -->

* You can use large numbers of genes (e.g., see an example of
50000 in section \@ref(mcf50070)).

* Simulations are generally very fast: I use C++ to implement the BNB
algorithm (see sections \@ref(bnbmutation) and \@ref(bnbdensdep) for
more detailed comments on the usage of this algorithm).

* You can obtain the true sequence of events and the phylogenetic
relationships between clones (see section \@ref(meaningclone)
for the details of what we mean by "clone").

* You can generate random fitness landscapes (under the House of
Cards, Rough Mount Fuji, or additive models, or combinations of the
former and under the NK model) and use those landscapes as input to the simulation
functions.

* You can plot fitness landscapes.

* You can obtain statistics of evolutionary predictability
from the simulations.

* You can now also use simulations with frequency-dependent fitness:
fitness (birth rate) is not fixed for a genotype, but can be a
function of the frequecies of the clones (see section
\@ref(fdf)). We can therefore use OncoSimulR to examine, via
simulations, results from game theory and adaptive dynamics and
study complex scenarios that are not amenable to analytical
solutions. More generally, we can model predation and parasitism,
cooperation and mutualism, and commensalism.

* It is possible to start the simulation with arbitrary initial
composition (section \@ref(minitmut)) and to simulate multiple species
(section \@ref(multispecies)). You can thus run simulations
that involve both ecological and evolutionary processes involving
inter-species relationships plus genetic restrictions in evolution.

* It is possible to simulate many different therapeutic
interventions. Section \@ref(timefdf) shows examples of
interventions where certain genotypes change fitness (because of
chemotherapy) at specified times. More generally, since fitness
(birth rates) can be made a function of total populations sizes
and/or frequencies (see section \@ref(fdf)), many different
arbitrary intervention schemes can be simulated. Possible models
are, of course, not limited to cancer chemotherapy, but could
include antibiotic
treatment of bacteria, antiviral therapy, etc.
<!-- Evaluating frequently
the fitness across --> <!-- the simulation, you can obtain a
dynamic fitness landscape . -->

The table below, modified from the table at the
[Genetics Simulation Resources (GSR) page](https://popmodels.cancercontrol.cancer.gov/gsr/packages/oncosimulr/#detailed),
provides a summary of the key features of OncoSimulR. (An
explanation of the meaning of terms specific to the GSR table is
available from
https://popmodels.cancercontrol.cancer.gov/gsr/search/ or from the
[Genetics Simulation Resources table itself](https://popmodels.cancercontrol.cancer.gov/gsr/packages/oncosimulr/#detailed),
by moving the mouse over each term).

\clearpage

|Attribute Category                  | Attribute                                     |
|-------------------------------|-----------------------------------------------|
|**Target**                           |  |
|&nbsp; Type of Simulated Data        |           Haploid DNA Sequence|
|&nbsp; Variations                    |           Biallelic Marker, Genotype or Sequencing Error|
|**Simulation Method**                |           Forward-time|
|&nbsp; Type of Dynamical Model       | Continuous time|
|&nbsp; Entities Tracked              | Clones (see \@ref(trackindivs))|
|**Input** | Program specific (R data frames and matrices specifying genotypes' fitness, gene effects, and starting genotype) |
|**Output**||
|&nbsp; Data Type| Genotype or Sequence, Individual Relationship (complete parent-child relationships between clones), Demographic (populations sizes of all clones at sampling times), Diversity Measures (LOD, POM, diversity of genotypes), Fitness|
|&nbsp; Sample Type|	Random or Independent, Longitudinal, Other (proportional to population size)|
|**Evolutionary Features**	||
|&nbsp; Mating Scheme| Asexual Reproduction |
|&nbsp; Demographic                   ||
|&nbsp; &nbsp; Population Size Changes|	Exponential (two models), Logistic (McFarland et al., 2013)|
|&nbsp; Fitness Components||
|&nbsp; &nbsp; Birth Rate|	Individually Determined from Genotype (models "Exp", "McFL", "McFLD"). Frequency-Dependently Determined from Genotype (models "Exp", "McFL", "McFLD")|
|&nbsp; &nbsp; Death Rate|	Individually Determined from Genotype (model "Bozic"), Influenced by Environment ---population size (models "McFL" and "McFLD")|
|&nbsp;Natural Selection||
|&nbsp; &nbsp; Determinant|	Single and Multi-locus, Fitness of Offspring,  Environmental Factors (population size, genotype frequencies)|
|&nbsp; &nbsp; Models|	Directional Selection, Multi-locus models, Epistasis, Random Fitness Effects, Frequency-Dependent|
|&nbsp; Mutation Models|	Two-allele Mutation Model (wildtype, mutant), without back mutation|
|&nbsp; Events Allowed|	Varying Genetic Features: change of individual mutation rates (mutator/antimutator genes)|
|&nbsp; Spatial Structure| No Spatial Structure (perfectly mixed and no migration)|

Table:(\#tab:osrfeatures) Key features of OncoSimulR. Modified from
the original table from
https://popmodels.cancercontrol.cancer.gov/gsr/packages/oncosimulr/#detailed
.

<!-- Why not "Carrying cappacity" instead of logistic? Both are very -->
<!-- similar, but the GSR page says, for carrying capacity "This includes models with age or stage-specific carrying capacities" -->

Further details about the original motivation for wanting to
simulate data this way in the context of tumor progression can be
parameters and caveats are discussed.

Are there similar programs? The Java program by @Reiter2013a, TTP, offers
somewhat similar functionality to the previous version of OncoSimulR, but
it is restricted to at most four drivers (whereas v.1 of OncoSimulR
allowed for up to 64), you cannot use arbitrary CBNs or OTs (or XORs or
semimonotone graphs) to specify restrictions, there is no allowance for
passengers, and a single type of model (a discrete time Galton-Watson
process) is implemented. The current functionality of OncoSimulR goes well
beyond the the previous version (and, thus, also the TPT of
@Reiter2013a). We now allow you to specify all types of fitness effects
in other general forward genetic simulators such as FFPopSim
[@Zanini2012], and some that, to our knowledge (e.g., order effects) are
not available from any genetics simulator. In addition, the "Lego system"
to flexibly combine different fitness specifications is also unique; by
"Lego system" I mean that we can combine different pieces and blocks,
similarly to what we do with Lego bricks. (I find this an intuitive and
very graphical analogy, which I have copied from @Hothorn_2006 and
@Hothorn_2008). In a nutshell, salient features of OncoSimulR compared to
other simulators are the unparalleled flexibility to specify fitness and
mutator effects, with modules and order effects as particularly unique,
and the options for sampling and stopping the simulations, particularly
convenient in cancer evolution models. Also unique in this type of
software is the addition of functions for simulating fitness landscapes
and assessing evolutionary predictability.

## What kinds of questions is OncoSimulR suited for? {#generalwhatfor}

OncoSimulR can be used to address questions that span from the
effect of mutator genes in cancer to the interplay between fitness
landscapes and mutation rates. The main types of questions that
OncoSimulR can help address involve combinations of:

* Simulating asexual evolution (the oncoSimul* functions) where:
- Fitness is:
- A function of specific epistatic effects between genes
- A function of order effects
- A function of epistatic effects specified using
DAGs/posets where these DAGs/posets:
- Are user-specified
- Generated randomly (simOGraph)
- Any mapping between genotypes and fitness where this mapping is:
- User-specified
- Generated randomly from families of random fitness landscapes (rfitness)
- A function of the frequency of other genotypes (i.e.,
frequency-dependent fitness), such as in adaptive dynamics
(see section \@ref(fdf) for more details). This also
allows you to model competition, cooperation and
mutualism, parasitism and predation, and commensalism
between clones.
- Mutation rates can:
- Vary between genes
- Be affected by other genes

* Examining times to evolutionarily or biomedically relevant events
(fixation of genotypes, reaching a minimal size, acquiring a
minimal number of driver genes, etc ---specified with the stopping
conditions to the oncoSimul* functions).

* Using different sampling schemes (samplePop) that are related
to:
- Assessing genotypes from single-cell vs. whole tumor (or whole
population) with the  typeSample argument
- Genotyping error (propError argument)
- Timing of samples (timeSample argument)
- ... and assessing the consequences of those on the observed
genotypes and their diversity (sampledGenotypes) and any other
inferences that depend on the observational process.
- (OncoSimulR returns the abundances of all genotypes at each of
the sampling points, so you are not restricted by what the
samplePop function provides.)

* Tracking the genealogical relationships of clones
(plotClonePhylog) and assessing evolutionary predictability
(LOD, POM).

Some specific questions that you can address with the help of
OncoSimulR are discussed in section \@ref(whatfor).

-----

A quick overview of the main functions and their relationships is shown in
Figure \@ref(fig:frelats), where we use italics for the type/class of R
object and courier font for the name of the functions.
<!-- Note: figure1.png, and how to create it, explained in miscell-files -->
<!-- in the repo -->
<!-- ![Relationship between the main functions in OncoSimulR.](figure1.png) -->

{r frelats, eval=TRUE,echo=FALSE, fig.cap="Relationships between the main functions in OncoSimulR."}
knitr::include_graphics("relfunct.png")


\clearpage

## Examples of questions that can be addressed with OncoSimulR {#whatfor}

Most of the examples in the rest of this vignette, starting with those in
\@ref(quickexample), focus on the mechanics. Here, we will illustrate some
problems in cancer genomics and evolutionary genetics where OncoSimulR
could be of help. This section does not try to provide an answer to any of
these questions (those would be full papers by themselves). Instead, this
section simply tries to illustrate some kinds of questions where you can
use OncoSimulR; of course, the possible uses of OncoSimulR are only
limited by your ingenuity. Here, I will only use short snippets of working
code as we are limited by time of execution; for real work you would want
to use many more scenarios and many more simulations, you would use
appropriate statistical methods to compare the output of runs, etc, etc,
etc.

{r firstload}
library(OncoSimulR)


### Recovering restrictions in the order of accumulation of mutations {#ex-order}

This is a question that was addressed, for instance, in
@Diaz-Uriarte2015: do methods that try to infer restrictions in the
order of accumulation of mutations [e.g., @Szabo2008; @Gerstung2009;
@ramazzotti_capri_2015] work well under different evolutionary
models and with different sampling schemes? (This issue is also
touched upon in section \@ref(sample-1)).

A possible way to examine that question would involve:

- generating random DAGs that encode restrictions;
- simulating cancer evolution using those DAGs;
- sampling the data and adding different levels of noise to the sampled data;
- running the inferential method;
- comparing the inferred DAG with the original, true, one.

{r, echo=FALSE}
set.seed(2)
RNGkind("L'Ecuyer-CMRG")


{r ex-dag-inf}
## For reproducibility
set.seed(2)
RNGkind("L'Ecuyer-CMRG")

## Simulate a DAG
g1 <- simOGraph(4, out = "rT")

## Simulate 10 evolutionary trajectories
s1 <- oncoSimulPop(10, allFitnessEffects(g1, drvNames = 1:4),
seed = NULL) ## for reproducibility of vignette

## Sample those data uniformly, and add noise
d1 <- samplePop(s1, timeSample = "unif", propError = 0.1)

## You would now run the appropriate inferential method and
## compare observed and true. For example

## require(Oncotree)
## fit1 <- oncotree.fit(d1)

## Now, you'd compare fitted and original. This is well beyond
## the scope of this document (and OncoSimulR itself).



{r hidden-rng-exochs, echo = FALSE}
## set.seed(NULL)


### Sign epistasis and probability of crossing fitness valleys {#ex-ochs}

This question, and the question in the next section (\@ref(ex-predict)),
encompass a wide range of issues that have been addressed in evolutionary
genetics studies and which include from detailed analysis of simple models
with a few uphill paths and valleys as in @Weissman2009 or @Ochs2015, to
questions that refer to larger, more complex fitness landscapes as in
@szendro_predictability_2013 or @franke_evolutionary_2011 (see below).

Using as an example @Ochs2015 (we will see this example again in section
\@ref(ochsdesai), where we cover different ways of specifying fitness), we
could specify the fitness landscape and run simulations until fixation
(with argument fixation to oncoSimulPop ---see more details in section
\@ref(fixation) and \@ref(fixationG), again with this example). We would
then examine the proportion of genotypes fixed under different
scenarios. And we can extend this example by adding mutator genes:

{r hiddenochs, echo=FALSE}
set.seed(2)
RNGkind("L'Ecuyer-CMRG")


{r exochs}
## For reproducibility
set.seed(2)
RNGkind("L'Ecuyer-CMRG")

## Specify fitness effects.

## Numeric values arbitrary, but set the intermediate genotype en
## route to ui as mildly deleterious so there is a valley.

## As in Ochs and Desai, the ui and uv genotypes
## can never appear.

u <- 0.2; i <- -0.02; vi <- 0.6; ui <- uv <- -Inf

od <- allFitnessEffects(
epistasis = c("u" = u,  "u:i" = ui,
"u:v" = uv, "i" = i,
"v:-i" = -Inf, "v:i" = vi))

## For the sake of extending this example, also turn i into a
## mutator gene

odm <- allMutatorEffects(noIntGenes = c("i" = 50))

## How do mutation and fitness look like for each genotype?


Ochs and Desai explicitly say "Each simulated population was evolved
until either the uphill genotype or valley-crossing genotype fixed."
So we will use fixation.

{r exochsb}
## Set a small initSize, as o.w. unlikely to pass the valley
initS <- 10
## The number of replicates is tiny, 10, for the sake of speed
## of creation of the vignette
od_sim <- oncoSimulPop(10, od, muEF = odm,
fixation = c("u", "i, v"), initSize = initS,
model = "McFL",
mu = 1e-4, detectionDrivers = NA,
finalTime = NA,
detectionSize = NA, detectionProb = NA,
onlyCancer = TRUE,
seed = NULL) ## for reproducibility
## What is the frequency of each final genotype?
sampledGenotypes(samplePop(od_sim))


{r hidden-rng-exochs33, echo = FALSE}
## set.seed(NULL)


### Predictability of evolution in complex fitness landscapes {#ex-predict}

Focusing now on predictability in more general fitness landscapes,
we would run simulations under random fitness landscapes with varied
ruggedness, and would then examine the evolutionary predictability
of the trajectories with measures such as "Lines of Descent" and
"Path of the Maximum" [@szendro_predictability_2013] and the
diversity of the sampled genotypes under different sampling regimes (see
details in section \@ref(evolpredszend)).

{r hiddenrng0szen, echo=FALSE}
set.seed(7)
RNGkind("L'Ecuyer-CMRG")


<!-- FIXME: why can't I issue "Magellan_stats" now in the BioC repo? -->

{r exszendro}
## For reproducibility
set.seed(7)
RNGkind("L'Ecuyer-CMRG")

## Repeat the following loop for different combinations of whatever
## interests you, such as number of genes, or distribution of the
## c and sd (which affect how rugged the landscape is), or
## reference genotype, or evolutionary model, or stopping criterion,
## or sampling procedure, or ...

##  Generate a random fitness landscape, from the Rough Mount
##  Fuji model, with g genes, and c ("slope" constant) and
##  reference chosen randomly (reference is random by default and
##  thus not specified below). Require a minimal number of
##  accessible genotypes

g <- 6
c <- runif(1, 1/5, 5)
rl <- rfitness(g, c = c, min_accessible_genotypes = g)

## Plot it if you want; commented here as it takes long for a
## vignette

## plot(rl)

## Obtain landscape measures from MAGELLAN. Export to MAGELLAN and
## call your own copy of MAGELLAN's binary

## to_Magellan(rl, file = "rl1.txt") ## (Commented out here to avoid writing files)

## or use the binary copy provided with OncoSimulR

Magellan_stats(rl) ## (Commented out here to avoid writing files)

## Simulate evolution in that landscape many times (here just 10)
simulrl <- oncoSimulPop(10, allFitnessEffects(genotFitness = rl),
keepPhylog = TRUE, keepEvery = 1,
initSize = 4000,
seed = NULL, ## for reproducibility

## Obtain measures of evolutionary predictability
diversityLOD(LOD(simulrl))
diversityPOM(POM(simulrl))
sampledGenotypes(samplePop(simulrl, typeSample = "whole"))


{r hidden-rng-exszend, echo = FALSE}
## set.seed(NULL)


### Mutator and antimutator genes {#exmutantimut}

The effects of mutator and antimutator genes have been examined both
in cancer genetics [@nowak_evolutionary_2006;
@tomlinson_mutation_1996] and in evolutionary genetics
[@gerrish_complete_2007], and are related to wider issues such as
Muller's ratchet and the evolution of sex. There are, thus, a large
range of questions related to mutator and antimutator genes.

One question addressed in @tomlinson_mutation_1996 concerns under what
circumstances mutator genes are likely to play a role in cancer
progression. For instance, @tomlinson_mutation_1996 find that an increased
mutation rate is more likely to matter if the number of required mutations
in driver genes needed to reach cancer is large and if the mutator effect is
large.

We might want to ask, then, how long it takes before to reach cancer under
different scenarios. Time to reach cancer is stored in the component
FinalTime of the output. We would specify different numbers and effects
of mutator genes (argument muEF). We would also change the criteria for
reaching cancer and in our case we can easily do that by specifying
different numbers in detectionDrivers. Of course, we would also want to
examine the effects of varying numbers of mutators, drivers, and possibly
fitness consequences of mutators. Below we assume mutators are neutral and
we assume there are no additional genes with deleterious mutations, but
@tomlinson_mutation_1996; @gerrish_complete_2007; @McFarland2014].

Let us run an example. For the sake of simplicity, we assume no
epistatic interactions.

{r ex-tomlin1}
sd <- 0.1 ## fitness effect of drivers
sm <- 0 ## fitness effect of mutator
nd <- 20 ## number of drivers
nm <- 5  ## number of mutators
mut <- 10 ## mutator effect

fitnessGenesVector <- c(rep(sd, nd), rep(sm, nm))
names(fitnessGenesVector) <- 1:(nd + nm)
mutatorGenesVector <- rep(mut, nm)
names(mutatorGenesVector) <- (nd + 1):(nd + nm)

ft <- allFitnessEffects(noIntGenes = fitnessGenesVector,
drvNames = 1:nd)
mt <- allMutatorEffects(noIntGenes = mutatorGenesVector)



Now, simulate using the fitness and mutator specification. We fix
the number of drivers to cancer, and we stop when those numbers of
drivers are reached. Since we only care about the time it takes to
reach cancer, not the actual trajectories, we set keepEvery = NA:

{r hiddentom, echo=FALSE}
set.seed(2)
RNGkind("L'Ecuyer-CMRG")


{r ex-tomlin2}
## For reproducibility
set.seed(2)
RNGkind("L'Ecuyer-CMRG")

ddr <- 4
st <- oncoSimulPop(4, ft, muEF = mt,
detectionDrivers = ddr,
finalTime = NA,
detectionSize = NA,
detectionProb = NA,
onlyCancer = TRUE,
keepEvery = NA,
seed = NULL) ## for reproducibility

## How long did it take to reach cancer?
unlist(lapply(st, function(x) x$FinalTime))  {r hidden-rng-tom, echo = FALSE} ## set.seed(NULL)  (Incidentally, notice that it is easy to get OncoSimulR to throw an exception if you accidentally specify a huge mutation rate when all mutator genes are mutated: see section \@ref(tomlinexcept).) ### Epistatic interactions between drivers and passengers in cancer and the consequences of order effects {#exbauer} #### Epistatic interactions between drivers and passengers {#bauer0} @Bauer2014 have examined the effects of epistatic relationships between drivers and passengers in cancer initiation. We could use their model as a starting point, and examine how likely cancer is to develop under different variations of their model and different evolutionary scenarios (e.g., initial sample size, mutation rates, evolutionary model, etc). There are several ways to specify their model, as we discuss in section \@ref(bauer). We will use one based on DAGs here: {r exusagebau} K <- 4 sp <- 1e-5 sdp <- 0.015 sdplus <- 0.05 sdminus <- 0.1 cnt <- (1 + sdplus)/(1 + sdminus) prod_cnt <- cnt - 1 bauer <- data.frame(parent = c("Root", rep("D", K)), child = c("D", paste0("s", 1:K)), s = c(prod_cnt, rep(sdp, K)), sh = c(0, rep(sp, K)), typeDep = "MN") fbauer <- allFitnessEffects(bauer) (b1 <- evalAllGenotypes(fbauer, order = FALSE, addwt = TRUE)) ## How does the fitness landscape look like? plot(b1, use_ggrepel = TRUE) ## avoid overlapping labels  Now run simulations and examine how frequently the runs end up with population sizes larger than a pre-specified threshold; for instance, below we look at increasing population size 4x in the default maximum number of 2281 time periods (for real, you would of course increase the number of total populations, the range of initial population sizes, model, mutation rate, required population size or number of drivers, etc): {r hiddenbau, echo=FALSE} set.seed(2) RNGkind("L'Ecuyer-CMRG")  {r exusagebau2} ## For reproducibility set.seed(2) RNGkind("L'Ecuyer-CMRG") totalpops <- 5 initSize <- 100 sb1 <- oncoSimulPop(totalpops, fbauer, model = "Exp", initSize = initSize, onlyCancer = FALSE, mc.cores = 2, ## adapt to your hardware seed = NULL) ## for reproducibility ## What proportion of the simulations reach 4x initSize? sum(summary(sb1)[, "TotalPopSize"] > (4 * initSize))/totalpops  {r hidden-rng-exbau, echo = FALSE} ## set.seed(NULL)  Alternatively, to examine how long it takes to reach cancer for a pre-specified size, you could look at the value of FinalTime as we did above (section \@ref(exmutantimut)) after running simulations with onlyCancer = TRUE and detectionSize set to some reasonable value: {r hiddenbau22, echo=FALSE} set.seed(2) RNGkind("L'Ecuyer-CMRG")  {r hhhhbbbb22} totalpops <- 5 initSize <- 100 sb2 <- oncoSimulPop(totalpops, fbauer, model = "Exp", initSize = initSize, onlyCancer = TRUE, detectionSize = 10 * initSize, mc.cores = 2, ## adapt to your hardware seed = NULL) ## for reproducibility ## How long did it take to reach cancer? unlist(lapply(sb2, function(x) x$FinalTime))


{r hidden-rng-exbau22, echo = FALSE}
## set.seed(NULL)


#### Consequences of order effects for cancer initiation {#exorder1intro}

Instead of focusing on different models for epistatic interactions,
you might want to examine the consequences of order effects
[@Ortmann2015]. You would proceed as above, but using models that
differ by, say, the presence or absence of order effects. Details on
their specification are provided in section \@ref(oe). Here is one
particular model (you would, of course, want to compare this to
models without order effects or with other magnitudes and types of
order effects):

{r oex1intro}
## Order effects involving three genes.

## Genotype "D, M" has different fitness effects
## depending on whether M or D mutated first.
## Ditto for genotype "F, D, M".

## Meaning of specification: X > Y means
## that X is mutated before Y.

o3 <- allFitnessEffects(orderEffects = c(
"F > D > M" = -0.3,
"D > F > M" = 0.4,
"D > M > F" = 0.2,
"D > M"     = 0.1,
"M > D"     = 0.5))

## With the above specification, let's double check
## the fitness of the possible genotypes

(oeag <- evalAllGenotypes(o3, addwt = TRUE, order = TRUE))



Now, run simulations and examine how frequently the runs do not end
up in extinction. As above, for real, you would of course increase
the number of total populations, the range of initial population
sizes, mutation rate, etc:

{r hiddoef, echo=FALSE}
set.seed(2)
RNGkind("L'Ecuyer-CMRG")


{r exusageoe2}
## For reproducibility
set.seed(2)
RNGkind("L'Ecuyer-CMRG")

totalpops <- 5
soe1 <- oncoSimulPop(totalpops, o3, model = "Exp",
initSize = 500,
onlyCancer = FALSE,
seed = NULL) ## for reproducibility

## What proportion of the simulations do not end up extinct?
sum(summary(soe1)[, "TotalPopSize"] > 0)/totalpops



{r hidden-rng-exoef, echo = FALSE}
## set.seed(NULL)


As we just said, alternatively, to examine how long it takes to
reach cancer you could run simulations with onlyCancer = TRUE and
look at the value of FinalTime as we did above (section
\@ref(exmutantimut)).

### Simulating evolution with frequency-dependent fitness

The new frequency-dependent fitness funcionality allows users to run
simulations in a different way, defining fitness (birth rates) as
functions of clone's frequencies.  We can thus model
frequency-dependent selection, as well as predation and parasitism,
cooperation and mutualism, and commensalism. See section \@ref(fdf)
for further details and examples.

## Trade-offs and what is OncoSimulR not well suited for {#whatnotfor}

OncoSimulR is designed for complex fitness specifications and selection
scenarios and uses forward-time simulations; the types of questions where
OncoSimulR can be of help are discussed in sections \@ref(generalwhatfor)
and \@ref(whatfor) and running time and space consumption of OncoSimulR are
addressed in section \@ref(timings). You should be aware that **coalescent
simulations**, sometimes also called backward-time simulations, are much
more efficient for simulating neutral data as well as some special selection
scenarios [@Yuan2012; @Carvajal-Rodriguez2010; @Hoban2011].

In addition, since OncoSimulR allows you to specify fitness with
arbitrary epistatic and order effects, as well as mutator effects,
you need to learn the syntax of how to specify those effects and you
might be paying a performance penalty if your scenario does not
require this complexity. For instance, in the model of
@Beerenwinkel2007b, the fitness of a genotype depends only on the
total number of drivers mutated, but not on which drivers are
mutated (and, thus, not on the epistatic interactions nor the order
of accumulation of the drivers). This means that the syntax for
specifying that model could probably be a lot simpler
(e.g., specify $s$ per driver).

But it also means that code written for just that case could
probably run much faster. First, because fitness evaluation is
easier. Second, and possibly much more important, because what we
need to keep track of leads to much simpler and economic structures:
we do not need to keep track of clones (where two cells are regarded
as different clones if they differ anywhere in their genotype), but
only of clone types or clone classes as defined by the number of
mutated drivers, and keeping track of clones can be expensive ---see
sections \@ref(timings) and \@ref(trackindivs).

So for those cases where you do not need the full flexibility of OncoSimulR,
special purpose software might be easier to use and faster to run. Of
course, for some types of problems this special purpose software might not
be available, though.

## Steps for using OncoSimulR {#steps}

Using this package will often involve the following steps:

1. Specify fitness effects: sections \@ref(specfit) and \@ref(litex).

2. Simulate cancer progression: section \@ref(simul). You can
simulate for a single individual or subject or for a set of
subjects. You will need to:

- Decide on a model. This basically amounts to choosing a model with
exponential growth ("Exp" or "Bozic") or a model with carrying capacity
("McFL"). If exponential growth, you can choose whether the the effects
of mutations operate on the death rate ("Bozic") or the birth rate
("Exp")[^1].

- Specify other parameters of the simulation. In particular, decide
when to stop the simulation, mutation rates, etc.

Of course, at least for initial playing around, you can use the
defaults.

3. Sample from the simulated data and do something with those
simulated data (e.g., fit an OT model to them, examine diversity
or time until cancer, etc). Most of what you do with the data,
however, is outside the scope of this package and this vignette.

[^1]:It is of course possible to do this with the carrying capacity (or
gompertz-like) models, but there probably is little reason to do
it. @McFarland2013 discuss this has little effect on their results,
for example. In addition, decreasing the death rate will more easily
lead to numerical problems as shown in section \@ref(ex-0-death).

Before anything else, let us load the package in case it was not yet
loaded. We also explicitly load r Biocpkg("graph") and
r CRANpkg("igraph") for the vignette to work (you do not need that
for your usual interactive work). And I set the default color for
vertices in igraph.

{r, results="hide",message=FALSE, echo=TRUE, include=TRUE}
library(OncoSimulR)
library(graph)
library(igraph)
igraph_options(vertex.color = "SkyBlue2")


{r, echo=FALSE, results='hide'}
options(width = 68)


To be explicit, what version are we running?
{r}
packageVersion("OncoSimulR")


## Two quick examples of fitness specifications {#quickexample}

Following \@ref(steps) we will run two very minimal examples. First a
model with a few genes and **epistasis**:

{r, fig.width=6.5, fig.height=10}
## 1. Fitness effects: here we specify an
##    epistatic model with modules.
sa <- 0.1
sb <- -0.2
sab <- 0.25
sac <- -0.1
sbc <- 0.25
sv2 <- allFitnessEffects(epistasis = c("-A : B" = sb,
"A : -B" = sa,
"A : C" = sac,
"A:B" = sab,
"-A:B:C" = sbc),
geneToModule = c(
"A" = "a1, a2",
"B" = "b",
"C" = "c"),
drvNames = c("a1", "a2", "b", "c"))

## 2. Simulate the data. Here we use the "McFL" model and set
##    explicitly parameters for mutation rate, initial size, size
##    of the population that will end the simulations, etc

RNGkind("Mersenne-Twister")
set.seed(983)
ep1 <- oncoSimulIndiv(sv2, model = "McFL",
mu = 5e-6,
sampleEvery = 0.025,
keepEvery = 0.5,
initSize = 2000,
finalTime = 3000,
onlyCancer = FALSE)


{r iep1x1,fig.width=6.5, fig.height=4.5, fig.cap="Plot of drivers of an epistasis simulation."}
## 3. We will not analyze those data any further. We will only plot
## them.  For the sake of a small plot, we thin the data.
plot(ep1, show = "drivers", xlim = c(0, 1500),
thinData = TRUE, thinData.keep = 0.5)


As a second example, we will use a model where we specify
**restrictions in the order of accumulation of mutations using a
DAG** with the
pancreatic cancer poset in @Gerstung2011 (see more
details in section \@ref(pancreas)):

{r fepancr1, fig.width=5}
## 1. Fitness effects:
pancr <- allFitnessEffects(
data.frame(parent = c("Root", rep("KRAS", 4),
"TP53", "TP53", "MLL3"),
"TP53", "MLL3",
rep("PXDN", 3), rep("TGFBR2", 2)),
s = 0.1,
sh = -0.9,
typeDep = "MN"),
drvNames = c("KRAS", "SMAD4", "CDNK2A", "TP53",
"MLL3", "TGFBR2", "PXDN"))


{r figfpancr1, fig.width=5, fig.cap="Plot of DAG corresponding to fitnessEffects object."}
## Plot the DAG of the fitnessEffects object
plot(pancr)


{r}
## 2. Simulate from it. We change several possible options.

set.seed(4) ## Fix the seed, so we can repeat it
ep2 <- oncoSimulIndiv(pancr, model = "McFL",
mu = 1e-6,
sampleEvery = 0.02,
keepEvery = 1,
initSize = 1000,
finalTime = 10000,
onlyCancer = FALSE)


{r iep2x2, fig.width=6.5, fig.height=5, fig.cap= "Plot of genotypes of a simulation from a DAG."}
## 3. What genotypes and drivers we get? And play with limits
##    to show only parts of the data. We also aggressively thin
##    the data.
par(cex = 0.7)
plot(ep2, show = "genotypes", xlim = c(1000, 8000),
ylim = c(0, 2400),
thinData = TRUE, thinData.keep = 0.03)


The rest of this vignette explores all of those functions and arguments in
much more detail.

## Citing OncoSimulR and other documentation {#citing}

In R, you can do
{r}
citation("OncoSimulR")

which will tell you how to cite the package. Please, do cite the
Bionformatics paper if you use the package in publications.

This is the URL for the Bioinformatics paper: [https://doi.org/10.1093/bioinformatics/btx077](https://doi.org/10.1093/bioinformatics/btx077)
(there is also an early preprint
at [bioRxiv](http://biorxiv.org/content/early/2016/08/14/069500),
but it should now point to the Bioinformatics paper).

<https://rdiaz02.github.io/OncoSimul/pdfs/OncoSimulR.pdf>.  And an
HTML version from
<https://rdiaz02.github.io/OncoSimul/OncoSimulR.html>. These files
should correspond to the most recent, GitHub version, of the package
(i.e., they might include changes not yet available from the
BioConductor package). Beware that the PDF might have figures
and R code that do not fit on the page, etc.

## Testing, code coverage, and other examples {#codecover}

OncoSimulR includes more than 2000 tests that are run at every check
cycle. These tests provide a code coverage of more than 90%
including both the C++ and R code. Another set of over 500
long-running (several hours) tests can be run on demand (see
directory '/tests/manual'). In addition to serving as test cases,
some of that code also provides further examples of usage.

## Versions {#versions}

In this vignette and the documentation I often refer to version 1 (v.1) and
version 2 of OncoSimulR. Version 1 is the version available up to, and
including, BioConductor v. 3.1. Version 2 of OncoSimulR is available
starting from BioConductor 3.2 (and, of course, available too from
development versions of BioC).  So, if you are using the current stable or
development version of BioConductor, or you grab the sources from GitHub
(<https://github.com/rdiaz02/OncoSimul>) you are using what we call
version 2. Please note that **the functionality of version 1 will soon be removed.**

\clearpage

# Running time and space consumption of OncoSimulR {#timings}

Time to complete the simulations and size of returned objects (space
consumption) depend on several, interacting factors. The usual rule
of "experiment before launching a large number of simulations"
applies, but here we will walk through several cases to get a
feeling for the major factors that affect speed and size. Many of
the comments on this section need to use ideas discussed in other
places of this document; if you read this section first, you might
want to come back after reading the relevant parts.

Speed will depend on:

* The evolutionary model.
* The granularity of how often you keep data (keepEvery
argument). Note that the default, which is to keep as often as you
sample (so that we preserve all history) can lead to slow execution
times.
* The mutation rate, because higher mutation rates lead to more
clones, and more clones means we need to iterate over, well, more clones,
and keep larger data structures.
* The fitness specification: more complex fitness specifications tend
to be slightly slower but specially different fitness specifications can
have radically different effects on the evolutionary trajectories,
accessibility of fast growing genotypes and, generally, the evolutionary dynamics.
* The stopping conditions (detectionProb, detectionDrivers,
detectionSize arguments) and whether or not simulations are run until
cancer is reached (onlyCancer argument).
* Most of the above factors can interact in complex ways.

Size of returned objects will depend on:

* Any factor that affects the number of clones tracked/returned, in
particular: initial sizes and stopping conditions, mutation rate,
and how often you keep data (the keepEvery argument can make a
huge difference here).
* Whether or not you keep the complete genealogy of clones (this affects
slightly the size of returned object, not speed).

In the sections that follow, we go over several cases to understand
some of the main settings that affect running time (or execution
time) and space consumption (the size of returned objects). It
should be understood, however, that many of the examples shown below
do not represent typical use cases of OncoSimulR and are used only
to identify what and how affects running time and space
consumption. As we will see in most examples in this vignette,
typical use cases of OncoSimulR involve hundreds to thousands of
genes on population sizes up to $10^5$ to $10^7$.

Note that most of the code in this section is not executed during the
building of the vignette to keep vignette build time reasonable and prevent
using huge amounts of RAM. All of the code, ready to be sourced and run, is
available from the 'inst/miscell' directory (and the summary output from
some of the benchmarks is available from the
'miscell-files/vignette_bench_Rout' directory of the main OncoSimul
repository at https://github.com/rdiaz02/OncoSimul).

{r colnames_benchmarks, echo = FALSE, eval = TRUE}

data(benchmark_1)
data(benchmark_1_0.05)
data(benchmark_2)
data(benchmark_3)

colnames(benchmark_1)[
match(c(
"time_per_simul",
"size_mb_per_simul", "NumClones.Median", "NumIter.Median",
"FinalTime.Median", "TotalPopSize.Median", "TotalPopSize.Mean",
"TotalPopSize.Max.", "keepEvery",  "Attempts.Median",
"Attempts.Mean", "Attempts.Max.",
"PDBaseline", "n2", "onlyCancer"),
colnames(benchmark_1)
)] <- c("Elapsed Time, average per simulation (s)",
"Object Size, average per simulation (MB)",
"Number of Clones, median",
"Number of Iterations, median",
"Final Time, median",
"Total Population Size, median",
"Total Population Size, mean",
"Total Population Size, max.",
"keepEvery",
"Attempts until Cancer, median",
"Attempts until Cancer, mean",
"Attempts until Cancer, max.",
"PDBaseline", "n2", "onlyCancer"
)

colnames(benchmark_1_0.05)[
match(c("time_per_simul",
"size_mb_per_simul", "NumClones.Median", "NumIter.Median",
"FinalTime.Median", "TotalPopSize.Median", "TotalPopSize.Mean",
"TotalPopSize.Max.",
"keepEvery",
"PDBaseline", "n2", "onlyCancer", "Attempts.Median"),
colnames(benchmark_1_0.05))] <- c("Elapsed Time, average per simulation (s)",
"Object Size, average per simulation (MB)",
"Number of Clones, median",
"Number of Iterations, median",
"Final Time, median",
"Total Population Size, median",
"Total Population Size, mean",
"Total Population Size, max.",
"keepEvery",
"PDBaseline", "n2", "onlyCancer",
"Attempts until Cancer, median"
)

colnames(benchmark_2)[match(c("Model", "fitness", "time_per_simul",
"size_mb_per_simul", "NumClones.Median", "NumIter.Median",
"FinalTime.Median", "TotalPopSize.Median", "TotalPopSize.Mean",
"TotalPopSize.Max."), colnames(benchmark_2))] <-  c("Model",
"Fitness",
"Elapsed Time, average per simulation (s)",
"Object Size, average per simulation (MB)",
"Number of Clones, median",
"Number of Iterations, median",
"Final Time, median",
"Total Population Size, median",
"Total Population Size, mean",
"Total Population Size, max."
)

colnames(benchmark_3)[match(c("Model", "fitness", "time_per_simul",
"size_mb_per_simul", "NumClones.Median", "NumIter.Median",
"FinalTime.Median", "TotalPopSize.Median", "TotalPopSize.Mean",
"TotalPopSize.Max."), colnames(benchmark_3))] <-  c("Model",
"Fitness",
"Elapsed Time, average per simulation (s)",
"Object Size, average per simulation (MB)",
"Number of Clones, median",
"Number of Iterations, median",
"Final Time, median",
"Total Population Size, median",
"Total Population Size, mean",
"Total Population Size, max."
)


## Exp and McFL with "detectionProb" and pancreas example {#bench1}

To get familiar with some of they factors that affect time and size,
we will use the fitness specification from section
\@ref(quickexample), with the detectionProb stopping mechanism
(see \@ref(detectprob)).  We will use the two main growth models
(exponential and McFarland). Each model will be run with two
settings of keepEvery. With keepEvery = 1 (runs exp1 and
mc1), population samples are stored at time intervals of 1 (even
if most of the clones in those samples later become extinct). With
keepEvery = NA (runs exp2 and mc2) no intermediate population
samples are stored, so clones that become extinct at any sampling
period are pruned and only the existing clones at the end of the
simulation are returned (see details in \@ref(prune)).

Will run r unique(benchmark_1Numindiv) simulations. The results I show are for a laptop with an 8-core Intel Xeon E3-1505M CPU, running Debian GNU/Linux (the results from these benchmarks are available as data(benchmark_1)). {r timing1, eval=FALSE} ## Specify fitness pancr <- allFitnessEffects( data.frame(parent = c("Root", rep("KRAS", 4), "SMAD4", "CDNK2A", "TP53", "TP53", "MLL3"), child = c("KRAS","SMAD4", "CDNK2A", "TP53", "MLL3", rep("PXDN", 3), rep("TGFBR2", 2)), s = 0.1, sh = -0.9, typeDep = "MN"), drvNames = c("KRAS", "SMAD4", "CDNK2A", "TP53", "MLL3", "TGFBR2", "PXDN")) Nindiv <- 100 ## Number of simulations run. ## Increase this number to decrease sampling variation ## keepEvery = 1 t_exp1 <- system.time( exp1 <- oncoSimulPop(Nindiv, pancr, detectionProb = "default", detectionSize = NA, detectionDrivers = NA, finalTime = NA, keepEvery = 1, model = "Exp", mc.cores = 1))["elapsed"]/Nindiv t_mc1 <- system.time( mc1 <- oncoSimulPop(Nindiv, pancr, detectionProb = "default", detectionSize = NA, detectionDrivers = NA, finalTime = NA, keepEvery = 1, model = "McFL", mc.cores = 1))["elapsed"]/Nindiv ## keepEvery = NA t_exp2 <- system.time( exp2 <- oncoSimulPop(Nindiv, pancr, detectionProb = "default", detectionSize = NA, detectionDrivers = NA, finalTime = NA, keepEvery = NA, model = "Exp", mc.cores = 1))["elapsed"]/Nindiv t_mc2 <- system.time( mc2 <- oncoSimulPop(Nindiv, pancr, detectionProb = "default", detectionSize = NA, detectionDrivers = NA, finalTime = NA, keepEvery = NA, model = "McFL", mc.cores = 1))["elapsed"]/Nindiv  We can obtain times, sizes of objects, and summaries of numbers of clones, iterations, and final times doing, for instance:  {r, eval=FALSE} cat("\n\n\n t_exp1 = ", t_exp1, "\n") object.size(exp1)/(Nindiv * 1024^2) cat("\n\n") summary(unlist(lapply(exp1, "[[", "NumClones"))) summary(unlist(lapply(exp1, "[[", "NumIter"))) summary(unlist(lapply(exp1, "[[", "FinalTime"))) summary(unlist(lapply(exp1, "[[", "TotalPopSize")))  The above runs yield the following: \blandscape Table: (\#tab:bench1) Benchmarks of Exp and McFL models using the default detectionProb with two settings of keepEvery. {r bench1, eval=TRUE, echo = FALSE} panderOptions('table.split.table', 99999999) panderOptions('table.split.cells', 900) ## For HTML ## panderOptions('table.split.cells', 8) ## For PDF set.alignment('right') panderOptions('round', 2) panderOptions('big.mark', ',') panderOptions('digits', 2) pander(benchmark_1[1:4, c("Elapsed Time, average per simulation (s)", "Object Size, average per simulation (MB)", "Number of Clones, median", "Number of Iterations, median", "Final Time, median", "Total Population Size, median", "Total Population Size, max.", "keepEvery")], justify = c('left', rep('right', 8)), ## o.w. hlines not right ## caption = "\\label{tab:bench1}Benchmarks of Exp and McFL models using the default detectionProb with two settings of keepEvery." )  \elandscape \clearpage The above table shows that a naive comparison (looking simply at execution time) might conclude that the McFL model is much, much slower than the Exp model. But that is not the complete story: using the detectionProb stopping mechanism (see \@ref(detectprob)) will lead to stopping the simulations very quickly in the exponential model because as soon as a clone with fitness>1appears it starts growing exponentially. In fact, we can see that the number of iterations and the final time are much smaller in the Exp than in the McFL model. We will elaborate on this point below (section \@ref(common1)), when we discuss the setting for checkSizePEvery (here left at its default value of 20): checking the exiting condition more often (smaller checkSizePEvery) would probably be justified here (notice also the very large final times) and would lead to a sharp decrease in number of iterations and, thus, running time. This table also shows that the keepEvery = NA setting, which was in effect in simulations exp2 and mc2, can make a difference especially for the McFL models, as seen by the median number of clones and the size of the returned object. Models exp2 and mc2 do not store any intermediate population samples so clones that become extinct at any sampling period are pruned and only the existing clones at the end of the simulation are returned. In contrast, models exp1 and mc1 store population samples at time intervals of 1 (keepEvery = 1), even if many of those clones eventually become extinct. We will return to this issue below as execution time and object size depend strongly on the number of clones tracked. We can run the exponential model again modifying the arguments of the detectionProb mechanism; in two of the models below (exp3 and exp4) no detection can take place unless populations are at least 100 times larger than the initial population size, and probability of detection is 0.1 with a population size 1,000 times larger than the initial one (PDBaseline = 5e4, n2 = 5e5). In the other two models (exp5 and exp6), no detection can take place unless populations are at least 1,000 times larger than the initial population size, and probability of detection is 0.1 with a population size 100,000 times larger than the initial one (PDBaseline = 5e5, n2 = 5e7)[^rva]. In runs exp3 and exp5 we set keepEvery = 1 and in runs exp4 and exp6 we set keepEvery = NA. [^rva]:Again, these are not necessarily reasonable or common settings. We are using them to understand what and how affects running time and space consumption. {r timing2, eval = FALSE} t_exp3 <- system.time( exp3 <- oncoSimulPop(Nindiv, pancr, detectionProb = c(PDBaseline = 5e4, p2 = 0.1, n2 = 5e5, checkSizePEvery = 20), detectionSize = NA, detectionDrivers = NA, finalTime = NA, keepEvery = 1, model = "Exp", mc.cores = 1))["elapsed"]/Nindiv t_exp4 <- system.time( exp4 <- oncoSimulPop(Nindiv, pancr, detectionProb = c(PDBaseline = 5e4, p2 = 0.1, n2 = 5e5, checkSizePEvery = 20), detectionSize = NA, detectionDrivers = NA, finalTime = NA, keepEvery = NA, model = "Exp", mc.cores = 1))["elapsed"]/Nindiv t_exp5 <- system.time( exp5 <- oncoSimulPop(Nindiv, pancr, detectionProb = c(PDBaseline = 5e5, p2 = 0.1, n2 = 5e7), detectionSize = NA, detectionDrivers = NA, finalTime = NA, keepEvery = 1, model = "Exp", mc.cores = 1))["elapsed"]/Nindiv t_exp6 <- system.time( exp6 <- oncoSimulPop(Nindiv, pancr, detectionProb = c(PDBaseline = 5e5, p2 = 0.1, n2 = 5e7), detectionSize = NA, detectionDrivers = NA, finalTime = NA, keepEvery = NA, model = "Exp", mc.cores = 1))["elapsed"]/Nindiv  \blandscape Table: (\#tab:bench1b) Benchmarks of Exp models modifying the default detectionProb with two settings of keepEvery. {r bench1b, eval=TRUE, echo = FALSE} panderOptions('table.split.table', 99999999) panderOptions('table.split.cells', 900) ## For HTML ## panderOptions('table.split.cells', 8) ## For PDF set.alignment('right') panderOptions('round', 2) panderOptions('big.mark', ',') panderOptions('digits', 2) pander(benchmark_1[5:8, c("Elapsed Time, average per simulation (s)", "Object Size, average per simulation (MB)", "Number of Clones, median", "Number of Iterations, median", "Final Time, median", "Total Population Size, median", "Total Population Size, max.", "keepEvery", "PDBaseline", "n2")], justify = c('left', rep('right', 10)), ## o.w. hlines not right ## round = c(rep(2, 3), rep(0, 7)), ## digits = c(rep(2, 3), rep(1, 7)), ## caption = "\\label{tab:bench1b}Benchmarks of Exp and McFL models modifying the default detectionProb with two settings of keepEvery." )  \elandscape \clearpage As above, keepEvery = NA (in exp4 and exp6) leads to much smaller object sizes and slightly smaller numbers of clones and execution times. Changing the exiting conditions (by changing detectionProb arguments) leads to large increases in number of iterations (in this case by factors of about 15x to 25x) and a corresponding increase in execution time as well as much larger population sizes (in some cases>10^{10}$). In some of the runs of exp5 and exp6 we get the (recoverable) exception message from the C++ code: Recoverable exception ti set to DBL_MIN. Rerunning, which is related to those simulations reaching total population sizes$>10^{10}$; we return to this below (section \@ref(popgtzx)). You might also wonder why total and median population sizes are so large in these two runs, given the exiting conditions. One of the reasons is that we are using the default checkSizePEvery = 20, so the interval between successive checks of the exiting condition is large; this is discussed at greater length in section \@ref(common1). All the runs above used the default value onlyCancer = TRUE. This means that simulations will be repeated until the exiting conditions are reached (see details in section \@ref(endsimul)) and, therefore, any simulation that ends up in extinction will be repeated. This setting can thus have a large effect on the exponential models, because when the initial population size is not very large and we start from the wildtype, it is not uncommon for simulations to become extinct (when birth and death rates are equal and the population size is small, it is easy to reach extinction before a mutation in a gene that increases fitness occurs). But this is rarely the case in the McFarland model (unless we use really tiny initial population sizes) because of the dependency of death rate on total population size (see section \@ref(mcfl)). The number of attempts until cancer was reached in the above models is shown in Table \@ref(tab:bench1c) (the values can be obtained from any of the above runs doing, for instance, median(unlist(lapply(exp1, function(x) x$otherattemptsUsed))) ): Table: (\#tab:bench1c) Number of attempts until cancer. {r bench1c, eval=TRUE, echo = FALSE} panderOptions('table.split.table', 99999999) panderOptions('table.split.cells', 900) ## For HTML ## panderOptions('table.split.cells', 12) ## For PDF set.alignment('right') panderOptions('round', 2) panderOptions('big.mark', ',') panderOptions('digits', 2) pander(benchmark_1[1:8, c( "Attempts until Cancer, median", "Attempts until Cancer, mean", "Attempts until Cancer, max.", "PDBaseline", "n2")], justify = c('left', rep('right', 5)), ## o.w. hlines not right ## round = c(rep(2, 3), rep(0, 7)), ## digits = c(rep(2, 3), rep(1, 7)), ## caption = "\\label{tab:bench1c}Number of attempts until cancer." ) ## ## data(benchmark_1) ## knitr::kable(benchmark_1[1:8, c("Attempts.Median", ## "PDBaseline", "n2"), drop = FALSE], ## booktabs = TRUE, ## row.names = TRUE, ## col.names = c("Attempts until cancer", "PDBaseline", "n2"), ## caption = "Median number of attempts until cancer.", ## align = "r")  The McFL models finish in a single attempt. The exponential model simulations where we can exit with small population sizes (exp1, exp2) need many fewer attempts to reach cancer than those where large population sizes are required (exp3 to exp6). There is no relevant different among those last four, which is what we would expect: a population that has already reached a size of 50,000 cells from an initial population size of 500 is obviously a growing population where there is at least one mutant with positive fitness; thus, it unlikely to go extinct and therefore having to grow up to at least 500,000 will not significantly increase the risk of extinction. We will now rerun all of the above models with argument onlyCancer = FALSE. The results are shown in Table \@ref(tab:timing3) (note that the differences between this table and Table \@ref(tab:bench1) for the McFL models are due only to sampling variation). \bslandscape Table: (\#tab:timing3) Benchmarks of models in Table \@ref(tab:bench1) and \@ref(tab:bench1b) when run with onlyCancer = FALSE {r bench1d, eval=TRUE, echo = FALSE} panderOptions('table.split.table', 99999999) panderOptions('table.split.cells', 900) ## For HTML ## panderOptions('table.split.cells', 8) ## For PDF panderOptions('table.split.cells', 15) ## does not fit otherwise set.alignment('right') panderOptions('round', 3) pander(benchmark_1[9:16, c("Elapsed Time, average per simulation (s)", "Object Size, average per simulation (MB)", "Number of Clones, median", "Number of Iterations, median", "Final Time, median", "Total Population Size, median", "Total Population Size, mean", "Total Population Size, max.", "keepEvery", "PDBaseline", "n2")], justify = c('left', rep('right', 11)), ## o.w. hlines not right ## caption = "\\label{tab:timing3} Benchmarks of models in Table \\@ref(tab:bench1) and \\@ref(tab:bench1b) when run with onlyCancer = FALSE." )  \eslandscape \clearpage Now most simulations under the exponential model end up in extinction, as seen by the median population size of 0 (but not all, as the mean and max. population size are clearly away from zero). Consequently, simulations under the exponential model are now faster (and the size of the average returned object is smaller). Of course, whether one should run simulations with onlyCancer = TRUE or onlyCancer = FALSE will depend on the question being asked (see, for example, section \@ref(exbauer) for a question where we will naturally want to use onlyCancer = FALSE). To make it easier to compare results with those of the next section, Table \@ref(tab:allr1bck) shows all the runs so far. \bslandscape Table: (\#tab:allr1bck) Benchmarks of all models in Tables \@ref(tab:bench1), \@ref(tab:bench1b), and \@ref(tab:timing3). {r bench1dx0, eval=TRUE, echo = FALSE} panderOptions('table.split.table', 99999999) ## panderOptions('table.split.cells', 900) ## For HTML panderOptions('table.split.cells', 19) set.alignment('right') panderOptions('round', 3) pander(benchmark_1[ , c("Elapsed Time, average per simulation (s)", "Object Size, average per simulation (MB)", "Number of Clones, median", "Number of Iterations, median", "Final Time, median", "Total Population Size, median", "Total Population Size, mean", "Total Population Size, max.", "keepEvery", "PDBaseline", "n2", "onlyCancer")], justify = c('left', rep('right', 12)), ## o.w. hlines not right ## caption = "\\label{tab:allr1bck}Benchmarks of all models in Tables \\@ref(tab:bench1), \\@ref(tab:bench1b), and \\@ref(tab:timing3)." )  \eslandscape \clearpage ### Changing fitness:s=0.1$and$s=0.05${#bench1xf} In the above fitness specification the fitness effect of each gene (when its restrictions are satisfied) is$s = 0.1$(see section \@ref(numfit) for details). Here we rerun all the above benchmarks using$s= 0.05$(the results from these benchmarks are available as data(benchmark_1_0.05)) and results are shown below in Table \@ref(tab:timing3xf). \bslandscape Table: (\#tab:timing3xf) Benchmarks of all models in Table \@ref(tab:allr1bck) using$s=0.05$(instead of$s=0.1). {r bench1dx, eval=TRUE, echo = FALSE} ## data(benchmark_1_0.05) ## knitr::kable(benchmark_1_0.05[, c("time_per_simul", ## "size_mb_per_simul", "NumClones.Median", "NumIter.Median", ## "FinalTime.Median", "TotalPopSize.Median", "TotalPopSize.Mean", ## "TotalPopSize.Max.", ## "keepEvery", ## "PDBaseline", "n2", "onlyCancer")], ## booktabs = TRUE, ## col.names = c("Elapsed Time, average per simulation (s)", ## "Object Size, average per simulation (MB)", ## "Number of Clones, median", ## "Number of Iterations, median", ## "Final Time, median", ## "Total Population Size, median", ## "Total Population Size, mean", ## "Total Population Size, max.", ## "keepEvery", ## "PDBaseline", "n2", "onlyCancer" ## ), ## ## caption = "Benchmarks of models in Table \@ref(tab:bench1) and ## ## \@ref(tab:bench1b) when run with onlyCancer = FALSE", ## align = "c") panderOptions('table.split.table', 99999999) ## panderOptions('table.split.cells', 900) ## For HTML panderOptions('table.split.cells', 19) set.alignment('right') panderOptions('round', 3) pander(benchmark_1_0.05[ , c("Elapsed Time, average per simulation (s)", "Object Size, average per simulation (MB)", "Number of Clones, median", "Number of Iterations, median", "Final Time, median", "Total Population Size, median", "Total Population Size, mean", "Total Population Size, max.", "keepEvery", "PDBaseline", "n2", "onlyCancer")], justify = c('left', rep('right', 12)), ## o.w. hlines not right ## caption = "\\label{tab:timing3xf}Benchmarks of all models in Table \\@ref(tab:allr1bck) usings=0.05$(instead of$s=0.1$)." )  \eslandscape \clearpage As expected, having a smaller$s$leads to slower processes in most cases, since it takes longer to reach the exiting conditions sooner. Particularly noticeable are the runs for the McFL models (notice the increases in population size and number of iterations ---see also below). That is not the case, however, for exp5 and exp6 (and exp5_noc and exp6_noc). When running with$s=0.05$the simulations exit at a later time (see column "Final Time") but they exit with smaller population sizes. Here we have an interaction between sampling frequency, speed of growth of the population, mutation events and number of clones. In populations that grow much faster mutation events will happen more often (which will trigger further iterations of the algorithm); in addition, more new clones will be created, even if they only exist for short times and become extinct by the following sampling period (so they are not reflected in the pops.by.time matrix). These differences are proportionally larger the larger the rate of growth of the population. Thus, they are larger between, say, the exp5 at$s=0.1$and$s=0.05$than between the exp4 at the two different$s$: the exp5 exit conditions can only be satisfied at much larger population sizes so at populations sizes when growth is much faster (recall we are dealing with exponential growth). Recall also that with the default settings in detectionProb, we assess the exiting condition every 20 time periods (argument checkSizePEvery); this means that for fast growing populations, the increase in population size between successive checks of the exit conditions will be much larger (this phenomenon is also discussed in section \@ref(common1)). Thus, what is happening in the exp5 and exp6 with$s=0.1$is that close to the time the exit conditions could be satisfied, they are growing very fast, accumulating mutants, and incurring in additional iterations. They exit sooner in terms of time periods, but they do much more work before arriving there. The setting of checkSizePEvery is also having a huge effect on the McFL model simulations (the number of iterations is$>10^6$). Even more than in the previous section, checking the exiting condition more often (smaller checkSizePEvery) would probably be justified here (notice also the very large final times) and would lead to a sharp decrease in number of iterations and, thus, running time. The moral here is that in complex simulations like this (and most simulations are complex), the effects of some parameters ($s$in this case) might look counter-intuitive at first. Thus the need to "experiment before launching a large number of simulations". ## Several "common use cases" runs {#benchusual} Let us now execute some simulations under more usual conditions. We will use seven different fitness specifications: the pancreas example, two random fitness landscapes, and four sets of independent genes (200 to 4000 genes) with fitness effects randomly drawn from exponential distributions: {r fitusualb, echo = TRUE, eval = FALSE} pancr <- allFitnessEffects( data.frame(parent = c("Root", rep("KRAS", 4), "SMAD4", "CDNK2A", "TP53", "TP53", "MLL3"), child = c("KRAS","SMAD4", "CDNK2A", "TP53", "MLL3", rep("PXDN", 3), rep("TGFBR2", 2)), s = 0.1, sh = -0.9, typeDep = "MN"), drvNames = c("KRAS", "SMAD4", "CDNK2A", "TP53", "MLL3", "TGFBR2", "PXDN")) ## Random fitness landscape with 6 genes ## At least 50 accessible genotypes rfl6 <- rfitness(6, min_accessible_genotypes = 50) attributes(rfl6)$accessible_genotypes ## How many accessible
rf6 <- allFitnessEffects(genotFitness = rfl6)

## Random fitness landscape with 12 genes
## At least 200 accessible genotypes
rfl12 <- rfitness(12, min_accessible_genotypes = 200)
attributes(rfl12)$accessible_genotypes ## How many accessible rf12 <- allFitnessEffects(genotFitness = rfl12) ## Independent genes; positive fitness from exponential distribution ## with mean around 0.1, and negative from exponential with mean ## around -0.02. Half of genes positive fitness effects, half ## negative. ng <- 200 re_200 <- allFitnessEffects(noIntGenes = c(rexp(ng/2, 10), -rexp(ng/2, 50))) ng <- 500 re_500 <- allFitnessEffects(noIntGenes = c(rexp(ng/2, 10), -rexp(ng/2, 50))) ng <- 2000 re_2000 <- allFitnessEffects(noIntGenes = c(rexp(ng/2, 10), -rexp(ng/2, 50))) ng <- 4000 re_4000 <- allFitnessEffects(noIntGenes = c(rexp(ng/2, 10), -rexp(ng/2, 50)))  ### Common use cases, set 1. {#common1} We will use the Exp and the McFL models, run with different parameters. The script is provided as 'benchmark_2.R', under '/inst/miscell', with output in the 'miscell-files/vignette_bench_Rout' directory of the main OncoSimul repository at https://github.com/rdiaz02/OncoSimul. The data are available as data(benchmark_2). For the Exp model the call will be {r exp-usual-r, eval = FALSE, echo = TRUE} oncoSimulPop(Nindiv, fitness, detectionProb = NA, detectionSize = 1e6, initSize = 500, detectionDrivers = NA, keepPhylog = TRUE, model = "Exp", errorHitWallTime = FALSE, errorHitMaxTries = FALSE, finalTime = 5000, onlyCancer = FALSE, mc.cores = 1, sampleEvery = 0.5, keepEvery = 1)  And for McFL: {r mc-usual-r, eval = FALSE, echo = TRUE} initSize <- 1000 oncoSimulPop(Nindiv, fitness, detectionProb = c( PDBaseline = 1.4 * initSize, n2 = 2 * initSize, p2 = 0.1, checkSizePEvery = 4), initSize = initSize, detectionSize = NA, detectionDrivers = NA, keepPhylog = TRUE, model = "McFL", errorHitWallTime = FALSE, errorHitMaxTries = FALSE, finalTime = 5000, max.wall.time = 10, onlyCancer = FALSE, mc.cores = 1, keepEvery = 1)  For the exponential model we will stop simulations when populations have$>10^6$cells (simulations start from 500 cells). For the McFarland model we will use the detectionProb mechanism (see section \@ref(detectprob) for details); we could have used as stopping mechanism detectionSize = 2 * initSize (which would be basically equivalent to reaching cancer, as argued in [@McFarland2013]) but we want to provide further examples under the detectionProb mechanism. We will start from 1000 cells, not 500 (starting from 1000 we almost always reach cancer in a single run). Why not use the detectionProb mechanism with the Exp models? Because it can be hard to intuitively understand what are reasonable settings for the parameters of the detectionProb mechanism when used in a population that is growing exponentially, especially if different genes have very different effects on fitness. Moreover, we are using fitness specifications that are very different (compare the fitness landscape of six genes, the pancreas specification, and the fitness specification with 4000 genes with fitness effects drawn from an exponential distribution ---re_4000). In contrast, the detectionProb mechanism might be simpler to reason about in a population that is growing under a model of carrying capacity with possibly large periods of stasis. Let us emphasize that it is not that the detectionProb mechanism does not make sense with the Exp model; it is simply that the parameters might need finer adjustment for them to make sense, and in these benchmarks we are dealing with widely different fitness specifications. Note also that we specify checkSizePEvery = 4 (instead of the default, which is 20). Why? Because the fitness specifications where fitness effects are drawn from exponential distributions (re_200 to re_4000 above) include many genes (well, up to 4000) some of them with possibly very large effects. In these conditions, simulations can run very fast in the sense of "units of time". If we check exiting conditions every 20 units the population could have increased its size several orders of magnitude in between checks (this is also discussed in sections \@ref(bench1xf) and \@ref(detectprob)). You can verify this by running the script with other settings for checkSizePEvery (and being aware that large settings might require you to wait for a long time). To ensure that populations have really grown, we have increased the setting of PDBaseline so that no simulation can be considered for stopping unless its size is 1.4 times larger than initSize. In all cases we use keepEvery = 1 and keepPhylog = TRUE (so we store the population sizes of all clones every 1 time unit and we keep the complete genealogy of clones). Finally, we run all models with errorHitWallTime = FALSE and errorHitMaxTries = FALSE so that we can see results even if stopping conditions are not met. <!-- {r loadbench2usual, echo = FALSE, eval = TRUE} --> <!-- data(benchmark_2) --> <!--  --> The results of the benchmarks, using r unique(benchmark_2$Numindiv)
individual simulations, are shown in Table \@ref(tab:timingusual).

\blandscape

Table: (\#tab:timingusual) Benchmarks under some common use cases, set 1.
{r benchustable, eval=TRUE, echo = FALSE}
## data(benchmark_2)

## knitr::kable(benchmark_2[, c("Model", "fitness", "time_per_simul",
##     "size_mb_per_simul", "NumClones.Median", "NumIter.Median",
## 	"FinalTime.Median", "TotalPopSize.Median", "TotalPopSize.Mean",
## 	"TotalPopSize.Max.")],
##     booktabs = TRUE,
## 	col.names = c("Model",
## 				  "Fitness",
## 	"Elapsed Time, average per simulation (s)",
## 	              "Object Size, average per simulation (MB)",
## 				  "Number of Clones, median",
## 				  "Number of Iterations, median",
## 				  "Final Time, median",
## 				  "Total Population Size, median",
## 				  "Total Population Size, mean",
## 				  "Total Population Size, max."
## 				  ),
## 	align = "c")

panderOptions('table.split.table', 99999999)
panderOptions('table.split.cells', 900)  ## For HTML
## panderOptions('table.split.cells', 8) ## For PDF

## set.alignment('right', row.names = 'center')
panderOptions('table.alignment.default', 'right')

panderOptions('round', 3)

pander(benchmark_2[ , c(
"Model", "Fitness",
"Elapsed Time, average per simulation (s)",
"Object Size, average per simulation (MB)",
"Number of Clones, median",
"Number of Iterations, median",
"Final Time, median",
"Total Population Size, median",
"Total Population Size, mean",
"Total Population Size, max.")],
justify = c('left', 'left', rep('right', 8)),
## caption = "\\label{tab:timingusual}Benchmarks under some common use cases, set 1."
)



\elandscape

\clearpage

In most cases, simulations run reasonably fast (under 0.1 seconds per
individual simulation) and the returned objects are small. I will only
focus on a few cases.

The McFL model with random fitness landscape rf12 and with pancr does
not satisfy the conditions of detectionProb in most cases: its median
final time is 5000, which was the maximum final time specified. This
suggests that the fitness landscape is such that it is unlikely that we
will reach population sizes $> 1400$ (remember we the setting for
PDBaseline) before 5000 time units. There is nothing particular about
using a fitness landscape of 12 genes and other runs in other 12-gene
random fitness landscapes do not show this pattern. However, complex
fitness landscapes might be such that genotypes of high fitness (those
that allow reaching a large population size quickly) are not easily
accessible[^access] so reaching them might take a long time. This does not
affect the exponential model in the same way because, well, because there
is exponential growth in that model: any genotype with fitness $>1$ will
grow exponentially (of course, at possibly very different rates). You
might want to play with the script and modify the call to rfitness
(using different values of reference and c, for instance) to have
simpler paths to a maximum or modify the call to oncoSimulPop (with,
say, finalTime to much larger values). Some of these issues are related
to more general questions about fitness landscapes and accessibility (see
section \@ref(ex-ochs) and references therein).

[^access]:By easily accessible I mean that there are many, preferably
short, paths of non-decreasing fitness from the wildtype to this
genotype. See definitions and discussion in, e.g.,
@franke_evolutionary_2011.

You could also set onlyCancer = TRUE. This might make sense if you are
interested in only seeing simulations that "reach cancer" (where "reach
cancer" means reaching a state you define as a function of population size
or drivers). However, if you are exploring fitness landscapes, onlyCancer
= TRUE might not always be reasonable as reaching a particular population
size, for instance, might just not be possible under some fitness
landscapes (this phenomenon is of course not restricted to random fitness

As we anticipated above, the detectionProb mechanism has to be used with
care: some of the simulations run in very short "time units", such as
those for the fitness specifications with 2000 and 4000 genes. Having used
a checkSizePEvery = 20  probably would not have made sense.

Finally, it is interesting that in the cases examined here, the two
slowest running simulations are from "Exp", with fitnesses re_2000
and re_4000 (and the third slowest is also Exp, under
re_500). These are also the cases with the largest number of
clones. Why? In the "Exp" model there is no competition, and fitness
specifications re_2000 and re_4000 have genomes with many genes
with positive fitness contributions. It is thus very easy to obtain,
from the wildtype ancestor, a large number of clones all of which
have birth rates $>1$ and, thus, clones that are unlikely to become
extinct.

### Common use cases, set 2. {#common2}

We will now rerun the simulations above changing the following:

- finalTime  set to 25000.
- onlyCancer  set to TRUE.
- The "Exp" models will stop when population size $> 10^5$.

This is in script 'benchmark_3.R', under '/inst/miscell', with
output in the 'miscell-files/vignette_bench_Rout' directory of the
main OncoSimul repository at https://github.com/rdiaz02/OncoSimul.
The data are available as data(benchmark_3).

\blandscape

Table: (\#tab:timingusual2) Benchmarks under some common use cases, set 2.
{r benchustable2, eval=TRUE, echo = FALSE}
## data(benchmark_3)

## knitr::kable(benchmark_3[, c("Model", "fitness", "time_per_simul",
##     "size_mb_per_simul", "NumClones.Median", "NumIter.Median",
## 	"FinalTime.Median", "TotalPopSize.Median", "TotalPopSize.Mean",
## 	"TotalPopSize.Max.")],
##     booktabs = TRUE,
## 	col.names = c("Model",
## 				  "Fitness", "Elapsed Time, average per simulation (s)",
## 	              "Object Size, average per simulation (MB)",
## 				  "Number of Clones, median",
## 				  "Number of Iterations, median",
## 				  "Final Time, median",
## 				  "Total Population Size, median",
## 				  "Total Population Size, mean",
## 				  "Total Population Size, max."
## 				  ),
## 	align = "c")

panderOptions('table.split.table', 99999999)
panderOptions('table.split.cells', 900)  ## For HTML
## panderOptions('table.split.cells', 8) ## For PDF

panderOptions('round', 3)
panderOptions('table.alignment.default', 'right')

pander(benchmark_3[ , c(
"Model", "Fitness",
"Elapsed Time, average per simulation (s)",
"Object Size, average per simulation (MB)",
"Number of Clones, median",
"Number of Iterations, median",
"Final Time, median",
"Total Population Size, median",
"Total Population Size, mean",
"Total Population Size, max.")],
justify = c('left', 'left', rep('right', 8)),
## caption = "\\label{tab:timingusual2}Benchmarks under some common use cases, set 2."
)


\elandscape

\clearpage

Since we increased the maximum final time and forced runs to "reach
cancer" the McFL run with the pancreas fitness specification takes a bit
longer because it also has to do a larger number of
iterations. Interestingly, notice that the median final time is close to
10000, so the runs in \@ref(common1) with maximum final time of 5000 would
have had a hard time finishing with onlyCancer = TRUE.

Forcing simulations to "reach cancer" and just random differences between
the random fitness landscape also affect the McFL run under rf12: final
time is below 5000 and the median number of iterations is about half of
what was above.

Finally, by stopping the Exp simulations at $10^5$, simulations with
re_2000 and re_4000 finish now in much shorter times (but they still
take longer than their McFL counterparts) and the number of clones created
is much smaller.

## Can we use a large number of genes? {#lnum}

Yes. In fact, in OncoSimulR there is no pre-set limit on genome
size. However, large numbers of genes can lead to unacceptably large
returned object sizes and/or running time. We discuss several examples
next that illustrate some of the major issues to consider. Another example
with 50,000 genes is shown in section \@ref(mcf50070).

We have seen in \@ref(bench1) and \@ref(common1) that for the Exp model,
benchmark results using detectionProb require a lot of care and can be
misleading. Here, we will fix initial population sizes (to 500) and all
final population sizes will be set to $\geq 10^6$. In addition, to avoid
the confounding factor of the onlyCancer = TRUE argument, we will set it
to FALSE, so we measure directly the time of individual runs.

### Exponential model with 10,000 and 50,000 genes {#exp50000}

#### Exponential, 10,000 genes, example 1  {#exp100001}

We will start with 10000 genes and an exponential model, where we
stop when the population grows over $10^6$ individuals:

{r exp10000, echo = TRUE, eval = FALSE}
ng <- 10000
u <- allFitnessEffects(noIntGenes = c(rep(0.1, ng/2),
rep(-0.1, ng/2)))

t_e_10000 <- system.time(
e_10000 <- oncoSimulPop(5, u, model = "Exp", mu = 1e-7,
detectionSize = 1e6,
detectionDrivers = NA,
detectionProb = NA,
keepPhylog = TRUE,
onlyCancer = FALSE,
mutationPropGrowth = TRUE,
mc.cores = 1))


{r exp10000-out, echo = TRUE, eval = FALSE}
t_e_10000
##    user  system elapsed
##   4.368   0.196   4.566

summary(e_10000)[, c(1:3, 8, 9)]
##   NumClones TotalPopSize LargestClone FinalTime NumIter
## 1      5017      1180528       415116       143    7547
## 2      3726      1052061       603612       131    5746
## 3      4532      1100721       259510       132    6674
## 4      4150      1283115       829728        99    6646
## 5      4430      1139185       545958       146    6748

print(object.size(e_10000), units = "MB")
## 863.9 Mb



Each simulation takes about 1 second but note that the number of clones
for most simulations is already over 4000 and that the size of the returned
object is close to 1 GB (a more detailed explanation of where this 1 GB
comes from is deferred until section \@ref(wheresizefrom)).

#### Exponential, 10,000 genes, example 2 {#exp10000_2}

We can decrease the size of the returned object if we use the keepEvery =
NA argument (this setting was explained in detail in section
\@ref(bench1)):

{r exp10000b, eval = FALSE, echo = TRUE}
t_e_10000b <- system.time(
e_10000b <- oncoSimulPop(5,
u,
model = "Exp",
mu = 1e-7,
detectionSize = 1e6,
detectionDrivers = NA,
detectionProb = NA,
keepPhylog = TRUE,
onlyCancer = FALSE,
keepEvery = NA,
mutationPropGrowth = TRUE,
mc.cores = 1
))



{r exp10000b-out, echo = TRUE, eval = FALSE}
t_e_10000b
##    user  system elapsed
##   5.484   0.100   5.585

summary(e_10000b)[, c(1:3, 8, 9)]
##   NumClones TotalPopSize LargestClone FinalTime NumIter
## 1      2465      1305094       727989        91    6447
## 2      2362      1070225       400329       204    8345
## 3      2530      1121164       436721       135    8697
## 4      2593      1206293       664494       125    8149
## 5      2655      1186994       327835       191    8572

print(object.size(e_10000b), units = "MB")
## 488.3 Mb



#### Exponential,  50,000 genes, example 1 {#exp500001}

Let's use 50,000 genes. To keep object sizes reasonable we use
keepEvery = NA. For now, we also set mutationPropGrowth = FALSE
so that the mutation rate does not become really large in clones
with many mutations but, of course, whether or not this is a

{r exp50000, echo = TRUE, eval = FALSE}
ng <- 50000
u <- allFitnessEffects(noIntGenes = c(rep(0.1, ng/2),
rep(-0.1, ng/2)))
t_e_50000 <- system.time(
e_50000 <- oncoSimulPop(5,
u,
model = "Exp",
mu = 1e-7,
detectionSize = 1e6,
detectionDrivers = NA,
detectionProb = NA,
keepPhylog = TRUE,
onlyCancer = FALSE,
keepEvery = NA,
mutationPropGrowth = FALSE,
mc.cores = 1
))

t_e_50000
##    user  system elapsed
##  44.192   1.684  45.891

summary(e_50000)[, c(1:3, 8, 9)]
##   NumClones TotalPopSize LargestClone FinalTime NumIter
## 1      7367      1009949       335455     75.00   18214
## 2      8123      1302324       488469     63.65   17379
## 3      8408      1127261       270690     72.57   21144
## 4      8274      1138513       318152     80.59   20994
## 5      7520      1073131       690814     70.00   18569

print(object.size(e_50000), units = "MB")
## 7598.6 Mb


Of course, simulations now take longer and the size of the returned
object is over 7 GB (we are keeping more than 7,000 clones, even if when
we prune all those that went extinct).

#### Exponential, 50,000 genes, example 2 {#exp50000_2}

What if we had not pruned?

{r exp50000np, echo = TRUE, eval = FALSE}
ng <- 50000
u <- allFitnessEffects(noIntGenes = c(rep(0.1, ng/2),
rep(-0.1, ng/2)))
t_e_50000np <- system.time(
e_50000np <- oncoSimulPop(5,
u,
model = "Exp",
mu = 1e-7,
detectionSize = 1e6,
detectionDrivers = NA,
detectionProb = NA,
keepPhylog = TRUE,
onlyCancer = FALSE,
keepEvery = 1,
mutationPropGrowth = FALSE,
mc.cores = 1
))

t_e_50000np
##   user  system elapsed
## 42.316   2.764  45.079

summary(e_50000np)[, c(1:3, 8, 9)]
##   NumClones TotalPopSize LargestClone FinalTime NumIter
## 1     13406      1027949       410074     71.97   19469
## 2     12469      1071325       291852     66.00   17834
## 3     11821      1089834       245720     90.00   16711
## 4     14008      1165168       505607     77.61   19675
## 5     14759      1074621       205954     87.68   20597

print(object.size(e_50000np), units = "MB")
## 12748.4 Mb


The main effect is not on execution time but on object size (it has
grown by 5 GB). We are tracking more than 10,000 clones.

#### Exponential,  50,000 genes, example 3 {#exp50000_3}

What about the mutationPropGrowth setting? We will rerun the example in
\@ref(exp500001) leaving keepEvery = NA but with the default
mutationPropGrowth:

{r exp50000mpg, echo = TRUE, eval = FALSE}

ng <- 50000
u <- allFitnessEffects(noIntGenes = c(rep(0.1, ng/2),
rep(-0.1, ng/2)))

t_e_50000c <- system.time(
e_50000c <- oncoSimulPop(5,
u,
model = "Exp",
mu = 1e-7,
detectionSize = 1e6,
detectionDrivers = NA,
detectionProb = NA,
keepPhylog = TRUE,
onlyCancer = FALSE,
keepEvery = NA,
mutationPropGrowth = TRUE,
mc.cores = 1
))

t_e_50000c
##    user  system elapsed
## 84.228   2.416  86.665

summary(e_50000c)[, c(1:3, 8, 9)]
##   NumClones TotalPopSize LargestClone FinalTime NumIter
## 1     11178      1241970       344479     84.74   27137
## 2     12820      1307086       203544     91.94   33448
## 3     10592      1126091       161057     83.81   26064
## 4     11883      1351114       148986     65.68   25396
## 5     10518      1101392       253523     99.79   26082

print(object.size(e_50000c), units = "MB")
## 10904.9 Mb



As expected (because the mutation rate per unit time is increasing
in the fastest growing clones), we have many more clones, larger
objects, and longer times of execution here: we almost double the
time and the size of the object increases by almost 3 GB.

What about larger population sizes or larger mutation rates? The
number of clones starts growing fast, which means much slower
below).

#### Interlude: where is that 1 GB coming from? {#wheresizefrom}

In section \@ref(exp100001) we have seen an apparently innocuous
simulation producing a returned object of almost 1 GB. Where is that coming
from? It means that each simulation produced almost 200 MB of output.

Let us look at one simulation in more detail:

{r sizedetail, eval = FALSE, echo = TRUE}
r1 <- oncoSimulIndiv(u,
model = "Exp",
mu = 1e-7,
detectionSize = 1e6,
detectionDrivers = NA,
detectionProb = NA,
keepPhylog = TRUE,
onlyCancer = FALSE,
mutationPropGrowth = TRUE
)
summary(r1)[c(1, 8)]
##   NumClones  FinalTime
## 1      3887        345

print(object.size(r1), units = "MB")
## 160 Mb

## Size of the two largest objects inside:
sizes <- lapply(r1, function(x) object.size(x)/(1024^2))
sort(unlist(sizes), decreasing = TRUE)[1:2]
## Genotypes pops.by.time
##       148.28        10.26

dim(r1$Genotypes) ## [1] 10000 3887  The above shows the reason: the Genotypes matrix is a 10,000 by 3,887 integer matrix (with a 0 and 1 indicating not-mutated/mutated for each gene in each genotype) and in R integers use 4 bytes each. The pops.by.time matrix is 346 by 3,888 (the 1 in$346 = 345 + 1$comes from starting at 0 and going up to the final time, both included; the 1 in$3888 = 3887 + 1$is from the column of time) double matrix and doubles use 8 bytes[^popsbytime]. [^popsbytime]:These matrices do not exist during most of the execution of the C++ code; they are generated right before returning from the C++ code. ### McFarland model with 50,000 genes; the effect of keepEvery {#mc50000} We show an example of McFarland's model with 50,000 genes in section \@ref(mcf50070). We will show here a few more examples with those many genes but with a different fitness specification and changing several other settings. #### McFarland, 50,000 genes, example 1 {#mc50000ex1} Let's start with mutationPropGrowth = FALSE and keepEvery = NA. Simulations end when population size$\geq 10^6$. {r mc50000_1, echo = TRUE, eval = FALSE} ng <- 50000 u <- allFitnessEffects(noIntGenes = c(rep(0.1, ng/2), rep(-0.1, ng/2))) t_mc_50000_nmpg <- system.time( mc_50000_nmpg <- oncoSimulPop(5, u, model = "McFL", mu = 1e-7, detectionSize = 1e6, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, keepEvery = NA, mutationPropGrowth = FALSE, mc.cores = 1 )) t_mc_50000_nmpg ## user system elapsed ## 30.46 0.54 31.01 summary(mc_50000_nmpg)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 1902 1002528 582752 284.2 31137 ## 2 2159 1002679 404858 274.8 36905 ## 3 2247 1002722 185678 334.5 42429 ## 4 2038 1009606 493574 218.4 32519 ## 5 2222 1004661 162628 291.0 38470 print(object.size(mc_50000_nmpg), units = "MB") ## 2057.6 Mb  We are already dealing with 2000 clones. #### McFarland, 50,000 genes, example 2 {#mc50000ex2} Setting keepEvery = 1 (i.e., keeping track of clones with an interval of 1): {r mc50000_kp, echo = TRUE, eval = FALSE} t_mc_50000_nmpg_k <- system.time( mc_50000_nmpg_k <- oncoSimulPop(5, u, model = "McFL", mu = 1e-7, detectionSize = 1e6, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, keepEvery = 1, mutationPropGrowth = FALSE, mc.cores = 1 )) t_mc_50000_nmpg_k ## user system elapsed ## 30.000 1.712 31.714 summary(mc_50000_nmpg_k)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 8779 1000223 136453 306.7 38102 ## 2 7442 1006563 428150 345.3 35139 ## 3 8710 1003509 224543 252.3 35659 ## 4 8554 1002537 103889 273.7 36783 ## 5 8233 1003171 263005 301.8 35236 print(object.size(mc_50000_nmpg_k), units = "MB") ## 8101.4 Mb  Computing time increases slightly but the major effect is seen on the size of the returned object, that increases by a factor of about 4x, up to 8 GB, corresponding to the increase in about 4x in the number of clones being tracked (see details of where the size of this object comes from in section \@ref(wheresizefrom)). #### McFarland, 50,000 genes, example 3 {#mc50000ex3} We will set keepEvery = NA again, but we will now increase detection size by a factor of 3 (so we stop when total population size becomes$\geq 3 * 10^6$). {r mc50000_popx, echo = TRUE, eval = FALSE} ng <- 50000 u <- allFitnessEffects(noIntGenes = c(rep(0.1, ng/2), rep(-0.1, ng/2))) t_mc_50000_nmpg_3e6 <- system.time( mc_50000_nmpg_3e6 <- oncoSimulPop(5, u, model = "McFL", mu = 1e-7, detectionSize = 3e6, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, keepEvery = NA, mutationPropGrowth = FALSE, mc.cores = 1 )) t_mc_50000_nmpg_3e6 ## user system elapsed ## 77.240 1.064 78.308 summary(mc_50000_nmpg_3e6)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 5487 3019083 836793 304.5 65121 ## 2 4812 3011816 789146 286.3 53087 ## 3 4463 3016896 1970957 236.6 45918 ## 4 5045 3028142 956026 360.3 63464 ## 5 4791 3029720 916692 358.1 55012 print(object.size(mc_50000_nmpg_3e6), units = "MB") ## 4759.3 Mb  Compared with the first run (\@ref(mc50000ex1)) we have approximately doubled computing time, number of iterations, number of clones, and object size. #### McFarland, 50,000 genes, example 4 {#mc50000ex4} Let us use the same detectionSize = 1e6 as in the first example (\@ref(mc50000ex1)), but with 5x the mutation rate: {r mc50000_mux, echo = TRUE, eval = FALSE} t_mc_50000_nmpg_5mu <- system.time( mc_50000_nmpg_5mu <- oncoSimulPop(5, u, model = "McFL", mu = 5e-7, detectionSize = 1e6, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, keepEvery = NA, mutationPropGrowth = FALSE, mc.cores = 1 )) t_mc_50000_nmpg_5mu ## user system elapsed ## 167.332 1.796 169.167 summary(mc_50000_nmpg_5mu)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 7963 1004415 408352 99.03 57548 ## 2 8905 1010751 120155 130.30 74738 ## 3 8194 1005465 274661 96.98 58546 ## 4 9053 1014049 119943 112.23 75379 ## 5 8982 1011817 95047 99.95 76757 print(object.size(mc_50000_nmpg_5mu), units = "MB") ## 8314.4 Mb  The number of clones we are tracking is about 4x the number of clones of the first example (\@ref(mc50000ex1)), and roughly similar to the number of clones of the second example (\@ref(mc50000ex2)), and size of the returned object is similar to that of the second example. But computing time has increased by a factor of about 5x and iterations have increased by a factor of about 2x. Iterations increase because mutation is more frequent; in addition, at each sampling period each iteration needs to do more work as it needs to loop over a larger number of clones and this larger number includes clones that are not shown here, because they are pruned (they are extinct by the time we exit the simulation ---again, pruning is discussed with further details in \@ref(prune)). #### McFarland, 50,000 genes, example 5 {#mc50000ex5} Now let's run the above example but with keepEvery = 1: {r mcf5muk, echo = TRUE, eval = FALSE} t_mc_50000_nmpg_5mu_k <- system.time( mc_50000_nmpg_5mu_k <- oncoSimulPop(5, u, model = "McFL", mu = 5e-7, detectionSize = 1e6, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, keepEvery = 1, mutationPropGrowth = FALSE, mc.cores = 1 )) t_mc_50000_nmpg_5mu_k ## user system elapsed ## 174.404 5.068 179.481 summary(mc_50000_nmpg_5mu_k)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 25294 1001597 102766 123.4 74524 ## 2 23766 1006679 223010 124.3 71808 ## 3 21755 1001379 203638 114.8 62609 ## 4 24889 1012103 161003 119.3 75031 ## 5 21844 1002927 255388 108.8 64556 print(object.size(mc_50000_nmpg_5mu_k), units = "MB") ## 22645.8 Mb  We have already seen these effects before in section \@ref(mc50000ex2): using keepEvery = 1 leads to a slight increase in execution time. What is really affected is the size of the returned object which increases by a factor of about 3x (and is now over 20GB). That 3x corresponds, of course, to the increase in the number of clones being tracked (now over 20,000). This, by the way, also allows us to understand the comment above, where we said that in these two cases (where we have increased mutation rate) at each iteration we need to do more work as at every update of the population the algorithm needs to loop over a much larger number of clones (even if many of those are eventually pruned). #### McFarland, 50,000 genes, example 6 {#mc50000ex6} Finally, we will run the example in section \@ref(mc50000ex1) with the default of mutationPropGrowth = TRUE: {r mc50000_2, echo = TRUE, eval = FALSE} t_mc_50000 <- system.time( mc_50000 <- oncoSimulPop(5, u, model = "McFL", mu = 1e-7, detectionSize = 1e6, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, keepEvery = NA, mutationPropGrowth = TRUE, mc.cores = 1 )) t_mc_50000 ## user system elapsed ## 303.352 2.808 306.223 summary(mc_50000)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 13928 1010815 219814 210.9 91255 ## 2 12243 1003267 214189 178.1 67673 ## 3 13880 1014131 124354 161.4 88322 ## 4 14104 1012941 75521 205.7 98583 ## 5 12428 1005594 232603 167.4 70359 print(object.size(mc_50000), units = "MB") ## 12816.6 Mb  Note the huge increase in computing time (related of course to the huge increase in number of iterations) and in the size of the returned object: we have gone from having to track about 2000 clones to tracking over 12000 clones even when we prune all clones without descendants. ### Examples with$s = 0.05${#largegenes005} A script with the above runs but using$s=0.05$instead of$s=0.1$is available from the repository ('miscell-files/vignette_bench_Rout/large_num_genes_0.05.Rout'). I will single out a couple of cases here. First, we repeat the run shown in section \@ref(mc50000ex5): {r mcf5muk005, echo = TRUE, eval = FALSE} t_mc_50000_nmpg_5mu_k <- system.time( mc_50000_nmpg_5mu_k <- oncoSimulPop(2, u, model = "McFL", mu = 5e-7, detectionSize = 1e6, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, keepEvery = 1, mutationPropGrowth = FALSE, mc.cores = 1 )) t_mc_50000_nmpg_5mu_k ## user system elapsed ## 305.512 5.164 310.711 summary(mc_50000_nmpg_5mu_k)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 61737 1003273 104460 295.8731 204214 ## 2 65072 1000540 133068 296.6243 210231 print(object.size(mc_50000_nmpg_5mu_k), units = "MB") ## 24663.6 Mb  Note we use only two replicates, since those two already lead to a 24 GB returned object as we are tracking more than 60,000 clones, more than twice those with$s=0.1$. The reason for the difference in number of clones and iterations is of course the change from$s=0.1$to$s=0.05$: under the McFarland model to reach population sizes of$10^6$starting from an equilibrium population of 500 we need about 43 mutations (whereas only about 22 are needed if$s=0.1$[^mcnum]). [^mcnum]: Given the dependence of death rates on population size in McFarland's model (section \@ref(mcfl) and \@ref(mcfldeath)), if all mutations have the same fitness effects we can calculate the equilibrium population size (where birth and death rates are equal) for a given number of mutated genes as:$K * (e^{(1 + s)^p} - 1)$, where$K$is the initial equilibrium size,$s$the fitness effect of each mutation, and$p$the number of mutated genes. Next, let us rerun \@ref(mc50000ex1): {r mc50000_1_005, echo = TRUE, eval = FALSE} t_mc_50000_nmpg <- system.time( mc_50000_nmpg <- oncoSimulPop(5, u, model = "McFL", mu = 1e-7, detectionSize = 1e6, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, keepEvery = NA, mutationPropGrowth = FALSE, mc.cores = 1 )) t_mc_50000_nmpg ## user system elapsed ## 111.236 0.596 111.834 summary(mc_50000_nmpg)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 2646 1000700 217188 734.475 108566 ## 2 2581 1001626 209873 806.500 107296 ## 3 2903 1001409 125148 841.700 120859 ## 4 2310 1000146 473948 906.300 91519 ## 5 2704 1001290 448409 838.800 103556 print(object.size(mc_50000_nmpg), units = "MB") ## 2638.3 Mb  Using$s=0.05$leads to a large increase in final time and number of iterations. However, as we are using the keepEvery = NA setting, the increase in number of clones tracked and in size of returned object is relatively small. ### The different consequences of keepEvery = NA in the Exp and McFL models {#kpexpmc} We have seen that keepEvery = NA often leads to much smaller returned objects when using the McFarland model than when using the Exp model. Why? Because in the McFarland model there is strong competition and there can be complete clonal sweeps so that in extreme cases a single clone might be all that is left after some time. This is not the case in the exponential models. Of course, the details depend on the difference in fitness effects between different genotypes (or clones). In particular, we have seen several examples where even with keepEvery=NA there are a lot of clones in the McFL models. In those examples many clones had identical fitness (the fitness effects of all genes with positive fitness was the same, and ditto for the genes with negative fitness effects), so no clone ends up displacing all the others. ### Are we keeping the complete history (genealogy) of the clones? {#histlargegenes} Yes we are if we run with keepPhylog = TRUE, regardless of the setting for keepEvery. As explained in section \@ref(trackindivs), OncoSimulR prunes clones that never had a population size larger than zero at any sampling period (so they are not reflected in the pops.by.time matrix in the output). And when we set keepEvery = NA we are telling OncoSimulR to discard all sampling periods except the very last one (i.e., the pops.by.time matrix contains only the clones with 1 or more cells at the end of the simulation). keepPhylog operates differently: it records the exact time at which a clone appeared and the clone that gave rise to it. This information is kept regardless of whether or not those clones appear in the pops.by.time matrix. Keeping the complete genealogy might be of limited use if the pops.by.time matrix only contains the very last period. However, you can use plotClonePhylog and ask to be shown only clones that exist in the very last period (while of course showing all of their ancestors, even if those are now extinct ---i.e., regardless of their abundance). For instance, in run \@ref(exp500001) we could have looked at the information stored about the genealogy of clones by doing (we look at the first "individual" of the simulation, of the five "individuals" we simulated): {r filog_exp50000_1, echo = TRUE, eval = FALSE} head(e_50000[[1]]$other$PhylogDF) ## parent child time ## 1 3679 0.8402 ## 2 4754 1.1815 ## 3 20617 1.4543 ## 4 15482 2.3064 ## 5 4431 3.7130 ## 6 41915 4.0628 tail(e_50000[[1]]$other$PhylogDF) ## parent child time ## 20672 3679, 20282 3679, 20282, 22359 75.0 ## 20673 3679, 17922, 22346 3679, 17922, 22346, 35811 75.0 ## 20674 2142, 3679 2142, 3679, 25838 75.0 ## 20675 3679, 17922, 19561 3679, 17922, 19561, 43777 75.0 ## 20676 3679, 15928, 19190, 20282 3679, 15928, 19190, 20282, 49686 75.0 ## 20677 2142, 3679, 16275 2142, 3679, 16275, 24201 75.0  where each row corresponds to one event of appearance of a new clone, the column labeled "parent" are the mutated genes in the parent, and the column labeled "child" are the mutated genes in the child. And we could plot the genealogical relationships of clones that have a population size of at least one in the last period (again, while of course showing all of their ancestors, even if those are now extinct ---i.e., regardless of their current numbers) doing: {r noplotlconephylog, echo = TRUE, eval = FALSE} plotClonePhylog(e_50000[[1]]) ## plot not shown  What is the cost of keep the clone genealogies? In terms of time it is minor. In terms of space, and as shown in the example above, we can end up storing a data frame with tends of thousands of rows and three columns (two factors, one float). In the example above the size of that data frame is approximately 2 MB for a single simulation. This is much smaller than the pops.by.time or Genotypes matrices, but it can quickly build up if you routinely launch, say, 1000 simulations via oncoSimulPop. That is why the default is keepPhylog = FALSE as this information is not needed as often as that in the other two matrices (pops.by.time and Genotypes). ## Population sizes$\geq 10^{10}${#popgtzx} We have already seen examples where population sizes reach$10^{8}$to$10^{10}$, as in Tables \@ref(tab:bench1b), \@ref(tab:timing3), \@ref(tab:timing3xf). What about even larger population sizes? The C++ code will unconditionally alert if population sizes exceed$4*10^{15}$as in those cases loosing precision (as we are using doubles) would be unavoidable, and we would also run into problems with the generation of binomial random variates (code that illustrates and discusses this problem is available in file "example-binom-problems.cpp", in directory "/inst/miscell"). However, well before we reach$4*10^{15}$we loose precision from other sources. One of the most noticeable ones is that when we reach population sizes around$10^{11}$the C++ code will often alert us by throwing exceptions with the message Recoverable exception ti set to DBL_MIN. Rerunning. I throw this exception because$t_i$, the random variable for time to next mutation, is less than DBL_MIN, the minimum representable floating-point number. This happens because, unless we use really tiny mutation rates, the time to a mutation starts getting closer to zero as population sizes grow very large. It might be possible to ameliorate these problems somewhat by using long doubles (instead of doubles) or special purpose libraries that provide more precision. However, this would make it harder to run the same code in different operating systems and would likely decrease execution speed on the rest of the common scenarios for which OncoSimulR has been designed. The following code shows some examples where we use population sizes of$10^{10}$or larger. Since we do not want simulations in the exponential model to end because of extinction, I use a fitness specification where all genes have a positive fitness effect and we start all simulations from a large population (to make it unlikely that the population will become extinct before cells mutate and start increasing in numbers). We set the maximum running time to 10 minutes. We keep the genealogy of the clones and use keepEvery = 1. {r ex-large-pop-size, eval = FALSE, echo = TRUE} ng <- 50 u <- allFitnessEffects(noIntGenes = c(rep(0.1, ng)))  {r ex-large-mf, eval = FALSE, echo = TRUE} t_mc_k_50_1e11 <- system.time( mc_k_50_1e11 <- oncoSimulPop(5, u, model = "McFL", mu = 1e-7, detectionSize = 1e11, initSize = 1e5, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, mutationPropGrowth = FALSE, keepEvery = 1, finalTime = 5000, mc.cores = 1, max.wall.time = 600 )) ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Recoverable exception ti set to DBL_MIN. Rerunning. t_mc_k_50_1e11 ## user system elapsed ## 613.612 0.040 613.664 summary(mc_k_50_1e11)[, c(1:3, 8, 9)] ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 5491 100328847809 44397848771 1019.950 942764 ## 2 3194 100048090441 34834178374 789.675 888819 ## 3 5745 100054219162 24412502660 927.950 929231 ## 4 4017 101641197799 60932177160 750.725 480938 ## 5 5393 100168156804 41659212367 846.250 898245 ## print(object.size(mc_k_50_1e11), units = "MB") ## 177.8 Mb  We get to$10^{11}$. But notice the exception with the warning about$t_i$. Notice also that this takes a long time and we run a very large number of iterations (getting close to one million in some cases). Now the exponential model with detectionSize = 1e11: {r ex-large-exp, eval = FALSE, echo = TRUE} t_exp_k_50_1e11 <- system.time( exp_k_50_1e11 <- oncoSimulPop(5, u, model = "Exp", mu = 1e-7, detectionSize = 1e11, initSize = 1e5, detectionDrivers = NA, detectionProb = NA, keepPhylog = TRUE, onlyCancer = FALSE, mutationPropGrowth = FALSE, keepEvery = 1, finalTime = 5000, mc.cores = 1, max.wall.time = 600, errorHitWallTime = FALSE, errorHitMaxTries = FALSE )) ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Hitted wall time. Exiting. ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Hitted wall time. Exiting. ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Recoverable exception ti set to DBL_MIN. Rerunning. ## Hitted wall time. Exiting. ## Hitted wall time. Exiting. t_exp_k_50_1e11 ## user system elapsed ## 2959.068 0.128 2959.556 try(summary(exp_k_50_1e11)[, c(1:3, 8, 9)]) ## NumClones TotalPopSize LargestClone FinalTime NumIter ## 1 6078 65172752616 16529682757 235.7590 1883438 ## 2 5370 106476643712 24662446729 232.0000 2516675 ## 3 2711 21911284363 17945303353 224.8608 543698 ## 4 2838 13241462284 2944300245 216.8091 372298 ## 5 7289 76166784312 10941729810 240.0217 1999489 print(object.size(exp_k_50_1e11), units = "MB") ## 53.5 Mb  Note that we almost reached max.wall.time (600 * 5 = 3000). What if we wanted to go up to$10^{12}$? We would not be able to do it in 10 minutes. We could set max.wall.time to a value larger than 600 to allow us to reach larger sizes but then we would be waiting for a possibly unacceptable time for simulations to finish. Moreover, this would eventually fail as simulations would keep hitting the$t_i$exception without ever being able to complete. Finally, even if we were very patient, hitting that$t_i$exception should make us worry about possible biases in the samples. ## A summary of some determinants of running time and space consumption To summarize this section, we have seen: - Both McFL and Exp can be run in short times over a range of sizes for the detectionProb and detectionSize mechanisms using a complex fitness specification with moderate numbers of genes. These are the typical or common use cases of OncoSimulR. - The keepEvery argument can have a large effect on time in the McFL models and specially on object sizes. If only the end result of the simulation is to be used, you should set keepEvery = NA. - The distribution of fitness effects and the fitness landscape can have large effects on running times. Sometimes these are intuitive and simple to reason about, sometimes they are not as they interact with other factors (e.g., stopping mechanism, numbers of clones, etc). In general, there can be complex interactions between different settings, from mutation rate to fitness effects to initial size. As usual, test before launching a massive simulation. - Simulations start to slow down and lead to a very large object size when we keep track of around 6000 to 10000 clones. Anything that leads to these patterns will slow down the simulations. - OncoSimulR needs to keep track of genotypes (or clones), not just numbers of drivers and passengers, because it allows you to use complex fitness and mutation specifications that depend on specific genotypes. The keepEvery = NA is an approach to store only the minimal information needed, but it is unavoidable that during the simulations we might be forced to deal with many thousands of different clones. \clearpage # Specifying fitness effects {#specfit} OncoSimulR uses a standard continuous time model, where individual cells divide, die, and mutate with rates that can depend on genotype and population size; over time the abundance of the different genotypes changes by the action of selection (due to differences in net growth rates among genotypes), drift, and mutation. As a result of a mutation in a pre-existing clone new clones arise, and the birth rate of a newly arisen clone is determined at the time of its emergence as a function of its genotype. Simulations can use an use exponential growth model or a model with carrying capacity that follows @McFarland2013. For the exponential growth model, the death rate is fixed at one whereas in the model with carrying capacity death rate increases with population size. In both cases, therefore, fitness differences among genotypes in a given population at a given time are due to differences in the mapping between genotype and birth rate. There is second exponential model (called "Bozic") where birth rate is fixed at one, and genotype determines death rate instead of birth rate (see details in \@ref(numfit)). So when we discuss specifying fitness effects or the effects of genes on fitness, we are actually referring to specifying effects on birth (or death) rates, which then translate into differences in fitness (since the other rate, death or birth, is either fixed, as in the Exp and Bozic models, or depends on the population size). This is also shown in Table \@ref(tab:osrfeatures), in the rows for "Fitness components", under "Evolutionary Features". In the case of frequency-dependent fitness simulations (\@ref(fdf)), the fitness effects must be reevaluated frequently so that birth rate, death rate, or both, depending the model used, are updated. To do this it is necessary to use a short step to reevaluate fitness; this is done using a small value for sampleEvery parameter in oncoSimulindv (see \@ref(whatgoodsampleevery) for more details), as is the case when using McFarland model. Incidentally, notice that with OncoSimulR we do not directly specify fitness itself (even if, for the sake of simplicity, we often refer to fitness in the documentation) as fitness is, arguably, a derived quantity [@doebeli2017]. Rather, we specify how birth and/or death rates, which are the actual mechanistic drivers of evolutionary dynamics, are related to genotypes (or to the frequencies of the different genotypes). ## Introduction to the specification of fitness effects {#introfit} With OncoSimulR you can specify different types of effects on fitness: * A special type of epistatic effect that is particularly amenable to be represented as a graph (a DAG). In this graph having, say, "B" be a child of "A" means that a mutation in B can only accumulate if a mutation in A is already present. This is what OT [@Desper1999JCB; @Szabo2008], CBN [@Beerenwinkel2007; @Gerstung2009; @Gerstung2011], progression networks [@Farahani2013], and other similar models [@Korsunsky2014] generally mean. Details are provided in section \@ref(posetslong). Note that this is not an order effect (discussed below): the fitness of a genotype from this DAGs is a function of whether or not the restrictions in the graph are satisfied, not the historical sequence of how they were satisfied. * Effects where the order in which mutations are acquired matters, as illustrated in section \@ref(oe). There is, in fact, empirical evidence of these effects [@Ortmann2015]. For instance, the fitness of genotype "A, B" would differ depending on whether A or B was acquired first (or, as in the actual example in [@Ortmann2015], the fitness of the mutant with JAK2 and TET2 mutated will depend on which of the genes was mutated first). * General epistatic effects (e.g., section \@ref(epi)), including synthetic viability (e.g., section \@ref(sv)) and synthetic lethality/mortality (e.g., section \@ref(sl)). * Genes that have independent effects on fitness (section \@ref(noint)). * Modules (see section \@ref(modules0)) allow you to specify any of the above effects (except those for genes without interactions, as it would not make sense there) in terms of modules (sets of genes), not individual genes. We will introduce them right after \@ref(posetslong), and we will continue using them thereafter. A guiding design principle of OncoSimulR is to try to make the specification of those effects as simple as possible but also as flexible as possible. Thus, there are two main ways of specifying fitness effects: * Combining different types of effects in a single specification. For instance, you can combine epistasis with order effects with no interaction genes with modules. What you would do here is specify the effects that different mutations (or their combinations) have on fitness (the fitness effects) and then have OncoSimulR take care of combining them as if each of these were lego pieces. We will refer to this as the **lego system of fitness effects**. (As explained above, I find this an intuitive and very graphical analogy, which I have copied from @Hothorn_2006 and @Hothorn_2008). * Explicitly passing to OncoSimulR a mapping of genotypes to fitness. Here you specify the fitness of each genotype. We will refer to this as the **explicit mapping of genotypes to fitness**. Both approaches have advantages and disadvantages. Here I emphasize some relevant differences. * With the lego system you can specify huge genomes with an enormous variety of interactions, since the possible genotypes are not constructed in advance. You would not be able to do this with the explicit mapping of genotypes to fitness if you wanted to, say, construct that mapping for a modest genotype of 500 genes (you'd have more genotypes than particles in the observable Universe). * For many models/data you often intuitively start with the fitness of the genotypes, not the fitness consequences of the different mutations. In these cases, you'd need to do the math to specify the terms you want if you used the lego system so you'll probably use the specification with the direct mapping genotype$\rightarrow$fitness. * Likewise, sometimes you already have a moderate size genotype$\rightarrow$fitness mapping and you certainly do not want to do the math by hand: here the lego system would be painful to use. * But sometimes we do think in terms of "the effects on fitness of such and such mutations are" and that immediately calls for the lego system, where you focus on the effects, and let OncoSimulR take care of doing the math of combining. * If you want to use order effects, you must use the lego system (at least for now). * If you want to specify modules, you must use the lego system (the explicit mapping of genotypes is, by its very nature, ill-suited for this). * The lego system might help you see what your model really means: in many cases, you can obtain fairly succinct specifications of complex fitness models with just a few terms. Similarly, depending on what your emphasis is, you can often specify the same fitness landscape in several different ways. Regardless of the route, you need to get that information into OncoSimulR's functions. The main function we will use is allFitnessEffects: this is the function in charge of reading the fitness specifications. We also need to discuss how, what, and where you have to pass to allFitnessEffects. ### Explicit mapping of genotypes to fitness {#explicitmap} Conceptually, the simplest way to specify fitness is to specify the mapping of all genotypes to fitness explicitly. An example will make this clear. Let's suppose you have a simple two-gene scenario, so a total of four genotypes, and you have a data frame with genotypes and fitness, where genoytpes are specified as character vectors, with mutated genes separated by commas: {r} m4 <- data.frame(G = c("WT", "A", "B", "A, B"), F = c(1, 2, 3, 4))  Now, let's give that to the allFitnessEffects function: {r} fem4 <- allFitnessEffects(genotFitness = m4)  (The message is just telling you what the program guessed you wanted.) That's it. You can try to plot that fitnessEffects object {r} try(plot(fem4))  In this case, you probably want to plot the fitness landscape. {r, fig.width=6.5, fig.height = 6.5} plotFitnessLandscape(evalAllGenotypes(fem4))  You can also check what OncoSimulR thinks the fitnesses are, with the evalAllGenotypes function that we will use repeatedly below (of course, here we should see the same fitnesses we entered): {r} evalAllGenotypes(fem4, addwt = TRUE)  And you can plot the fitness landscape: {r} plotFitnessLandscape(evalAllGenotypes(fem4))  To specify the mapping you can also use a matrix (or data frame) with$g + 1$columns; each of the first$g$columns contains a 1 or a 0 indicating that the gene of that column is mutated or not. Column$g+ 1$contains the fitness values. And you do not even need to specify all the genotypes: the missing genotypes are assigned a fitness 0 ---except for the WT genotype which, if missing, is assigned a fitness of 1: {r} m6 <- cbind(c(1, 1), c(1, 0), c(2, 3)) fem6 <- allFitnessEffects(genotFitness = m6) evalAllGenotypes(fem6, addwt = TRUE) ## plot(fem6)  {r, fig.width=6.5, fig.height = 6.5} plotFitnessLandscape(evalAllGenotypes(fem6))  This way of giving a fitness specification to OncoSimulR might be ideal if you directly generate random mappings of genotypes to fitness (or random fitness landscapes), as we will do in section \@ref(gener-fit-land). Specially when the fitness landscape contains many non-viable genotypes (which are considered those with fitness ---birth rate---$<1e-9$) this can result in considerable savings as we only need to check the fitness of the viable genotypes in a table (a C++ map). Note, however, that using the Bozic model with the fitness landscape specification is not tested. In addition, for speed, missing genotypes from the fitness landscape specification are taken to be non-viable genotypes (**beware!! this is a breaking change relative to versions < 2.9.1**)[^flfast]. [^flfast]: Note for curious readers: it used to be the case that we converted the table of fitness of genotypes to a fitness specification with all possible epistatic interactions; you can take a look at the test file test.genot_fitness_to_epistasis.R that uses the fem6 object. We no longer do that but instead pass directly the fitness landscape. In the case of frequency-dependent fitness situations, the only way to specify fitness effects is using genoFitnes as we have shown before, but now you need to set frequencyDependentFitness = TRUE in allFitnessEffects. The fundamental difference is the Fitness column in genoFitnes. Now this column must be a character vector and each element (character also) is a function whose variables are the relative frequencies of the clones in the population. You must specify the variables like f_, for frequency of wild type, f_1 or f_A for frequency of mutant A or position 1, f_1_2 or f_A_B for double mutant, and so on. Mathematical operations and symbols allowed are described in the documentation of C++ library ExprTk (<http://www.partow.net/programming/exprtk/>). ExprTk is the library used to parse and evaluate the fitness equations. The numeric vector spPopSizes is only necesary to evaluate genotypes through evalGenotype or evalAllGenotypes functions because population sizes are needed to calculate the clone's frequencies. {r rj68v3x} r <- data.frame(Genotype = c("WT", "A", "B", "A, B"), Fitness = c("10 * f_", "10 * f_1", "50 * f_2", "200 * (f_1 + f_2) + 50 * f_1_2")) afe <- allFitnessEffects(genotFitness = r, frequencyDependentFitness = TRUE, frequencyType = "rel") plotFitnessLandscape(evalAllGenotypes(afe, spPopSizes = c(WT = 2500, A = 2000, B = 5500, "A, B" = 700)))  The above example is simple enough in terms of genes and genotypes that using f_1 is OK. But it will be better, as examples get more complex, to use: {r j8hhkiu} r <- data.frame(Genotype = c("WT", "A", "B", "A, B"), Fitness = c("10 * f_", "10 * f_A", "50 * f_B", "200 * (f_A + f_B) + 50 * f_A_B"))  which makes explicit what depends on what (i.e., you do not need to keep in mind the mapping of letters to numbers). In other words, we write f_genotype expressed as combination of gene names, with the gene names we are actually using. And those f_something_other, will match the genotypes given in Genotype (there will a something, other genotype). ### How to specify fitness effects with the lego system {#howfit} An alternative general approach followed in many genetic simulators is to specify how particular combinations of alleles modify the wildtype genotype or the genotype that contains the individual effects of the interacting genes (e.g., see equation 1 in the supplementary material for FFPopSim [@Zanini2012]). For example, if we specify that a mutation in "A" contributes 0.04, a mutation in "B" contributes 0.03, and the double mutation "A:B" contributes 0.1, that means that the fitness of the "A, B" genotype (the genotype with A and B mutated) is that of the wildtype (1, by default), plus (actually, times ---see section \@ref(numfit)--- but plus on the log scale) the effects of having A mutated, plus (times) the effects of having B mutated, plus (times) the effects of "A:B" both being mutated. We will see below that with the "lego system" it is possible to do something very similar to the explicit mapping of section \@ref(explicitmap). But this will sometimes require a more cumbersome notation (and sometimes also will require your doing some math). We will see examples in sections \@ref(e2), \@ref(e3) and \@ref(theminus) or the example in \@ref(weis1b). But then, if we can be explicit about (at least some of) the mappings$genotype \rightarrow fitness$, how are these procedures different? When you use the "lego system" you can combine both a partial explicit mapping of genotypes to fitness with arbitrary fitness effects of other genes/modules. In other words, with the "lego system" OncoSimulR makes it simple to be explicit about the mapping of specific genotypes, while also using the "how this specific effects modifies previous effects" logic, leading to a flexible specification. This also means that in many cases the same fitness effects can be specified in several different ways. Most of the rest of this section is devoted to explaining how to combine those pieces. Before that, however, we need to discuss the fitness model we use. ## Numeric values of fitness effects {#numfit} We evaluate fitness using the usual [@Zanini2012; @Gillespie1993; @Beerenwinkel2007; @Datta2013] multiplicative model: fitness is$\prod (1 + s_i)$where$s_i$is the fitness effect of gene (or gene interaction)$i$. In all models except Bozic, this fitness refers to the growth rate (the death rate being fixed to 1[^2]). The original model of @McFarland2013 has a slightly different parameterization, but you can go easily from one to the other (see section \@ref(mcfl)). For the Bozic model [@Bozic2010], however, the birth rate is set to 1, and the death rate then becomes$\prod (1 - s_i)$. [^2]: You can change this if you really want to. <!-- On their interpretation/naming: --> <!-- I do \prod (1 + s_i). The s_i I could call "selection coefficients", --> <!-- as Gillespie, 1993; or "mutation effects", as in Fogle et al., 2008, --> <!-- or Dayarian and Shraiman, 2014. --> <!-- - The multiplicative \Prod (1+ s_j) is typicalone, as in Beerenwinkel --> <!-- 2007, PLoS Comp Biol --> ### McFarland parameterization {#mcfl} In the original model of @McFarland2013, the effects of drivers contribute to the numerator of the birth rate, and those of the (deleterious) passengers to the denominator as:$\frac{(1 +
s)^d}{(1 + s_p)^p}$, where$d$and$p$are, respectively, the total number of drivers and passengers in a genotype, and here the fitness effects of all drivers is the same ($s$) and that of all passengers the same too ($s_p$). Note that, as written above, and as explicitly said in @McFarland2013 (see p. 2911) and @McFarland2014-phd (see p. 9), "(...)$s_p$is the fitness disadvantage conferred by a passenger". In other words, the larger the$s_p$the more deleterious the passenger. This is obvious, but I make it explicit because in our parameterization a positive$s$means fitness advantage, whereas fitness disadvantages are associated with negative$s$. Of course, if you rewrite the above expression as$\frac{(1 + s)^d}{(1 -
s_p)^p}$then we are back to the "positive means fitness advantage and negative means fitness disadvantage". As @McFarland2014-phd explains (see p.\ 9, bottom), we can rewrite the above expression so that there are no terms in the denominator. McFarland writes it as (I copy verbatim from the fourth and fifth lines from the bottom on his p.\ 9)$(1 + s_d)^{n_d} (1 - s_p^{'})^{n_p}$where$s_p^{'} = s_p/(1 + s_p)$. However, if we want to express everything as products (no ratios) and use the "positive s means advantage and negative s means disadvantage" rule, we want to write the above expression as$(1 + s_d)^{n_d} (1 + s_{pp})^{n_p}$where$s_{pp} = -s_p/(1 + s_p)$. And this is actually what we do in v.2. There is an example, for instance, in section \@ref(mcf5070) where you will see: {r mcflparam} sp <- 1e-3 spp <- -sp/(1 + sp)  so we are going from the "(...)$s_p$is the fitness disadvantage conferred by a passenger" in @McFarland2013 (p. 2911) and @McFarland2014-phd (p. 9) to the expression where we have a product$\prod (1 + s_i)$, with the "positive s means advantage and negative s means disadvantage" rule. This reparameterization applies to v.2. In v.1 we use the same parameterization as in the original one in @McFarland2013, but with the "positive s means advantage and negative s means disadvantage" rule (so we are using expression$\frac{(1 + s)^d}{(1 - s_p)^p}$). <!-- However, we can map from this ratio to the usual product of terms by --> <!-- using a different value of$s_p$, that we will call$s_{pp} = -->
<!-- -s_p/(1 + s_p)$(see @McFarland2014-phd, his eq. 2.1 in p.9). --> #### Death rate under the McFarland model {#mcfldeath} For death rate, we use the expression that @McFarland2013 (see their p. 2911) use "(...) for large cancers (grown to$10^6$cells)":$D(N) =
\log(1 + N/K)$where$K$is the initial equilibrium population size. As the authors explain, for large N/K the above expression "(...) recapitulates Gompertzian dynamics observed experimentally for large tumors". By default, OncoSimulR uses a value of$K=initSize/(e^{1} - 1)$so that the starting population is at equilibrium. A consequence of the above expression for death rate is that if the population size decreases the death rate decreases. This is not relevant in most cases (as mutations, or some mutations, will inexorably lead to population size increases). And this prevents the McFL model from resulting in extinction even with very small population sizes as long as birth rate$\ge$death rate. (For small population sizes, it is likely that the population will become extinct if birth rate = death rate; you can try this with the exponential model). But this is not what we want in some other models, such as frequency-dependent ones, where modeling population collapse (which will happen if birth rate < death rate) can be important (as in the example in \@ref(fdfabs)). Here, it makes sense to set$D(N) =
\max(1, \log(1 + N/K))$so that the death rate never decreases below 1. (Using 1 is reasonable if we consider the equilibrium birth rate in the absence of any mutants to be 1). You can specify this behaviour using model McFLD (a shorthand for McFarlandLogD). ### No viability of clones and types of models {#noviab} For all models where fitness affects directly the birth rate (all except Bozic), if you specify that some event (say, mutating gene A) has$s_A \le
-1$, if that event happens then birth rate becomes zero. This is taken to indicate that the clone is not even viable and thus disappears immediately without any chance for mutation[^3]. [^3]:This is a shortcut that we take because we think that it is what you mean. Note, however, that technically a clone with birth rate of 0 might have a non-zero probability of mutating before becoming extinct because in the continuous time model we use mutation is not linked to reproduction. In the present code, we are not allowing for any mutation when birth rate is 0. There are other options, but none which I find really better. An alternative implementation makes a clone immediately extinct if and only if any of the$s_i = -\infty$. However, we still need to handle the case with$s_i < -1$as a special case. We either make it identical to the case with any$s_i = -\infty$or for any$s_i >
-\infty$we set$(1 + s_i) = \max(0, 1 + s_i)$(i.e., if$s_i <
-1$then$(1 + s_i) = 0$), to avoid obtaining negative birth rates (that make no sense) and the problem of multiplying an even number of negative numbers. I think only the second would make sense as an alternative. Models based on Bozic, however, have a birth rate of 1 and mutations affect the death rate. In this case, a death rate larger than birth rate, *per se*, does not signal immediate extinction and, moreover, even for death rates that are a few times larger than birth rates, the clone could mutate before becoming extinct[^4]. [^4]:We said "a few times". For a clone of population size 1 ---which is the size at which all clones start from mutation---, if death rate is, say, 90 but birth rate is 1, the probability of mutating before becoming extinct is very, very close to zero for all reasonable values of mutation rate}. How do we signal immediate extinction or no viability in this case? You can set the value of$s = -\infty$. In general, if you want to identify some mutations or some combinations of mutations as leading to immediate extinction (i.e., no viability), of the affected clone, set it to$-\infty$as this would work even if how birth rates of 0 are handled changes. Most examples below evaluate fitness by its effects on the birth rate. You can see one where we do it both ways in Section \@ref(fit-neg-pos). ## Genes without interactions {#noint} This is a simple scenario. Each gene$i$has a fitness effect$s_i$if mutated. The$s_i$can come from any distribution you want. As an example let's use three genes. We know there are no order effects, but we will also see what happens if we examine genotypes as ordered. {r} ai1 <- evalAllGenotypes(allFitnessEffects( noIntGenes = c(0.05, -.2, .1)), order = FALSE)  We can easily verify the first results: {r} ai1  {r} all(ai1[, "Fitness"] == c( (1 + .05), (1 - .2), (1 + .1), (1 + .05) * (1 - .2), (1 + .05) * (1 + .1), (1 - .2) * (1 + .1), (1 + .05) * (1 - .2) * (1 + .1)))  And we can see that considering the order of mutations (see section \@ref(oe)) makes no difference: {r} (ai2 <- evalAllGenotypes(allFitnessEffects( noIntGenes = c(0.05, -.2, .1)), order = TRUE, addwt = TRUE))  (The meaning of the notation in the output table is as follows: "WT" denotes the wild-type, or non-mutated clone. The notation$x > y$means that a mutation in "x" happened before a mutation in "y". A genotype$x > y\ \_\ z$means that a mutation in "x" happened before a mutation in "y"; there is also a mutation in "z", but that is a gene for which order does not matter). And what if I want genes without interactions but I want modules (see section \@ref(modules0))? Go to section \@ref(mod-no-epi). ## Using DAGs: Restrictions in the order of mutations as extended posets {#posetslong} ### AND, OR, XOR relationships {#andorxor} The literature on Oncogenetic trees, CBNs, etc, has used graphs as a way of showing the restrictions in the order in which mutations can accumulate. The meaning of "convergent arrows" in these graphs, however, differs. In Figure 1 of @Korsunsky2014 we are shown a simple diagram that illustrates the three basic different meanings of convergent arrows using two parental nodes. We will illustrate it here with three. Suppose we focus on node "g" in the following figure (we will create it shortly) {r, fig.height=4} data(examplesFitnessEffects) plot(examplesFitnessEffects[["cbn1"]])  * In relationships of the type used in **Conjunctive Bayesian Networks (CBN)** [e.g., @Gerstung2009], we are modeling an **AND** relationship, also called **CMPN** by @Korsunsky2014 or **monotone** relationship by @Farahani2013. If the relationship in the graph is fully respected, then "g" will only appear if all of "c", "d", and "e" are already mutated. * **Semimonotone** relationships *sensu* @Farahani2013 or **DMPN** *sensu* @Korsunsky2014 are **OR** relationships: "g" will appear if one or more of "c", "d", or "e" are already mutated. * **XMPN** relationships [@Korsunsky2014] are **XOR** relationships: "g" will be present only if exactly one of "c", "d", or "e" is present. Note that Oncogenetic trees [@Desper1999JCB; @Szabo2008] need not deal with the above distinctions, since the DAGs are trees: no node has more than one incoming connection or more than one parent[^5]. [^5]: OTs and CBNs have some other technical differences about the underlying model they assume, such as the exponential waiting time in CBNs. We will not discuss them here. To have a flexible way of specifying all of these restrictions, we will want to be able to say what kind of dependency each child node has on its parents. ### Fitness effects {#fitnessposets} Those DAGs specify dependencies and, as explained in @Diaz-Uriarte2015, it is simple to map them to a simple evolutionary model: any set of mutations that does not conform to the restrictions encoded in the graph will have a fitness of 0. However, we might not want to require absolute compliance with the DAG. This means we might want to allow deviations from the DAG with a corresponding penalization that is, however, not identical to setting fitness to 0 [again, see @Diaz-Uriarte2015]. This we can do by being explicit about the fitness effects of the deviations from the restrictions encoded in the DAG. We will use below a column of s for the fitness effect when the restrictions are satisfied and a column of sh when they are not. (See also \@ref(numfit) for the details about the meaning of the fitness effects). That way of specifying fitness effects makes it also trivial to use the model in @Hjelm2006 where all mutations might be allowed to occur, but the presence of some mutations increases the probability of occurrence of other mutations. For example, the values of sh could be all small positive ones (or for mildly deleterious effects, small negative numbers), while the values of s are much larger positive numbers. ### Extended posets In version 1 of this package we used posets in the sense of @Beerenwinkel2007 and @Gerstung2009, as explained in section \@ref(poset) and in the help for poset. Here, we continue using two columns, that specify parents and children, but we add columns for the specific values of fitness effects (both s and sh ---i.e., fitness effects for what happens when restrictions are and are not satisfied) and for the type of dependency as explained in section \@ref(andorxor). We can now illustrate the specification of different fitness effects using DAGs. ### DAGs: A first conjunction (AND) example {#cbn1} {r} cs <- data.frame(parent = c(rep("Root", 4), "a", "b", "d", "e", "c"), child = c("a", "b", "d", "e", "c", "c", rep("g", 3)), s = 0.1, sh = -0.9, typeDep = "MN") cbn1 <- allFitnessEffects(cs)  (We skip one letter, just to show that names need not be consecutive or have any particular order.) We can get a graphical representation using the default "graphNEL" {r, fig.height=3} plot(cbn1)  or one using "igraph": {r, fig.height=5} plot(cbn1, "igraph")  <!-- %% The vignette crashes if I try to use the layout. --> Since we have a parent and children, the reingold.tilford layout is probably the best here, so you might want to use that: {r, fig.height=5} library(igraph) ## to make the reingold.tilford layout available plot(cbn1, "igraph", layout = layout.reingold.tilford)  And what is the fitness of all genotypes? {r} gfs <- evalAllGenotypes(cbn1, order = FALSE, addwt = TRUE) gfs[1:15, ]  You can verify that for each genotype, if a mutation is present without all of its dependencies present, you get a$(1 - 0.9)$multiplier, and you get a$(1 + 0.1)$multiplier for all the rest with its direct parents satisfied. For example, genotypes "a", or "b", or "d", or "e" have fitness$(1 + 0.1)$, genotype "a, b, c" has fitness$(1 + 0.1)^3$, but genotype "a, c" has fitness$(1 + 0.1) (1 - 0.9) = 0.11$. ### DAGs: A second conjunction example {#cbn2} Let's try a first attempt at a somewhat more complex example, where the fitness consequences of different genes differ. {r} c1 <- data.frame(parent = c(rep("Root", 4), "a", "b", "d", "e", "c"), child = c("a", "b", "d", "e", "c", "c", rep("g", 3)), s = c(0.01, 0.02, 0.03, 0.04, 0.1, 0.1, rep(0.2, 3)), sh = c(rep(0, 4), c(-.1, -.2), c(-.05, -.06, -.07)), typeDep = "MN") try(fc1 <- allFitnessEffects(c1))  If you try this, you'll get an error. There is an error because the "sh" varies within a child, and we do not allow that for a poset-type specification, as it is ambiguous. If you need arbitrary fitness values for arbitrary combinations of genotypes, you can specify them using epistatic effects as in section \@ref(epi) and order effects as in section \@ref(oe). Why do we need to specify as many "s" and "sh" as there are rows (or a single one, that gets expanded to those many) when the "s" and "sh" are properties of the child node, not of the edges? Because, for ease, we use a data.frame. <!-- %% (By the way, yes, we convert all factors to strings in the parent, child, --> <!-- %% and typeDep columns, so no need to specify stringsAsFactor = TRUE). --> We fix the error in our specification. Notice that the "sh" is not set to$-1$in these examples. If you want strict compliance with the poset restrictions, you should set$sh = -1$or, better yet,$sh = -\infty$(see section \@ref(noviab)), but having an$sh > -1$will lead to fitnesses that are$> 0$and, thus, is a way of modeling small deviations from the poset [see discussion in @Diaz-Uriarte2015]. <!-- %% In these examples, the reason to set "sh" to values larger than$-1$and --> <!-- %% different among the genes is to allow us to easily see the actual, --> <!-- %% different, terms that enter into the multiplication of the fitness effects --> <!-- %% (and, also, to make it easier to catch bugs). --> Note that for those nodes that depend only on "Root" the type of dependency is irrelevant. {r} c1 <- data.frame(parent = c(rep("Root", 4), "a", "b", "d", "e", "c"), child = c("a", "b", "d", "e", "c", "c", rep("g", 3)), s = c(0.01, 0.02, 0.03, 0.04, 0.1, 0.1, rep(0.2, 3)), sh = c(rep(0, 4), c(-.9, -.9), rep(-.95, 3)), typeDep = "MN") cbn2 <- allFitnessEffects(c1)  We could get graphical representations but the figures would be the same as in the example in section \@ref(cbn1), since the structure has not changed, only the numeric values. What is the fitness of all possible genotypes? Here, order of events *per se* does not matter, beyond that considered in the poset. In other words, the fitness of genotype "a, b, c" is the same no matter how we got to "a, b, c". What matters is whether or not the genes on which each of "a", "b", and "c" depend are present or not (I only show the first 10 genotypes) {r} gcbn2 <- evalAllGenotypes(cbn2, order = FALSE) gcbn2[1:10, ]  Of course, if we were to look at genotypes but taking into account order of occurrence of mutations, we would see no differences {r} gcbn2o <- evalAllGenotypes(cbn2, order = TRUE, max = 1956) gcbn2o[1:10, ]  (The$max = 1956$is there so that we show all the genotypes, even if they are more than 256, the default.) You can check the output and verify things are as they should. For instance: {r} all.equal( gcbn2[c(1:21, 22, 28, 41, 44, 56, 63 ) , "Fitness"], c(1.01, 1.02, 0.1, 1.03, 1.04, 0.05, 1.01 * c(1.02, 0.1, 1.03, 1.04, 0.05), 1.02 * c(0.10, 1.03, 1.04, 0.05), 0.1 * c(1.03, 1.04, 0.05), 1.03 * c(1.04, 0.05), 1.04 * 0.05, 1.01 * 1.02 * 1.1, 1.01 * 0.1 * 0.05, 1.03 * 1.04 * 0.05, 1.01 * 1.02 * 1.1 * 0.05, 1.03 * 1.04 * 1.2 * 0.1, ## notice this 1.01 * 1.02 * 1.03 * 1.04 * 1.1 * 1.2 ))  A particular one that is important to understand is genotype with mutated genes "c, d, e, g": {r} gcbn2[56, ] all.equal(gcbn2[56, "Fitness"], 1.03 * 1.04 * 1.2 * 0.10)  where "g" is taken as if its dependencies are satisfied (as "c", "d", and "e" are present) even when the dependencies of "c" are not satisfied (and that is why the term for "c" is 0.9). ### DAGs: A semimonotone or "OR" example {#mn1} We will reuse the above example, changing the type of relationship: {r} s1 <- data.frame(parent = c(rep("Root", 4), "a", "b", "d", "e", "c"), child = c("a", "b", "d", "e", "c", "c", rep("g", 3)), s = c(0.01, 0.02, 0.03, 0.04, 0.1, 0.1, rep(0.2, 3)), sh = c(rep(0, 4), c(-.9, -.9), rep(-.95, 3)), typeDep = "SM") smn1 <- allFitnessEffects(s1)  It looks like this (where edges are shown in blue to denote the semimonotone relationship): {r, fig.height=3} plot(smn1)  {r} gsmn1 <- evalAllGenotypes(smn1, order = FALSE)  Having just one parental dependency satisfied is now enough, in contrast to what happened before. For instance: {r} gcbn2[c(8, 12, 22), ] gsmn1[c(8, 12, 22), ] gcbn2[c(20:21, 28), ] gsmn1[c(20:21, 28), ]  ### An "XMPN" or "XOR" example {#xor1} Again, we reuse the example above, changing the type of relationship: {r} x1 <- data.frame(parent = c(rep("Root", 4), "a", "b", "d", "e", "c"), child = c("a", "b", "d", "e", "c", "c", rep("g", 3)), s = c(0.01, 0.02, 0.03, 0.04, 0.1, 0.1, rep(0.2, 3)), sh = c(rep(0, 4), c(-.9, -.9), rep(-.95, 3)), typeDep = "XMPN") xor1 <- allFitnessEffects(x1)  It looks like this (edges in red to denote the "XOR" relationship): {r, fig.height=3} plot(xor1)  {r} gxor1 <- evalAllGenotypes(xor1, order = FALSE)  Whenever "c" is present with both "a" and "b", the fitness component for "c" will be$(1 - 0.1)$. Similarly for "g" (if more than one of "d", "e", or "c" is present, it will show as$(1 - 0.05)$). For example: {r} gxor1[c(22, 41), ] c(1.01 * 1.02 * 0.1, 1.03 * 1.04 * 0.05)  However, having just both "a" and "b" is identical to the case with CBN and the monotone relationship (see sections \@ref(cbn2) and \@ref(mn1)). If you want the joint presence of "a" and "b" to result in different fitness than the product of the individual terms, without considering the presence of "c", you can specify that using general epistatic effects (section \@ref(epi)). We also see a very different pattern compared to CBN (section \@ref(cbn2)) here: {r} gxor1[28, ] 1.01 * 1.1 * 1.2  as exactly one of the dependencies for both "c" and "g" are satisfied. But {r} gxor1[44, ] 1.01 * 1.02 * 0.1 * 1.2  is the result of a$0.1$for "c" (and a$1.2$for "g" that has exactly one of its dependencies satisfied). ### Posets: the three types of relationships {#p3} {r} p3 <- data.frame( parent = c(rep("Root", 4), "a", "b", "d", "e", "c", "f"), child = c("a", "b", "d", "e", "c", "c", "f", "f", "g", "g"), s = c(0.01, 0.02, 0.03, 0.04, 0.1, 0.1, 0.2, 0.2, 0.3, 0.3), sh = c(rep(0, 4), c(-.9, -.9), c(-.95, -.95), c(-.99, -.99)), typeDep = c(rep("--", 4), "XMPN", "XMPN", "MN", "MN", "SM", "SM")) fp3 <- allFitnessEffects(p3)  This is how it looks like: {r, fig.height=3} plot(fp3)  We can also use "igraph": {r, fig.height=6} plot(fp3, "igraph", layout.reingold.tilford)  {r} gfp3 <- evalAllGenotypes(fp3, order = FALSE)  Let's look at a few: {r} gfp3[c(9, 24, 29, 59, 60, 66, 119, 120, 126, 127), ] c(1.01 * 1.1, 1.03 * .05, 1.01 * 1.02 * 0.1, 0.1 * 0.05 * 1.3, 1.03 * 1.04 * 1.2, 1.01 * 1.02 * 0.1 * 0.05, 0.1 * 1.03 * 1.04 * 1.2 * 1.3, 1.01 * 1.02 * 0.1 * 1.03 * 1.04 * 1.2, 1.02 * 1.1 * 1.03 * 1.04 * 1.2 * 1.3, 1.01 * 1.02 * 1.03 * 1.04 * 0.1 * 1.2 * 1.3)  As before, looking at the order of mutations makes no difference (look at the test directory to see a test that verifies this assertion). ## Modules {#modules0} As already mentioned, we can think of all the effects of fitness in terms not of individual genes but, rather, modules. This idea is discussed in, for example, @Raphael2014a, @Gerstung2011: the restrictions encoded in, say, the DAGs can be considered to apply not to genes, but to modules, where each module is a set of genes (and the intersection between modules is the empty set). Modules, then, play the role of a "union operation" over sets of genes. Of course, if we can use modules for the restrictions in the DAGs we should also be able to use them for epistasis and order effects, as we will see later (e.g., \@ref(oemod)). ### What does a module provide {#module-what-for} Modules can provide very compact ways of specifying relationships when you want to, well, model the existence of modules. For simplicity suppose there is a module, "A", made of genes "a1" and "a2", and a module "B", made of a single gene "b1". Module "B" can mutate if module "A" is mutated, but mutating both "a1" and "a2" provides no additional fitness advantage compared to mutating only a single one of them. We can specify this as: {r} s <- 0.2 sboth <- (1/(1 + s)) - 1 m0 <- allFitnessEffects(data.frame( parent = c("Root", "Root", "a1", "a2"), child = c("a1", "a2", "b", "b"), s = s, sh = -1, typeDep = "OR"), epistasis = c("a1:a2" = sboth)) evalAllGenotypes(m0, order = FALSE, addwt = TRUE)  Note that we need to add an epistasis term, with value "sboth" to capture the idea of "mutating both "a1" and "a2" provides no additional fitness advantage compared to mutating only a single one of them"; see details in section \@ref(epi). Now, specify it using modules: {r} s <- 0.2 m1 <- allFitnessEffects(data.frame( parent = c("Root", "A"), child = c("A", "B"), s = s, sh = -1, typeDep = "OR"), geneToModule = c("Root" = "Root", "A" = "a1, a2", "B" = "b1")) evalAllGenotypes(m1, order = FALSE, addwt = TRUE)  This captures the ideas directly. The typing savings here are small, but they can be large with modules with many genes. ### Specifying modules {#modules} How do you specify modules? The general procedure is simple: you pass a vector that makes explicit the mapping from modules to sets of genes. We just saw an example. There are several additional examples such as \@ref(pm3), \@ref(oemod), \@ref(epimod). <!-- %% Why do we force you to specify "Root" = "Root"? We could check for it, --> <!-- %% and add it if it is not present. But we want you to be explicit (and we --> <!-- %% want to avoid you shooting yourself in the foot having a gene that is not --> <!-- %% the root of the tree but is called "Root", etc). --> It is important to note that, once you specify modules, we expect all of the relationships (except those that involve the non interacting genes) to be specified as modules. Thus, all elements of the epistasis, posets (the DAGs) and order effects components should be specified in terms of modules. But you can, of course, specify a module as containing a single gene (and a single gene with the same name as the module). What about the "Root" node? If you use a "restriction table", that restriction table (that DAG) must have a node named "Root" and in the mapping of genes to module there **must** be a first entry that has a module and gene named "Root", as we saw above with geneToModule = c("Root" = "Root", .... We force you to do this to be explicit about the "Root" node. This is not needed (thought it does not hurt) with other fitness specifications. For instance, if we have a model with two modules, one of them with two genes (see details in section \@ref(mod-no-epi)) we do not need to pass a "Root" as in {r} fnme <- allFitnessEffects(epistasis = c("A" = 0.1, "B" = 0.2), geneToModule = c("A" = "a1, a2", "B" = "b1")) evalAllGenotypes(fnme, order = FALSE, addwt = TRUE)  but it is also OK to have a "Root" in the geneToModule: {r} fnme2 <- allFitnessEffects(epistasis = c("A" = 0.1, "B" = 0.2), geneToModule = c( "Root" = "Root", "A" = "a1, a2", "B" = "b1")) evalAllGenotypes(fnme, order = FALSE, addwt = TRUE)  ### Modules and posets again: the three types of relationships and modules {#pm3} We use the same specification of poset, but add modules. To keep it manageable, we only add a few genes for some modules, and have some modules with a single gene. Beware that the number of genotypes is starting to grow quite fast, though. We capitalize to differentiate modules (capital letters) from genes (lowercase with a number), but this is not needed. {r} p4 <- data.frame( parent = c(rep("Root", 4), "A", "B", "D", "E", "C", "F"), child = c("A", "B", "D", "E", "C", "C", "F", "F", "G", "G"), s = c(0.01, 0.02, 0.03, 0.04, 0.1, 0.1, 0.2, 0.2, 0.3, 0.3), sh = c(rep(0, 4), c(-.9, -.9), c(-.95, -.95), c(-.99, -.99)), typeDep = c(rep("--", 4), "XMPN", "XMPN", "MN", "MN", "SM", "SM")) fp4m <- allFitnessEffects( p4, geneToModule = c("Root" = "Root", "A" = "a1", "B" = "b1, b2", "C" = "c1", "D" = "d1, d2", "E" = "e1", "F" = "f1, f2", "G" = "g1"))  By default, plotting shows the modules: {r, fig.height=3} plot(fp4m)  but we can show the gene names instead of the module names: {r, fig.height=3} plot(fp4m, expandModules = TRUE)  or {r, fig.height=6} plot(fp4m, "igraph", layout = layout.reingold.tilford, expandModules = TRUE)  We obtain the fitness of all genotypes in the usual way: {r} gfp4 <- evalAllGenotypes(fp4m, order = FALSE, max = 1024)  Let's look at a few of those: {r} gfp4[c(12, 20, 21, 40, 41, 46, 50, 55, 64, 92, 155, 157, 163, 372, 632, 828), ] c(1.01 * 1.02, 1.02, 1.02 * 1.1, 0.1 * 1.3, 1.03, 1.03 * 1.04, 1.04 * 0.05, 0.05 * 1.3, 1.01 * 1.02 * 0.1, 1.02 * 1.1, 0.1 * 0.05 * 1.3, 1.03 * 0.05, 1.03 * 0.05, 1.03 * 1.04 * 1.2, 1.03 * 1.04 * 1.2, 1.02 * 1.1 * 1.03 * 1.04 * 1.2 * 1.3)  ## Order effects {#oe} As explained in the introduction (section \@ref(introdd)), by order effects we mean a phenomenon such as the one shown empirically by @Ortmann2015: the fitness of a double mutant "A", "B" is different depending on whether "A" was acquired before "B" or "B" before "A". This, of course, can be generalized to more than two genes. Note that order effects are different from the restrictions in the order of accumulation of mutations discussed in section \@ref(posetslong). With restrictions in the order of accumulation of mutations we might say that acquiring "B" depends or is facilitated by having "A" mutated (and, unless we allowed for multiple mutations, having "A" mutated means having "A" mutated before "B"). However, once you have the genotype "A, B", its fitness does not depend on the order in which "A" and "B" appeared. ### Order effects: three-gene orders {#oeftres} Consider this case, where three specific three-gene orders and two two-gene orders (one of them a subset of one of the three) lead to different fitness compared to the wild-type. We add also modules, to show its usage (but just limit ourselves to using one gene per module here). Order effects are specified using a$x > y$, which means that that order effect is satisfied when module$x$is mutated before module$y$. {r} o3 <- allFitnessEffects(orderEffects = c( "F > D > M" = -0.3, "D > F > M" = 0.4, "D > M > F" = 0.2, "D > M" = 0.1, "M > D" = 0.5), geneToModule = c("M" = "m", "F" = "f", "D" = "d") ) (ag <- evalAllGenotypes(o3, addwt = TRUE, order = TRUE))  (The meaning of the notation in the output table is as follows: "WT" denotes the wild-type, or non-mutated clone. The notation$x > y$means that a mutation in "x" happened before a mutation in "y". A genotype$x > y\ \_\ z$means that a mutation in "x" happened before a mutation in "y"; there is also a mutation in "z", but that is a gene for which order does not matter). The values for the first nine genotypes come directly from the fitness specifications. The 10th genotype matches$D > F > M$($= (1 + 0.4)$) but also$D > M$($(1 + 0.1)$). The 11th matches$D > M > F$and$D >
M$. The 12th matches$F > D > M$but also$D > M$. Etc. ### Order effects and modules with multiple genes {#oemod} Consider the following case: {r} ofe1 <- allFitnessEffects( orderEffects = c("F > D" = -0.3, "D > F" = 0.4), geneToModule = c("F" = "f1, f2", "D" = "d1, d2") ) ag <- evalAllGenotypes(ofe1, order = TRUE)  There are four genes,$d1, d2, f1, f2$, where each$d$belongs to module$D$and each$f$belongs to module$F$. What to expect for cases such as$d1 > f1$or$f1 > d1$is clear, as shown in {r} ag[5:16,]  Likewise, cases such as$d1 > d2 > f1$or$f2 > f1 > d1$are clear, because in terms of modules they map to$ D > F$or$F > D$: the observed order of mutation$d1 > d2 > f1$means that module$D$was mutated first and module$F$was mutated second. Similar for$d1 > f1 > f2$or$f1 > d1 > d2$: those map to$D > F$and$F > D$. We can see the fitness of those four case in: {r} ag[c(17, 39, 19, 29), ]  and they correspond to the values of those order effects, where$F > D =
(1 - 0.3)$and$D > F = (1 + 0.4)$: {r} ag[c(17, 39, 19, 29), "Fitness"] == c(1.4, 0.7, 1.4, 0.7)  What if we match several patterns? For example,$d1 > f1 > d2 > f2$and$d1 > f1 > f2 > d2$? The first maps to$D > F > D > F$and the second to$D > F > D$. But since we are concerned with which one happened first and which happened second we should expect those two to correspond to the same fitness, that of pattern$D > F$, as is the case: {r} ag[c(43, 44),] ag[c(43, 44), "Fitness"] == c(1.4, 1.4)  More generally, that applies to all the patterns that start with one of the "d" genes: {r} all(ag[41:52, "Fitness"] == 1.4)  Similar arguments apply to the opposite pattern,$F > D$, which apply to all the possible gene mutation orders that start with one of the "f" genes. For example: {r} all(ag[53:64, "Fitness"] == 0.7)  ### Order and modules with 325 genotypes We can of course have more than two genes per module. This just repeats the above, with five genes (there are 325 genotypes, and that is why we pass the "max" argument to evalAllGenotypes, to allow for more than the default 256). {r} ofe2 <- allFitnessEffects( orderEffects = c("F > D" = -0.3, "D > F" = 0.4), geneToModule = c("F" = "f1, f2, f3", "D" = "d1, d2") ) ag2 <- evalAllGenotypes(ofe2, max = 325, order = TRUE)  We can verify that any combination that starts with a "d" gene and then contains at least one "f" gene will have a fitness of$1+0.4$. And any combination that starts with an "f" gene and contains at least one "d" genes will have a fitness of$1 - 0.3$. All other genotypes have a fitness of 1: {r} all(ag2[grep("^d.*f.*", ag2[, 1]), "Fitness"] == 1.4) all(ag2[grep("^f.*d.*", ag2[, 1]), "Fitness"] == 0.7) oe <- c(grep("^f.*d.*", ag2[, 1]), grep("^d.*f.*", ag2[, 1])) all(ag2[-oe, "Fitness"] == 1)  ### Order effects and genes without interactions We will now look at both order effects and interactions. To make things more interesting, we name genes so that the ordered names do split nicely between those with and those without order effects (this, thus, also serves as a test of messy orders of names). {r} foi1 <- allFitnessEffects( orderEffects = c("D>B" = -0.2, "B > D" = 0.3), noIntGenes = c("A" = 0.05, "C" = -.2, "E" = .1))  You can get a verbose view of what the gene names and modules are (and their automatically created numeric codes) by: {r} foi1[c("geneModule", "long.geneNoInt")]  We can get the fitness of all genotypes (we set$max = 325$because that is the number of possible genotypes): {r} agoi1 <- evalAllGenotypes(foi1, max = 325, order = TRUE) head(agoi1)  Now: {r} rn <- 1:nrow(agoi1) names(rn) <- agoi1[, 1] agoi1[rn[LETTERS[1:5]], "Fitness"] == c(1.05, 1, 0.8, 1, 1.1)  According to the fitness effects we have specified, we also know that any genotype with only two mutations, one of which is either "A", "C" "E" and the other is "B" or "D" will have the fitness corresponding to "A", "C" or "E", respectively: {r} agoi1[grep("^A > [BD]$", names(rn)), "Fitness"] == 1.05
agoi1[grep("^C > [BD]$", names(rn)), "Fitness"] == 0.8 agoi1[grep("^E > [BD]$", names(rn)), "Fitness"] == 1.1
agoi1[grep("^[BD] > A$", names(rn)), "Fitness"] == 1.05 agoi1[grep("^[BD] > C$", names(rn)), "Fitness"] == 0.8
agoi1[grep("^[BD] > E$", names(rn)), "Fitness"] == 1.1  We will not be playing many additional games with regular expressions, but let us check those that start with "D" and have all the other mutations, which occupy rows 230 to 253; fitness should be equal (within numerical error, because of floating point arithmetic) to the order effect of "D" before "B" times the other effects$(1 - 0.3) * 1.05 * 0.8 * 1.1 = 0.7392${r} all.equal(agoi1[230:253, "Fitness"] , rep((1 - 0.2) * 1.05 * 0.8 * 1.1, 24))  and that will also be the value of any genotype with the five mutations where "D" comes before "B" such as those in rows 260 to 265, 277, or 322 and 323, but it will be equal to$(1 + 0.3) * 1.05 * 0.8 * 1.1 =
1.2012$in those where "B" comes before "D". Analogous arguments apply to four, three, and two mutation genotypes. ## Epistasis {#epi} ### Epistasis: two alternative specifications {#e2} We want the following mapping of genotypes to fitness: ------------------------ A B Fitness -- -- -------------- wt wt 1 wt M$1 + s_b$M wt$1 + s_a$M M$1 + s_{ab}$-- -- --------------- Suppose that the actual numerical values are$s_a = 0.2, s_b = 0.3, s_{ab}
= 0.7$. We specify the above as follows: {r} sa <- 0.2 sb <- 0.3 sab <- 0.7 e2 <- allFitnessEffects(epistasis = c("A: -B" = sa, "-A:B" = sb, "A : B" = sab)) evalAllGenotypes(e2, order = FALSE, addwt = TRUE)  That uses the "-" specification, so we explicitly exclude some patterns: with "A:-B" we say "A when there is no B". But we can also use a specification where we do not use the "-". That requires a different numerical value of the interaction, because now, as we are rewriting the interaction term as genotype "A is mutant, B is mutant" the double mutant will incorporate the effects of "A mutant", "B mutant" and "both A and B mutants". We can define a new$s_2$that satisfies$(1 + s_{ab}) = (1 + s_a) (1 + s_b) (1 + s_2)$so$(1 + s_2) = (1 + s_{ab})/((1 + s_a) (1 + s_b))$and therefore specify as: {r} s2 <- ((1 + sab)/((1 + sa) * (1 + sb))) - 1 e3 <- allFitnessEffects(epistasis = c("A" = sa, "B" = sb, "A : B" = s2)) evalAllGenotypes(e3, order = FALSE, addwt = TRUE)  Note that this is the way you would specify effects with FFPopsim [@Zanini2012]. Whether this specification or the previous one with "-" is simpler will depend on the model. For synthetic mortality and viability, I think the one using "-" is simpler to map genotype tables to fitness effects. See also section \@ref(e3) and \@ref(theminus) and the example in section \@ref(weis1b). Finally, note that we can also specify some of these effects by combining the graph and the epistasis, as shown in section \@ref(misra1a) or \@ref(weis1b). ### Epistasis with three genes and two alternative specifications {#e3} Suppose we have ------------------------------------- A B C Fitness -- -- -- -------------------------- M wt wt$1 + s_a$wt M wt$1 + s_b$wt wt M$1 + s_c$M M wt$1 + s_{ab}$wt M M$1 + s_{bc}$M wt M$(1 + s_a) (1 + s_c)$M M M$1 + s_{abc}$-- -- -- -------------------------- where missing rows have a fitness of 1 (they have been deleted for conciseness). Note that the mutant for exactly A and C has a fitness that is the product of the individual terms (so there is no epistasis in that case). {r} sa <- 0.1 sb <- 0.15 sc <- 0.2 sab <- 0.3 sbc <- -0.25 sabc <- 0.4 sac <- (1 + sa) * (1 + sc) - 1 E3A <- allFitnessEffects(epistasis = c("A:-B:-C" = sa, "-A:B:-C" = sb, "-A:-B:C" = sc, "A:B:-C" = sab, "-A:B:C" = sbc, "A:-B:C" = sac, "A : B : C" = sabc) ) evalAllGenotypes(E3A, order = FALSE, addwt = FALSE)  We needed to pass the$s_{ac}$coefficient explicitly, even if it that term was just the product. We can try to avoid using the "-", however (but we will need to do other calculations). For simplicity, I use capital "S" in what follows where the letters differ from the previous specification: {r} sa <- 0.1 sb <- 0.15 sc <- 0.2 sab <- 0.3 Sab <- ( (1 + sab)/((1 + sa) * (1 + sb))) - 1 Sbc <- ( (1 + sbc)/((1 + sb) * (1 + sc))) - 1 Sabc <- ( (1 + sabc)/ ( (1 + sa) * (1 + sb) * (1 + sc) * (1 + Sab) * (1 + Sbc) ) ) - 1 E3B <- allFitnessEffects(epistasis = c("A" = sa, "B" = sb, "C" = sc, "A:B" = Sab, "B:C" = Sbc, ## "A:C" = sac, ## not needed now "A : B : C" = Sabc) ) evalAllGenotypes(E3B, order = FALSE, addwt = FALSE)  The above two are, of course, identical: {r} all(evalAllGenotypes(E3A, order = FALSE, addwt = FALSE) == evalAllGenotypes(E3B, order = FALSE, addwt = FALSE))  We avoid specifying the "A:C", as it just follows from the individual "A" and "C" terms, but given a specified genotype table, we need to do a little bit of addition and multiplication to get the coefficients. ### Why can we specify some effects with a "-"? {#theminus} Let's suppose we want to specify the synthetic viability example seen before: ----------------- A B Fitness -- -- ---------- wt wt 1 wt M 0 M wt 0 M M (1 + s) -- -- -------- where "wt" denotes wild type and "M" denotes mutant. If you want to directly map the above table to the fitness table for the program, to specify the genotype "A is wt, B is a mutant" you can specify it as "-A,B", not just as "B". Why? Because just the presence of a "B" is also compatible with genotype "A is mutant and B is mutant". If you use "-" you are explicitly saying what should not be there so that "-A,B" is NOT compatible with "A, B". Otherwise, you need to carefully add coefficients. Depending on what you are trying to model, different specifications might be simpler. See the examples in section \@ref(e2) and \@ref(e3). You have both options. ### Epistasis: modules {#epimod} There is nothing conceptually new, but we will show an example here: {r} sa <- 0.2 sb <- 0.3 sab <- 0.7 em <- allFitnessEffects(epistasis = c("A: -B" = sa, "-A:B" = sb, "A : B" = sab), geneToModule = c("A" = "a1, a2", "B" = "b1, b2")) evalAllGenotypes(em, order = FALSE, addwt = TRUE)  Of course, we can do the same thing without using the "-", as in section \@ref(e2): {r} s2 <- ((1 + sab)/((1 + sa) * (1 + sb))) - 1 em2 <- allFitnessEffects(epistasis = c("A" = sa, "B" = sb, "A : B" = s2), geneToModule = c("A" = "a1, a2", "B" = "b1, b2") ) evalAllGenotypes(em2, order = FALSE, addwt = TRUE)  ## I do not want epistasis, but I want modules! {#mod-no-epi} Sometimes you might want something like having several modules, say "A" and "B", each with a number of genes, but with "A" and "B" showing no interaction. It is a terminological issue whether we should allow noIntGenes (no interaction genes), as explained in section \@ref(noint) to actually be modules. The reasoning for not allowing them is that the situation depicted above (several genes in module A, for example) actually is one of interaction: the members of "A" are combined using an "OR" operator (i.e., the fitness consequences of having one or more genes of A mutated are the same), not just simply multiplying their fitness; similarly for "B". This is why no interaction genes also mean no modules allowed. So how do you get what you want in this case? Enter the names of the modules in the epistasis component but have no term for ":" (the colon). Let's see an example: {r} fnme <- allFitnessEffects(epistasis = c("A" = 0.1, "B" = 0.2), geneToModule = c("A" = "a1, a2", "B" = "b1, b2, b3")) evalAllGenotypes(fnme, order = FALSE, addwt = TRUE)  In previous versions these was possible using the longer, still accepted way of specifying a : with a value of 0, but this is no longer needed: {r} fnme <- allFitnessEffects(epistasis = c("A" = 0.1, "B" = 0.2, "A : B" = 0.0), geneToModule = c("A" = "a1, a2", "B" = "b1, b2, b3")) evalAllGenotypes(fnme, order = FALSE, addwt = TRUE)  This can, of course, be extended to more modules. ## Synthetic viability {#sv} Synthetic viability and synthetic lethality [e.g., @Ashworth2011; @Hartman2001] are just special cases of epistasis (section \@ref(epi)) but we deal with them here separately. ### A simple synthetic viability example A simple and extreme example of synthetic viability is shown in the following table, where the joint mutant has fitness larger than the wild type, but each single mutant is lethal. --------------- A B Fitness -- -- ---------- wt wt 1 wt M 0 M wt 0 M M (1 + s) -- -- -------- where "wt" denotes wild type and "M" denotes mutant. We can specify this (setting$s = 0.2$) as (I play around with spaces, to show there is a certain flexibility with them): {r} s <- 0.2 sv <- allFitnessEffects(epistasis = c("-A : B" = -1, "A : -B" = -1, "A:B" = s))  Now, let's look at all the genotypes (we use "addwt" to also get the wt, which by decree has fitness of 1), and disregard order: {r} (asv <- evalAllGenotypes(sv, order = FALSE, addwt = TRUE))  Asking the program to consider the order of mutations of course makes no difference: {r} evalAllGenotypes(sv, order = TRUE, addwt = TRUE)  Another example of synthetic viability is shown in section \@ref(misra1b). Of course, if multiple simultaneous mutations are not possible in the simulations, it is not possible to go from the wildtype to the double mutant in this model where the single mutants are not viable. ### Synthetic viability, non-zero fitness, and modules This is a slightly more elaborate case, where there is one module and the single mutants have different fitness between themselves, which is non-zero. Without the modules, this is the same as in @Misra2014, Figure 1b, which we go over in section \@ref(misra). --------------------- A B Fitness -- -- ------------- wt wt 1 wt M$1 + s_b$M wt$1 + s_a$M M$1 + s_{ab}$-- -- ---------------- where$s_a, s_b < 0$but$s_{ab} > 0$. {r} sa <- -0.1 sb <- -0.2 sab <- 0.25 sv2 <- allFitnessEffects(epistasis = c("-A : B" = sb, "A : -B" = sa, "A:B" = sab), geneToModule = c( "A" = "a1, a2", "B" = "b")) evalAllGenotypes(sv2, order = FALSE, addwt = TRUE)  And if we look at order, of course it makes no difference: {r} evalAllGenotypes(sv2, order = TRUE, addwt = TRUE)  ## Synthetic mortality or synthetic lethality {#sl} In contrast to section \@ref(sv), here the joint mutant has decreased viability: ------------------------- A B Fitness --- --- ------------- wt wt 1 wt M$1 + s_b$M wt$1 + s_a$M M$1 + s_{ab}$-- -- ---------------- where$s_a, s_b > 0$but$s_{ab} < 0$. {r} sa <- 0.1 sb <- 0.2 sab <- -0.8 sm1 <- allFitnessEffects(epistasis = c("-A : B" = sb, "A : -B" = sa, "A:B" = sab)) evalAllGenotypes(sm1, order = FALSE, addwt = TRUE)  And if we look at order, of course it makes no difference: {r} evalAllGenotypes(sm1, order = TRUE, addwt = TRUE)  ## Possible issues with Bozic model {#boznumissues} ### Synthetic viability using Bozic model {#fit-neg-pos} If we were to use the above specification with Bozic's models, we might not get what we think we should get: {r} evalAllGenotypes(sv, order = FALSE, addwt = TRUE, model = "Bozic")  What gives here? The simulation code would alert you of this (see section \@ref(ex-0-death)) in this particular case because there are "-1", which might indicate that this is not what you want. The problem is that you probably want the Death rate to be infinity (the birth rate was 0, so no clone viability, when we used birth rates ---section \@ref(noviab)). Let us say so explicitly: {r} s <- 0.2 svB <- allFitnessEffects(epistasis = c("-A : B" = -Inf, "A : -B" = -Inf, "A:B" = s)) evalAllGenotypes(svB, order = FALSE, addwt = TRUE, model = "Bozic")  Likewise, values of$s$larger than one have no effect beyond setting$s =
1$(a single term of$(1 - 1)$will drive the product to 0, and as we cannot allow negative death rates negative values are set to 0): {r} s <- 1 svB1 <- allFitnessEffects(epistasis = c("-A : B" = -Inf, "A : -B" = -Inf, "A:B" = s)) evalAllGenotypes(svB1, order = FALSE, addwt = TRUE, model = "Bozic") s <- 3 svB3 <- allFitnessEffects(epistasis = c("-A : B" = -Inf, "A : -B" = -Inf, "A:B" = s)) evalAllGenotypes(svB3, order = FALSE, addwt = TRUE, model = "Bozic")  Of course, death rates of 0.0 are likely to lead to trouble down the road, when we actually conduct simulations (see section \@ref(ex-0-death)). ### Numerical issues with death rates of 0 in Bozic model {#ex-0-death} As we mentioned above (section \@ref(fit-neg-pos)) death rates of 0 can lead to trouble when using Bozic's model: {r} i1 <- allFitnessEffects(noIntGenes = c(1, 0.5)) evalAllGenotypes(i1, order = FALSE, addwt = TRUE, model = "Bozic") i1_b <- oncoSimulIndiv(i1, model = "Bozic")  Of course, there is no problem in using the above with other models: {r} evalAllGenotypes(i1, order = FALSE, addwt = TRUE, model = "Exp") i1_e <- oncoSimulIndiv(i1, model = "Exp") summary(i1_e)  ## A longer example: Poset, epistasis, synthetic mortality and viability, order effects and genes without interactions, with some modules {#exlong} We will now put together a complex example. We will use the poset from section \@ref(pm3) but will also add: * Order effects that involve genes in the poset. In this case, if C happens before F, fitness decreases by$1 - 0.1$. If it happens the other way around, there is no effect on fitness beyond their individual contributions. <!-- but if it happens the other way around it increases by$1 + 0.13$. --> * Order effects that involve two new modules, "H" and "I" (with genes "h1, h2" and "i1", respectively), so that if H happens before I fitness increases by$1 + 0.12$. * Synthetic mortality between modules "I" (already present in the epistatic interaction) and "J" (with genes "j1" and "j2"): the joint presence of these modules leads to cell death (fitness of 0). * Synthetic viability between modules "K" and "M" (with genes "k1", "k2" and "m1", respectively), so that their joint presence is viable but adds nothing to fitness (i.e., mutation of both has fitness$1$), whereas each single mutant has a fitness of$1 - 0.5$. * A set of 5 driver genes ($n1, \ldots, n5$) with fitness that comes from an exponential distribution with rate of 10. As we are specifying many different things, we will start by writing each set of effects separately: {r} p4 <- data.frame( parent = c(rep("Root", 4), "A", "B", "D", "E", "C", "F"), child = c("A", "B", "D", "E", "C", "C", "F", "F", "G", "G"), s = c(0.01, 0.02, 0.03, 0.04, 0.1, 0.1, 0.2, 0.2, 0.3, 0.3), sh = c(rep(0, 4), c(-.9, -.9), c(-.95, -.95), c(-.99, -.99)), typeDep = c(rep("--", 4), "XMPN", "XMPN", "MN", "MN", "SM", "SM")) oe <- c("C > F" = -0.1, "H > I" = 0.12) sm <- c("I:J" = -1) sv <- c("-K:M" = -.5, "K:-M" = -.5) epist <- c(sm, sv) modules <- c("Root" = "Root", "A" = "a1", "B" = "b1, b2", "C" = "c1", "D" = "d1, d2", "E" = "e1", "F" = "f1, f2", "G" = "g1", "H" = "h1, h2", "I" = "i1", "J" = "j1, j2", "K" = "k1, k2", "M" = "m1") set.seed(1) ## for reproducibility noint <- rexp(5, 10) names(noint) <- paste0("n", 1:5) fea <- allFitnessEffects(rT = p4, epistasis = epist, orderEffects = oe, noIntGenes = noint, geneToModule = modules)  How does it look? {r, fig.height=5.5} plot(fea)  or {r, fig.height=5.5} plot(fea, "igraph")  We can, if we want, expand the modules using a "graphNEL" graph {r, fig.height=5.5} plot(fea, expandModules = TRUE)  or an "igraph" one {r, fig.height=6.5} plot(fea, "igraph", expandModules = TRUE)  We will not evaluate the fitness of all genotypes, since the number of all ordered genotypes is$> 7*10^{22}$. We will look at some specific genotypes: {r} evalGenotype("k1 > i1 > h2", fea) ## 0.5 evalGenotype("k1 > h1 > i1", fea) ## 0.5 * 1.12 evalGenotype("k2 > m1 > h1 > i1", fea) ## 1.12 evalGenotype("k2 > m1 > h1 > i1 > c1 > n3 > f2", fea) ## 1.12 * 0.1 * (1 + noint[3]) * 0.05 * 0.9  Finally, let's generate some ordered genotypes randomly: {r} randomGenotype <- function(fe, ns = NULL) { gn <- setdiff(c(fe$geneModule$Gene, fe$long.geneNoInt$Gene), "Root") if(is.null(ns)) ns <- sample(length(gn), 1) return(paste(sample(gn, ns), collapse = " > ")) } set.seed(2) ## for reproducibility evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: k2 > i1 > c1 > n1 > m1 ## Individual s terms are : 0.0755182 -0.9 ## Fitness: 0.107552 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: n2 > h1 > h2 ## Individual s terms are : 0.118164 ## Fitness: 1.11816 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: d2 > k2 > c1 > f2 > n4 > m1 > n3 > f1 > b1 > g1 > n5 > h1 > j2 ## Individual s terms are : 0.0145707 0.0139795 0.0436069 0.02 0.1 0.03 -0.95 0.3 -0.1 ## Fitness: 0.0725829 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: h2 > c1 > f1 > n2 > b2 > a1 > n1 > i1 ## Individual s terms are : 0.0755182 0.118164 0.01 0.02 -0.9 -0.95 -0.1 0.12 ## Fitness: 0.00624418 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: h2 > j1 > m1 > d2 > i1 > b2 > k2 > d1 > b1 > n3 > n1 > g1 > h1 > c1 > k1 > e1 > a1 > f1 > n5 > f2 ## Individual s terms are : 0.0755182 0.0145707 0.0436069 0.01 0.02 -0.9 0.03 0.04 0.2 0.3 -1 -0.1 0.12 ## Fitness: 0 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: n1 > m1 > n3 > i1 > j1 > n5 > k1 ## Individual s terms are : 0.0755182 0.0145707 0.0436069 -1 ## Fitness: 0 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: d2 > n1 > g1 > f1 > f2 > c1 > b1 > d1 > k1 > a1 > b2 > i1 > n4 > h2 > n2 ## Individual s terms are : 0.0755182 0.118164 0.0139795 0.01 0.02 -0.9 0.03 -0.95 0.3 -0.5 ## Fitness: 0.00420528 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: j1 > f1 > j2 > a1 > n4 > c1 > n3 > k1 > d1 > h1 ## Individual s terms are : 0.0145707 0.0139795 0.01 0.1 0.03 -0.95 -0.5 ## Fitness: 0.0294308 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: n5 > f2 > f1 > h2 > n4 > c1 > n3 > b1 ## Individual s terms are : 0.0145707 0.0139795 0.0436069 0.02 0.1 -0.95 ## Fitness: 0.0602298 evalGenotype(randomGenotype(fea), fea, echo = TRUE, verbose = TRUE) ## Genotype: h1 > d1 > f2 ## Individual s terms are : 0.03 -0.95 ## Fitness: 0.0515  ## Homozygosity, heterozygosity, oncogenes, tumor suppressors {#oncog} We are using what is conceptually a single linear chromosome. However, you can use it to model scenarios where the numbers of copies affected matter, by properly duplicating the genes. Suppose we have a tumor suppressor gene, G, with two copies, one from Mom and one from Dad. We can have a table like: ----------------------------$O_MO_D$Fitness ----- ----- -------------- wt wt 1 wt M 1 M wt 1 M M$(1 + s)$---- ----- --------------- where$s > 0$, meaning that you need two hits, one in each copy, to trigger the clonal expansion. What about oncogenes? A simple model is that one single hit leads to clonal expansion and additional hits lead to no additional changes, as in this table for gene O, where again the M or D subscript denotes the copy from Mom or from Dad: ----------------------------$O_MO_D$Fitness ----- ----- -------------- wt wt 1 wt M$(1 + s)$M wt$(1 + s)$M M$(1 + s)$---- ----- -------------- If you have multiple copies you can proceed similarly. As you can see, these are nothing but special cases of synthetic mortality (\@ref(sl)), synthetic viability (\@ref(sv)) and epistasis (\@ref(epi)). ## Gene-specific mutation rates {#per-gene-mutation} You can specify gene-specific mutation rates. Instead of passing a scalar value for mu, you pass a named vector. (This does not work with the old v. 1 format, though; yet another reason to stop using that format). This is a simple example (many more are available in the tests, see file ./tests/testthat/test.per-gene-mutation-rates.R). {r} muvar2 <- c("U" = 1e-6, "z" = 5e-5, "e" = 5e-4, "m" = 5e-3, "D" = 1e-4) ni1 <- rep(0, 5) names(ni1) <- names(muvar2) ## We use the same names, of course fe1 <- allFitnessEffects(noIntGenes = ni1) bb <- oncoSimulIndiv(fe1, mu = muvar2, onlyCancer = FALSE, initSize = 1e5, finalTime = 25, seed =NULL)  ## Mutator genes {#mutator} You can specify mutator/antimutator genes [e.g. @gerrish_complete_2007; @tomlinson_mutation_1996]. These are genes that, when mutated, lead to an increase/decrease in the mutation rate all over the genome (similar to what happens with, say, mutations in mismatch-repair genes or microsatellite instability in cancer). The specification is very similar to that for fitness effects, except we do not (at least for now) allow the use of DAGs nor of order effects (we have seen no reference in the literature to suggest any of these would be relevant). You can, however, specify epistasis and use modules. Note that the mutator genes must be a subset of the genes in the fitness effects; if you want to have mutator genes that have no direct fitness effects, give them a fitness effect of 0. This first is a very simple example with simple fitness effects and modules for mutators. We will specify the fitness and mutator effects and evaluate the fitness and mutator effects: {r} fe2 <- allFitnessEffects(noIntGenes = c(a1 = 0.1, a2 = 0.2, b1 = 0.01, b2 = 0.3, b3 = 0.2, c1 = 0.3, c2 = -0.2)) fm2 <- allMutatorEffects(epistasis = c("A" = 5, "B" = 10, "C" = 3), geneToModule = c("A" = "a1, a2", "B" = "b1, b2, b3", "C" = "c1, c2")) ## Show the fitness effect of a specific genotype evalGenotype("a1, c2", fe2, verbose = TRUE) ## Show the mutator effect of a specific genotype evalGenotypeMut("a1, c2", fm2, verbose = TRUE) ## Fitness and mutator of a specific genotype evalGenotypeFitAndMut("a1, c2", fe2, fm2, verbose = TRUE)  You can also use the evalAll functions. We do not show the output here to avoid cluttering the vignette: {r, eval=FALSE} ## Show only all the fitness effects evalAllGenotypes(fe2, order = FALSE) ## Show only all mutator effects evalAllGenotypesMut(fm2) ## Show all fitness and mutator evalAllGenotypesFitAndMut(fe2, fm2, order = FALSE)  Building upon the above, the next is an example where we have a bunch of no interaction genes that affect fitness, and a small set of genes that affect the mutation rate (but have no fitness effects). {r} set.seed(1) ## for reproducibility ## 17 genes, 7 with no direct fitness effects ni <- c(rep(0, 7), runif(10, min = -0.01, max = 0.1)) names(ni) <- c("a1", "a2", "b1", "b2", "b3", "c1", "c2", paste0("g", 1:10)) fe3 <- allFitnessEffects(noIntGenes = ni) fm3 <- allMutatorEffects(epistasis = c("A" = 5, "B" = 10, "C" = 3, "A:C" = 70), geneToModule = c("A" = "a1, a2", "B" = "b1, b2, b3", "C" = "c1, c2"))  Let us check what the effects are of a few genotypes: {r} ## These only affect mutation, not fitness evalGenotypeFitAndMut("a1, a2", fe3, fm3, verbose = TRUE) evalGenotypeFitAndMut("a1, b3", fe3, fm3, verbose = TRUE) ## These only affect fitness: the mutator multiplier is 1 evalGenotypeFitAndMut("g1", fe3, fm3, verbose = TRUE) evalGenotypeFitAndMut("g3, g9", fe3, fm3, verbose = TRUE) ## These affect both evalGenotypeFitAndMut("g3, g9, a2, b3", fe3, fm3, verbose = TRUE)  Finally, we will do a simulation with those data {r} set.seed(1) ## so that it is easy to reproduce mue1 <- oncoSimulIndiv(fe3, muEF = fm3, mu = 1e-6, initSize = 1e5, model = "McFL", detectionSize = 5e6, finalTime = 500, onlyCancer = FALSE)  {r, eval=FALSE} ## We do not show this in the vignette to avoid cluttering it ## with output mue1  Of course, it is up to you to keep things reasonable: mutator effects are multiplicative, so if you specify, say, 20 genes (without modules), or 20 modules, each with a mutator effect of 50, the overall mutation rate can be increased by a factor of$50^{20}$and that is unlikely to be what you really want (see also section \@ref(tomlinexcept)). You can play with the following case (an extension of the example above), where a clone with a mutator phenotype and some fitness enhancing mutations starts giving rise to many other clones, some with additional mutator effects, and thus leading to the number of clones blowing up (as some also accumulate additional fitness-enhancing mutations). Things start getting out of hand shortly after time 250. The code below takes a few minutes to run and is not executed here, but you can run it to get an idea of the increase in the number of clones and their relationships (the usage of plotClonePhylog is explained in section \@ref(phylog)). {r, eval=FALSE} set.seed(1) ## for reproducibility ## 17 genes, 7 with no direct fitness effects ni <- c(rep(0, 7), runif(10, min = -0.01, max = 0.1)) names(ni) <- c("a1", "a2", "b1", "b2", "b3", "c1", "c2", paste0("g", 1:10)) ## Next is for nicer figure labeling. ## Consider as drivers genes with s >0 gp <- which(ni > 0) fe3 <- allFitnessEffects(noIntGenes = ni, drvNames = names(ni)[gp]) set.seed(12) mue1 <- oncoSimulIndiv(fe3, muEF = fm3, mu = 1e-6, initSize = 1e5, model = "McFL", detectionSize = 5e6, finalTime = 270, keepPhylog = TRUE, onlyCancer = FALSE) mue1 ## If you decrease N even further it gets even more cluttered op <- par(ask = TRUE) plotClonePhylog(mue1, N = 10, timeEvents = TRUE) plot(mue1, plotDrivers = TRUE, addtot = TRUE, plotDiversity = TRUE) ## The stacked plot is slow; be patient ## Most clones have tiny population sizes, and their lines ## are piled on top of each other plot(mue1, addtot = TRUE, plotDiversity = TRUE, type = "stacked") par(op)  \clearpage # Plotting fitness landscapes {#plot-fit-land} The evalAllGenotypes and related functions allow you to obtain tables of the genotype to fitness mappings. It might be more convenient to actually plot that, allowing us to quickly identify local minima and maxima and get an idea of how the fitness landscape looks. In plotFitnessLandscape I have blatantly and shamelessly copied most of the looks of the plots of MAGELLAN [@brouillet_magellan:_2015] (see also <http://wwwabi.snv.jussieu.fr/public/Magellan/>), a very nice web-based tool for fitness landscape plotting and analysis (MAGELLAN provides some other extra functionality and epistasis statistics not provided here). As an example, let us show the example of Weissman et al. we saw in \@ref(weissmanex): {r} d1 <- -0.05 ## single mutant fitness 0.95 d2 <- -0.08 ## double mutant fitness 0.92 d3 <- 0.2 ## triple mutant fitness 1.2 s2 <- ((1 + d2)/(1 + d1)^2) - 1 s3 <- ( (1 + d3)/((1 + d1)^3 * (1 + s2)^3) ) - 1 wb <- allFitnessEffects( epistasis = c( "A" = d1, "B" = d1, "C" = d1, "A:B" = s2, "A:C" = s2, "B:C" = s2, "A:B:C" = s3))  {r, fig.width=6.5, fig.height=5} plotFitnessLandscape(wb, use_ggrepel = TRUE)  We have set use_ggrepel = TRUE to avoid overlap of labels. \clearpage For some types of objects, directly invoking plot will give you the fitness landscape plot: {r, fig.width=6.5, fig.height=5} (ewb <- evalAllGenotypes(wb, order = FALSE)) plot(ewb, use_ggrepel = TRUE)  \clearpage This is example (section \@ref(pancreas)) will give a very busy plot: {r wasthis111, fig.width=9.5, fig.height=9.5} par(cex = 0.7) pancr <- allFitnessEffects( data.frame(parent = c("Root", rep("KRAS", 4), "SMAD4", "CDNK2A", "TP53", "TP53", "MLL3"), child = c("KRAS","SMAD4", "CDNK2A", "TP53", "MLL3", rep("PXDN", 3), rep("TGFBR2", 2)), s = 0.1, sh = -0.9, typeDep = "MN")) plot(evalAllGenotypes(pancr, order = FALSE), use_ggrepel = TRUE)  \clearpage # Specifying fitness effects: some examples from the literature {#litex} ## Bauer et al., 2014 {#bauer} In the model of Bauer and collaborators [@Bauer2014, pp. 54] we have "For cells without the primary driver mutation, each secondary driver mutation leads to a change in the cell's fitness by$s_P$. For cells with the primary driver mutation, the fitness advantage obtained with each secondary driver mutation is$s_{DP}$." The proliferation probability is given as: *$\frac{1}{2}(1 + s_p)^k$when there are$k$secondary drivers mutated and no primary diver; *$\frac{1}{2}\frac{1+S_D^+}{1+S_D^-} (1 + S_{DP})^k$when the primary driver is mutated; apoptosis is one minus the proliferation rate. ### Using a DAG We cannot find a simple mapping from their expressions to our fitness parameterization, but we can get fairly close by using a DAG; in this one, note the unusual feature of having one of the "s" terms (that for the driver dependency on root) be negative. Using the parameters given in the legend of their Figure 3 for$s_p, S_D^+, S_D^-, S_{DP}$and obtaining that negative value for the dependency of the driver on root we can do: {r} K <- 4 sp <- 1e-5 sdp <- 0.015 sdplus <- 0.05 sdminus <- 0.1 cnt <- (1 + sdplus)/(1 + sdminus) prod_cnt <- cnt - 1 bauer <- data.frame(parent = c("Root", rep("D", K)), child = c("D", paste0("s", 1:K)), s = c(prod_cnt, rep(sdp, K)), sh = c(0, rep(sp, K)), typeDep = "MN") fbauer <- allFitnessEffects(bauer) (b1 <- evalAllGenotypes(fbauer, order = FALSE, addwt = TRUE))  (We use "D" for "driver" or "primary driver", as is it is called in the original paper, and "s" for secondary drivers, somewhat similar to passengers). Note that what we specify as "typeDep" is irrelevant (MN, SMN, or XMPN make no difference). This is the DAG: {r, fig.height=3} plot(fbauer)  And if you compare the tabular output of evalAllGenotypes you can see that the values of fitness reproduces the fitness landscape that they show in their Figure 1. We can also use our plot for fitness landscapes: {r, fig.width=6, fig.height=6} plot(b1, use_ggrepel = TRUE)  ### Specifying fitness of genotypes directly An alternative approach to specify the fitness, if the number of genotypes is reasonably small, is to directly evaluate fitness as given by their expressions. Then, use the genotFitness argument to allFitnessEffects. We will create all possible genotypes; then we will write a function that gives the fitness of each genotype according to their expression; finally, we will call this function on the data frame of genotypes, and pass this data frame to allFitnessEffects. {r} m1 <- expand.grid(D = c(1, 0), s1 = c(1, 0), s2 = c(1, 0), s3 = c(1, 0), s4 = c(1, 0)) fitness_bauer <- function(D, s1, s2, s3, s4, sp = 1e-5, sdp = 0.015, sdplus = 0.05, sdminus = 0.1) { if(!D) { b <- 0.5 * ( (1 + sp)^(sum(c(s1, s2, s3, s4)))) } else { b <- 0.5 * (((1 + sdplus)/(1 + sdminus) * (1 + sdp)^(sum(c(s1, s2, s3, s4))))) } fitness <- b - (1 - b) our_fitness <- 1 + fitness ## prevent negative fitness and ## make wt fitness = 1 return(our_fitness) } m1$Fitness <-
apply(m1, 1, function(x) do.call(fitness_bauer, as.list(x)))

bauer2 <- allFitnessEffects(genotFitness = m1)


Now, show the fitness of all genotypes:

{r}
evalAllGenotypes(bauer2, order = FALSE, addwt = TRUE)


Can we use modules in this example, if we use the "lego system"? Sure,
as in any other case.

## Misra et al., 2014 {#misra}

Figure 1 of @Misra2014 presents three scenarios which
are different types of epistasis.

### Example 1.a {#misra1a}
{r, echo=FALSE, fig.height=4, fig.width=4}

df1 <- data.frame(x = c(1, 1.2, 1.4), f = c(1, 1.2, 1.2),
names = c("wt", "A", "B"))
plot(df1[, 2] ~ df1[, 1], axes = TRUE, xlab= "",
ylab = "Fitness", xaxt = "n", yaxt = "n", ylim = c(1, 1.21))
segments(1, 1, 1.2, 1.2)
segments(1, 1, 1.4, 1.2)
text(1, 1, "wt", pos = 4)
text(1.2, 1.2, "A", pos = 2)
text(1.4, 1.2, "B", pos = 2)
## axis(1,  tick = FALSE, labels = FALSE)
## axis(2,  tick = FALSE, labels = FALSE)


In that figure it is evident that the fitness effect of "A" and "B"
are the same. There are two different models depending on whether "AB"
is just the product of both, or there is epistasis. In the first case
probably the simplest is:

{r}
s <- 0.1 ## or whatever number
m1a1 <- allFitnessEffects(data.frame(parent = c("Root", "Root"),
child = c("A", "B"),
s = s,
sh = 0,
typeDep = "MN"))
evalAllGenotypes(m1a1, order = FALSE, addwt = TRUE)


If the double mutant shows epistasis, as we saw before (section \@ref(e2))
we have a range of options. For example:

{r}
s <- 0.1
sab <- 0.3
m1a2 <- allFitnessEffects(epistasis = c("A:-B" = s,
"-A:B" = s,
"A:B" = sab))
evalAllGenotypes(m1a2, order = FALSE, addwt = TRUE)


But we could also modify the graph dependency structure, and we have to
change the value of the coefficient, since that is what multiplies each of
the terms for "A" and "B": $(1 + s_{AB}) = (1 + s)^2(1 + s_{AB3})$

{r}
sab3 <- ((1 + sab)/((1 + s)^2)) - 1
m1a3 <- allFitnessEffects(data.frame(parent = c("Root", "Root"),
child = c("A", "B"),
s = s,
sh = 0,
typeDep = "MN"),
epistasis = c("A:B" = sab3))
evalAllGenotypes(m1a3, order = FALSE, addwt = TRUE)


And, obviously
{r}
all.equal(evalAllGenotypes(m1a2, order = FALSE, addwt = TRUE),
evalAllGenotypes(m1a3, order = FALSE, addwt = TRUE))


### Example 1.b {#misra1b}

This is a specific case of synthetic viability (see also section \@ref(sv)):

{r, echo=FALSE, fig.width=4, fig.height=4}

df1 <- data.frame(x = c(1, 1.2, 1.2, 1.4), f = c(1, 0.4, 0.3, 1.3),
names = c("wt", "A", "B", "AB"))
plot(df1[, 2] ~ df1[, 1], axes = TRUE, xlab= "", ylab = "Fitness",
xaxt = "n", yaxt = "n", ylim = c(0.29, 1.32))
segments(1, 1, 1.2, 0.4)
segments(1, 1, 1.2, 0.3)
segments(1.2, 0.4, 1.4, 1.3)
segments(1.2, 0.3, 1.4, 1.3)
text(x = df1[, 1], y = df1[, 2], labels = df1[, "names"], pos = c(4, 2, 2, 2))
## text(1, 1, "wt", pos = 4)
## text(1.2, 1.2, "A", pos = 2)
## text(1.4, 1.2, "B", pos = 2)


Here, $S_A, S_B < 0$, $S_B < 0$, $S_{AB} > 0$ and $(1 + S_{AB}) (1 + S_A) (1 + S_B) > 1$.

As before, we can specify this in several different ways. The simplest is
to specify all genotypes:
{r}
sa <- -0.6
sb <- -0.7
sab <- 0.3
m1b1 <- allFitnessEffects(epistasis = c("A:-B" = sa,
"-A:B" = sb,
"A:B" = sab))
evalAllGenotypes(m1b1, order = FALSE, addwt = TRUE)


We could also use a tree and modify the "sab" for the epistasis, as
before (\@ref(misra1a)).

### Example 1.c {#misra1c}

The final case, in figure 1.c of Misra et al., is just epistasis, where a
mutation in one of the genes is deleterious (possibly only mildly), in the
other is beneficial, and the double mutation has fitness larger than any
of the other two.

{r, echo=FALSE, fig.width=4, fig.height=4}

df1 <- data.frame(x = c(1, 1.2, 1.2, 1.4), f = c(1, 1.2, 0.7, 1.5),
names = c("wt", "A", "B", "AB"))
plot(df1[, 2] ~ df1[, 1], axes = TRUE, xlab = "", ylab = "Fitness",
xaxt = "n", yaxt = "n", ylim = c(0.69, 1.53))
segments(1, 1, 1.2, 1.2)
segments(1, 1, 1.2, 0.7)
segments(1.2, 1.2, 1.4, 1.5)
segments(1.2, 0.7, 1.4, 1.5)
text(x = df1[, 1], y = df1[, 2], labels = df1[, "names"], pos = c(3, 3, 3, 2))
## text(1, 1, "wt", pos = 4)
## text(1.2, 1.2, "A", pos = 2)
## text(1.4, 1.2, "B", pos = 2)



Here we have that $s_A > 0$, $s_B < 0$, $(1 + s_{AB}) (1 + s_A) (1 + s_B) > (1 + s_{AB})$ so $s_{AB} > \frac{-s_B}{1 + s_B}$

As before, we can specify this in several different ways. The simplest is
to specify all genotypes:
{r}
sa <- 0.2
sb <- -0.3
sab <- 0.5
m1c1 <- allFitnessEffects(epistasis = c("A:-B" = sa,
"-A:B" = sb,
"A:B" = sab))
evalAllGenotypes(m1c1, order = FALSE, addwt = TRUE)


We could also use a tree and modify the "sab" for the epistasis, as
before (\@ref(misra1a)).

## Ochs and Desai, 2015 {#ochsdesai}

In @Ochs2015 the authors present a model shown graphically as (the
actual numerical values are arbitrarily set by me):

{r, echo=FALSE, fig.width=4.5, fig.height=3.5}

df1 <- data.frame(x = c(1, 2, 3, 4), f = c(1.1, 1, 0.95, 1.2),
names = c("u", "wt", "i", "v"))
plot(df1[, 2] ~ df1[, 1], axes = FALSE, xlab = "", ylab = "")
par(las = 1)
axis(2)
axis(1, at = c(1, 2, 3, 4), labels = df1[, "names"], ylab = "")
box()
arrows(c(2, 2, 3), c(1, 1, 0.95),
c(1, 3, 4), c(1.1, 0.95, 1.2))
## text(1, 1, "wt", pos = 4)
## text(1.2, 1.2, "A", pos = 2)
## text(1.4, 1.2, "B", pos = 2)


In their model, $s_u > 0$, $s_v > s_u$, $s_i < 0$, we can only arrive at
$v$ from $i$, and the mutants "ui" and "uv" can never appear as their
fitness is 0, or $-\infty$, so $s_{ui} = s_{uv} = -1$ (or $-\infty$).

We can specify this combining a graph and epistasis specifications:

{r}
su <- 0.1
si <- -0.05
fvi <- 1.2 ## the fitness of the vi mutant
sv <- (fvi/(1 + si)) - 1
sui <- suv <- -1
od <- allFitnessEffects(
data.frame(parent = c("Root", "Root", "i"),
child = c("u", "i", "v"),
s = c(su, si, sv),
sh = -1,
typeDep = "MN"),
epistasis = c(
"u:i" = sui,
"u:v" = suv))


A figure showing that model is
{r, fig.width=3, fig.height=3}
plot(od)


And the fitness of all genotype is
{r}
evalAllGenotypes(od, order = FALSE, addwt = TRUE)


We could alternatively have specified fitness either directly
specifying the fitness of each genotype or specifying epistatic
effects. Let us use the second approach:

%% this was wrong
%% u <- 0.2; i <- -0.02; vi <- 0.6; ui <- uv <- -Inf

{r}
u <- 0.1; i <- -0.05; vi <- (1.2/0.95) - 1; ui <- uv <- -Inf
od2 <- allFitnessEffects(
epistasis = c("u" = u,  "u:i" = ui,
"u:v" = uv, "i" = i,
"v:-i" = -Inf, "v:i" = vi))



We will return to this model when we explain the usage of fixation
for stopping the simulations (see \@ref(fixation) and \@ref(fixationG)).

## Weissman et al., 2009 {#weissmanex}
In their figure 1a, @Weissman2009 present this model
(actual numeric values are set arbitrarily)

### Figure 1.a {#weiss1a}

{r, echo=FALSE, fig.width=4, fig.height=3}

df1 <- data.frame(x = c(1, 2, 3), f = c(1, 0.95, 1.2),
names = c("wt", "1", "2"))
plot(df1[, 2] ~ df1[, 1], axes = FALSE, xlab = "", ylab = "")
par(las = 1)
axis(2)
axis(1, at = c(1, 2, 3), labels = df1[, "names"], ylab = "")
box()
segments(c(1, 2), c(1, 0.95),
c(2, 3), c(0.95, 1.2))
## text(1, 1, "wt", pos = 4)
## text(1.2, 1.2, "A", pos = 2)
## text(1.4, 1.2, "B", pos = 2)



where the "1" and "2" in the figure refer to the total number of mutations
in two different loci. This is, therefore, very similar to the example in
section \@ref(misra1b). Here we have, in their notation, $\delta_1 < 0$,
fitness of single "A" or single "B" = $1 + \delta_1$, $S_{AB} > 0$, $(1 + S_{AB})(1 + \delta_1)^2 > 1$.

### Figure 1.b {#weis1b}

In their figure 1b they show

{r, echo=FALSE, fig.width=4, fig.height=3}

df1 <- data.frame(x = c(1, 2, 3, 4), f = c(1, 0.95, 0.92, 1.2),
names = c("wt", "1", "2", "3"))
plot(df1[, 2] ~ df1[, 1], axes = FALSE, xlab = "", ylab = "")
par(las = 1)
axis(2)
axis(1, at = c(1, 2, 3, 4), labels = df1[, "names"], ylab = "")
box()
segments(c(1, 2, 3), c(1, 0.95, 0.92),
c(2, 3, 4), c(0.95, 0.92, 1.2))
## text(1, 1, "wt", pos = 4)
## text(1.2, 1.2, "A", pos = 2)
## text(1.4, 1.2, "B", pos = 2)


Where, as before, 1, 2, 3, denote the total number of mutations over three
different loci and $\delta_1 < 0$, $\delta_2 < 0$, fitness of single
mutant is $(1 + \delta_1)$, of double mutant is $(1 + \delta_2)$ so that
$(1 + \delta_2) = (1 + \delta_1)^2 (1 + s_2)$ and of triple mutant is
$(1 + \delta_3)$, so that
$(1 + \delta_3) = (1 + \delta_1)^3 (1 + s_2)^3 (1 + s_3)$.

We can specify this combining a graph with epistasis:

{r}

d1 <- -0.05 ## single mutant fitness 0.95
d2 <- -0.08 ## double mutant fitness 0.92
d3 <- 0.2   ## triple mutant fitness 1.2

s2 <- ((1 + d2)/(1 + d1)^2) - 1
s3 <- ( (1 + d3)/((1 + d1)^3 * (1 + s2)^3) ) - 1

w <- allFitnessEffects(
data.frame(parent = c("Root", "Root", "Root"),
child = c("A", "B", "C"),
s = d1,
sh = -1,
typeDep = "MN"),
epistasis = c(
"A:B" = s2,
"A:C" = s2,
"B:C" = s2,
"A:B:C" = s3))


The model can be shown graphically as:
{r, fig.width=4, fig.height=4}
plot(w)


And fitness of all genotypes is:

{r}
evalAllGenotypes(w, order = FALSE, addwt = TRUE)


Alternatively, we can directly specify what each genotype adds to the
fitness, given the included genotype. This is basically replacing the
graph by giving each of "A", "B", and "C" directly:

{r}
wb <- allFitnessEffects(
epistasis = c(
"A" = d1,
"B" = d1,
"C" = d1,
"A:B" = s2,
"A:C" = s2,
"B:C" = s2,
"A:B:C" = s3))

evalAllGenotypes(wb, order = FALSE, addwt = TRUE)


The plot, of course, is not very revealing and we cannot show that there
is a three-way interaction (only all three two-way interactions):

{r, , fig.width=3, fig.height=3}
plot(wb)


As we have seen several times already (sections \@ref(e2), \@ref(e3),
\@ref(theminus)) we can also give the genotypes directly and, consequently,
the fitness of each genotype (not the added contribution):

{r}
wc <- allFitnessEffects(
epistasis = c(
"A:-B:-C" = d1,
"B:-C:-A" = d1,
"C:-A:-B" = d1,
"A:B:-C" = d2,
"A:C:-B" = d2,
"B:C:-A" = d2,
"A:B:C" = d3))
evalAllGenotypes(wc, order = FALSE, addwt = TRUE)


## Gerstung et al., 2011, pancreatic cancer poset {#pancreas}

Similar to what we did in v.1 (see section \@ref(poset)) we can specify the
pancreatic cancer poset in @Gerstung2011 (their
figure 2B, left). We use directly the names of the genes, since that is
immediately supported by the new version.

{r, fig.width=4}

pancr <- allFitnessEffects(
data.frame(parent = c("Root", rep("KRAS", 4),
"TP53", "TP53", "MLL3"),
"TP53", "MLL3",
rep("PXDN", 3), rep("TGFBR2", 2)),
s = 0.1,
sh = -0.9,
typeDep = "MN"))

plot(pancr)


Of course the "s" and "sh" are set arbitrarily here.

## Raphael and Vandin's 2014 modules {#raphael-ex}

In @Raphael2014a, the authors show several progression models
in terms of modules. We can code the extended poset for the colorectal
cancer model in their Figure 4.a is (s and sh are arbitrary):

{r, fig.height = 4}
rv1 <- allFitnessEffects(data.frame(parent = c("Root", "A", "KRAS"),
child = c("A", "KRAS", "FBXW7"),
s = 0.1,
sh = -0.01,
typeDep = "MN"),
geneToModule = c("Root" = "Root",
"A" = "EVC2, PIK3CA, TP53",
"KRAS" = "KRAS",
"FBXW7" = "FBXW7"))

plot(rv1, expandModules = TRUE, autofit = TRUE)



We have used the (experimental) autofit option to fit the labels to the
edges. Note how we can use the same name for genes and modules, but we
need to specify all the modules.

Their Figure 5b is

{r, fig.height=6}
rv2 <- allFitnessEffects(
data.frame(parent = c("Root", "1", "2", "3", "4"),
child = c("1", "2", "3", "4", "ELF3"),
s = 0.1,
sh = -0.01,
typeDep = "MN"),
geneToModule = c("Root" = "Root",
"1" = "APC, FBXW7",
"2" = "ATM, FAM123B, PIK3CA, TP53",
"3" = "BRAF, KRAS, NRAS",
"ELF3" = "ELF3"))

plot(rv2, expandModules = TRUE,   autofit = TRUE)


\clearpage

# Running and plotting the simulations: starting, ending, and examples {#simul}

## Starting and ending {#starting-ending}

After you have decided the specifics of the fitness effects and the model,
you need to decide:

* Where will you start your simulation from. This involves deciding
the initial population size (argument initSize) and, possibly,
the genotype of the initial population; the later is covered in section
\@ref(initmut).

* When will you stop it: how long to run it, and whether or not to
require simulations to reach cancer (under some definition of what it
means to reach cancer). This is covered in \@ref(endsimul).

## Can I start the simulation from a specific mutant? {#initmut}

You bet. In version 2 you can specify the genotype for the
initial mutant with the same flexibility as in evalGenotype. Here we show
a couple of examples (we use the representation of the parent-child
relationships ---discussed in section \@ref(phylog)--- of the clones so that
you can see which clones appear, and from which, and check that we are not
making mistakes).
<!-- In v.1 you can only give the initial mutant as one with a single -->
<!-- mutated gene. -->

{r prbau003, fig.height=6}

o3init <- allFitnessEffects(orderEffects = c(
"M > D > F" = 0.99,
"D > M > F" = 0.2,
"D > M"     = 0.1,
"M > D"     = 0.9),
noIntGenes = c("u" = 0.01,
"v" = 0.01,
"w" = 0.001,
"x" = 0.0001,
"y" = -0.0001,
"z" = -0.001),
geneToModule =
c("M" = "m",
"F" = "f",
"D" = "d") )

oneI <- oncoSimulIndiv(o3init, model = "McFL",
mu = 5e-5, finalTime = 500,
detectionDrivers = 3,
onlyCancer = FALSE,
initSize = 1000,
keepPhylog = TRUE,
initMutant = c("m > u > d")
)
plotClonePhylog(oneI, N = 0)


{r prbau003bb, fig.height=6}
## Note we also disable the stopping stochastically as a function of size
## to allow the population to grow large and generate may different
## clones.
ospI <- oncoSimulPop(2,
o3init, model = "Exp",
mu = 5e-5, finalTime = 500,
detectionDrivers = 3,
onlyCancer = TRUE,
initSize = 10,
keepPhylog = TRUE,
initMutant = c("d > m > z"),
mc.cores = 2
)

## Show just one example
## op <- par(mar = rep(0, 4), mfrow = c(1, 2))
plotClonePhylog(ospI[[1]])
## plotClonePhylog(ospI[[2]])
## par(op)

ossI <- oncoSimulSample(2,
o3init, model = "Exp",
mu = 5e-5, finalTime = 500,
detectionDrivers = 2,
onlyCancer = TRUE,
initSize = 10,
initMutant = c("z > d"),
## check presence of initMutant:
thresholdWhole = 1
)

## No phylogeny is kept with oncoSimulSample, but look at the
## OcurringDrivers and the sample
ossI$popSample ossI$popSummary[, "OccurringDrivers", drop = FALSE]


Since version 2.21.994, it is possible to start the simulations from
arbitrary initial configurations: this uses multiple initial
mutants (see section \@ref(minitmut)) and allows for multispecies
simulations (section \@ref(multispecies)).

## Ending the simulations {#endsimul}

OncoSimulR provides very flexible ways to decide when to stop a
simulation. Here we focus on a single simulation; see further options with
multiple simulations in \@ref(sample).

### Ending the simulations: conditions

* **onlyCancer = TRUE**. A simulation will be repeated until any
one of the "reach cancer" conditions is met, if this happens before
the simulation reaches finalTime[^6]. These conditions are:

[^6]: Of course, the "reach cancer" idea and the onlyCancer argument
are generic names; this could have been labeled "reach whatever
interests me".

+ Total population size becomes larger than detectionSize.
+ The number of drivers in any one genotype or clone becomes equal
to, or larger than, detectionDrivers; note that this allows you
to stop the simulation as soon as a **specific genotype** is
found, by using exactly and only the genes that make that genotype as
the drivers. This is not allowed by the moment in frequency-dependent
fitness simulations.
+ A gene or gene combination among those listed in fixation
becomes fixed in the population (i.e., has a frequency is 1)
(see details in (\@ref(fixation) and \@ref(fixationG)).
+ The tumor is detected according to a stochastic detection
mechanism, where the probability of "detecting the tumor" increases
with population size; this is explained below (\@ref(detectprob)) and
is controlled by argument detectionProb.

As we exit as soon as any of the exiting conditions is reached,
if you only care about one condition, set the other to NA (see
also section \@ref(anddrvprob)).

* **onlyCancer = FALSE**. A simulation will run only once, and
will exit as soon as any of the above conditions are met or as soon as
the total population size becomes zero or we reach finalTime.

As an example of onlyCancer = TRUE, focusing on the first two
mechanisms, suppose you give detectionSize = 1e4 and detectionDrivers
=3 (and you have detectionProb = NA).  A simulation will exit as soon
as it reaches a total population size of $10^4$ or any clone has four
drivers, whichever comes first (if any of these happen before
finalTime).

In the onlyCancer = TRUE case, what happens if we reach
finalTime (or the population size becomes zero) before any of the
"reach cancer" conditions have been fulfilled?  The simulation will be
repeated again, within the following limits:

* max.wall.time: the total wall time we allow an individual
simulation to run;
* max.num.tries: the maximum number of times we allow a
simulation to be repeated to reach cancer;
* max.wall.time.total and max.num.tries.total,
similar to the above but over a set of simulations in function
oncoSimulSample.

Incidentally, we keep track of the number of attempts used (the component
other$attemptsUsed$) before we reach cancer, so you can estimate
(as from a negative binomial sampling) the probability of reaching your
desired end point under different scenarios.

The onlyCancer = FALSE case might be what you want to do when you
examine general population genetics scenarios without focusing on possible
sampling issues. To do this, set finalTime to the value you want
and set onlyCancer = FALSE; in addition, set
detectionProb to "NA" and detectionDrivers and
detectionSize to "NA" or to huge numbers^[Setting
detectionDrivers and detectionSize to "NA" is in
fact equivalent to setting them to the largest possible numbers for
these variables: $2^{32} -1$ and $\infty$, respectively.]. In this
scenario you simply collect the simulation output at the end of the run,
regardless of what happened with the population (it became extinct, it did
not reach a large size, it did not accumulate drivers, etc).

### Stochastic detection mechanism: "detectionProb"  {#detectprob}

This is the process that is controlled by the argument
detectionProb. Here the probability of tumor detection increases
with the total population size. This is biologically a reasonable
assumption: the larger the tumor, the more likely it is it will be
detected.

At regularly spaced times during the simulation, we compute the
probability of detection as a function of size and determine (by comparing
against a random uniform number) if the simulation should finish. For
simplicity, and to make sure the probability is bounded between 0 and 1,
we use the function

$$P(N) = \begin{cases} 1 - e^{ -c ( (N - B)/B)} & \text{if } N > B \\ 0 & \text{if } N \leq B \end{cases} \label{eq:2}$$

where $P(N)$ is the probability that a tumor with a population size $N$
will be detected, and $c$ (argument $cPDetect$ in the oncoSimul*
functions) controls how fast $P(N)$ increases with increasing population
size relative to a baseline, $B$ ($PDBaseline$ in the oncoSimul*
functions); with $B$ we both control the minimal population size at which
this mechanism stats operating (because we will rarely want detection
unless there is some meaningful increase of population size over
initSize) and we model the increase in $P(N)$ as a function of relative
differences with respect to $B$. (Note that this is **a major change** in
version 2.9.9. Before version 2.9.9, the expression used was
$P(N) = 1 - e^{ -c ( N - B)}$, so we did not make the increase relative to
$B$; of course, you can choose an appropriate $c$ to make different models
comparable, but the expression used before 2.9.9 made it much harder to
compare simulations with very different initial population sizes, as
baselines are often naturall a function of initial population sizes.)

The $P(N)$ refers to the probability of detection at each one of the
occasions when we assess the probability of exiting. When, or how often,
do we do that? When we assess probability of exiting is controlled by
checkSizePEvery, which will often be much larger than
sampleEvery^[We assess probability of exiting at every
sampling time, as given by sampleEvery, that is the smallest
possible sampling time that is separated from the previous time of
assessment by at least checkSizePEvery. In other words, the
interval between successive assessments will be the smallest multiple
integer of sampleEvery that is larger than
checkSizePEvery. For example, suppose sampleEvery = 2
and checkSizePEvery = 3: we will assess exiting at times
$4, 8, 12, 16, \ldots$. If sampleEvery = 3 and
checkSizePEvery = 3: we will assess exiting at times
$6, 12, 18, \ldots$.]. Biologically, a way to think of
checkSizePEvery is "time between doctor appointments".

An important **warning**, though: for populations that are growing
very, very fast or where some genes might have very large effects on
fitness even a moderate checkSizePEvery of, say, 10, might be
inappropriate, since populations could have increased by several
orders of magnitude between successive checks. This issue is also
discussed in section \@ref(bench1xf) and \@ref(benchusual).

Finally, you can specify $c$ ($cPDetect$) directly (you will need to set
n2 and p2 to NA). However, it might be more intuitive to specify the
pair n2, p2, such that $P(n2) = p2$ (and from that pair we solve for
the value of $cPDetect$).

You can get a feeling for the effects of these arguments by playing with
the following code, that we do not execute here for the sake of
speed. Here no mutation has any effect, but there is a non-zero
probability of exiting as soon as the total population size becomes larger
than the initial population size. So, eventually, all simulations will
exit and, as we are using the McFarland model, population size will vary
slightly around the initial population size.

{r prbaux002, eval=FALSE}
gi2 <- rep(0, 5)
names(gi2) <- letters[1:5]
oi2 <- allFitnessEffects(noIntGenes = gi2)
s5 <- oncoSimulPop(200,
oi2,
model = "McFL",
initSize = 1000,
detectionProb = c(p2 = 0.1,
n2 = 2000,
PDBaseline = 1000,
checkSizePEvery = 2),
detectionSize = NA,
finalTime = NA,
keepEvery = NA,
detectionDrivers = NA)
s5
hist(unlist(lapply(s5, function(x) x$FinalTime)))  As you decrease checkSizePEvery the distribution of "FinalTime" will resemble more and more an exponential distribution. In this vignette, there are some further examples of using this mechanism in \@ref(s-cbn1) and \@ref(mcf5070), with the default arguments. #### Stochastic detection mechanism and minimum number of drivers {#anddrvprob} We said above that we exit as soon as any of the conditions is reached (i.e., we use an OR operation over the exit conditions). There is a special exception to this procedure: if you set AND_DrvProbExit = TRUE, both the number of drivers and the detectionProb mechanism condition must fulfilled. This means that the detectionProb mechanism not assessed unless the detectionDrivers condition is. Using AND_DrvProbExit = TRUE allows to run simulations and ensure that all of the returned simulations will have at least some cells with the number of drivers as specified by detectionDrivers. Note, though, that this does not guarantee that when you sample the population, all those drivers will be detected (as this depends on the actual proportion of cells with the drivers and the settings of samplePop). ### Fixation of genes/gene combinations {#fixation} In some cases we might be interested in running simulations until a particular set of genes, or gene combinations, reaches fixation. This exit condition might be more relevant than some of the above in many non-cancer-related evolutionary genetics scenarios. Simulations will stop as soon as any of the genes or gene combinations in the vector (or list) fixation reaches a frequency of 1. These gene combinations might have non-zero intersection (i.e., they might share genes), and those genes need not be drivers. If we want simulations to only stop when fixation of those genes/gene combinations is reached, we will set all other stopping conditions to NA. It is, of course, up to you to ensure that those stopping conditions are reasonable (that they can be reached) and to use, or not, finalTime; otherwise, simulations will eventually abort (e.g., when max.wall.time or max.num.tries are reached). Since we are asking for fixation, the Exp or Bozic models will often not be appropriate here; instead, models with competition such as McFL are more appropriate. We return here to the example from section \@ref(ochsdesai). {r} u <- 0.2; i <- -0.02; vi <- 0.6; ui <- uv <- -Inf od2 <- allFitnessEffects( epistasis = c("u" = u, "u:i" = ui, "u:v" = uv, "i" = i, "v:-i" = -Inf, "v:i" = vi))  Ochs and Desai explain that "Each simulated population was evolved until either the uphill genotype or valley-crossing genotype fixed." (see @Ochs2015, p.2, section "Simulations"). We will do the same here. We specify that we want to end the simulation when either the "u" or the "v, i" genotypes have reached fixation, by passing those genotype combinations as the fixation argument (in this example using fixation = c("u", "v") would have been equivalent, since the "v" genotype by itself has fitness of 0). We want to be explicit that fixation will be the one and only condition for ending the simulations, and thus we set arguments detectionDrivers, finalTime, detectionSize and detectionProb explicitly to NA. (We set the number of repetitions only to 10 for the sake of speed when creating the vignette). {r simul-ochs} initS <- 20 ## We use only a small number of repetitions for the sake ## of speed. od100 <- oncoSimulPop(10, od2, fixation = c("u", "v, i"), model = "McFL", mu = 1e-4, detectionDrivers = NA, finalTime = NA, detectionSize = NA, detectionProb = NA, onlyCancer = TRUE, initSize = initS, mc.cores = 2)  What is the frequency of each genotype among the simulations? (or, what is the frequency of fixation of each genotype?) {r ochs-freq-genots} sampledGenotypes(samplePop(od100))  Note the very large variability in reaching fixation {r sum-simul-ochs} head(summary(od100)[, c(1:3, 8:9)])  ### Fixation of genotypes {#fixationG} Section \@ref(fixation) deals with the fixation of gene/gene combinations. What if you want fixation on specific genotypes? To give an example, suppose we have a five loci genotype and suppose that you want to stop the simulations only if genotypes "A", "B, E", or "A, B, C, D, E" reach fixation. You do not want to stop it if, say, genotype "A, B, E" reaches fixation. To specify genotypes, you prepend the genotype combinations with a "_,", and that tells OncoSimulR that you want fixation of **genotypes**, not just gene combinations. An example of the differences between the mechanisms can be seen from this code: {r fixationG1} ## Create a simple fitness landscape rl1 <- matrix(0, ncol = 6, nrow = 9) colnames(rl1) <- c(LETTERS[1:5], "Fitness") rl1[1, 6] <- 1 rl1[cbind((2:4), c(1:3))] <- 1 rl1[2, 6] <- 1.4 rl1[3, 6] <- 1.32 rl1[4, 6] <- 1.32 rl1[5, ] <- c(0, 1, 0, 0, 1, 1.5) rl1[6, ] <- c(0, 0, 1, 1, 0, 1.54) rl1[7, ] <- c(1, 0, 1, 1, 0, 1.65) rl1[8, ] <- c(1, 1, 1, 1, 0, 1.75) rl1[9, ] <- c(1, 1, 1, 1, 1, 1.85) class(rl1) <- c("matrix", "genotype_fitness_matrix") ## plot(rl1) ## to see the fitness landscape ## Gene combinations local_max_g <- c("A", "B, E", "A, B, C, D, E") ## Specify the genotypes local_max <- paste0("_,", local_max_g) fr1 <- allFitnessEffects(genotFitness = rl1, drvNames = LETTERS[1:5]) initS <- 2000 ######## Stop on gene combinations ##### r1 <- oncoSimulPop(10, fp = fr1, model = "McFL", initSize = initS, mu = 1e-4, detectionSize = NA, sampleEvery = .03, keepEvery = 1, finalTime = 50000, fixation = local_max_g, detectionDrivers = NA, detectionProb = NA, onlyCancer = TRUE, max.num.tries = 500, max.wall.time = 20, errorHitMaxTries = TRUE, keepPhylog = FALSE, mc.cores = 2) sp1 <- samplePop(r1, "last", "singleCell") sgsp1 <- sampledGenotypes(sp1) ## often you will stop on gene combinations that ## are not local maxima in the fitness landscape sgsp1 sgsp1$Genotype %in% local_max_g

####### Stop on genotypes   ####

r2 <- oncoSimulPop(10,
fp = fr1,
model = "McFL",
initSize = initS,
mu = 1e-4,
detectionSize = NA,
sampleEvery = .03,
keepEvery = 1,
finalTime = 50000,
fixation = local_max,
detectionDrivers = NA,
detectionProb = NA,
onlyCancer = TRUE,
max.num.tries = 500,
max.wall.time = 20,
errorHitMaxTries = TRUE,
keepPhylog = FALSE,
mc.cores = 2)
## All final genotypes should be local maxima
sp2 <- samplePop(r2, "last", "singleCell")
sgsp2 <- sampledGenotypes(sp2)
sgsp2$Genotype %in% local_max_g  ### Fixation: tolerance, number of periods, minimal size In particular if you specify stopping on genotypes, you might want to think about three additional parameters: fixation_tolerance, min_successive_fixation, and fixation_min_size. fixation_tolerance: fixation is considered to have happened if the genotype/gene combinations specified as genotypes/gene combinations for fixation have reached a frequency$> 1 - fixation\_tolerance$. (The default is 0, so we ask for genotypes/gene combinations with a frequency of 1, which might not be what you want with large mutation rates and complex fitness landscape with genotypes of similar fitness.) min_successive_fixation: during how many successive sampling periods the conditions of fixation need to be fulfilled before declaring fixation. These must be successive sampling periods without interruptions (i.e., a single period when the condition is not fulfilled will set the counter to 0). This can help to exclude short, transitional, local maxima that are quickly replaced by other genotypes. (The default is 50, but this is probably too small for "real life" usage). fixation_min_size: you might only want to consider fixation to have happened if a minimal size has been reached (this can help weed out local maxima that have fitness that is barely above that of the wild-type genotype). (The default is 0). An example of using those options: {r fixationG2} ## Create a simple fitness landscape rl1 <- matrix(0, ncol = 6, nrow = 9) colnames(rl1) <- c(LETTERS[1:5], "Fitness") rl1[1, 6] <- 1 rl1[cbind((2:4), c(1:3))] <- 1 rl1[2, 6] <- 1.4 rl1[3, 6] <- 1.32 rl1[4, 6] <- 1.32 rl1[5, ] <- c(0, 1, 0, 0, 1, 1.5) rl1[6, ] <- c(0, 0, 1, 1, 0, 1.54) rl1[7, ] <- c(1, 0, 1, 1, 0, 1.65) rl1[8, ] <- c(1, 1, 1, 1, 0, 1.75) rl1[9, ] <- c(1, 1, 1, 1, 1, 1.85) class(rl1) <- c("matrix", "genotype_fitness_matrix") ## plot(rl1) ## to see the fitness landscape ## The local fitness maxima are ## c("A", "B, E", "A, B, C, D, E") fr1 <- allFitnessEffects(genotFitness = rl1, drvNames = LETTERS[1:5]) initS <- 2000 ## Stop on genotypes r3 <- oncoSimulPop(10, fp = fr1, model = "McFL", initSize = initS, mu = 1e-4, detectionSize = NA, sampleEvery = .03, keepEvery = 1, finalTime = 50000, fixation = c(paste0("_,", c("A", "B, E", "A, B, C, D, E")), fixation_tolerance = 0.1, min_successive_fixation = 200, fixation_min_size = 3000), detectionDrivers = NA, detectionProb = NA, onlyCancer = TRUE, max.num.tries = 500, max.wall.time = 20, errorHitMaxTries = TRUE, keepPhylog = FALSE, mc.cores = 2)  ### Mixing stopping on gene combinations and genotypes {#fixationmix} This would probably be awfully confusing and is not tested formally (though it should work). Let me know if you think this is an important feature. (Pull requests with tests welcome.) ## Plotting genotype/driver abundance over time; plotting the simulated trajectories {#plotraj} We have seen many of these plots already, starting with Figure \@ref(fig:iep1x1) and Figure \@ref(fig:iep2x2) and we will see many more below, in the examples, starting with section \@ref(bauer2) such as in figures \@ref(fig:baux1) and \@ref(fig:baux2). In a nutshell, what we are plotting is the information contained in the pops.by.time matrix, the matrix that contains the abundances of all the clones (or genotypes) at each of the sampling periods. The functions that do the work are called plot and these are actually methods for objects of class "oncosimul" and "oncosimulpop". You can access the help by doing ?plot.oncosimul, for example. What entities are shown in the plot? You can show the trajectories of: - numbers of drivers (e.g., \@ref(fig:baux1)); - genotypes or clones (e.g., \@ref(fig:baux2)). (Of course, showing "drivers" requires that you have specified certain genes as drivers.) What types of plots are available? - line plots; - stacked plots; - stream plots. All those three are shown in both of Figure \@ref(fig:baux1) and Figure \@ref(fig:baux2). If you run multiple simulations using oncoSimulPop you can plot the trajectories of all of the simulations. ## Several examples of simulations and plotting simulation trajectories {#severalexplot} ### Bauer's example again {#bauer2} We will use the model of @Bauer2014 that we saw in section \@ref(bauer). {r prbaux001} K <- 5 sd <- 0.1 sdp <- 0.15 sp <- 0.05 bauer <- data.frame(parent = c("Root", rep("p", K)), child = c("p", paste0("s", 1:K)), s = c(sd, rep(sdp, K)), sh = c(0, rep(sp, K)), typeDep = "MN") fbauer <- allFitnessEffects(bauer, drvNames = "p") set.seed(1) ## Use fairly large mutation rate b1 <- oncoSimulIndiv(fbauer, mu = 5e-5, initSize = 1000, finalTime = NA, onlyCancer = TRUE, detectionProb = "default")  We will now use a variety of plots {r baux1,fig.width=6.5, fig.height=10, fig.cap="Three drivers' plots of a simulation of Bauer's model"} par(mfrow = c(3, 1)) ## First, drivers plot(b1, type = "line", addtot = TRUE) plot(b1, type = "stacked") plot(b1, type = "stream")  {r baux2,fig.width=6.5, fig.height=10, fig.cap="Three genotypes' plots of a simulation of Bauer's model"} par(mfrow = c(3, 1)) ## Next, genotypes plot(b1, show = "genotypes", type = "line") plot(b1, show = "genotypes", type = "stacked") plot(b1, show = "genotypes", type = "stream")  In this case, probably the stream plots are most helpful. Note, however, that (in contrast to some figures in the literature showing models of clonal expansion) the stream plot (or the stacked plot) does not try to explicitly show parent-descendant relationships, which would hardly be realistically possible in these plots (although the plots of phylogenies in section \@ref(phylog) could be of help). ### McFarland model with 5000 passengers and 70 drivers {#mcf5070} {r, fig.width=6} set.seed(678) nd <- 70 np <- 5000 s <- 0.1 sp <- 1e-3 spp <- -sp/(1 + sp) mcf1 <- allFitnessEffects(noIntGenes = c(rep(s, nd), rep(spp, np)), drvNames = seq.int(nd)) mcf1s <- oncoSimulIndiv(mcf1, model = "McFL", mu = 1e-7, detectionProb = "default", detectionSize = NA, detectionDrivers = NA, sampleEvery = 0.025, keepEvery = 8, initSize = 2000, finalTime = 4000, onlyCancer = FALSE) summary(mcf1s)  <!-- %% --> <!-- %% set.seed(456) --> {r mcf1sx1,fig.width=6.5, fig.height=10} par(mfrow = c(2, 1)) ## I use thinData to make figures smaller and faster plot(mcf1s, addtot = TRUE, lwdClone = 0.9, log = "", thinData = TRUE, thinData.keep = 0.5) plot(mcf1s, show = "drivers", type = "stacked", thinData = TRUE, thinData.keep = 0.3, legend.ncols = 2)  With the above output (where we see there are over 500 different genotypes) trying to represent the genotypes makes no sense. ### McFarland model with 50,000 passengers and 70 drivers: clonal competition {#mcf50070} The next is too slow (takes a couple of minutes in an i5 laptop) and too big to run in a vignette, because we keep track of over 4000 different clones (which leads to a result object of over 800 MB): {r, eval=FALSE} set.seed(123) nd <- 70 np <- 50000 s <- 0.1 sp <- 1e-4 ## as we have many more passengers spp <- -sp/(1 + sp) mcfL <- allFitnessEffects(noIntGenes = c(rep(s, nd), rep(spp, np)), drvNames = seq.int(nd)) mcfLs <- oncoSimulIndiv(mcfL, model = "McFL", mu = 1e-7, detectionSize = 1e8, detectionDrivers = 100, sampleEvery = 0.02, keepEvery = 2, initSize = 1000, finalTime = 2000, onlyCancer = FALSE)  But you can access the pre-stored results and plot them (beware: this object has been trimmed by removing empty passenger rows in the Genotype matrix) {r, mcflsx2,fig.width=6} data(mcfLs) plot(mcfLs, addtot = TRUE, lwdClone = 0.9, log = "", thinData = TRUE, thinData.keep = 0.3, plotDiversity = TRUE)  The argument plotDiversity = TRUE asks to show a small plot on top with Shannon's diversity index. {r} summary(mcfLs) ## number of passengers per clone summary(colSums(mcfLs$Genotypes[-(1:70), ]))


Note that we see clonal competition between clones with the same number of
drivers (and with different drivers, of course). We will return to this
(section \@ref(clonalint)).

A stacked plot might be better to show the extent of clonal
competition (plotting takes some time ---a stream plot reveals
similar patterns and is also slower than the line plot). I will
aggressively thin the data for this plot so it is faster and smaller
(but we miss some of the fine grain, of course):

{r mcflsx3}
plot(mcfLs, type = "stacked", thinData = TRUE,
thinData.keep = 0.1,
plotDiversity = TRUE,
xlim = c(0, 1000))


<!-- %% %% The problem is the Genotype matrix. We remove empty passenger rows. -->
<!-- %% <<>>= -->
<!-- %% g1 <- mcfLs$Genotypes[1:nd, ] --> <!-- %% g2 <- mcfLs$Genotypes[(nd+1):(nd+np), ] -->
<!-- %% rs <- rowSums(g2) -->
<!-- %% g3 <- g2[which(rs == 0), ] -->
<!-- %% g4 <- rbind(g1, g3) -->
<!-- %% @  -->

### Simulation with a conjunction example {#s-cbn1}

We will use several of the previous examples. Most of them are in file
examplesFitnessEffects, where they are stored inside a list,
with named components (names the same as in the examples above):

{r}
data(examplesFitnessEffects)
names(examplesFitnessEffects)


{r seedsmmmcfls}
set.seed(1)


We will simulate using the simple CBN-like restrictions of
section \@ref(cbn1) with two different models.

{r smmcfls}
data(examplesFitnessEffects)
evalAllGenotypes(examplesFitnessEffects$cbn1, order = FALSE)[1:10, ] sm <- oncoSimulIndiv(examplesFitnessEffects$cbn1,
model = "McFL",
mu = 5e-7,
detectionSize = 1e8,
detectionDrivers = 2,
detectionProb = "default",
sampleEvery = 0.025,
keepEvery = 5,
initSize = 2000,
onlyCancer = TRUE)
summary(sm)


{r smbosb1}
set.seed(1234)
evalAllGenotypes(examplesFitnessEffects$cbn1, order = FALSE, model = "Bozic")[1:10, ] sb <- oncoSimulIndiv(examplesFitnessEffects$cbn1,
model = "Bozic",
mu = 5e-6,
detectionProb = "default",
detectionSize = 1e8,
detectionDrivers = 4,
sampleEvery = 2,
initSize = 2000,
onlyCancer = TRUE)
summary(sb)


As usual, we will use several plots here.

{r sbx1,fig.width=6.5, fig.height=3.3}
## Show drivers, line plot
par(cex = 0.75, las = 1)
plot(sb,show = "drivers", type = "line", addtot = TRUE,
plotDiversity = TRUE)

{r sbx2,fig.width=6.5, fig.height=3.3}
## Drivers, stacked
par(cex = 0.75, las = 1)
plot(sb,show = "drivers", type = "stacked", plotDiversity = TRUE)

{r sbx3,fig.width=6.5, fig.height=3.3}
## Drivers, stream
par(cex = 0.75, las = 1)
plot(sb,show = "drivers", type = "stream", plotDiversity = TRUE)


{r sbx4,fig.width=6.5, fig.height=3.3}
## Genotypes, line plot
par(cex = 0.75, las = 1)
plot(sb,show = "genotypes", type = "line", plotDiversity = TRUE)

{r sbx5,fig.width=6.5, fig.height=3.3}
## Genotypes, stacked
par(cex = 0.75, las = 1)
plot(sb,show = "genotypes", type = "stacked", plotDiversity = TRUE)

{r sbx6,fig.width=6.5, fig.height=3.3}
## Genotypes, stream
par(cex = 0.75, las = 1)
plot(sb,show = "genotypes", type = "stream", plotDiversity = TRUE)


The above illustrates again that different types of plots can be useful to
reveal different patterns in the data. For instance, here, because of the
huge relative frequency of one of the clones/genotypes, the stacked and
stream plots do not reveal the other clones/genotypes as we cannot use a
log-transformed y-axis, even if there are other clones/genotypes present.

### Simulation with order effects and McFL model {#clonalint}

(We use a somewhat large mutation rate than usual, so that the simulation
runs quickly.)

{r, fig.width=6}

set.seed(4321)
tmp <-  oncoSimulIndiv(examplesFitnessEffects[["o3"]],
model = "McFL",
mu = 5e-5,
detectionSize = 1e8,
detectionDrivers = 3,
sampleEvery = 0.025,
max.num.tries = 10,
keepEvery = 5,
initSize = 2000,
finalTime = 6000,
onlyCancer = FALSE)


We show a stacked and a line plot of the drivers:

{r tmpmx1,fig.width=6.5, fig.height=4.1}
par(las = 1, cex = 0.85)
plot(tmp, addtot = TRUE, log = "", plotDiversity = TRUE,
thinData = TRUE, thinData.keep = 0.2)

{r tmpmx2,fig.width=6.5, fig.height=4.1}
par(las = 1, cex = 0.85)
plot(tmp, type = "stacked", plotDiversity = TRUE,
ylim = c(0, 5500), legend.ncols = 4,
thinData = TRUE, thinData.keep = 0.2)


In this example (and at least under Linux, with both GCC and clang
---random number streams in C++, and thus simulations, can differ
between combinations of operating system and compiler), we can see
that the mutants with three drivers do not get established when we
stop the simulation at time 6000. This is one case where the summary
statistics about number of drivers says little of value, as fitness
is very different for genotypes with the same number of mutations,
and does not increase in a simple way with drivers:

{r}
order = TRUE)


A few figures could help:

{r tmpmx3,fig.width=6.5, fig.height=5.5}
plot(tmp, show = "genotypes", ylim = c(0, 5500), legend.ncols = 3,
thinData = TRUE, thinData.keep = 0.5)


(When reading the figure legends, recall that genotype  $x > y\ \_\ z$ is
one where a mutation in "x" happened before a mutation in "y", and
there is also a mutation in "z" for which order does not matter. Here,
there are no genes for which order does not matter and thus there is
nothing after the "_").

In this case, the clones with three drivers end up displacing those with
two by the time we stop; moreover, notice how those with one driver never
really grow to a large population size, so we basically go from a
population with clones with zero drivers to a population made of clones
with two or three drivers:

{r}
set.seed(15)
tmp <-  oncoSimulIndiv(examplesFitnessEffects[["o3"]],
model = "McFL",
mu = 5e-5,
detectionSize = 1e8,
detectionDrivers = 3,
sampleEvery = 0.025,
max.num.tries = 10,
keepEvery = 5,
initSize = 2000,
finalTime = 20000,
onlyCancer = FALSE,
extraTime = 1500)
tmp


use a drivers plot:
{r tmpmdx5,fig.width=6.5, fig.height=4}
par(las = 1, cex = 0.85)
plot(tmp, addtot = TRUE, log = "", plotDiversity = TRUE,
thinData = TRUE, thinData.keep = 0.5)

{r tmpmdx6,fig.width=6.5, fig.height=4}
par(las = 1, cex = 0.85)
plot(tmp, type = "stacked", plotDiversity = TRUE,
legend.ncols = 4, ylim = c(0, 5200), xlim = c(3400, 5000),
thinData = TRUE, thinData.keep = 0.5)


Now show the genotypes explicitly:
{r tmpmdx7,fig.width=6.5, fig.height=5.3}
## Improve telling apart the most abundant
## genotypes by sorting colors
## differently via breakSortColors
## Modify ncols of legend, so it is legible by not overlapping
## with plot
par(las = 1, cex = 0.85)
plot(tmp, show = "genotypes", breakSortColors = "distave",
plotDiversity = TRUE, legend.ncols = 4,
ylim = c(0, 5300), xlim = c(3400, 5000),
thinData = TRUE, thinData.keep = 0.5)


As before, the argument plotDiversity = TRUE asks to show a small
plot on top with Shannon's diversity index. Here, as before, the quick
clonal expansion of the clone with two drivers leads to a sudden drop in
diversity (for a while, the population is made virtually of a single
clone). Note, however, that compared to section \@ref(mcf50070), we are
modeling here a scenario with very few genes, and correspondingly very few
possible genotypes, and thus it is not strange that we observe very little
diversity.

(We have used extraTime to continue the simulation well past the
point of detection, here specified as three drivers. Instead of specifying
extraTime we can set the detectionDrivers value to a
number larger than the number of existing possible drivers, and the
simulation will run until finalTime if onlyCancer = FALSE.)

## Interactive graphics {#interactive}

It is possible to create interactive stacked area and stream plots using
the r Githubpkg("hrbrmstr/streamgraph") package, available from
<https://github.com/hrbrmstr/streamgraph>.  However, that package is
not available as a CRAN or BioConductor package, and thus we cannot depend
on it for this vignette (or this package). You can, however, paste the
code below and make it run locally.

Before calling the streamgraph function, though, we need to
convert the data from the original format in which it is stored into
"long format". A simple convenience function is provided as
OncoSimulWide2Long in r Biocpkg("OncoSimulR").

As an example, we will use the data we generated above for section
\@ref(bauer2).

{r, eval=FALSE}
## Convert the data
lb1 <- OncoSimulWide2Long(b1)

## Install the streamgraph package from GitHub and load
library(devtools)
devtools::install_github("hrbrmstr/streamgraph")
library(streamgraph)

## Stream plot for Genotypes
sg_legend(streamgraph(lb1, Genotype, Y, Time, scale = "continuous"),
show=TRUE, label="Genotype: ")

## Staked area plot and we use the pipe
streamgraph(lb1, Genotype, Y, Time, scale = "continuous",
offset = "zero") %>%
sg_legend(show=TRUE, label="Genotype: ")


<!-- %% (Note: the idiomatic way of doing the above with r CRANpkg("tidyr") is using  -->
<!-- %% \verb= %>% =, the pipe operator. Something like  -->
<!-- %% \begin{verbatim} -->
<!-- %% streamgraph(lb1, Genotype, Y, Time, scale = "continuous",   -->
<!-- %%            offset = "zero") \%>\%                                                                                                                                sg_legend(show=TRUE, label=Genotype: ")  -->
<!-- %% \end{verbatim} -->

<!-- %% but it gives me problems with knitr, etc). -->

## Multiple initial mutants: starting the simulation from arbitrary configurations {#minitmut}

You can specify the population composition when you start the
simulation: in other words, you can use multiple initial
mutants. Simply pass a vector to initMutant and a vector of the
same length to initSize: the first are the genotypes/clones, the
second the population sizes of the corresponding genotypes/clones.

(It often makes no sense to start the simulation with genotypes with
birth rate of 0: you can try it, but you will be told about it.)

Two examples.

{r minitm1}
r2 <- rfitness(6)
## Make sure these always viable for interesting stuff
r2[2, 7] <- 1 + runif(1) # A
r2[4, 7] <- 1 + runif(1) # C
r2[8, 7] <- 1 + runif(1) # A, B
o2 <- allFitnessEffects(genotFitness = r2)
ag <- evalAllGenotypes(o2)

out1 <- oncoSimulIndiv(o2, initMutant = c("A", "C"),
initSize = c(100, 200),
onlyCancer = FALSE,
finalTime = 200)


No WT, nor any other genotypes with a single mutation (except "A"
and "C") would thus be possible either (it is impossible to obtain,
say, a "B" if there are no WT).

We can do something similar with the frequency-dependent
functionality (section \@ref(fdf)):

{r minitm1fdf}
gffd0 <- data.frame(
Genotype = c(
"A", "A, B",
"C", "C, D", "C, E"),
Fitness = c(
"1.3",
"1.4",
"1.4",
"1.1 + 0.7*((f_A + f_A_B) > 0.3)",
"1.2 + sqrt(f_A + f_C + f_C_D)"))

afd0 <- allFitnessEffects(genotFitness = gffd0,
frequencyDependentFitness = TRUE)

sp <- 1:5
names(sp) <- c("A", "C", "A, B", "C, D", "C, E")
eag0 <- evalAllGenotypes(afd0, spPopSizes = sp)

os0 <- oncoSimulIndiv(afd0,
initMutant = c("A", "C"),
finalTime = 20, initSize = c(1e4, 1e5),
onlyCancer = FALSE, model = "McFLD")


## Multispecies simulations {#multispecies}

Since we can use arbitrary initial populations to start the
simulation (section \@ref(minitmut)) and we can use arbitrary
fitness specifications, you can run multi-species simulations using
a simple trick.

Suppose you want to use a two species simulation, where the first
species has two loci and the second three loci. This is a possible procedure:

* Create a genotype of total length (1 + 2) + (1 + 3).
* The first locus in each set we will use as the "species indicator".
* Thus, Species A will use loci 1, 2, 3 and Species B loci 4 to 7.
* Make all genotype combinations where loci from different species
are mutated lethal (e.g., a genotype with loci 2 and 5 mutated is
not viable).
* Now you can start the simulation from the "WT of each species": the
initMutants will have genotypes with only loci 1 or loci 4
mutated.

This trick is really only an approximation: mutation to the other
species is actually death. So there is "leakage" from mutation to
death, as in example \@ref(predprey): both species are leaking a
small number of children via mutation to non-viable
"hybrids". Factor this into your equations for death rate, but this
should be negligible if death rate $\gg$ mutation rate. (You can
ameliorate this problem slightly by making mutation to the "species
indicator" locus very small, say $10^{10}$ ---do not set it to 0, as
you will get an error).

Of course, you can extend the scheme above to arbitrary numbers of
species.

Let's give several examples.

We use a capital letter for the "species indicator locus" and name
each of the species-specific loci with the lower case and a
number. We then ameliorate the leakage issue by making mutation to
"A" or "B" tiny (though there is still leakage from, say, "A" to "A,
b1").

{r mspeci1}

mspec <- data.frame(
Genotype = c("A",
"A, a1", "A, a2", "A, a1, a2",
"B",
"B, b1", "B, b2", "B, b3",
"B, b1, b2", "B, b1, b3", "B, b1, b2, b3"),
Fitness = 1 + runif(11)
)
fmspec <- allFitnessEffects(genotFitness = mspec)
afmspec <- evalAllGenotypes(fmspec)

## Show only viable ones
afmspec[afmspec$Fitness >= 1, ] muv <- c(1e-10, rep(1e-5, 2), 1e-10, rep(1e-5, 3)) names(muv) <- c("A", paste0("a", 1:2), "B", paste0("b", 1:3)) out1 <- oncoSimulIndiv(fmspec, initMutant = c("A", "B"), initSize = c(100, 200), mu = muv, onlyCancer = FALSE, finalTime = 200)  We can do something similar with the frequency-dependent-fitness functionality. (We use a somewhat silly specification, so that checking equations is easy) {r mspeci2} mspecF <- data.frame( Genotype = c("A", "A, a1", "A, a2", "A, a1, a2", "B", "B, b1", "B, b2", "B, b3", "B, b1, b2", "B, b1, b3", "B, b1, b2, b3"), Fitness = c("1 + f_A_a1", "1 + f_A_a2", "1 + f_A_a1_a2", "1 + f_B", "1 + f_B_b1", "1 + f_B_b2", "1 + f_B_b3", "1 + f_B_b1_b2", "1 + f_B_b1_b3", "1 + f_B_b1_b2_b3", "1 + f_A") ) fmspecF <- allFitnessEffects(genotFitness = mspecF, frequencyDependentFitness = TRUE) ## Remeber, spPopSizes correspond to the genotypes ## shown in fmspecF$full_FDF_spec
## in exactly that order if it is unnamed.

afmspecF <- evalAllGenotypes(fmspecF,
spPopSizes = 1:11)

## Alternatively, pass a named vector, which is the recommended approach

spp <- 1:11
names(spp) <- c("A","B",
"A, a1", "A, a2",
"B, b1", "B, b2", "B, b3",
"A, a1, a2",
"B, b1, b2", "B, b1, b3", "B, b1, b2, b3")

afmspecF <- evalAllGenotypes(fmspecF,
spPopSizes = spp)

## Show only viable ones
afmspecF[afmspecF$Fitness >= 1, ] ## Expected values of fitness exv <- 1 + c(3, 5, 4, 8, 6, 7, 9, 2, 10, 11, 1)/sum(1:11) stopifnot(isTRUE(all.equal(exv, afmspecF[afmspecF$Fitness >= 1, ]$Fitness))) muv <- c(1e-10, rep(1e-5, 2), 1e-10, rep(1e-5, 3)) names(muv) <- c("A", paste0("a", 1:2), "B", paste0("b", 1:3)) out1 <- oncoSimulIndiv(fmspecF, initMutant = c("A", "B"), initSize = c(1e4, 1e5), mu = muv, finalTime = 20, model = "McFLD", onlyCancer = FALSE)  Some further examples are given below, as in \@ref(competition1mult). \clearpage # Sampling multiple simulations {#sample} Often, you will want to simulate multiple runs of the same scenario, and then obtain the matrix of runs by mutations (a matrix of individuals/samples by genes or, equivalently, a vector of "genotypes"), and do something with them. OncoSimulR offers several ways of doing this. The key function here is samplePop, either called explicitly after oncoSimulPop (or oncoSimulIndiv), or implicitly as part of a call to oncoSimulSample. With samplePop you can use **single cell** or **whole tumor** sampling (for details see the help of samplePop). Depending on how the simulations were conducted, you might also sample at different times, or as a function of population sizes. A major difference between procedures has to do with whether or not you want to keep the complete history of the simulations. **You want to keep the complete history of population sizes of clones during the simulations**. You will simulate using: - oncoSimulIndiv repeatedly (maybe within mclapply, to parallelize the run). - oncoSimulPop. oncoSimulPop is basically a thin wrapper around oncoSimulIndiv that uses mclapply. In both cases, you specify the conditions for ending the simulations (as explained in \@ref(endsimul)). Then, you use function samplePop to obtain the matrix of samples by mutations. **You do not want to keep the complete history of population sizes of clones during the simulations**. You will simulate using: - oncoSimulIndiv repeatedly, with argument keepEvery = NA. - oncoSimulPop, with argument keepEvery = NA. In both cases you specify the conditions for ending the simulations (as explained in \@ref(endsimul)). Then, you use function samplePop. - oncoSimulSample, specifying the conditions for ending the simulations (as explained in \@ref(endsimul)). In this case, you will not use samplePop, as that is implicitly called by oncoSimulSample. The output is directly the matrix (and a little bit of summary from each run), and during the simulation it only stores one time point. Why the difference between the above cases? If you keep the complete history of population sizes, you can take samples at any of the times between the beginning and the end of the simulations. If you do not keep the history, you can only sample at the time the simulation exited (see section \@ref(trackindivs)). Why would you want to use the second route? If we are only interested in the final matrix of individuals by mutations, keeping the complete history above is wasteful because we store fully all of the simulations (for example in the call to oncoSimulPop) and then sample (in the call to samplePop). Further criteria to use when choosing between sampling procedures is whether you need detectionSize and detectionDrivers do differ between simulations: if you use oncoSimulPop the arguments for detectionSize and detectionDrivers must be the same for all simulations but this is not the case for oncoSimulSample. See further comments in \@ref(diffsample). Finally, parallelized execution is available for oncoSimulPop but, by design, not for oncoSimulSample. The following are a few examples. First we run oncoSimulPop to obtain 4 simulations and in the last line we sample from them: {r pancrpopcreate} pancrPop <- oncoSimulPop(4, pancr, detectionSize = 1e7, keepEvery = 10, mc.cores = 2) summary(pancrPop) samplePop(pancrPop)  Now a simple multiple call to oncoSimulIndiv wrapped inside mclapply; this is basically the same we just did above. We set the class of the object to allow direct usage of samplePop. (Note: in Windows mc.cores > 1 is not supported, so for the vignette to run in Windows, Linux, and Mac we explicitly set it here in the call to mclapply. For regular usage, you will not need to do this; just use whatever is appropriate for your operating system and number of cores. As well, we do not need any of this with oncoSimulPop because the code inside oncoSimulPop already takes care of setting mc.cores to 1 in Windows). {r} library(parallel) if(.Platform$OS.type == "windows") {
mc.cores <- 1
} else {
mc.cores <- 2
}

p2 <- mclapply(1:4, function(x) oncoSimulIndiv(pancr,
detectionSize = 1e7,
keepEvery = 10),
mc.cores = mc.cores)
class(p2) <- "oncosimulpop"
samplePop(p2)


Above, we have kept the complete history of the simulations as you can
check by doing, for instance

{r}
tail(pancrPop[[1]]$pops.by.time)  If we were not interested in the complete history of simulations we could have done instead (note the argument keepEvery = NA) {r} pancrPopNH <- oncoSimulPop(4, pancr, detectionSize = 1e7, keepEvery = NA, mc.cores = 2) summary(pancrPopNH) samplePop(pancrPopNH)  which only keeps the very last sample: {r} pancrPopNH[[1]]$pops.by.time


Or we could have used oncoSimulSample:

{r}
pancrSamp <- oncoSimulSample(4, pancr)
pancrSamp$popSamp  Again, why the above differences? If we are only interested in the final matrix of populations by mutations, keeping the complete history the above is wasteful, because we store fully all of the simulations (in the call to oncoSimulPop) and then sample (in the call to samplePop). ## Whole-tumor and single-cell sampling, and do we always want to sample? {#alwayssamp} samplePop is designed to emulate the process of obtaining a sample from a (set of) "patient(s)". But there is no need to sample. The history of the population, with a granularity that is controlled by argument keepEvery, is kept in the matrix pops.by.time which contains the number of cells of every clone at every sampling point (see further details in \@ref(trackindivs)). This is the information used in the plots that show the trajectory of a simulation: the plots that show the change in genotype or driver abundance over time (see section \@ref(plotraj) and examples mentioned there). Regardless of whether and how you plot the information in pops.by.time, you can also sample one or multiple simulations using samplePop. In **whole-tumor** sampling the resolution is the whole tumor (or the whole population). Thus, a key argument is thresholdWhole, the threshold for detecting a mutation: a gene is considered mutated if it is altered in at least "thresholdWhole" proportion of the cells in that simulation (at a particular time point). This of course means that your "sampled genotype" might not correspond to any existing genotype because we are summing over all cells in the population. For instance, suppose that at the time we take the sample there are only two clones in the population, one clone with a frequency of 0.4 that has gene A mutated, and a second clone one with a frequency of 0.6 that has gene B mutated. If you set thresholdWhole to values$\leq 0.4$the sampled genotype will show both A and B mutated. **Single-cell** sampling is provided as an option in contrast to whole-tumor sampling. Here any sampled genotype will correspond to an existing genotype as you are sampling with single-cell resolution. When samplePop is run on a set of simulated data of, say, 100 simulated trajectories (100 "subjects"), it will produce a matrix with 100 rows (100 "subjects"). But if it makes sense in the context of your problem (e.g., multiple samples per patient?) you can of course run samplePop repeatedly. ## Differences between "samplePop" and "oncoSimulSample" {#diffsample} samplePop provides two sampling times: "last" and "uniform". It also allows you to sample at the first sample time(s) at which the population(s) reaches a given size, which can be either the same or different for each simulation (with argument popSizeSample). "last" means to sample each individual in the very last time period of the simulation. "uniform" means sampling each individual at a time chosen uniformly from all the times recorded in the simulation between the time when the first driver appeared and the final time period. "unif" means that it is almost sure that different individuals will be sampled at different times. "last" does not guarantee that different individuals will be sampled at the same time unit, only that all will be sampled in the last time unit of their simulation. With oncoSimulSample we obtain samples that correspond to timeSample = "last" in samplePop by specifying a unique value for detectionSize and detectionDrivers. The data from each simulation will correspond to the time point at which those are reached (analogous to timeSample = "last"). How about uniform sampling? We pass a vector of detectionSize and detectionDrivers, where each value of the vector comes from a uniform distribution. This is not identical to the "uniform" sampling of oncoSimulSample, as we are not sampling uniformly over all time periods, but are stopping at uniformly distributed values over the stopping conditions. Arguably, however, the procedure in samplePop might be closer to what we mean with "uniformly sampled over the course of the disease" if that course is measured in terms of drivers or size of tumor. An advantage of oncoSimulSample is that we can specify arbitrary sampling schemes, just by passing the appropriate vector detectionSize and detectionDrivers. A disadvantage is that if we change the stopping conditions we can not just resample the data, but we need to run it again. There is no difference between oncoSimulSample and oncoSimulPop + samplePop in terms of the typeSample argument (whole tumor or single cell). Finally, there are some additional differences between the two functions. oncoSimulPop can run parallelized (it uses mclapply). This is not done with oncoSimulSample because this function is designed for simulation experiments where you want to examine many different scenarios simultaneously. Thus, we provide additional stopping criteria (max.wall.time.total and max.num.tries.total) to determine whether to continue running the simulations, that bounds the total running time of all the simulations in a call to oncoSimulSample. And, if you are running multiple different scenarios, you might want to make multiple, separate, independent calls (e.g., from different R processes) to oncoSimulSample, instead of relying in mclapply, since this is likely to lead to better usage of multiple cores/CPUs if you are examining a large number of different scenarios. \clearpage # Showing the genealogical relationships of clones {#phylog} If you run simulations with keepPhylog = TRUE, the simulations keep track of when every clone is generated, and that will allow us to see the parent-child relationships between clones. (This is disabled by default). Let us re-run a previous example: {r} set.seed(15) tmp <- oncoSimulIndiv(examplesFitnessEffects[["o3"]], model = "McFL", mu = 5e-5, detectionSize = 1e8, detectionDrivers = 3, sampleEvery = 0.025, max.num.tries = 10, keepEvery = 5, initSize = 2000, finalTime = 20000, onlyCancer = FALSE, extraTime = 1500, keepPhylog = TRUE) tmp  We can plot the parent-child relationships^[There are several packages in R devoted to phylogenetic inference and related issues. For instance, r CRANpkg("ape"). I have not used that infrastructure because of our very specific needs and circumstances; for instance, internal nodes are observed, we can have networks instead of trees, and we have no uncertainty about when events occurred.] of every clone ever created (with fitness larger than 0 ---clones without viability are never shown): {r} plotClonePhylog(tmp, N = 0)  However, we often only want to show clones that exist (have number of cells$>0$) at a certain time (while of course showing all of their ancestors, even if those are now extinct ---i.e., regardless of their current numbers). {r} plotClonePhylog(tmp, N = 1)  If we set keepEvents = TRUE the arrows show how many times each clone appeared: (The next can take a while) {r pcpkeepx1} plotClonePhylog(tmp, N = 1, keepEvents = TRUE)  And we can show the plot so that the vertical axis is proportional to time (though you might see overlap of nodes if a child node appeared shortly after the parent): {r} plotClonePhylog(tmp, N = 1, timeEvents = TRUE)  We can obtain the adjacency matrix doing {r, fig.keep="none"} get.adjacency(plotClonePhylog(tmp, N = 1, returnGraph = TRUE))  We can see another example here: {r} set.seed(456) mcf1s <- oncoSimulIndiv(mcf1, model = "McFL", mu = 1e-7, detectionSize = 1e8, detectionDrivers = 100, sampleEvery = 0.025, keepEvery = 2, initSize = 2000, finalTime = 1000, onlyCancer = FALSE, keepPhylog = TRUE)  Showing only clones that exist at the end of the simulation (and all their parents): {r} plotClonePhylog(mcf1s, N = 1)  Notice that the labels here do not have a "_", since there were no order effects in fitness. However, the labels show the genes that are mutated, just as before. Similar, but with vertical axis proportional to time: {r} par(cex = 0.7) plotClonePhylog(mcf1s, N = 1, timeEvents = TRUE)  What about those that existed in the last 200 time units? {r} par(cex = 0.7) plotClonePhylog(mcf1s, N = 1, t = c(800, 1000))  And try now to show also when the clones appeared (we restrict the time to between 900 and 1000, to avoid too much clutter): {r} par(cex = 0.7) plotClonePhylog(mcf1s, N = 1, t = c(900, 1000), timeEvents = TRUE)  (By playing with t, it should be possible to obtain animations of the phylogeny. We will not pursue it here.) If the previous graph seems cluttered, we can represent it in a different way by calling r CRANpkg("igraph") directly after storing the graph and using the default layout: {r fig.keep="none"} g1 <- plotClonePhylog(mcf1s, N = 1, t = c(900, 1000), returnGraph = TRUE)  {r} plot(g1)  which might be easier to show complex relationships or identify central or key clones. It is of course quite possible that, especially if we consider few genes, the parent-child relationships will form a network, not a tree, as the same child node can have multiple parents. You can play with this example, modified from one we saw before (section \@ref(mn1)): {r, eval=FALSE} op <- par(ask = TRUE) while(TRUE) { tmp <- oncoSimulIndiv(smn1, model = "McFL", mu = 5e-5, finalTime = 500, detectionDrivers = 3, onlyCancer = FALSE, initSize = 1000, keepPhylog = TRUE) plotClonePhylog(tmp, N = 0) } par(op)  ## Parent-child relationships from multiple runs {#phylogmult} If you use oncoSimulPop you can store and plot the "phylogenies" of the different runs: {r} oi <- allFitnessEffects(orderEffects = c("F > D" = -0.3, "D > F" = 0.4), noIntGenes = rexp(5, 10), geneToModule = c("F" = "f1, f2, f3", "D" = "d1, d2") ) oiI1 <- oncoSimulIndiv(oi, model = "Exp") oiP1 <- oncoSimulPop(4, oi, keepEvery = 10, mc.cores = 2, keepPhylog = TRUE)  We will plot the first two: {r, fig.height=9} op <- par(mar = rep(0, 4), mfrow = c(2, 1)) plotClonePhylog(oiP1[[1]]) plotClonePhylog(oiP1[[2]]) par(op)  This is so far disabled in function oncoSimulSample, since that function is optimized for other uses. This might change in the future. \clearpage # Generating random fitness landscapes {#gener-fit-land} ## Random fitness landscapes from a Rough Mount Fuji model {#rmfmodel} In most of the examples seen above, we have fully specified the fitness of the different genotypes (either by providing directly the full mapping genotypes to fitness, or by providing that mapping by specifying the effects of the different gene combinations). In some cases, however, we might want to specify a particular model that generates the fitness landscape, and then have fitnesses be random variables obtained under this model. In other words, in this random fitness landscape the fitness of the genotypes is a random variable generated under some specific model. Random fitness landscapes are used extensively, for instance, to understand the evolutionary consequences of different types of epistatic interactions [e.g., @szendro_quantitative_2013; @franke_evolutionary_2011] and there are especially developed tools for plotting and analyzing random fitness landscapes [e.g., @brouillet_magellan:_2015]. With OncoSimulR it is possible to generate mappings of genotype to fitness using the function rfitness that allows you to use from a pure House of Cards model to a purely additive model (see \@ref(nkmodel) for NK model). I have followed @szendro_quantitative_2013 and @franke_evolutionary_2011 and model fitness as $$f_i = -c\ d(i, reference) + x_i \label{eq:1}$$ where$d(i, j)$is the Hamming distance between genotypes$i$and$j$(the number of positions that differ),$c$is the decrease in fitness of a genotype per each unit increase in Hamming distance from the reference genotype, and$x_i$is a random variable (in this case, a normal deviate of mean 0 and standard deviation$sd$). You can change the reference genotype to any of the genotypes: for the deterministic part, you make the fittest genotype be the one with all positions mutated by setting reference = "max", or use the wildtype by using a string of 0s, or randomly select a genotype as a reference by using reference = "random" or reference = "random2". And by changing$c$and$sd$you can flexibly modify the relative weight of the purely House of Cards vs. additive component. The expression used above is also very similar to the one on @greene_changing_2014 if you use rfitness with the argument reference = "max". What can you do with these genotype to fitness mappings? You could plot them, you could use them as input for oncoSimulIndiv and related functions, or you could export them (to_Magellan) and plot them externally (e.g., in MAGELLAN: <http://wwwabi.snv.jussieu.fr/public/Magellan/>, @brouillet_magellan:_2015). {r} ## A small example rfitness(3) ## A 5-gene example, where the reference genotype is the ## one with all positions mutated, similar to Greene and Crona, ## 2014. We will plot the landscape and use it for simulations ## We downplay the random component with a sd = 0.5 r1 <- rfitness(5, reference = rep(1, 5), sd = 0.6) plot(r1) oncoSimulIndiv(allFitnessEffects(genotFitness = r1))  ## Random fitness landscapes from Kauffman's NK model {#nkmodel} You can also use Kauffman's NK model [e.g., @ferretti_measuring_2016; @brouillet_magellan:_2015]. We call the function fl_generate from MAGELLAN [@brouillet_magellan:_2015]. {r nkex1} rnk <- rfitness(5, K = 3, model = "NK") plot(rnk) oncoSimulIndiv(allFitnessEffects(genotFitness = rnk))  ## Random fitness landscapes from an additive model {#additivemodel} This model evaluates fitness with different contributions of each allele, which will be randomly generated. Given a number a genes by the user, the code uses rnorm to generate random contribution for the mutated allele in each locus. Later, this constributions will be used in the generation of the matrix that gives the value of fitness for each combination of wild type/mutated alleles by addition of the values for each locus and combination. {r addex1} radd <- rfitness(4, model = "Additive", mu = 0, sd = 0.5) plot(radd)  ## Random fitness landscapes from Eggbox model {#eggboxmodel} You can also use Eggbox model [e.g., @ferretti_measuring_2016; @brouillet_magellan:_2015], where each locus is either high or low fitness (depending on the "e" parameter value), with a systematic change between each neighbor. We call the function fl_generate from MAGELLAN [@brouillet_magellan:_2015] to generate these landscapes. <!-- "e" parameter: every other genotype is +/- e. --> <!-- "E" parameter: add noise on the mean effect for eggbox. --> {r eggex1} regg <- rfitness(4, model = "Eggbox", e = 1, E = 0.5) plot(regg)  ## Random fitness landscapes from Ising model {#isingmodel} In the Ising model [e.g., @ferretti_measuring_2016; @brouillet_magellan:_2015], loci are arranged sequentially and each locus interacts with its physical neighbors. For each pair of interacting loci, there is a cost to (log)fitness if both alleles are not identical (and therefore 'compatible'); in this case, the cost for incompatibility i is applied. The last and the first loci will interact only if 'circular' is set. The implementation of this model is decribedin [@brouillet_magellan:_2015], and we use a call to MAGELLAN code to generate the landscape. {r isingex1} ris <- rfitness(g = 4, model = "Ising", i = 0.002, I = 0.45) plot(ris)  ## Random fitness landscapes from Full models {#fullmodel} MAGELLAN also offers the possibility to combine different models with their own parameters in order to generate a Full model. The models combined are: * House of cards: H is the number of interacting genes. * Multiplicative (what we call additive): s and S mean and SD for generating random fitnesses. d is a diminishing (negative) or increasing (positive) return as you approach the peak. * Kauffman NK: each locus interacts with any other K loci that can be chosen randomly pasing "r = TRUE" or among its neigbors. * RMF: explained at \@ref(rmfmodel). * Ising: i and I mean and SD for incompatibility. If circular option is provided, the last and first alleles can interact (circular arrangement). * Eggbox: In this model, each locus is considered as high or low fitness. From one locus to another the fitness changes its sign so that one is benefficial and its neigbor is detrimental. e and E are fitness and noise for fitness. * Optimum: there is an optimum fitness contribution defined by o$mu$and O$sigma$and every locus has a production pand P (also mean and sd respectively). All models can be taken into account for the fitness calculation. With default parameters, neither of Ising, Eggbox or Optimum contribute to fitness lanadcape generation as all i, e, o and p all == 0. Also, as all parameters refering to standard deviations have value == -1, those are also have no effect unless changed. Further details can be found in MAGELLAN's webpage <http://wwwabi.snv.jussieu.fr/public/Magellan/> and [@brouillet_magellan:_2015]. {r fullex1} rnk <- rfitness(4, model = "Full", i = 0.5, I = 0.1, e = 2, s = 0.3, S = 0.08) plot(rnk)  ## Epistasis and fitness landscape statistics {#epistats} We can call MAGELLAN's [@brouillet_magellan:_2015] fl_statistics to obtain fitness landscape statistics, including measures of sign and reciprocal sign epistasis. See the help of Magellan_stats for further details on output format. For example: {r magstats1} rnk1 <- rfitness(6, K = 1, model = "NK") Magellan_stats(rnk1) rnk2 <- rfitness(6, K = 4, model = "NK") Magellan_stats(rnk2)  <!-- % % % % %% For poster --> <!-- % <<>>= --> <!-- % pdf(file = "fl1.pdf", height = 5.8, width = 5) --> <!-- % plot(r1, use_ggrepel = TRUE) --> <!-- % dev.off() --> <!-- % @ --> (These fitness landscapes are, of course, frequency-independent fitness landscapes; with frequency-dependent fitness, as in section \@ref{fdf} fitness landscapes as such are not defined.) \clearpage # Frequency-dependent fitness {#fdf} <!-- **NOTE: This functionality is only available in the freq-dep-fitness --> <!-- branch** See: --> <!-- https://github.com/rdiaz02/OncoSimul/tree/freq-dep-fitness. --> <!-- --> (*Note that except for the example of \@ref(hurlbut), based on @hurlbut2018, the examples below are not used because of their biological realism, but rather to show some key features of the software*) With frequency-dependence fitness we can make fitness (actually, birth rate) depend on the frequency of other genotypes. We specify how the fitness (birth rate) of each genotype depends (or not) on other genotypes. Thus, this is similar to the explicit mapping of genotypes to fitness (see \@ref(explicitmap)), but fitness can be a function of the abundance (relative or absolute) of other genotypes. Frequency-dependent fitness allows you to examine models from **game theory** and **adaptive dynamics**. Game theory has long tradition in evolutionary biology [@maynardsmith1982] and has been widely used in cancer [see, for example, @tomlinson1997a; @basanta2008; @archetti2019, for classical papers that cover from early uses to a very recent review]. Since birth rate can be an arbitrary function of the frequencies of other clones, we can model competition, cooperation and mutualism, parasitism and predation, and commensalism. (Recall that in the "Exp" model death rate is constant and fixed to 1. In the "McFL" and "McFLD" models, death rate is density-dependent ---but not frequency-dependent. You can thus model all those phenomena by, for example, making the effects of clones$i$,$j$on each other and on their own be asymmetric on their birth rates). See examples in section \@ref(predprey); as explained there, if you use the "Exp" model, you might want to decrease the value of sampleEvery. The procedure for working with the frequency-dependent functionality is the general one with OncoSimulR. <!-- Specify the mapping between --> <!-- genotypes and fitness (here, fitness as a function of the frequency --> <!-- of different genotypes), and then simulate. Thus, --> We first create a data frame with the mapping between genotypes and their (frequency-dependent) fitness, similar to section \@ref(explicitmap). For example, a two-column data frame, where the first column are the genotypes and the second column contains, as strings, the expressions for the function that relate fitness to frequencies of other genotypes. (We can also use a data frame with$g + 1$columns; each of the first$g$columns contains a 1 or a 0 indicating that the gene of that column is mutated or not. Column$g+ 1$contains the expressions for the fitness specifications; see oncoSimulIndiv and allFitnessEffects for examples). Once this data frame is created, we pass it to allFitnessEffects. From there, simulation proceeds as usual. How complex can the functions that specify fitness be? We use library [ExprTk](https://github.com/ArashPartow/exprtk) for the fitness specifications so the range of functions you can use is very large (http://www.partow.net/programming/exprtk/), including of course the usual arithmetic expressions, logical expressions (so you can model thresholds or jumps and use step functions), and a wide range of mathematical functions [so linear, non-linear, convex, concave, etc, functions can be used, including of course affine fitness functions as in @gerstung2011]. ## A first example with frequency-dependent fitness {#fdfex1} The following is an arbitrary example. We will model birth rate of some genotypes as a function of the relative frequencies of other genotypes; we use f_1 to denote the relative frequency of the genotype with the first gene mutated, f_1_2 to denote the relative frequency of the genotype with the first and second genes mutated, etc, and f_ to denote the frequency of the WT genotype ---below, in sections \@ref(fdfabs), \@ref(fdfrelabs), and \@ref(predprey), we will use absolute number of cells instead of relative frequencies). (As we have discussed already, instead of f_1 you can, and probably should for any example except trivial ones, use f_A or f_genotype expressed as combination of gene names). As you can see below, the birth rate of genotype "A"$= 1.2 + 1.5*
f\_A\_B$and that of the wildtype$= 1 + 1.5* f\_A\_B$. Genotype "A, B" in this example could be a genotype whose presence leads to an increase in the growth of other genotypes (maybe via diffusible factors, induction of angiogenesis, etc). Genotype "B" does not show frequency-dependence. The birth rate of genotype "C" increases with the frequency of f_A_B and increases (adding 0.7) with the frequency of genotypes "A" and "B", but only if the sum of the frequencies of genotypes "A" and "B" is larger than 0.3. For genotype "A, B" its fitness increases with the square root of the sum of the frequencies of genotypes "A", "B", and "C", but it decreases (i.e., shows increased intra-clone competition) if its own frequency is larger than 0.5. Genotypes not defined explicitly have a fitness of 0. <!-- See the documentation of allFitnessEffects for --> <!-- further details. As we said above, since we can use all of the --> <!-- functionality from ExprTk, we can make fitness and arbitrarily --> <!-- complex function of the frequencies of genotypes. --> {r fdf1} ## Define fitness of the different genotypes gffd <- data.frame( Genotype = c("WT", "A", "B", "C", "A, B"), Fitness = c("1 + 1.5 * f_A_B", "1.3 + 1.5 * f_A_B", "1.4", "1.1 + 0.7*((f_A + f_B) > 0.3) + f_A_B", "1.2 + sqrt(f_1 + f_C + f_B) - 0.3 * (f_A_B > 0.5)"))  (In the data frame creation, we use stringsAsFactors = FALSE to avoid messages about conversions between factors and characters in former versions of R). You could also specify that as {r fdf1named} ## Define fitness of the different genotypes gffdn <- data.frame( Genotype = c("WT", "A", "B", "C", "A, B"), Fitness = c("1 + 1.5 * f_1_2", "1.3 + 1.5 * f_1_2", "1.4", "1.1 + 0.7*((f_1 + f_2) > 0.3) + f_1_2", "1.2 + sqrt(f_1 + f_3 + f_2) - 0.3 * (f_1_2 > 0.5)"), stringsAsFactors = FALSE)  but it is *strongly preferred* to use explicit gene name letters (otherwise, you must keep in mind how R orders names of genes when making the mapping from letters to numbers). Let us verify that we have specified what we think we have specified using evalAllGenotypes (we have done this repeatedly in this vignette, for example in \@ref(ex-ochs) or \@ref(quickexample) or \@ref(bauer). Because fitness can depend on population sizes of different populations, we need to pass the populations sizes at which we want fitness evaluated in evalAllGenotypes. Note that when calling allFitnessEffects we have to set the paramenter frequencyDependentFitness to TRUE. Since we are using relative frequencies, we can be explicit and specify freqType = "rel" (though it is not needed). We will see below (\@ref(fdfabs), \@ref(fdfrelabs), and \@ref(predprey)) several examples with absolute numbers. When passing spPopSizes it is also strongly preferred to use a named vector as that allows the code to run some checks. Otherwise, the order of the population sizes *must* be identical to that in the table with the fitness descriptions (component full_FDF_spec in the fitness effects object). {r fdf1b} evalAllGenotypes(allFitnessEffects(genotFitness = gffd, frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(WT = 100, A = 20, B = 20, C = 30, "A, B" = 0)) ## Notice the warning evalAllGenotypes(allFitnessEffects(genotFitness = gffd, frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(100, 30, 40, 0, 10)) evalAllGenotypes(allFitnessEffects(genotFitness = gffd, frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(100, 30, 40, 0, 100))  The numbered one gives the same results. Note as well that using frequencyType is not needed (the default, auto, infers the type) {r fdf1bnamed} evalAllGenotypes(allFitnessEffects(genotFitness = gffdn, frequencyDependentFitness = TRUE), spPopSizes = c(100, 20, 20, 30, 0)) evalAllGenotypes(allFitnessEffects(genotFitness = gffdn, frequencyDependentFitness = TRUE), spPopSizes = c(100, 30, 40, 0, 10)) evalAllGenotypes(allFitnessEffects(genotFitness = gffdn, frequencyDependentFitness = TRUE), spPopSizes = c(100, 30, 40, 0, 100))  The fitness specification is correct. Let us now create the allFitnessEffects object and simulate. We will use the McFL model, so in addition to the frequency dependence in the birth rates, there is also density dependence in the death rate (see section \@ref(specfit)). {r fdf1c} afd <- allFitnessEffects(genotFitness = gffd, frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(1) ## for reproducibility sfd <- oncoSimulIndiv(afd, model = "McFL", onlyCancer = FALSE, finalTime = 55, ## short, for speed mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(sfd, show = "genotypes")  <!-- no expression on fitness zero in FDF: zz:FIXME:remove_restriction --> There is no need to specify the fitness of all possible genotypes (and no need to always specify the fitness of a WT): those are taken to be 0. But no fitness expression can, thus, contain a function of the genotypes for which fitness is not specified (e.g., suppose you do not pass the fitness of genotype "B": it will be taken as 0; but no genotype can have, in its fitness, a function such as "2 * f_B"). ## Hurlbut et al., 2018: a four-cell example with angiogenesis and cytotoxicity {#hurlbut} The following example is based on @hurlbut2018. As explained in p. 3 of that paper, "Stromal cancer cells (A-) [WT in the code below] have no particular benefit or cost unique to themselves, and they are considered a baseline neutral cell within the context of the model. In contrast, angiogenesis-factor producing cells (A+) [A in the code below] vascularize the local tumor area which consequently introduces a nutrient rich blood to the benefit of all interacting cells. Nutrient recruitment expands when A+ cells interact with one another. Cytotoxic cells (C) release a chemical compound which harms heterospecific cells and increases their rate of cell death. The cytotoxic cells benefit from the resulting disruption in competition caused by the interaction. For simplicity, our model presumes that cytotoxic cells are themselves immune to this class of agent. Finally, proliferative cells (P) possess a reproductive or metabolic advantage relative to the other cell types. In our model this advantage does not compound with the nutrient enrichment produced by vascularization when A+ cells are present; however, it does place the proliferative cell at a greater vulnerability to cytotoxins." They provide, in p. 4, the payoff matrix reproduced in Figure \@ref(fig:hurlbutpay): <!-- Yes, when making the pdf we get a an error ---> <!-- for Input file OncoSimulR-tex_files/figure-latex/hurlbutpay-1.pdf' ---> <!-- not found! ---> <!-- but not a problem ---> {r hurlbutpay, eval=TRUE,echo=FALSE, fig.cap="Payoff matrix from Table 2 of Hurlbut et al., 2018, 'Game Theoretical Model of Cancer Dynamics withFour Cell Phenotypes', *Games*, 9, 61; doi:10.3390/g9030061."} knitr::include_graphics("hurlbut.png")  As explained in p. 6 (equation 1) of @hurlbut2018, we can write the fitness of the four types as **f**=G**u**, where **f** and **u** are the vectors with the four fitnesses and frequencies (where each element of **u** corresponds to the relative frequencies of stromal, angiogenic, proliferative, and cytotoxic cells), and G is the payoff matrix in Figure \@ref(fig:hurlbutpay). To allow modelling scenarios with different values for the parameters in Figure \@ref(fig:hurlbutpay) we will define a function to create the data frame of frequency-dependent fitnesses. First, we will assume that each one of types A+, P, and C, are all derived from WT by a single mutation in one of three genes, say, A, P, C, respectively. {r hurlbutfit1} create_fe <- function(a, b, c, d, e, f, g, gt = c("WT", "A", "P", "C")) { data.frame(Genotype = gt, Fitness = c( paste0("1 + ", d, " * f_A ", "- ", c, " * f_C"), paste0("1 - ", a, " + ", d, " + ", f, " * f_A ", "- ", c, " * f_C"), paste0("1 + ", g, " + ", d, " * f_A ", "- ", c, " * (1 + ", g, ") * f_C"), paste0("1 - ", b, " + ", e, " * f_ + ", "(", d, " + ", e, ") * f_A + ", e , " * f_P"))) }  We can check we recover Figure \@ref(fig:hurlbutpay): {r hbf1check} create_fe("a", "b", "c", "d", "e", "f", "g")  We could model a different set of ancestor-dependent relationships: {r hurlbutfit2} ## Different assumption about origins from mutation: ## WT -> P; P -> A,P; P -> C,P create_fe2 <- function(a, b, c, d, e, f, g, gt = c("WT", "A", "P", "C", "A, P", "A, C", "C, P")) { data.frame(Genotype = gt, Fitness = c( paste0("1 + ", d, " * f_A_P ", "- ", c, " * f_P_C"), "0", paste0("1 + ", g, " + ", d, " * f_A_P ", "- ", c, " * (1 + ", g, ") * f_P_C"), "0", paste0("1 - ", a, " + ", d, " + ", f, " * f_A_P ", "- ", c, " * f_P_C"), "0", paste0("1 - ", b, " + ", e, " * f_ + ", "(", d, " + ", e, ") * f_A_P + ", e , " * f_P")), stringsAsFactors = FALSE) } ## And check: create_fe2("a", "b", "c", "d", "e", "f", "g")  Note: we are writing f_P_C: this is remapped internally to f_C_P (which is the genotype name, with gene names reordered). To show two examples, we will run the analyses @hurlbut2018 use for Figures 3a and 3b (p.8 of their paper): {r hurl3a, message=FALSE} ## Figure 3a afe_3_a <- allFitnessEffects( genotFitness = create_fe(0.02, 0.04, 0.08, 0.06, 0.15, 0.1, 0.06), frequencyDependentFitness = TRUE) set.seed(2) s_3_a <- oncoSimulIndiv(afe_3_a, model = "McFL", onlyCancer = FALSE, finalTime = 160, mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) ## plot(s_3_a, show = "genotypes", ## xlim = c(40, 200), ## col = c("black", "green", "red", "blue")) plot(s_3_a, show = "genotypes", type = "line", col = c("black", "green", "red", "blue"), thinData = TRUE)  {r hurl3b, message=FALSE} ## Figure 3b afe_3_b <- allFitnessEffects( genotFitness = create_fe(0.02, 0.04, 0.08, 0.1, 0.15, 0.1, 0.05), frequencyDependentFitness = TRUE) set.seed(2) ## Use a short finalTime, for speed of vignette execution s_3_b <- oncoSimulIndiv(afe_3_b, model = "McFL", onlyCancer = FALSE, finalTime = 100, ## 160, mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) ## plot(s_3_b, show = "genotypes", ## col = c("black", "green", "red", "blue")) plot(s_3_b, show = "genotypes", type = "line", col = c("black", "green", "red", "blue"), thinData = TRUE) ## thin for faster plotting  Of course, if we assume that the mutations leading to the different cell types are different, the results can change: {r hurl3b2} ## Figure 3b. Now with WT -> P; P -> A,P; P -> C,P ## For speed, we set finalTiem = 100 afe_3_b_2 <- allFitnessEffects( genotFitness = create_fe2(0.02, 0.04, 0.08, 0.1, 0.15, 0.1, 0.05), frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(2) s_3_b_2 <- oncoSimulIndiv(afe_3_b_2, model = "McFL", onlyCancer = FALSE, finalTime = 100, ## 300 mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s_3_b_2, show = "genotypes", type = "line", col = c("black", "green", "red", "blue"), thinData = TRUE)  (Examples for the remaining Figures 2 and 3 are provided, using also oncoSimulPop, in file 'inst/miscell/hurlbut-ex.R') ## An example with absolute numbers and population collapse {#fdfabs} In the following example we use absolute numbers (thus the n_1, etc, instead of the f_1 in the fitness definition). This is a toy model where there is a change in fitness in two of the genotypes if the other is above a specified threshold (this also shows again the usage of a logical inequality). The genotype with gene B mutated has birth rate less than 1, unless there are at least more than 10 cells with genotype A mutated. {r fdf2, message=FALSE} gffd3 <- data.frame(Genotype = c("WT", "A", "B"), Fitness = c("1", "1 + 0.2 * (n_B > 10)", ".9 + 0.4 * (n_A > 10)" )) afd3 <- allFitnessEffects(genotFitness = gffd3, frequencyDependentFitness = TRUE)  As usual, let us verify that we have specified what we think we have specified using evalAllGenotypes:<!-- (we have done this repeatedly in this --> <!-- vignette, for example in \@ref(ex-ochs) or \@ref(bauer) or --> <!-- \@ref{quickexample}). Because of the way the code works, we need to --> <!-- pass the populations sizes at which we want fitness evaluated in --> <!-- evalAllGenotypes (this we do now in allFitnessEffects, but this --> <!-- might be moved to evalAllGenotypes in the future): --> {r fdf2b, message=FALSE} evalAllGenotypes(allFitnessEffects(genotFitness = gffd3, frequencyDependentFitness = TRUE), spPopSizes = c(WT = 100, A = 1, B = 11)) evalAllGenotypes(allFitnessEffects(genotFitness = gffd3, frequencyDependentFitness = TRUE), spPopSizes = c(WT = 100, A = 11, B = 1))  In this simulation, the population collapses: genotype B is able to invade the population when there are some A's around. But as soon as A disappears due to competition from B, B collapses as its birth rate becomes 0.9, less than the death rate; we are using the "McFLD" model (where death rate$D(N) = \max(1, \log(1 + N/K))$); see details in \@ref(mcfldeath). {r fdf2c} set.seed(1) sfd3 <- oncoSimulIndiv(afd3, model = "McFLD", onlyCancer = FALSE, finalTime = 200, mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE)  {r echo=FALSE} op <- par(mfrow = c(1, 2))  {r } plot(sfd3, show = "genotypes", type = "line") plot(sfd3, show = "genotypes") sfd3  {r echo=FALSE} par(op)  Had we used the "usual" death rate expression, that can lead to death rates below 1 (see \@ref(mcfldeath)), we would have obtained a population that stabilizes around a final value slightly below the initial one (the one that corresponds to a death rate equal to 0.9): {r fdf2d} set.seed(1) sfd4 <- oncoSimulIndiv(afd3, model = "McFL", onlyCancer = FALSE, finalTime = 145, mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE)  {r, echo=FALSE} op <- par(mfrow = c(1, 2))  {r polotfdfv6} plot(sfd4, show = "genotypes", type = "line") plot(sfd4, show = "genotypes") sfd4  {r, echo=FALSE} par(op)  {r fdfpopfinal} ## Check final pop size corresponds to birth = death K <- 5000/(exp(1) - 1) K log1p(4290/K)  ## Predator-prey, commensalism, and consumer-resource models {#predprey} Since birth rates can be arbitrary functions of frequencies of other clones, we can easily model classical ecological models, such as predator-prey, competition, commensalism and, more generally, consumer-resource models [see, for example, section 3.4 in @Otto2007]. OncoSimulR was originally designed as a forward-time genetic simulator; thus, we used to need to use a simple trick to get the system going. For example, suppose we want to model a predator-prey system; we could do this having a WT that can mutate into either preys or predators. (This is no longer necessary since we can specify starting the simulation from populations with arbitrary numbers of different clones; see sections \@ref(minitmut) and \@ref(multispecies). But we have not yet updated the examples). Even with the There is, in fact, a small leakage in the system because both preys and predators are "leaking" a small number of children, via mutation to a non-viable predator-and-prey genotype, but this is negligible relative to their birth/death rates. We will use below the usual consumer-resource model with Lotka-Volterra equations. To model them, we use the "Exp" model, which has a constant death rate of 1, and directly translate the usual expressions [e.g., expressions 3.15a and 3.15b in p. 73 of @Otto2007] for rates of change into the birth rate. Of course, you can use any other function for how rates of change of each "species" depend on the numbers of the different species, including constant inflow and outflow, Type I, Type II, and Type III functional responses, etc. And you can model systems that involve multiple different types of preys, predators, commensals, etc (see the example in \@ref(hurlbut) for a four-type example). What about sampleEvery? In "for real" work, and specially with complex models, you might want to decrease it, or at least examine how much results are affected by changes in sampleEvery. Decreasing sampleEvery will result in birth rates being updated more frequently, and we use the BNB algorithm, which updates all rates only when the whole population is sampled. (Recall that by default, in the McFL and McFLD models the setting for sampleEvery is smaller than in the Exp model). Further discussion of these issues is provided in sections \@ref(bnbfdf) and \@ref(bnbdensdep). Since the WT genotype is just a trick used to get the system going, we will make sure it disappears from the system soon after we get it to have both preys and predators (and we use the max function to prevent birth rate from ever becoming negative or identically 0). Finally, note that we can make this much more sophisticated; for example, we could get the system going differently by having different mutations from WT to prey and predator. Remember that you can now start the simulation from arbitrary initial compositions (section \@ref(minitmut)). This is left here for historical purposes and to show additional use cases. <!-- FIXME: clarify how we use n_ or f_, since some of the examples --> <!-- below should use f_ or at least a ratio over the appropriate n_ --> <!-- (otherwise, we are passing propensities). --> <!-- Done --> ### Competition {#competition1} First, create a function that will generate the usual Lotka-Volterra expressions for competition models (see below for this example without using the WT, and directly starting from "S1" and "S2"). {r lotka1} G_fe_LV <- function(r1, r2, K1, K2, a_12, a_21, awt = 1e-4, gt = c("WT", "S1", "S2")) { data.frame(Genotype = gt, Fitness = c( paste0("max(0.1, 1 - ", awt, " * (n_2 + n_1))"), paste0("1 + ", r1, " * ( 1 - (n_1 + ", a_12, " * n_2)/", K1, ")"), paste0("1 + ", r2, " * ( 1 - (n_2 + ", a_21, " * n_1)/", K2, ")") )) } ## Show expressions for birth rates G_fe_LV("r1", "r2", "K1", "K2", "a_12", "a_21", "awt")  Note we use numbers, not letters, in the expressions above (n_1, etc). This allows for reusing the function, but requires extra care making sure that the numbers match the order of the genotypes (it is not a problem with "S1" and "S2", since there "S1" will always be 1 and "S2" 2; but what about "Predator" and "prey"?) Remember the above are the birth rates for a model with death rate = 1 (the "Exp" model). That is why we added a 1 to the birth rate. If you subtract 1 from the expressions for the birth rates of predators and prey above you get the standard expressions for the differential equations for Lotka-Volterra model of competition:$\frac{\mathrm{d}n_1}{\mathrm{d}t} = r_1 n_1 (1 - \frac{n_1 +
\alpha_{12} n_2}{K_1})$. (Verbosely: we are simulating using a model where we have, in a rather general expression,$\frac{\mathrm{d}n_1}{\mathrm{d}t} = (b\ - d)\ n_1$, where$b$and$d$are the birth and death rates (that could be arbitrary functions of other stuff); these are the birth and death rates used in the BNB algorithm. And when we simulate under the "Exp" model we have$d  = 1$. So just solve for$(b - d) n_1 =  r_1 n_1 (1 - \frac{n_1 + \alpha_{12} n_2}{K_1})$, with$b = 1$and you get the$b$you need to use). Now, run that model by setting appropriate parameters; see how we have$a\_12 > 0$and$a\_21 > 0$. {r, echo = FALSE} set.seed(1)  {r complv1, message=FALSE} fe_competition <- allFitnessEffects( genotFitness = G_fe_LV(1.5, 1.4, 10000, 4000, 0.6, 0.2, gt = c("WT","S1", "S2")), frequencyDependentFitness = TRUE, frequencyType = "abs") competition <- oncoSimulIndiv(fe_competition, model = "Exp", onlyCancer = FALSE, finalTime = 100, mu = 1e-4, initSize = 40000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE)  If we plot the whole simulation, we of course see the WT: {r pp1wt} plot(competition, show = "genotypes")  but we can avoid that by showing the plot after the WT are long gone: {r, echo=FALSE} op <- par(mfrow = c(1, 2))  {r pp1nowt} plot(competition, show = "genotypes", xlim = c(80, 100)) plot(competition, show = "genotypes", type = "line", xlim = c(80, 100), ylim = c(1500, 12000))  {r, echo=FALSE} par(op)  <!-- Fine, the op, etc do not seem to work. --> ### Competition {#competition1mult} We repeat the above, but starting directly from the two species, using the \@ref(multispecies) logic and \@ref(minitmut). {r lotka1multi} G_fe_LVm <- function(r1, r2, K1, K2, a_12, a_21, awt = 1e-4, gt = c("S1", "S2")) { data.frame(Genotype = gt, Fitness = c( paste0("1 + ", r1, " * ( 1 - (n_1 + ", a_12, " * n_2)/", K1, ")"), paste0("1 + ", r2, " * ( 1 - (n_2 + ", a_21, " * n_1)/", K2, ")") )) } ## Show expressions for birth rates G_fe_LVm("r1", "r2", "K1", "K2", "a_12", "a_21", "awt")  {r, echo = FALSE} set.seed(1)  {r complv1multi, message=FALSE} fe_competitionm <- allFitnessEffects( genotFitness = G_fe_LVm(1.5, 1.4, 10000, 4000, 0.6, 0.2, gt = c("S1", "S2")), frequencyDependentFitness = TRUE) fe_competitionm$full_FDF_spec

competitionm <- oncoSimulIndiv(fe_competitionm,
model = "Exp",
initMutant = c("S1", "S2"),
initSize = c(5000, 2000),
onlyCancer = FALSE,
finalTime = 100,
mu = 1e-4,
keepPhylog = TRUE,
seed = NULL,
errorHitMaxTries = FALSE,
errorHitWallTime = FALSE)


{r pp1wtmulti}
plot(competitionm, show = "genotypes")


<!-- ### Predator-prey, first example {#predprey1} -->

<!-- The simplest model would use the above Lotka-Volterra expressions -->
<!-- and set one of the a_ to be negative [see, for example, @Otto2007, -->
<!-- p. 73]. Let's turn former "S2" and thus a_21 < 0 (to make the -->
<!-- effects more salient, we also increase that value in magnitude). -->

<!-- {r echo = FALSE} -->
<!-- set.seed(1) -->
<!--  -->

<!-- FIXME and RECHECK!!!!! -->
<!-- I think this is wrong, because Predator is actually n_1, so -->
<!-- expressions are wrong.  -->

<!-- {r lotka2} -->
<!-- fe_pred_prey <- -->
<!--     allFitnessEffects( -->
<!--         genotFitness = -->
<!--             G_fe_LV(1.5, 1.4, 10000, 4000, 0.6, -0.5, awt = 1, -->
<!--                   gt = c("WT", "prey", "Predator")), -->
<!--         frequencyDependentFitness = TRUE, -->
<!--         frequencyType = "abs") -->

<!-- pred_prey <- oncoSimulIndiv(fe_pred_prey, -->
<!--                             model = "Exp", -->
<!--                             onlyCancer = FALSE,  -->
<!--                             finalTime = 100, -->
<!--                             mu = 1e-4, -->
<!--                             initSize = 40000,  -->
<!--                             keepPhylog = TRUE, -->
<!--                             seed = NULL,  -->
<!--                             errorHitMaxTries = FALSE,  -->
<!--                             errorHitWallTime = FALSE) -->
<!--  -->

<!-- {r echo=FALSE} -->
<!-- op <- par(mfrow = c(1, 2)) -->
<!--  -->

<!-- {r prepreylv2} -->
<!-- plot(pred_prey, show = "genotypes") -->
<!-- plot(pred_prey, show = "genotypes", -->
<!--      xlim = c(50, 100)) -->

<!--  -->
<!-- {r echo=FALSE} -->
<!-- op <- par(mfrow = c(1, 2)) -->
<!--  -->

<!-- You can easily play with a range of parameters, say the -->
<!-- carrying capacity of one of the species, to see how they affect the -->
<!-- stochasticity of the system. Here we also start from a large number -->
<!-- of WT (to generate preys and predators quickly) but we can set -->
<!-- carrying capacity to much smaller numbers: -->

<!-- {r echo=FALSE } -->
<!-- set.seed(2) -->
<!--  -->

<!-- {r ppsmallk, message=FALSE} -->
<!-- fe_pred_prey <- -->
<!--     allFitnessEffects( -->
<!--         genotFitness = -->
<!--             G_fe_LV(1.5, 1.4, 100, 40, 0.6, -0.5, awt = 1, -->
<!--                   gt = c("WT","prey", "Predator")), -->
<!--         frequencyDependentFitness = TRUE, -->
<!--         frequencyType = "abs") -->

<!-- pred_prey <- oncoSimulIndiv(fe_pred_prey, -->
<!--                             model = "Exp", -->
<!--                             onlyCancer = FALSE,  -->
<!--                             finalTime = 200, -->
<!--                             mu = 1e-3, -->
<!--                             initSize = 1000,  -->
<!--                             keepPhylog = TRUE, -->
<!--                             seed = NULL,  -->
<!--                             errorHitMaxTries = FALSE,  -->
<!--                             errorHitWallTime = FALSE) -->
<!--  -->

<!-- {r echo=FALSE} -->
<!-- op <- par(mfrow = c(1, 2)) -->
<!--  -->

<!-- Plotting the complete range shows the drop from the initial WT population -->
<!-- size to the final carrying capacities (and the second plot zooms in after -->
<!-- there are no WTs): -->

<!-- {r prepreylv7} -->
<!-- plot(pred_prey, show = "genotypes") -->
<!-- plot(pred_prey, show = "genotypes", -->
<!--      xlim = c(50, 200)) -->
<!--  -->

<!-- {r echo=FALSE} -->
<!-- par(op)	  -->
<!--  -->

<!-- If you run the above model repeatedly, you will frequently find that -->
<!-- only one of the species is left; and, yes, that could be the -->
<!-- "Predator", as in the Lotka-Volterra expressions above there can be -->
<!-- predators without prey. For example, you can check that the birth -->
<!-- rate of the predator is larger than 1 even if there are 0 prey -->
<!-- (identically 1 when n_2 = K_2: -->

<!-- {r checklvpredprey} -->
<!-- evalAllGenotypes(allFitnessEffects( -->
<!--     genotFitness = -->
<!--         G_fe_LV(1.5, 1.4, 100, 40, -->
<!--               0.6, -0.5, awt = 0.1, -->
<!--               gt = c("WT","prey", "Predator")), -->
<!--     frequencyDependentFitness = TRUE, -->
<!--     frequencyType = "abs"), -->
<!--     spPopSizes = c(0, 0, 20)) -->

<!-- evalAllGenotypes(allFitnessEffects( -->
<!--     genotFitness = -->
<!--         G_fe_LV(1.5, 1.4, 100, 40, -->
<!--               0.6, -0.5, awt = 0.1, -->
<!--               gt = c("WT","prey", "Predator")), -->
<!--     frequencyDependentFitness = TRUE, -->
<!--     frequencyType = "abs"), -->
<!--     spPopSizes = c(0, 0, 40)) -->
<!--  -->

<!-- (Of course, with those population sizes, even if prey had a birth -->
<!-- rate > 1, they cannot appear as there are no WT to generate prey). -->

### Predator-prey, first example {#predprey1}

The simplest model would use the above Lotka-Volterra expressions
and set one of the a_ to be negative [see, for example, @Otto2007,
p. 73]. Let's turn former "S2" and thus a_21 < 0 (to make the
effects more salient, we also increase that value in magnitude).

We will also use a general function to generate fitness
expressions. This is actually nicer than we did above, because it
allows us to give the names of the species, not codes such as "n_1"
that depend on how the names are ordered by R.

{r ppreydefvm2}
G_fe_LVm2 <- function(r1, r2, K1, K2, a_12, a_21, awt = 1e-4,
gt = c("S1", "S2")) {
data.frame(Genotype = gt,
Fitness = c(
paste0("1 + ", r1,
" * ( 1 - (n_", gt[1], " + ", a_12, " * n_", gt[2], ")/", K1,
")"),
paste0("1 + ", r2,
" * ( 1 - (n_", gt[2], " + ", a_21, " * n_", gt[1], ")/", K2,
")")
))
}

## But notice that, because of ordering, "prey" ends up being n_2
## but that is not a problem.

fe_pred_preym2 <-
allFitnessEffects(
genotFitness =
G_fe_LVm2(1.5, 1.4, 10000, 4000, 1.1, -0.5, awt = 1,
gt = c("prey", "Predator")),
frequencyDependentFitness = TRUE)
fe_pred_preym2$full_FDF_spec ## Change order and note how these are, of course, equivalent fe_pred_preym3 <- allFitnessEffects( genotFitness = G_fe_LVm2(1.4, 1.5, 4000, 10000, -0.5, 1.1, awt = 1, gt = c("Predator", "prey")), frequencyDependentFitness = TRUE) fe_pred_preym3$full_FDF_spec

evalAllGenotypes(fe_pred_preym2, spPopSizes = c(1000, 300))
evalAllGenotypes(fe_pred_preym3, spPopSizes = c(300, 1000))


{r, echo=FALSE}
set.seed(1)


{r pprey3}
s_pred_preym2 <- oncoSimulIndiv(fe_pred_preym2,
model = "Exp",
initMutant = c("prey", "Predator"),
initSize = c(1000, 1000),
onlyCancer = FALSE,
finalTime = 200,
mu = 1e-3,
keepPhylog = TRUE,
seed = NULL,
errorHitMaxTries = FALSE,
errorHitWallTime = FALSE)


{r prepreylv1237}
plot(s_pred_preym2, show = "genotypes")


You can easily play with a range of parameters, say the
carrying capacity of one of the species, to see how they affect the
stochasticity of the system.

If you run the above model repeatedly, you will frequently find that
only one of the species is left; and, yes, that could be the
"Predator", as in the Lotka-Volterra expressions above there can be
predators without prey. For example, you can check that the birth
rate of the predator is larger than 1 even if there are 0 prey
(identically 1 when n_1 = K_1:

{r prepreylv1238}
evalAllGenotypes(fe_pred_preym2, spPopSizes = c(0, 300))

evalAllGenotypes(allFitnessEffects(
genotFitness =
G_fe_LVm2(1.5, 1.4, 100, 40,
0.6, -0.5, awt = 0.1,
gt = c("prey", "Predator")),
frequencyDependentFitness = TRUE),
spPopSizes = c(0, 40))



### Predator-prey, second example {#predprey2}

We use now the model in p. 76 of @Otto2007, where prey grow
exponentially in the absence of predators (and predators will
eventually go extinct in the absence of prey):

$$\frac{\mathrm{d}n_1}{\mathrm{d}t} = r\ n_1 - a\ c\ n_1\ n_2$$
$$\frac{\mathrm{d}n_2}{\mathrm{d}t} = \epsilon\ a\ c\ n_1\ n_2 - \delta\ n2$$

(Recall what we explained in section \@ref(competition1) for how we
find the $b$, birth rate, to use in our simulations when we are using
and "Exp" model with death rate 1: basically, each of the birth
rates, $b_i$ is $1 + expression\ above/n_i$).

<!-- The next is wrong because prey is n2 -->
<!-- ## Use e for epsilon and d for delta -->
<!-- ## C_fe_pred_prey <- function(r, a, c, e, d, awt = 0.1, -->
<!-- ##                            gt = c("WT", "Prey", "predator")) { -->
<!-- ##     data.frame(Genotype = gt, -->
<!-- ##                Fitness = c( -->
<!-- ##                    paste0("max(0.1, 1 - ", awt, -->
<!-- ##                           " * (n_2 + n_1))"), -->
<!-- ##                    paste0("1 + ", r, " - ", a, -->
<!-- ##                           " * ", c, " * n_2"), -->
<!-- ##                    paste0("1 + ", e, " * ", a, -->
<!-- ##                           " * ", c, " * n_1 - ", d) -->
<!-- ##                )) -->
<!-- ## } -->

<!-- ## C_fe_pred_prey("r", "a", "c", "e", "d") -->

{r predprey2a}
C_fe_pred_prey2 <- function(r, a, c, e, d,
gt = c("s1", "s2")) {
data.frame(Genotype = gt,
Fitness = c(
paste0("1 + ", r, " - ", a,
" * ", c, " * n_2"),
paste0("1 + ", e, " * ", a,
" * ", c, " * n_1 - ", d)
))
}

C_fe_pred_prey2("r", "a", "c", "e", "d")


{r echo=FALSE }
set.seed(2)


Given how we wrote C_fe_pred_prey2, the prey is hardcoded as
n_1, so specify names of creatures so that the prey comes first,
in terms of order (note we avoided this problem in the example
above, \@ref(predprey1), by always using the full name of the
genotype we refered to in the function to generate the fitness
effects, G_fe_LVm2). (Yes, we could have used a classic pair:
"Hare" and "Lynx").

{r predprey2b}
fe_pred_prey2 <-
allFitnessEffects(
genotFitness =
C_fe_pred_prey2(r = .7, a = 1, c = 0.005,
e = 0.02, d = 0.4,
gt = c("Fly", "Lizard")),
frequencyDependentFitness = TRUE)

fe_pred_prey2$full_FDF_spec ## You want to make sure you start the simulation from ## a viable condition evalAllGenotypes(fe_pred_prey2, spPopSizes = c(5000, 100)) set.seed(2) pred_prey2 <- oncoSimulIndiv(fe_pred_prey2, model = "Exp", initMutant = c("Fly", "Lizard"), initSize = c(500, 100), sampleEvery = 0.1, mu = 1e-3, onlyCancer = FALSE, finalTime = 100, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) op <- par(mfrow = c(1, 2)) ## Nicer colors plot(pred_prey2, show = "genotypes") ## But this shows better what is going on plot(pred_prey2, show = "genotypes", type = "line") par(op)  If you run that model repeatedly, sometimes the system will go extinct quickly, or you will only get prey growing exponentially. You could now (left as an exercise) build a more complex model to simulate arms-race scenarios between predators and prey (maybe by having mutations with possibly opposing effects on different coefficients above). ### Commensalism {#commens} Modelling commensalism simply requires changing the values of the$\alpha$, the a_12 and a_21. Again, we can now avoid starting from a WT and start the simulation directly from "A" and "Commensal" (section \@ref(minitmut)). For example (not run, as this is just repetitive): {r commens, eval=FALSE} fe_commens <- allFitnessEffects( genotFitness = G_fe_LV(1.2, 1.3, 5000, 20000, 0, -0.2, gt = c("WT","A", "Commensal")), frequencyDependentFitness = TRUE, frequencyType = "abs") commens <- oncoSimulIndiv(fe_commens, model = "Exp", onlyCancer = FALSE, finalTime = 100, mu = 1e-4, initSize = 40000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(commens, show = "genotypes") plot(commens, show = "genotypes", xlim = c(80, 100)) plot(commens, show = "genotypes", type = "line", xlim = c(80, 100), ylim = c(2000, 22000))  ## Frequency-dependent fitness: can I mix relative and absolute frequencies? {#fdfrelabs} Yes, of course, since you can always use an absolute specification with the appropriate quotient. For example, the following two specifications are identical: {r fdfar, message=FALSE} rar <- data.frame(Genotype = c("WT", "A", "B", "C"), Fitness = c("1", "1.1 + .3*f_2", "1.2 + .4*f_1", "1.0 + .5 * (f_1 + f_2)")) afear <- allFitnessEffects(genotFitness = rar, frequencyDependentFitness = TRUE, frequencyType = "rel") evalAllGenotypes(afear, spPopSizes = c(100, 200, 300, 400)) rar2 <- data.frame(Genotype = c("WT", "A", "B", "C"), Fitness = c("1", "1.1 + .3*(n_2/N)", "1.2 + .4*(n_1/N)", "1.0 + .5 * ((n_1 + n_2)/N)")) afear2 <- allFitnessEffects(genotFitness = rar2, frequencyDependentFitness = TRUE, frequencyType = "abs") evalAllGenotypes(afear2, spPopSizes = c(100, 200, 300, 400))  and simulating with them leads to identical results {r relarres, message=FALSE} set.seed(1) tmp1 <- oncoSimulIndiv(afear, model = "McFL", onlyCancer = FALSE, finalTime = 30, mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) set.seed(1) tmp2 <- oncoSimulIndiv(afear2, model = "McFL", onlyCancer = FALSE, finalTime = 30, mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) stopifnot(identical(print(tmp1), print(tmp2)))  So you can always mix relative and absolute; here fitness of two genotypes depends on the relative frequencies of others, whereas fitness of the third on the absolute frequencies (number of cells): {r relar3a, message=FALSE} rar3 <- data.frame(Genotype = c("WT", "A", "B", "C"), Fitness = c("1", "1.1 + .3*(n_2/N)", "1.2 + .4*(n_1/N)", "1.0 + .5 * ( n_1 > 20)")) afear3 <- allFitnessEffects(genotFitness = rar3, frequencyDependentFitness = TRUE, frequencyType = "abs") evalAllGenotypes(afear3, spPopSizes = c(100, 200, 300, 400)) set.seed(1) tmp3 <- oncoSimulIndiv(afear3, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 1e-4, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(tmp3, show = "genotypes")  ## Frequency-dependent fitness: can I use genes with mutator effects? {#fdfmutator} Yes. The following examples show it: {r fdfmutex} ## Relative r1fd <- data.frame(Genotype = c("WT", "A", "B", "A, B"), Fitness = c("1", "1.4 + 1*(f_2)", "1.4 + 1*(f_1)", "1.6 + f_1 + f_2")) afe4 <- allFitnessEffects(genotFitness = r1fd, frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(1) s1fd <- oncoSimulIndiv(afe4, model = "McFL", onlyCancer = FALSE, finalTime = 50, mu = 1e-4, initSize = 5000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s1fd, show = "genotypes") mtfd <- allMutatorEffects(epistasis = c("A" = 0.1, "B" = 10)) set.seed(1) s2fd <- oncoSimulIndiv(afe4, muEF = mtfd, model = "McFL", onlyCancer = FALSE, finalTime = 50, mu = 1e-4, initSize = 5000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s2fd, show = "genotypes")  {r echo=FALSE} op <- par(mfrow = c(1, 2))  {r figmutfdf} plotClonePhylog(s1fd, keepEvents = TRUE) plotClonePhylog(s2fd, keepEvents = TRUE)  {r echo=FALSE} par(op)  Of course, it also works with absolute frequencies (code not executed for the sake of speed): {r exmutfdf2, eval=FALSE} ## Absolute r5 <- data.frame(Genotype = c("WT", "A", "B", "A, B"), Fitness = c("1", "1.25 - .0025*(n_2)", "1.25 - .0025*(n_1)", "1.4"), stringsAsFactors = FALSE) afe5 <- allFitnessEffects(genotFitness = r5, frequencyDependentFitness = TRUE, frequencyType = "abs") set.seed(8) s5 <- oncoSimulIndiv(afe5, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 1e-4, initSize = 5000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s5, show = "genotypes") plot(s5, show = "genotypes", log = "y", type = "line") mt <- allMutatorEffects(epistasis = c("A" = 0.1, "B" = 10)) set.seed(8) s6 <- oncoSimulIndiv(afe5, muEF = mt, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 1e-4, initSize = 5000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s6, show = "genotypes") plot(s6, show = "genotypes", log = "y", type = "line") plotClonePhylog(s5, keepEvents = TRUE) plotClonePhylog(s6, keepEvents = TRUE)  Note that **evalAllGenotypesFitAndMut** currently works with frequency-dependent fitness: {r noworkeval} evalAllGenotypes(allFitnessEffects(genotFitness = r1fd, frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(10, 20, 30, 40)) evalAllGenotypesFitAndMut(allFitnessEffects(genotFitness = r1fd, frequencyDependentFitness = TRUE, frequencyType = "rel"), mtfd, spPopSizes = c(10, 20, 30, 40))  ## Can we use the BNB algorithm to model frequency-dependent fitness? {#bnbfdf} This question is similar to the one we address in \@ref(bnbdensdep). Briefly, the answer is yes. You can think of this as an approximation to an exact simulation of a stochastic system. You can also think of a delay in the system in the sense that the changes in rates due to changes in the frequencies of the different genotypes are updated at periodic intervals, not immediately. <!-- ### Death rates in the frequency-dependent model {#fdfdeath} --> <!-- As explained in \@ref(mcfl), in the McFarland model we use death --> <!-- rate at population size N,$D(N) = \log(1 + N/K)$where$K$is the --> <!-- initial equilibrium population size. This, however, does not allow --> <!-- to properly model population collpases, since the death rate can be --> <!-- come less than 1. --> <!-- In the frequency-dependent models, the death rate for the McFarland --> <!-- model is set as$D(N) = \max(1, \log(1 + N/K)). This is reasonable --> <!-- if we consider the equilibrium birth rate in the absence of any --> <!-- mutants to be 1. (We will probably make this change to the rest of --> <!-- the code, but since it could break some existing code, special --> <!-- provisions will need to be taken). --> <!-- We create an --> <!-- allFitnessEffects object, passing a genoFitnes --> <!-- We first --> <!-- need to build an allFitnessEffects object, passing a genoFitnes --> <!-- as we can see bellow (see \@ref(explicitmap) for more details). --> <!-- In this kind of simulations fitness effects of clones are expressed by functions, --> <!-- where the variables are the relative frequencies of the clones in the tumour population. --> <!-- We need to build an allFitnessEffects object, --> <!-- passing a genoFitnes as we can see bellow (see \@ref(explicitmap) for more details). --> <!-- {r} --> <!-- r <- data.frame(Genotype = c("WT", "A", "B", "A, B"), --> <!-- Fitness = c("1 + 1.5*f_", --> <!-- "5 + 3*(f_A + f_B + f_A_B)", --> <!-- "5 + 3*(f_A + f_B + f_A_B)", --> <!-- "7 + 5*(f_A + f_B + f_A_B)")) --> <!-- afe <- allFitnessEffects(genotFitness = r, --> <!-- frequencyDependentFitness = TRUE, --> <!-- frequencyType = "rel") --> <!-- ## For reproducibility --> <!-- set.seed(10) --> <!-- osi <- oncoSimulIndiv(afe, --> <!-- model = "McFL", --> <!-- onlyCancer = FALSE, --> <!-- finalTime = 4000, --> <!-- mu = 1e-6, --> <!-- initSize = 5000, --> <!-- keepPhylog = FALSE, --> <!-- seed = NULL, --> <!-- errorHitMaxTries = FALSE, --> <!-- errorHitWallTime = FALSE) --> <!-- set.seed(NULL) --> <!-- osi --> <!-- plot(osi, show = "genotypes", type = "line") --> <!--  --> <!-- In this example, we can see how the Fitness column of r is passed as character --> <!-- vector, in which each element must be passed as character in the same way. In R, if --> <!-- you do that, Genotype and Fitness would be considered as factors in the data frame --> <!-- r, but allFitnessEffects transform both columns to character, showing the --> <!-- corresponding warnings that alert you of the transformation. If you dont want to --> <!-- see this sometimes ugly messages, just use stringsAsFactors = FALSE in the data frame --> <!-- definition (or change the corresponding global option). Setting the paramenter frequencyDependentFitness to TRUE, you are --> <!-- fixing that all downstream work is going to be done in a frequency-dependent --> <!-- Fitness mode. --> <!-- The case of the example above is inspired by @Axelrod2006, where all clones --> <!-- cooperate with each other in terms of the release of diffusion products, like --> <!-- growth factors, that stimulate the growth of all mutated genotypes. Here we set all --> <!-- fitness effects as linear functions, where fitness increases with the number of --> <!-- mutations acquired. We have set the cooperation adding the frequencies of all --> <!-- mutated clones in the fitness ecuations. We have used McFL model, so in this case --> <!-- the fitness effects are density dependent in terms of death rate and frequency --> <!-- dependent in terms of birth rate (see section \@ref(specfit)). --> <!-- The plot above shows that WT dominates when mutants are less frequent, but if one --> <!-- gets a high frequency, WT decreases fast because its frequency falls down and --> <!-- consequently its fitness decreasses as well. When a single mutant appears and it --> <!-- frequency is high enough, then the probability of the arisen of double mutant --> <!-- increases. Thanks to the large fitness of the double mutant it grows fast and --> <!-- dominates the entire population quickly. If we think of this double mutant as the --> <!-- cause of the malignancy of the tumor when it dominates, we can say that under this --> <!-- conditions and in this particular run the system has reached the state of cancer. --> <!-- Will we see this if the simulation is repeated a bunch --> <!-- of times (i.e., is this a common result under this conditions?) --> <!-- To answer this question we need to run the simulation a high number of times, of --> <!-- course without setting the seed in the same place in each iteration, and capture de --> <!-- final population result. Using this data we can plot a boxplot, like the one shown --> <!-- below in Figure \@ref(fig:boxplot). In this case we run the simulation 1000 times --> <!-- and we can appreciate that the final population composition under this situation is really stable and produces the same results with little variability. --> <!-- {r boxplot, eval=TRUE, echo=FALSE, fig.cap="Final population results box plot. 1000 simulations"} --> <!-- knitr::include_graphics("simulationsBoxPlot.png") --> <!--  --> # Additional examples of frequency-dependent fitness {#addfreqdepex} In this section, we provide additional examples that use frequency-dependent fitness. As mentioned also in \@ref(fdf), <!-- **This --> <!-- functionality is only available in the freq-dep-fitness branch**. --> <!-- See: https://github.com/rdiaz02/OncoSimul/tree/freq-dep-fitness. --> Note also that in most of these examples we make rather arbitrary and simple assumptions about the genetic basis of the different phenotypes or strategies (most are one-mutation-away from WT); see \@ref(predprey) and \@ref(hurlbut) (where we change the ancestor-dependent relationships). In some examples mutation rates are also very high, to speed up processes and because a high mutation rate is used as a procedure (a hack?) to quickly obtain descendants from WT (i.e., to get the game started with some representatives of the non-WT types). Examples \@ref(rockscissors), \@ref(hawkdove), \@ref(gtvasc), \@ref(prostatestroma), \@ref(edmyel) were originally prepared by Sara Dorado Alfaro, Miguel Hernández del Valle, Álvaro Huertas García, Diego Mañanes Cayero, Alejandro Martín Muñoz; example \@ref(parkex) was originally prepared by Marta Couce Iglesias, Silvia García Cobos, Carlos Madariaga Aramendi, Ana Rodríguez Ronchel, and Lucía Sánchez García; examples \@ref(wuAMicrobes), \@ref(breastC), \@ref(breastCQ) were prepared by Yolanda Benítez Quesada, Asier Fernández Pato, Esperanza López López, Alberto Manuel Parra Pérez. All of these as an exercisse for the course Programming and Statistics with R (Master's Degree in Bioinformatics and Computational Biology, Universidad Autónoma de Madrid), course 2019-20. <!-- example \@ref(ProsCaMo) was prepared by Jorge García --> <!-- Calleja, Ana del Ramo Galián, Alejandro de los Reyes Benítez, --> <!-- Guillermo Garcia Hoyos. Not used now, as same as prostatestroma --> ## Rock-paper-scissors model in bacterial community {#rockscissors} ### Introduction This example is inspired by @kerr2002a. It describes the relationship between three populations of _Escherichia coli_, that turns out to be very similar to a rock-paper-scissors game. An E. coli community can have a specific strain of colicinogenic bacteria, that are capable of creating colicin, a toxin to which this special strain is resistant. The wild-type bacteria is killed by this toxin, but can mutate into a resistant strain. So, there are three kinds of bacteria: wild-type (WT), colicinogenic (C) and resistant (R). The presence of C reduces the population of WT, but increases the population of R because R has an advantage over C, since R doesn't have the cost of creating the toxin. At the same time, WT has an advantage over R, because by losing the toxin receptors, R loses also some important functions. Therefore, every strain "wins" against one strain and "loses" against the other, creating a rock-paper-scissors game. {r rps1, message=F} crs <- function (a, b, c){ data.frame(Genotype = c("WT", "C", "R"), Fitness = c(paste0("1 + ", a, " * f_R - ", b, " * f_C"), paste0("1 + ", b, " * f_ - ", c, " * f_R"), paste0("1 + ", c, " * f_C - ", a, " * f_") )) }  The equations are: \begin{align} W\left(WT\right) = 1 + af_R - bf_C\\ W\left(C\right) = 1 + bf_{WT} - cf_R\\ W\left(R\right) = 1 + cf_C - af_{WT}\\ \end{align} wheref_{WT}$,$f_C$and$f_R$are the frequencies of WT, C and R, respectively. {r rps2, message=F} crs("a", "b", "c")  #### Case 1 We are going to study the scenario in which all the relationships have the same relative weight. {r sps3b, message=F} afcrs1 <- allFitnessEffects(genotFitness = crs(1, 1, 1), frequencyDependentFitness = TRUE, frequencyType = "rel") resultscrs1 <- oncoSimulIndiv(afcrs1, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 1e-2, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) op <- par(mfrow = c(1, 2)) plot(resultscrs1, show = "genotypes", type = "line", cex.lab=1.1, las = 1) plot(resultscrs1, show = "genotypes", type = "stacked") par(op)  An oscillatory equilibrium is reached, in which the same populations have a similar number of individuals but oscillates. This makes sense, because the rise on a particular strand will lead to a rise in the one that "wins" against it, and then to a rise in the one that "wins" against the second one, creating this cyclical behaviour. In the stacked plot we can see that the total population remains almost constant. Note, though, that altering mutation rate (which is huge here) can change the results of the model. #### Case 2 We are going to put a bigger weight in one of the coefficients, so a=10, b=1, c=1. {r rps4, message=F} afcrs2 <- allFitnessEffects(genotFitness = crs(10, 1, 1), frequencyDependentFitness = TRUE, frequencyType = "rel")  If we run multiple simulations, for example by doing {r rps4b, eval=FALSE} resultscrs2 <- oncoSimulPop(10, afcrs2, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 1e-2, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE)  we can verify there are two different scenarios. <!-- The following chart represents the average number of cells of each type during --> <!-- the last half of each simulation. As a boxplot would lose the informationof the --> <!-- different scenarios, so we decided to plot the data as points and join with --> <!-- lines the ones that come from the same simulation. --> <!-- {r message=F} --> <!-- meanCompositionPop(resultscrs2, ylab = "Number of cells", cex.lab=1.1, --> <!-- las = 1, legend.out = TRUE) --> <!--  --> The first one is the one in which all the strains coexist, with the colicinogenic bacteria having a much bigger population. {r rps5, message=F} set.seed(1) resultscrs2a <- oncoSimulIndiv(afcrs2, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 1e-2, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(resultscrs2a, show = "genotypes", type = "line")  In the second one, the wild type and the colicinogenic bacteria dissapear, so the resistant strain is the only one that survives. As above, though, decreasing the mutation rate can lead to a different solution and you will want to run the model for much longer to see the resistant strain appear and outcompete the others. {r rps6, message=F} set.seed(3) resultscrs2b <- oncoSimulIndiv(afcrs2, model = "McFL", onlyCancer = FALSE, finalTime = 60, mu = 1e-2, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(resultscrs2b, show = "genotypes", type = "line", cex.lab=1.1, las = 1)  #### Case 3 Finally, we are going to put more weight in two coefficients, so a=1, b=5, c=5. {r rps7, message=F} afcrs3 <- allFitnessEffects(genotFitness = crs(1, 5, 5), frequencyDependentFitness = TRUE, frequencyType = "rel") resultscrs3 <- oncoSimulIndiv(afcrs3, model = "McFL", onlyCancer = FALSE, finalTime = 60, mu = 1e-2, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(resultscrs3, show = "genotypes", type = "line", cex.lab=1.1, las = 1)  In all the cases all three strains survive, with C having a much smaller population than the other two. ## Hawk and Dove example {#hawkdove} The example we are going to show is one of the first games that Maynard Smith analyzed, for example in his classic @maynardsmith1982 (see also, e.g., <https://en.wikipedia.org/wiki/Chicken_%28game%29> ). In this game, the two competitors are subtypes of the same species but with different strategies. The Hawk first displays aggression, then escalates into a fight until it either wins or is injured (loses). The Dove first displays aggression, but if faced with major escalation runs for safety. If not faced with such escalation, the Dove attempts to share the resource (see the payoff matrix, for instance in https://en.wikipedia.org/wiki/Chicken_%28game%29#Hawk%E2%80%93dove ). <!-- ![Payoff Matrix for Hawk Dove Game](./Images_markdown/Hawk_Dove_payoff.PNG) --> Given that the resource is given the value V, the damage from losing a fight is given cost C: * If a Hawk meets a Dove he gets the full resource V to himself * If a Hawk meets a Hawk – half the time he wins, half the time he loses... so his average outcome is then V/2 minus C/2 * If a Dove meets a Hawk he will back off and get nothing – 0 * If a Dove meets a Dove both share the resource and get V/2 The actual payoff however depends on the probability of meeting a Hawk or Dove, which in turn is a representation of the percentage of Hawks and Doves in the population when a particular contest takes place. That in turn is determined by the results of all of the previous contests. If the cost of losing C is greater than the value of winning V (the normal situation in the natural world) the mathematics ends in an stationary point (ESS), a mix of the two strategies where the population of Hawks is V/C. In this case we assume a stable equilibrium in the population dynamics, that is, although there are external variations in the model, it recovers and returns to equilibrium.<!-- (as shown in the image below). --> <!-- ![Stable equilibrium](./Images_markdown/Stable_equilibrium.jpg) --> We are going to simulate with OncoSimulR the situation in which the cost of losing C is greater than the value of gaining V (C = 10, V = 2). We assume that both Hawk and Dove are derived from WT by one mutation (see also \@ref(predprey)) and we will use very high mutation rates to get some hawks and doves from WT quickly (see above). Before performing the simulation, let's look at the fitness of each competitor. {r hkdv, message=F} ## Stablish Genotype-Fitnees mapping. D = Dove, H = Hawk ## With newer OncoSimulR functionality, using WT to start the simulation ## would no longer be needed. H_D_fitness <- function(c, v, gt = c("WT", "H", "D")) { data.frame(Genotype = gt, Fitness = c( paste0("1"), paste0("1 + f_H *", (v-c)/2, "+ f_D *", v), paste0("1 + f_D *", v/2))) } ## Fitness Effects specification HD_competition <-allFitnessEffects( genotFitness = H_D_fitness(10, 2, gt = c("WT", "H", "D")), frequencyDependentFitness = TRUE, frequencyType = "rel") ## Plot fitness landscape of genotype "H, D" evaluation data.frame("Doves_fitness" = evalGenotype(genotype = "D", fitnessEffects = HD_competition, spPopSizes = c(5000, 5000, 5000)), "Hawks_fitness" = evalGenotype(genotype = "H", fitnessEffects = HD_competition, spPopSizes = c(5000, 5000, 5000)) )  We observe that the penalty of fighting (C > V) benefits the dove in terms of fitness respect to the hawk.  {r hkdv2, message=F} ## Simulated trajectories ## run only a few for the sake of speed simulation <- oncoSimulPop(2, mc.cores = 2, HD_competition, model = "McFL", # There is no collapse onlyCancer = FALSE, finalTime = 50, mu = 1e-2, # Quick emergence of D and H initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) ## Plot first trajectory as an example plot(simulation[[1]], show = "genotypes", type = "line", xlim = c(40, 50), lwdClone = 2, ylab = "Number of individuals", main = "Hawk and Dove trajectory", col = c("#a37acc", "#f8776d", "#7daf00"), font.main=2, font.lab=2, cex.main=1.4, cex.lab=1.1, las = 1)  <!-- Agreement: Show boxplot from several simulations. --> <!-- compositionPop2(simulation, --> <!-- ylab = "Number of individuals", --> <!-- main = "Hawk and Dove") --> <!-- plot(simulation[[1]], show = "genotypes", xlim = c(40, 500), lwdClone = 2, ---> <!-- ylab = "Number of individuals", main = "Hawk and Dove", ---> <!-- font.main=2, font.lab=2, ---> <!-- cex.main=1.4, cex.lab=1.1, ---> <!-- las = 1, legend.out = TRUE) ---> As mentioned above, mathematically when a stationary point (ESS) is reached the relative frequency of hawks is V/C and doves 1-(V/C). Considering f_H as relative frecuency of hawks and f_D = 1-f_H as frequency of doves: Hawk: $$1 + f_H*(v-c)/2 + (1-f_H)*v$$ Dove: $$1 + (1-f_H)*v/2$$ Hawk = Dove: $$1 + f_H*(v-c)/2 + (1-f_H)*v = 1 + (1-f_H)*v/2$$ Resolving for f_H: $$f_H = v/c$$ Therefore, the relative frequency of hawks in equilibrium is equal to V/C. In our case it would be 20% (C = 10, V = 2). Let's check it: {r hkdvx45} ## Recover the final result from first simulation result <- tail(simulation[[1]][[1]], 1) ## Get the number of organisms from each species n_WT <- result[2] n_D <- result[3] n_H <- result[4] total <- n_WT + n_D + n_H ## Dove percentage data.frame("Doves" = round(n_D/total, 2)*100, "Hawks" = round(n_H/total, 2)*100 )  To sum up, this example shows that when the risks of contest injury or death (the Cost C) is significantly greater than the potential reward (the benefit value V), the stable population will be mixed between aggressors and doves, and the proportion of doves will exceed that of the aggressors. This explains behaviours observed in nature. ## Game Theory with social dilemmas of tumour acidity and vasculature {#gtvasc} This example is based on @kaznatcheev2017. In this work, it is explained that the progression of cancer is marked by the acquisition of a number of hallmarks, including self-sufficiency of growth factor production for angiogenesis and reprogramming energy metabolism for aerobic glycolysis. Moreover, there is evidence of intra-tumour heterogeneity. Given that some cancer cells can not invest in something that benefits the whole tumor while others can free-ride on the benefits created by them (evolutionary social dilemmas), how do these population level traits evolve, and how are they maintained? The authors answer this question with a mathematical model that treats acid production through glycolysis as a tumour-wide public good that is coupled to the club good of oxygen from better vascularisation. The cell types of the model are: * VOP: VEGF (over)-producers. * GLY: glycolytic cells. * DEF: aerobic cells that do not call for more vasculature. On the other hand, the micro-environmental parameters of the model are: * a: the benefit per unit of acidification. * v: the benefit from oxygen per unit of vascularisation. * c: the cost of (over)-producing VEGF. The fitness equations derived from those populations and parameters are: <br> $$W\left(GLY\right) = 1 + a * \left(f_1 + 1\right)$$ <br> $$W\left(VOP\right) = 1 + a * f_1 + v * \left(f_2 + 1\right) - c$$ <br> $$W\left(DEF\right) = 1 + a * f_1 + v * f_2$$ <br> Where$f_1$is the GLY cells' frequency and$f_2$is the VOF cells' frequency at a given time. All fitness equations start from balance by the sum of 1. <!-- FIXME: it is unclear that$f_2$is really DEF and not VOP's frequency. --> <!-- I fix it --> Finally, depending of the parameter's values, the model can lead to three different situations (as in other examples, the different types are one mutation away from WT): ### Fully glycolytic tumours: If the fitness benefit of a single unit of acidification is higher than the maximum benefit from the club good for aerobic cells, then GLY cells will always have a strictly higher fitness than aerobic cells, and be selected for. In this scenario, the population will converge towards all GLY, regardless of the initial proportions (as long as there is at least some GLY in the population). {r glvop1, message=FALSE} # Definition of the function for creating the corresponding dataframe. avc <- function (a, v, c) { data.frame(Genotype = c("WT", "GLY", "VOP", "DEF"), Fitness = c("1", paste0("1 + ",a," * (f_GLY + 1)"), paste0("1 + ",a," * f_GLY + ",v," * (f_VOP + 1) - ",c), paste0("1 + ",a," * f_GLY + ",v," * f_VOP") )) } # Specification of the different effects on fitness. afavc <- allFitnessEffects(genotFitness = avc(2.5, 2, 1), frequencyDependentFitness = TRUE, frequencyType = "rel") ## For real, you would probably want to run ## this multiple times with oncoSimulPop simulation <- oncoSimulIndiv(afavc, model = "McFL", onlyCancer = FALSE, finalTime = 15, mu = 1e-3, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE)  {r glvop2, message=FALSE} # Representation of the plot of one simulation as an example (the others are # highly similar). plot(simulation, show = "genotypes", type = "line", ylab = "Number of individuals", main = "Fully glycolytic tumours", font.main=2, font.lab=2, cex.main=1.4, cex.lab=1.1, las = 1)  <!-- {r, message=FALSE} ---> <!-- #\ Representation of a boxplot considering all the simulations. ---> <!-- compositionPop2(simulation, ylab = "Number of individuals", ---> <!-- main = "Fully glycolytic tumours") ---> <!--  ---> ### Fully angiogenic tumours: If the benefit to VOP from their extra unit of vascularisation is higher than the cost c to produce that unit, then VOP will always have a strictly higher fitness than DEF, selecting the proportion of VOP cells towards 1. In addition, if the maximum possible benefit of the club good to aerobic cells is higher than the benefit of an extra unit of acidification, then for sufficiently high number of VOP, GLY will have lower fitness than aerobic cells. When both conditions are satisfied, the population will converge towards all VOP. {r glvop3, message=FALSE} # Definition of the function for creating the corresponding dataframe. avc <- function (a, v, c) { data.frame(Genotype = c("WT", "GLY", "VOP", "DEF"), Fitness = c("1", paste0("1 + ",a," * (f_GLY + 1)"), paste0("1 + ",a," * f_GLY + ",v, " * (f_VOP + 1) - ",c), paste0("1 + ",a," * f_GLY + ",v, " * f_VOP") )) } # Specification of the different effects on fitness. afavc <- allFitnessEffects(genotFitness = avc(2.5, 7, 1), frequencyDependentFitness = TRUE, frequencyType = "rel") simulation <- oncoSimulIndiv(afavc, model = "McFL", onlyCancer = FALSE, finalTime = 15, mu = 1e-4, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE)  {r glvop4, message=FALSE} ## We get a huge number of VOP very quickly ## (too quickly?) plot(simulation, show = "genotypes", type = "line", ylab = "Number of individuals", main = "Fully angiogenic tumours", font.main=2, font.lab=2, cex.main=1.4, cex.lab=1.1, las = 1)  <!-- {r, message=FALSE} ---> <!-- #\ Representation of a boxplot considering all the simulations. ---> <!-- compositionPop2(simulation, ylab = "Number of individuals", ---> <!-- main = "Fully angiogenic tumours") ---> <!--  ---> ### Heterogeneous tumours: If the benefit from an extra unit of vascularisation in a fully aerobic group is lower than the cost c to produce that unit, then for a sufficiently low proportion of GLY and thus sufficiently large number of aerobic cells sharing the club good, DEF will have higher fitness than VOP. This will lead to a decrease in the proportion of VOP among aerobic cells and thus a decrease in the average fitness of aerobic cells. A lower fitness in aerobic cells will lead to an increase in the proportion of GLY until the aerobic groups (among which the club good is split) get sufficiently small and fitness starts to favour VOP over DEF, swinging the dynamics back. {r glvop5, message=FALSE} # Definition of the function for creating the corresponding dataframe. avc <- function (a, v, c) { data.frame(Genotype = c("WT", "GLY", "VOP", "DEF"), Fitness = c("1", paste0("1 + ",a," * (f_GLY + 1)"), paste0("1 + ",a," * f_GLY + ",v," * (f_VOP + 1) - ",c), paste0("1 + ",a," * f_GLY + ",v," * f_VOP") )) } # Specification of the different effects on fitness. afavc <- allFitnessEffects(genotFitness = avc(7.5, 2, 1), frequencyDependentFitness = TRUE, frequencyType = "rel") # Launching of the simulation (20 times). simulation <- oncoSimulIndiv(afavc, model = "McFL", onlyCancer = FALSE, finalTime = 25, mu = 1e-4, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE)  {r glvop6, message=FALSE} # Representation of the plot of one simulation as an example (the others are # highly similar). plot(simulation, show = "genotypes", type = "line", ylab = "Number of individuals", main = "Heterogeneous tumours", font.main=2, font.lab=2, cex.main=1.4, cex.lab=1.1, las = 1)  ## Prostate cancer tumour–stroma interactions {#prostatestroma} <!-- For me: see below, ProsCaMo, for another implementation of this same --> <!-- example. From group 6. --> This example is based on @basanta_investigating_2012. The authors apply evolutionary game theory to model the behavior and progression of a prostate tumour formed by three different cell populations: stromal cells, a dependant tumour phenotype capable of co-opting stromal cells to support its growth and an independent tumour phenotype that does not require microenvironmental support, be it stromal associated or not. To enable this, the model has four variables, which is the minimun necessary to describe the relationships in terms of costs and benefits between the different types of cells and, of course, to describe the progression of the cancer. The different cell types, hence, are as follows: 1. S: stromal cells. 2. D: microenvironmental-dependent tumour cells. 3. I: microenvironmental-independent tumour cells. And the parameters that describe the relationships are as follows: *$\alpha$: benefit derived from the cooperation between a S cell and a D cell. *$\beta$: cost of extracting resources from the microenvironment. *$\gamma$: cost of being microenvironmentally independent. *$\rho$: benefit derived by D from paracrine growth factors produced by I cells. Table \@ref(tab:tableprostate) shows the payoffs for each cell type when interacting with others. We consider no other phenotypes are relevant in the context of the game and disregard spatial considerations. . | S | D | I - | ------------------ | ---------- | -------------------- **S** |$0$|$\alpha$|$0$**D** |$1+\alpha-\beta$|$1-2\beta$|$1-\beta+\rho$**I** |$1-\gamma$|$1-\gamma$|$1-\gamma$: (\#tab:tableprostate) Payoff table that represents the interactions between the three cell types considered by de model As in @basanta_investigating_2012, the I cells are relatively independent from the microenvironment and produce their own growth factors (e.g. testosterone) and thus are considered to have a comparatively constant fitness$(1-\gamma)$, where$\gamma$represents the fitness cost for I cells to be independent. The D cells rely more on their microenvironment for survival and growth at a fitness cost$(\beta)$that represents the scarcity of resources or space that I cells can procure themselves. A resource-poor microenvironment would then be characterised by a higher value of$\beta$. As I cells produce space and shareable growth factors, this model assumes that D cells derive a fitness advantage from their interactions with I cells represented by the variable$\rho$. On the other hand, D cells interacting with other D cells will have a harder time sharing existing microenvironmental resources with other equally dependant cells and thus are assumed to have double the cost$2\beta$for relying on the microenvironment for survival and growth and thus have a fitness of$1–2\beta$. The S cells can interact with tumour cells. In a normal situation, this population are relatively growth quiescent with low rates of proliferation and death. For this reason the fitness benefit derived by stromal cells from the interactions with tumour cells is assumed to be zero. However, they are able to undergo rapid proliferation and produce growth factors if they are stimulated by factors produced by I cells, giving rise to a mutualistic relationship. This relationship is represented by the parameter$\alpha$. A low$\alpha$represents tumours in which the stroma cannot be co-opted and vice versa. From these variables, the fitness of each cell population$(W\left(S\right), W\left(I\right), W\left(D\right))$is as follows: <br> $$W\left(S\right) = 1 + f_3\alpha (\#eq:fitnessS)$$ <br> $$W\left(I\right) = 2 - \gamma (\#eq:fitnessI)$$ <br> $$W\left(D\right) = 1 + \left(1 - f_2 - f_3\right)\left(1 - \beta + \alpha\right) +\\ f_2\left(1 - \beta + \rho\right) + f_3(1 - 2\beta) + \\ 1 - \beta + \alpha + f_2\left(\rho - \alpha\right) - f_3\left(\beta + \alpha\right) (\#eq:fitnessD)$$ <br> where$f_2$is the frequency of I cells and$f_3$is the frequency of D cells at a given time. All fitness equations start from balance by the sum of 1. ### Simulations First, we define the fitness of the different genotypes (see Equations \@ref(eq:fitnessS), \@ref(eq:fitnessI) and \@ref(eq:fitnessD)) through the function _fitness_rel_ that builds a data frame. It is important to note that this program models a situation where, from a WT cell population, the rest of the cell population types are formed. However, this model has also stromal cells that are not formed from a WT, since they are not tumour cells although interacting with it. Hence, for this model, we can not represent scenarios with total biological accuracy, something that we must consider when interpreting the results. {r example5_fitness, message=FALSE} fitness_rel <- function(a, b, r, g, gt = c("WT", "S", "I", "D")) { data.frame( Genotype = gt, Fitness = c("1", paste0("1 + ", a, " * f_D"), paste0("1 + 1 - ", g), paste0("1 + (1 - f_I - f_D) * (1 - ", b, " + ", a, ") + f_I * (1 - ", b, " + ", r, ") + f_D * (1 - 2 * ", b, ") + 1 - ", b, " + ", a, " + f_I * (", r, " - ", a, ") - f_D * (", b, " + ", a, ")")) ) }  Then, we are going to model different scenarios that represent different biological situations. In this case, we are going to explain four possible situations. **Note:** for these simulations the values of paratemers are normalised in the range (0 : 1) so 1 represents the maximum value for any parameter being positive of negative to fitness depending on the parameter. #### First scenario In this simulation, we are modelling a situation where the environment is relatively resource-poor. In addition, we set a intermediate cooperation between D-D and D-I and a very low benefit from coexistence of D with I. *$\alpha$(a) = 0.5: intermediate cooperation between D and D cells. *$\beta$(b) = 0.7: relatively resource-poor microenvironment. *$\rho$(p) = 0.1: low benefit of D cells. *$\gamma$(g) = 0.8: high cost of independence of I cells. We can observe that high values of$\alpha$and low values of$\rho$are translated in a larger profit of D cells from his interaction with S cells than from his interaction with I cells. Also, because of the high cost of independence of I cells ($\gamma$), it is not surprise that this population ends up becoming extinct. Finally, the tumour is composed by two cellular types: D and S cells. {r example5scen1, message=FALSE} scen1 <- allFitnessEffects(genotFitness = fitness_rel(a = 0.5, b = 0.7, r = 0.1, g = 0.8), frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(1) simulScen1 <- oncoSimulIndiv(scen1, model = "McFL", onlyCancer = FALSE, finalTime = 70, mu = 1e-4, initSize = 5000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) op <- par(mfrow = c(1, 2)) plot(simulScen1, show = "genotypes", type = "line", main = "First scenario", cex.main = 1.4, cex.lab = 1.1, las = 1) plot(simulScen1, show = "genotypes", main = "First scenario", cex.main = 1.4, cex.lab = 1.1, las = 1) par(op)  To understand the stability of the results, we should run multiple simulations. We will not pursue that here. Note that the results can be sensitive to the initial population size and the mutation rate. <!-- {r example5scenPop1, message=FALSE} ---> <!-- simulScen1Pop <- oncoSimulPop(20, ---> <!-- scen1, ---> <!-- model = "McFL", ---> <!-- onlyCancer = FALSE, ---> <!-- mc.cores = n_cores, ---> <!-- finalTime = 150, ---> <!-- mu = 1e-3, ---> <!-- initSize = 4000, ---> <!-- keepPhylog = TRUE, ---> <!-- seed = NULL, ---> <!-- errorHitMaxTries = FALSE, ---> <!-- errorHitWallTime = FALSE) ---> <!-- compositionPop2(simulScen1Pop, ---> <!-- main = "First scenario", ---> <!-- ylab = "Number of cells") ---> <!--  ---> #### Second scenario In this case, we set$\alpha$lower than in the first scenario and we enable the indepenence of I cells through a lower$\gamma$. *$\alpha$(a) = 0.3: low cooperation between D cells. *$\beta$(b) = 0.7: relatively resource-poor microenvironment. *$\rho$(r) = 0.1: low benefit of D cells from coexisting with I cells. *$\gamma$(g) = 0.7: lower cost of independence of I cells than in the first scenario. Because of we are easing the possibility of independence of I cells, instead of extinguishing as in the first scenario, they compose the bulk of the tumour along with D cells in spite of the low benefit of cooperation between them (low$\rho$). Besides, we can observe that the population of I cells is bigger than the population of D cells, being at the end of the simulation in balance. On the other hand, stromal cells drop at the beginning of the simulation. {r example5scen2, message=FALSE} scen2 <- allFitnessEffects(genotFitness = fitness_rel(a = 0.3, b = 0.7, r = 0.1, g = 0.7), frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(1) simulScen2 <- oncoSimulIndiv(scen2, model = "McFL", onlyCancer = FALSE, finalTime = 70, mu = 1e-4, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) op <- par(mfrow = c(1, 2)) plot(simulScen2, show = "genotypes", type = "line", main = "Second scenario", cex.main = 1.4, cex.lab = 1.1, las = 1) plot(simulScen2, show = "genotypes", main = "Second scenario", cex.main = 1.4, cex.lab = 1.1, las = 1) par(op)  #### Third scenario In this case, we have a extreme situation where the microenvironment is rich (high$\beta$) and the independence costs are very low ($\gamma$) in relation with the previous scenarios. *$\alpha$(a) = 0.2: low cooperation between D cells. *$\beta$(b) = 0.3: rich microenvironment, being beneficial for D cells. *$\rho$(r) = 0.1: low benefit of D cells from coexisting with I cells. *$\gamma$(g) = 0.3: independence costs very low, being beneficial for I cells. Although$\gamma$and$\rho$are very low, which could make us think that I cells will control the tumour, we can observe that the fact that the microenvironment is very rich (with a low value of$\beta$) allows to D cells lead the progression of the tumour over the rest of cell populations, including I cells. {r example5scen3, message=FALSE} scen3 <- allFitnessEffects(genotFitness = fitness_rel(a = 0.2, b = 0.3, r = 0.1, g = 0.3), frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(1) simulScen3 <- oncoSimulIndiv(scen3, model = "McFL", onlyCancer = FALSE, finalTime = 50, mu = 1e-4, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) op <- par(mfrow = c(1, 2)) plot(simulScen3, show = "genotypes", type = "line", main = "Third scenario", cex.main = 1.4, cex.lab = 1.1, las = 1) plot(simulScen3, show = "genotypes", main = "Third scenario", cex.main = 1.4, cex.lab = 1.1, las = 1) par(op)  #### Fourth scenario This is a variation of the third scenario to illustrate that, if we set a microenvironment more rich than in the previous scenario, we get a cooperation between D and I cells, although we can still observe the superiority of D cells over I cells. *$\alpha$(a) = 0.2: low cooperation between D cells. *$\beta$(b) = 0.4: lower richness than in the previous scenario. *$\rho$(r) = 0.1: low benefit of D cells from coexisting with I cells. *$\gamma(g) = 0.3: independence costs very low, being beneficial for I cells. {r example5scen4, message=FALSE} scen4 <- allFitnessEffects(genotFitness = fitness_rel(a = 0.2, b = 0.4, r = 0.1, g = 0.3), frequencyDependentFitness = TRUE, frequencyType = "rel") ## Set a different seed to show the results better since ## with set.seed(1) the progression of I cells was not shown set.seed(2) simulScen4 <- oncoSimulIndiv(scen4, model = "McFL", onlyCancer = FALSE, finalTime = 40, mu = 1e-4, initSize = 4000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) op <- par(mfrow = c(1, 2)) plot(simulScen4, show = "genotypes", type = "line", main = "Fourth scenario", cex.main = 1.4, cex.lab = 1.1, las = 1) plot(simulScen4, show = "genotypes", main = "Fourth scenario", cex.main = 1.4, cex.lab = 1.1, las = 1) par(op)  In this case, we can see that there is more variation in the size of population of I cells. There are cases where the I cell population cooperates with D cells and, in others, there is not cooperation. You can examine this running multiple simulations (or manually rerun the example above changing the seed). <!-- From Group 6; Jorge García --> <!-- Calleja, Ana del Ramo Galián, Alejandro de los Reyes Benítez, --> <!-- Guillermo Garcia Hoyos. --> <!-- It is the same example --> <!-- ## Prostate cancer model with stromal dependent and stromal independent genotypes {#ProsCaMo} --> <!-- The paper in which we have focused is ‘Investigating prostate --> <!-- cancer tumour–stroma interactions: clinical and biological insights --> <!-- from an evolutionary game’ by Bansanta et al., 2011. --> <!-- Knowing the highly heterogenity between cell types found --> <!-- intratumoral, they took observations from prostate cancer --> <!-- tumour to fit a mathematical model that could explain the --> <!-- different types of tumour and the prognostic of each one of them. --> <!-- To accomplish this, they establish three different cell --> <!-- populations, being stromal cells, tumor cells depending on --> <!-- the enviroment, and tumor cell non-dependent on the enviroment. --> <!-- Applying the payoff table we have developed the following example --> <!-- from the reference. For the sake of briefness, we are only --> <!-- gonna show 2 examples. In the first, we have --> <!-- modellized an medium richness environment (b = 0.8), --> <!-- with very little mutual benefit between S and D (a = 0.1), --> <!-- having D a high advantage of I cells (c = 1) and a high --> <!-- environmente-independece cost for the I cell (d = 0.8). --> <!-- We can appreciate how D and I benefit of the colapse of the --> <!-- stromal cells. --> <!--  --> <!-- create_fe2 <- function(a, b, c, d, gt = c("WT", "D", "I")) { --> <!-- data.frame(Genotype = gt, --> <!-- Fitness = c( --> <!-- paste0("1 + (",a,"*f_A)"), --> <!-- paste0("1 + (1 +",a," - ",b,")*f_ + ( 1 - 2* ",b,")*f_A", --> <!-- " + (1 - ",b," + ",c,")*f_B" ), --> <!-- paste0("(1 + f_*(1-",d,") + f_A*(1-",d,") + f_B*(1-",d,"))")), --> <!-- stringsAsFactors = FALSE) --> <!-- } --> <!-- prostate = create_fe2("0.1", "0.8", "1", "0.8") --> <!-- afe = allFitnessEffects(genotFitness = prostate, --> <!-- frequencyDependentFitness = T, --> <!-- frequencyType = "rel") --> <!-- set.seed(1) ## for reproducibility --> <!-- sfd <- oncoSimulIndiv(afe, --> <!-- model = "McFL", --> <!-- onlyCancer = FALSE, --> <!-- finalTime = 100, --> <!-- mu = 1e-4, --> <!-- initSize = 10000, --> <!-- keepPhylog = FALSE, --> <!-- seed = NULL, --> <!-- errorHitMaxTries = FALSE, --> <!-- errorHitWallTime = FALSE) --> <!-- plot(sfd, show = "genotypes",legend.ncols = 2, type = "line") --> <!--  --> <!-- We are going to see now another example in which we can visualize --> <!-- how a very small change in the genotype perfomance can lead to --> <!-- great changes in the tumour ongoing. We fixed the following values: --> <!-- a = 0.5, b = 0.7 and c = 0.1. This represents a medium mutual --> <!-- benefit of D and S, a poor environment and a low benefit of D --> <!-- from I. --> <!-- By changing d from 0.8 to 0.7, we change from a tumour with --> <!-- preponderance of D and S to a tumour where I rises and the --> <!-- other two genotypes, collapses. --> <!--  --> <!-- # Repeat above code changing prostate with this parameters --> <!-- # ----- Figure 3 (Basanta et al., 2012). Left ------ --> <!-- prostate = create_fe2("0.5", "0.7", "0.1", "0.8") --> <!-- # ----- Figure 3 (Basanta et al., 2012). Right ------ --> <!-- prostate = create_fe2("0.5", "0.7", "0.1", "0.7") --> <!--  --> ## Evolutionary Dynamics of Tumor-Stroma Interactions in Multiple Myeloma {#edmyel} This example is based on @sartakhti2016. The authors provide a frequency-dependent model to study the growth of malignant plasma cells in multiple myeloma. Assuming that cancer cells and stromal cells cooperate by exchanging diffusible factors, the study is carried out in the framework of evolutionary game theory. We first need to define a payoff strategy for this kind of scenario. The following definitions are needed: * There aren$phenotypes in a population denoted by$\{ P_1, \ldots, P_n \}$. * Each phenotype can produce one diffusible factor$\{ G_1, \ldots, G_n \}$. * Each diffusible factor$j$has a different effect$r_{i,j}$on the other phenotypes$i$. * The cost for$P_i$for growth factor$G_i$is denoted as$c_i$. *$M$is the number of cells within the diffusion range. * There are$M_j$individuals of type$P_j$among the other group members. Then, the payoff for strategy$P_jis: \begin{align} \pi_{P_j}(M_1,\ldots,M_n)=\frac{(M_j+1)\times c_j}{M}r_{j,j} + \sum_{i=1, i \neq j}^n \frac{M_i \times c_i}{M}r_{j,i} - c_j \;. \end{align} In multiple Myeloma we have three different types of cells that have autocrine and paracrine effects on the cells within their diffusion range: Malignant plasma cells (MM), Osteoblasts (OB) and Osteoclasts (OC). The specification of fitness is the following (see [[10]](#Sartakhti)): \begin{align} W_{OC} &= \frac{(f_{1}(M-1)+1)c_{1}}{M}r11+ \frac{((1-f_{3})(M-1)-f_{1}(M-1)-1)c_{2}}{M}r12 \\ &+\frac{(M-(1-f_3)(M-1))c_{3}}{M}r13-c_{1} \\ W_{OB} &= \frac{(f_{2}(M-1)+1)c_{2}}{M}r22+ \frac{((1-f_{1})(M-1)-f_{2}(M-1)-1)c_{3}}{M}r23 \\ &+\frac{(M-(1-f_{1})(M-1))c_{1}}{M}r21-c_{2} \\ W_{MM} &= \frac{(f_{3}(M-1)+1)c_{3}}{M}r33+ \frac{((1-f_{2})(M-1)-f_{3}(M-1)-1)c_{1}}{M}r31 \\ &+\frac{(M-(1-f_{2})(M-1))c_{2}}{M}r32-c_{3} \;, \end{align} wheref_1$,$f_2$and$f_3$denote the frequency of the phenotype OC, OB and MM in the population. The multiplication factors for diffusible factors produced by the cells are shown in the following table (taken from @sartakhti2016): {r smyeloma, eval=TRUE,echo=FALSE, fig.cap="Multiplication factor in myeloma interaction. Table 1 in Sartakhti et al., 2016, 'Evolutionary Dynamics of Tumor-Stroma Interactions in Multiple Myeloma' https://doi.org/10.1371/journal.pone.0168856 ."} knitr::include_graphics("Myeloma_interaction.png")  Several scenarios varying the values of the parameters are shown in @sartakhti2016. Here we reproduce some of them. ### Simulations First, we define the fitness of the different genotypes through the function _fitness_rel_. {r smyelo56j} f_cells <- function(c1, c2, c3, r11, r12, r13, r21, r22, r23, r31, r32, r33, M, awt = 1e-4, gt = c("WT", "OC", "OB", "MM")) { data.frame(Genotype = gt, Fitness = c( paste0("max(0.1, 1 - ", awt, " * (f_OC + f_OB+f_MM)*N)"), paste0("1", "+(((f_OC * (", M, "-1)+1)*", c1, ")/", M, ")*",r11, "+((((1-f_MM) * (", M, "-1)-f_OC*(", M, "-1)-1)*", c2, ")/", M, ")*", r12, "+(((", M, "-(1-f_MM)*(", M, "-1))*", c3, ")/", M, ")*", r13, "-", c1 ), paste0("1", "+(((f_OB*(", M, "-1)+1)*", c2, ")/", M, ")*", r22, "+((((1-f_OC)*(", M, "-1)-f_OB*(", M, "-1)-1)*", c3, ")/", M, ")*", r23, "+(((", M, "-(1-f_OC)*(", M, "-1))*", c1, ")/", M, ")*", r21, "-", c2 ), paste0("1", "+(((f_MM*(", M, "-1)+1)*", c3, ")/", M, ")*", r33, "+((((1-f_OB)*(", M, "-1)-f_MM*(", M, "-1)-1)*", c1, ")/", M, ")*", r31, "+(((", M, "-(1-f_OB)*(", M, "-1))*", c2, ")/", M, ")*", r32, "-", c3 ) ) ,stringsAsFactors = FALSE ) }  It is important to note that, in order to exactly reproduce the experiments of the paper, we need to create an initial population with three different types of cell, but we do not need the presence of a wild type. For this reason, we will increase the probability of mutation of the wild type, which will disappear in early stages of the simulation; this is a procedure we have used before in several cases too (e.g., \@ref(hawkdove)). This is something that we must consider when interpreting the results. ### Scenario 1 Here we model a common situation in multiple myeloma in which$c_1<c_2<c_3$. In the presence of a small number of MM cells, the stable point on the OB-OC border becomes a saddle point and clonal selection leads to a stable coexistence of OC and MM cells. Parameters for the simulation can be seen in the R code. {r smyelo3v57} N <- 40000 M <- 10 c1 <- 1 c2 <- 1.2 c3 <- 1.4 r11 <- 0 r12 <- 1 r13 <- 2.5 r21 <- 1 r22 <- 0 r23 <- -0.3 r31 <- 2.5 r32 <- 0 r33 <- 0 fe_cells <- allFitnessEffects( genotFitness = f_cells(c1, c2, c3, r11, r12, r13, r21, r22, r23, r31, r32, r33, M, gt = c("WT", "OC", "OB", "MM")), frequencyDependentFitness = TRUE, frequencyType = "rel") ## Simulated trajectories set.seed(2) simulation <- oncoSimulIndiv(fe_cells, model = "McFL", onlyCancer = FALSE, finalTime = 20, ## 30 mu = c("OC"=1e-1, "OB"=1e-1, "MM"=1e-4), initSize = N, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) ## Plot trajectories ## op <- par(mfrow = c(1, 2)) ## plot(simulation, show = "genotypes", type = "line") plot(simulation, show = "genotypes", thinData = TRUE) ## par(op)  Clearly, the appearance of MM cells quickly brings the system to an equilibrium point, which is stable. OB cells are extinct and cancer has propelled. ### Scenario 2 As in the second scenario of [[10]](#Sartakhti) ($c1=c2=c3$) configuration A (upper row in the grid of images). We should find one stable point on the OC-OB edge under certain conditions, which are met in the example. Further information about the parameters can be found in the R code shown below. {r smyeloc1v23} N <- 40000 M <- 10 c1 <- 1 c2 <- 1 c3 <- 1 r11 <- 0 r12 <- 1 r13 <- 0.5 r21 <- 1 r22 <- 0 r23 <- -0.3 r31 <- 0.5 r32 <- 0 r33 <- 0 fe_cells <- allFitnessEffects( genotFitness = f_cells(c1, c2, c3, r11, r12, r13, r21, r22, r23, r31, r32, r33, M, gt = c("WT", "OC", "OB", "MM")), frequencyDependentFitness = TRUE, frequencyType = "rel") ## Simulated trajectories set.seed(1) simulation <- oncoSimulIndiv(fe_cells, model = "McFL", onlyCancer = FALSE, finalTime = 15, ## 25 mu = c("OC"=1e-1, "OB"=1e-1, "MM"=1e-4), initSize = N, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) #Plot trajectorie plot(simulation, show = "genotypes", thinData = TRUE)  As expected, under these condtitions, MM cells are not able to propagate. The equilibrium point in the OB-OC edge is stable, resisting small variations in the number of MM cells. <!-- #\#\#\ Scenario 3 ---> <!-- Here we imitate the conditions presented in the third scenario of ---> <!-- [[10]](#\Sartakhti) ($c3<c1<c2$) configuration A (left). If diffusion range ---> <!-- increases ($M = 50$) the game has two stable points. See the R code for further ---> <!-- information about the parameters of this simulation. As we do not have control ---> <!-- in the initial population (it depends on random mutations of the wild type) we ---> <!-- will pay special attention to the box plot. ---> <!-- {r} ---> <!-- N <- 40000 ---> <!-- M <- 50 ---> <!-- c1 <- 1 ---> <!-- c2 <- 1.2 ---> <!-- c3 <- 0.8 ---> <!-- r11 <- 0 ---> <!-- r12 <- 1 ---> <!-- r13 <- 0.5 ---> <!-- r21 <- 1 ---> <!-- r22 <- 0 ---> <!-- r23 <- -0.3 ---> <!-- r31 <- 0.5 ---> <!-- r32 <- 0 ---> <!-- r33 <- 0 ---> <!-- fe_cells <- ---> <!-- allFitnessEffects( ---> <!-- genotFitness = ---> <!-- f_cells(c1, c2, c3, r11, r12, r13, ---> <!-- r21, r22, r23, r31, r32, r33, M, ---> <!-- gt = c("WT", "OC", "OB", "MM")), ---> <!-- frequencyDependentFitness = TRUE, ---> <!-- frequencyType = "rel") ---> <!-- #\#\ Simulated trajectories ---> <!-- simulation1 <- oncoSimulIndiv(fe_cells, ---> <!-- model = "McFL", ---> <!-- onlyCancer = FALSE, ---> <!-- finalTime = 30, ---> <!-- mu = c("OC"=1e-1, "OB"=1e-1, "MM"=1e-4), ---> <!-- initSize = N, ---> <!-- keepPhylog = FALSE, ---> <!-- seed = NULL, ---> <!-- errorHitMaxTries = FALSE, ---> <!-- errorHitWallTime = FALSE) ---> <!-- plot(simulation1, show = "genotypes") ---> <!--  ---> <!-- As explained in @sartakhti2016, there are two equilibrium points ---> <!-- under this configuration: a monomorphic equilibrium on the MM vertex ---> <!-- and a polymorphic equilibrium on the OC-MM edge. This can be clearly ---> <!-- seen in our boxplot: there is a huge variance in the results of the ---> <!--$20$simulations. Sometimes, MM cells become extint; but other times ---> <!-- they manage to proliferate, leading to a sharp reduction in the ---> <!-- number of OB and OC cells. ---> <!-- I can't reproduce those resutls. ---> ## An example of modellization in Parkinson disease related cell community {#parkex} The following example is based on @tsigelny2007, and it discusses the coexistance between cells that produce$\alpha$-synuclein and$\beta$-synuclein, related with pore-like oligomer development and Parkinson disease.<!-- is defined in the --> <!-- paper: "Accumulation of a-synuclein resulting in the formation of --> <!-- oligomers and protofibrils has been linked to Parkinson’s disease --> <!-- and Lewy body dementia. In contrast, b-synuclein (b-syn), a close --> <!-- homologue, does not aggregate and reduces a-synuclein --> <!-- (a-syn)-related pathology." --> {r parka , message=FALSE} park1<- data.frame(Genotype = c("WT", "A", "B", "A,B"), Fitness = c("1", "1 + 3*(f_1 + f_2 + f_1_2)", "1 + 2*(f_1 + f_2 + f_1_2)", ## We establish ## the fitness of B smaller than the one of A because ## it is an indirect cause of the disease and not a direct one. "1.5 + 4.5*(f_1 + f_2 + f_1_2)")) ## The baseline ## of the fitness is higher in the ## AB population (their growth is favored). parkgen1<- allFitnessEffects(genotFitness = park1, frequencyDependentFitness = TRUE, frequencyType = "rel")  *$\alpha$- – normal a-synuclein production *$\beta$- – normal b-synuclein production *$\alpha$+ – deleterious a-synuclein production, causing aggregation and the rest of mentioned effects *$\beta$+ – deleterious b-synuclein production, preventing it from slowing down the aggregation of a-synuclein * WT -$\alpha$- and$\beta$- (balance) * A -$\alpha$+ and$\beta$- (increases [slight] the probability of Parkinson's disease) * B –$\alpha$- and$\beta$+ (increases [slight] the probability of Parkinson's disease) * AB –$\alpha$+ and$\beta$+ (massive increase of probability of Parkinson's disease) In this simulation, at the very end, the only cells that remain alive are those from AB population (which means that both$\alpha$and$\beta$are mutated,$\alpha$+ and$\beta$+, which means that the individual has a high risk of developing the disease, and all the cells keep this mutation). Genotype AB is able to invade the population when there are some A's and B's around. Cooperation increases the fitness at 1.5 level respecting the fitness for just A's or just B's, so the rest of population (appart from AB) collapses. We can observe this cell behaviour in the following code and graphic: {r parkb} set.seed(1) fpark1 <- oncoSimulIndiv(parkgen1, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 1e-4, initSize = 5000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE)  {r parkplot1, message=FALSE} plot(fpark1, show = "genotypes", type = "line", col = c("black", "green", "red", "blue"))  Analyzing the graphic obtain from OncoSimulR we can see that A, B and the WT population dissapear at (more or less) the same point that AB population increases drastically, which makes sense because the fitness of AB population is greater than the other three population fitnesses. As the birth rate of the population depends directly of the fitness, at the end, just the AB population survives. We have a model of frequency-dependent fitness here, but the results are not really surprising given the fitness of each type, and no coexistence is possible. The AB population comes mainly from the A population, as would be expected, because of its fitness, and abundance, relative to that of the B population: {r parkplot2, message=FALSE} plotClonePhylog(fpark1, N = 0, keepEvents=TRUE, timeEvents=TRUE)  <!-- {r parkplot3, message=FALSE} --> <!-- #tabla: --> <!-- #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 --> <!-- #WT 0 0 0 0 0 0 0 0 0 0 --> <!-- #A 0 0 0 0 0 0 0 0 0 0 --> <!-- #B 0 0 0 0 0 0 0 0 0 0 --> <!-- #AB 1174724 1172091 1167764 1168742 1169176 1170901 1169737 1173600 1170617 1171011 --> <!-- WT <- c(0,0,0,0,0,0,0,0,0,0) --> <!-- A <- c(0,0,0,0,0,0,0,0,0,0) --> <!-- B <- c(0,0,0,0,0,0,0,0,0,0) --> <!-- AB <- c(1174724,1172091,1167764,1168742,1169176,1170901,1169737,1173600,1170617,1171011) --> <!-- matriz <- cbind(WT, A, B, AB) --> <!-- boxplot(matriz, main="Genotype number of cells") --> <!--  --> <!-- To finish, this is the boxplot. We made it using the R function --> <!-- 'boxplot', with the objective of seeing the variance that appears --> <!-- into the final population. But as you can see, there is no variance, --> <!-- because at the end, the size of AB population remains constant --> <!-- across simulation, and it appears as a line in the top (meaning that --> <!-- a lot of cells survive in that population, around 1 million), and --> <!-- the others, just dissapear. This happens always after running the --> <!-- function N times (being N a variable number of iterations). --> <!-- For the example from Group 2, 2019-20, --> <!-- madariaga_garcia_rodriguez_sanchez, based on Krezslak, see --> <!-- in additional files. It is very similar to Hurlbut. Would need to --> <!-- give details on how it differs, o.w., it is confusing because of the --> <!-- many similarities. --> ## Evolutionary Game between Commensal and Pathogenic Microbes in Intestinal Microbiota {#wuAMicrobes} The following adapted example is based on @wuA2016. As explained in p. 2 of the aforementioned paper, the commensal microbiota has been simplified into two phenotypic groups: antibiotic-sensitive bacteria (CS) [WT in the code below] and antibiotic-tolerant bacteria (CT). In addition, a third phenotypic group of pathogenic bacteria (PA) is considered which are kept in low numbers in absence of intestinal microbiota disturbances. We assume CS and CT bacteria cooperate and depend on each other for optimal proliferation, leading to a benefit (bG) for both of them as well as to a cost for factor growth (cG) production which permits a stable coexistence between CS and CT cells if the fraction of PA cells is negligible. Meanwhile, PA possess a reproductive or metabolic advantage relative to CS and CT. Without antibiotic administration CS population inhibits PA population via the release of a chemical compound which harms PA (iPA) when their relative frequency is equal to or greater than 0.2, carrying a production cost (cI). However, PA population takes over CS population in the presence of antibiotic (ab). In this situation PA and CT compete for resources. Finally, a cohabit cost (cS) is considered for all three cell types. The adapted payoff matrix obtained is shown in the next table. \clearpage | | CS | CT | PA | |------------------|-------------------|-------------------|-----------------------| |**CS** | bG – cG – cS - ab | bG – cG – cS - ab | bG – cG – cS -cI - ab | |**CT** | bG – cG – cS | bG – cG – cS | bG – cG – cS | |**PA** | bPA – iPA - cS | bPA – cS | bPA – cS | Table:(\#tab:payoff) Payoff matrix for the adapted example from Wu A, Ross D., 2016, ‘Evolutionary Game between Commensal and Pathogenic Microbes in Intestinal Microbiota’. Games. 2016;7(3); doi: 10.3390/g7030026 . On the basis of the interactions between the different microbe populations and the payoff matrix, we establish fitness as: * CS (Fcs = bG([CS] + [CT]) - cS*([CS] + [CT] + [PA]) - cI - cG - ab) * CT (Fct = bG([CS] + [CT]) - cS*([CS] + [CT] + [PA]) - cG) * PA (Fpa = bPA([PA]) - cS*([CS] + [CT] + [PA]) - iPA*[CS]) A function to create the data frame of frequency-dependent fitnesses is defined in order to be able to model situations with different values for the parameters, and it is assumed that WT derive to the other cell types by a single mutation. {r wuAMicrobesfit1} create_fe <- function(bG, cG, iPA, cI, cS, bPA, ab, gt = c("WT", "CT", "PA")) { data.frame(Genotype = gt, Fitness = c( paste0("1 + ", bG, " * (f_ + f_CT) - ", cS, " * (f_ + f_CT + f_PA) - ", cI, "(f_PA > 0.2) - ", cG, " - ", ab), paste0("1 + ", bG, " * (f_ + f_CT) - ", cS, " * (f_ + f_CT + f_PA) - ", cG), paste0("1 +", bPA, " - ", cS, " * (f_ + f_CT + f_PA) - ", iPA, " *(f_(f_PA > 0.2))")), stringsAsFactors = FALSE) }  We can check we recover the Table \@ref(tab:payoff) : {r wuAMicrobescheck} create_fe("bG", "cG", "iPA", "cI", "cS", "bPA", "ab")  We verify what we have specified executing evalAllGenotypes. We specify populations sizes for evaluating fitness at different moments in the total population evolution. In the absence of antibiotic we observe how, even though CS (WT) and CT population size is equal, CT fitness is greater than CS fitness due to the PA inhibitory factor releasing cost. PA fitness is decreased by means of this inhibitor produced by CS. {r wuAMicrobes2a} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(7, 1, 9, 0.5, 2, 5, 0), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(1000, 1000, 1000))  CS (WT) fitness decrease in the presence of antibiotic, while PA and CT fitness are not affected, and CT fitness is the largest.<!-- is affected --> <!-- by growth inhibitor released by WT to a lesser extent and CT fitness is not --> <!-- affected being the greatest one. --> <!-- while PA fitness is affected --> <!-- by growth inhibitor released by WT to a lesser extent and CT fitness is not --> <!-- affected being the greatest one. --> {r wuAMicrobes2b} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(7, 1, 9, 0.5, 2, 5, 2), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(1000, 1000, 1000))  <!-- We observe the extreme situation in which antibiotic is administrated, only PA --> <!-- population is present and WT and CT are unable to grow, so PA fitness takes --> <!-- precedence over WT and CT fitnesses. --> In the extreme situation in in which antibiotic is administrated and only PA is present, neither WT (CS) nor CT would be able to grow: {r wuAMicrobes2c} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(7, 1, 9, 0.5, 2, 5, 2), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(0, 0, 1000))  From a PA population size much greater than WT (CS) population size, the presence of WT decreases PA fitness via inhibitor production while WT fitness does not increase due to antibiotic administration. {r wuAMicrobes2d} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(7, 1, 9, 0.5, 2, 5, 2), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(100, 0, 1000))  Starting from a population of WT and with high antibiotic doses, WT does not have the capacity of growing while CT shows the largest fitness (and PA fitness is decreased by the inhibitory compound produced by WT): {r wuAMicrobes2e} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(7, 1, 9, 0.5, 2, 5, 5), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(1000, 0, 0))  At the same WT and PA population size and with high antibiotic dose administration, the fitness of both of them is decreased to the same extent since they inhibit each other while CT grow a little. {r wuAMicrobes2f} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(7, 1, 9, 0.5, 2, 5, 5), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(1000, 0, 1000))  We have verified that fitness specification gives the expected results: Now we create allFitnessEffects object and simulate two different situations: microbiota evolution in the absence and presence of antibiotic. The model used is McFL so density dependence in the death rate is considered. <!-- Parameters values are adapted for reaching the evolution desired in the simulations. --> ### Antibiotic absence situation {#woAntib} We observe how CT and PA cells emerge at time 0 from WT mutations. PA population starts to grow but when its frequency is greater than the established threshold, 0.2, WT population produces inhibitory compounds which harm PA and affect its fitness; when its frequency is under that threshold, WT stop releasing inhibitory PA growth factor and PA starts to grow again. This loop remains over time. Meanwhile, WT population decreases slowly due to the cost of producing the inhibitor when PA frequency exceed the established 0.2 and is reached by CT population, which grow until WT and CT are stabilized and cohabit taking in account the cost for sharing space. <!-- SLOW: FIXME --> {r woAntib1, eval = FALSE} woAntib <- allFitnessEffects( genotFitness = create_fe(7, 1, 9, 0.5, 2, 5, 0), frequencyDependentFitness = TRUE, frequencyType = "rel") ## We do not run this for speed but load it below set.seed(2) woAntibS <- oncoSimulIndiv(woAntib, model = "McFL", onlyCancer = FALSE, finalTime = 2000, mu = 1e-4, initSize = 1000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE, keepEvery = 2 ## store a smaller object )  {r woAntib1data} ## Load stored results data(woAntibS)  {r woAntib2} plot(woAntibS, show = "genotypes", type = "line", col = c("black", "green", "red"))  ### Antibiotic presence situation {#wiAntib} We observe how CT and PA cells emerge from WT mutations. WT cells decrease in number due to antibiotic administration and inhibitory PA growth factor when the frequency of this latest surpass the threshold imposed, so PA population grow with difficulty in comparison to CT. WT population finally disappear and CT and PA compete for resources, but CT takes over PA given its larger population size and CT population remain stable over time. {r wiAntib1} wiAntib <- allFitnessEffects( genotFitness = create_fe(7, 1, 9, 0.5, 2, 5, 2), frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(2) wiAntibS <- oncoSimulIndiv(wiAntib, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 1e-4, initSize = 1000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(wiAntibS, show = "genotypes", type = "line", col = c("black", "green", "red"))  ## Modeling of breast cancer through evolutionary game theory. {#breastC} The following example is based on @Barton2018. This model assumes that there are four different types of cells in the body: (a) the native cells (NC), which are the healthy stromal cells; (b) the macrophages (Mph), which are part of the immune system; (c) the benign tumor cells (BTC), lump-forming cancer cells that lack the ability to metastasize; (d) the motile tumor cells (MTC), metastatic cancer cells that can invade neighboring tissues. Both the native cells and macrophages produce growth factor, which benefits all types of cells.The cost of producing the growth factor, cG, and the benefits of the growth factor, bG, will be assumed to be the same for all types of the cells. The macrophages and motile tumor cells can move and we will assume that the ability comes at the costs cM,Mph, and cM,MTC respectively. The native cells and benign tumor cells stay in place and thus have to share the resources with other native and benign tumor cells, which comes at the cost cS. The cancer cells can reproduce faster than native cells or macrophages, which we model by additional benefit bR to the cancer cells, but the cancer cells can be destroyed by macrophages, which we model by additional cost cD to the cancer cells. They provide also the payoff matrix reproduced in next table : | | MTC | Mph | NC | BTC | |------------------|------------------|------------------|------------------|------------------| |**MTC** | bR - cMMTC | bR - cMMTC - cD + bG | bR - cMMTC + bG | bR - cMMTC | |**Mph** | - cG - cMMph |bG - cG - cMMph | bG - cG - cMMph | -cG - cMMph | |**NC** | - cG | bG - cG | bG - cG - cS | - cG - cS | |**BTC** | bR | bR + bG - cD | bR + bG - cS | bR - cS | Table:(\#tab:payoff2) Payoff matrix from Barton et al., 2018, ‘Modeling of breast cancer through evolutionary game theory’, Involve, a Journal of Mathematics, 11(4), 541-548; https://doi.org/10.2140/involve.2018.11.541 . Overall, when the concentrations of the cells are [NC], [Mph], [BTC] and [MTC], the net benefits (benefits minus the costs) to each type of the cells are: * W(NC) = bG([NC] + [Mph]) - cG - cS([NC] + [BTC]) * W(Mph) = bG([NC] + [Mph]) - cG - cMMph * W(BTC) = bR + bG([NC] + [Mph]) - cS([NC] + [BTC]) - cD[Mph] * W(MTC) = bR + bG([NC] + [Mph]) - cMMTC - cD[Mph] To allow modelling scenarios with different values for the parameters above we will define a function to create the data frame of frequency-dependent fitnesses. First, we will consider the NC cell type as the WT. Moreover, we will assume that each one of the other cell types types (Mph , BTC and MTC) are all derived from WT by a single mutation in one of three genes, say, O, B, M, respectively. {r breastCfit1} create_fe <- function(cG, bG, cS, cMMph, cMMTC, bR, cD, gt = c("WT", "Mph", "BTC", "MTC")) { data.frame(Genotype = gt, Fitness = c( paste0("1 + ", bG, "*(f_ + f_Mph) - ", cG, " - ", cS, "*(f_ + f_BTC)"), paste0("1 + ", bG, "*(f_ + f_Mph) - ", cG, " - ", cMMph), paste0("1 + ", bR, " + ", bG, "*(f_ + f_Mph) - ", cS, "* (f_ + f_BTC) -", cD , " * f_Mph"), paste0("1 + ", bR, " + ", bG, " *(f_ + f_Mph) -", cMMTC, " - ", cD , " * f_Mph") ), stringsAsFactors = FALSE) }  We can check we recover the Table \@ref(tab:payoff2) : {r breastCcheck} create_fe("cG", "bG","cS", "cMMph", "cMMTC", "bR", "cD")  We check that we have correctly specified the different parameters executing evalAllGenotypes. For this, we specify populations sizes for evaluating fitness at different moments in the total population evolution. When there are only wild-type cells, the fitness of the cancer cells is higher than the other type of cells’ fitness. This makes sense, since there are no macrophages that can affect them. {r breastC2a} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(2, 5, 1, 0.8, 1, 1, 9), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(WT = 1000, Mph = 0, BTC = 0, MTC = 0))  In case that there are wild-type cells and macrophages, fitness of cancer cells is lower than before.<!-- (although they are still going to --> <!-- proliferate). --> {r breastC2b} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(2, 5, 1, 0.8, 1, 1, 9), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(WT = 1000, Mph = 1000, BTC = 0, MTC = 0))  When cancer cells start to grow, the fitness of wild type cells and macrophages decrease. This makes sense for wild-type cells, since they will share space with BTC cells, reducing their resources; and for macrophages, because the decrease of wild-type cells will affect the benefit of growth factor produced by them. {r breastC2c} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(2, 5, 1, 0.8, 1, 1, 9), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(WT = 1000, Mph = 1000, BTC = 100, MTC = 100))  So, since the model seems correct, we create now the allFitnessEffects object and do the simulation. Here, we use the McFL model, with death density dependence in addition to the frequency dependence in the birth rates. In this case, we model three different situations: cancer being controlled, development of a non-metastatic cancer, and development of metastatic cancer. ### Cancer kept under control {#cancercontrol} In this example, cD value is increased in order to represent a highly functioning immune system that helps fighting against cancer cells, while the cost of producing growth factor (cG) is low to allow a better fitness of non-cancer cells. This results in the fitness of wild-type cells and macrophages being kept in high levels, helping to control the proliferation of cancer cells, which is maintained under acceptable levels. {r cancercontrol1} afe_3_a <- allFitnessEffects( genotFitness = create_fe(0.5, 4, 1, 0.2, 1, 0.5, 4), frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(2) s_3_a <- oncoSimulIndiv(afe_3_a, model = "McFL", onlyCancer = FALSE, finalTime = 50, mu = 1e-4, initSize = 10000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s_3_a, show = "genotypes", type = "line", col = c("black", "green", "red", "blue", "yellow"))  ### Development of a non-metastatic cancer {#cancerNM} In this second scenario, bR and cMMTC are increased, promoting a higher proliferative capacity of cancer cells but increasing the cost of the ability to move by metastatic cells (MTC), while Cs is slightly decreased, allowing a better fitness of non-motile cells that have to share resources (WT and BTC). This situation leads to the appearance of a non-metastatic cancer due to the higher fitness of BTC cells, thanks to their absence of mobility cost and their increased proliferative capacity, specially in the absence of other cell types that compete for resources. {r cancerNM1} afe_3_a <- allFitnessEffects( genotFitness = create_fe(1, 4, 0.5, 1, 1.5, 1, 4), frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(2) s_3_a <- oncoSimulIndiv(afe_3_a, model = "McFL", onlyCancer = FALSE, finalTime = 50, mu = 1e-4, initSize = 10000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s_3_a, show = "genotypes", type = "line", col = c("black", "green", "red", "blue", "yellow"))  ### Development of a metastatic cancer {#cancerM} In this last example, cS value is increased, hindering the growth and fitness of non-motile cells that compete for space and resources, whereas the cost of mobility of metastatic cancer cells (cMMTC) is considerably reduced, thus favoring their proliferation. This scenario leads to the development of metastatic cancer, due to a rapid increase in the proliferation of metastatic cancer cells, thanks to their low mobility cost, and a slightly slower increase in the fitness of benign tumor cells, that have to compete with resources with the wild-type cells until their disappearance. {r cancerM1} afe_3_a <- allFitnessEffects( genotFitness = create_fe(0.5, 4, 2, 0.5, 0.5, 1, 4), frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(2) s_3_a <- oncoSimulIndiv(afe_3_a, model = "McFL", onlyCancer = FALSE, finalTime = 50, mu = 1e-4, initSize = 10000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s_3_a, show = "genotypes", type = "line", col = c("black", "green", "red", "blue", "yellow"))  ## Improving the previous example. Modeling of breast cancer with the presence chemotherapy and resistance. {#breastCQ} With the aim of obtaining a more reliable and representative picture of what happens in a situation of cancer development and treatment, we model a more complex scenario inproving the previous example, \@ref(breastC). This alternative model considers the presence of seven cell types, four of which are the same that have been described in the previous model: the native cells (NC), macrophages (Mph), benign tumor cells (BTC) and metastatic cancer cells (MTC). Moreover, we include here the chemotherapy-resistant normal cells (R), chemotherapy-resistant benign tumor cells (BTC,R) and chemotherapy-resistant metastatic cancer cells (MTC,R). Most of the costs and benefits of this new model are similar to those described in the previous situation. Native cells and macrophages, but also the chemotherapy-resistant normal cells, produce growth factor bG, which benefits all cell types. These three cells types are considered to have the same cost of producing the growth factor, cG. The macrophages and motile tumor cells (both MTC and MTC,R) have the ability to move, assuming that the cost of this ability is cM,Mph, cM,MTC and cM,MTC,R respectively. The native cells and benign tumor cells (both BTC and BTC,R) have no motile capacity and have to stay in place, competing for the available resources with other native and benign tumor cells, which comes at the cost cS for all these cell types. As occurred in the previous model, considering that cancer cells have a higher reproductive rate than native cells or macrophages, we add an additional benefit bR to the cancer cells. However, as they can also be destroyed and attacked by macrophages, we add an additional cost cD to the cancer cells. Moreover, in this model we add an additional factor Q that represents the effect of chemotherapeutic treatment, which will not have any effect on cells that have been able to develop resistance to it, but it will have a negative effect on the rest of the cell types, being especially important on cancer cells, as they have a higher rate of reproduction. The payoff matrix will also introduce slight changes, which reproduced in next table: | | MTC | Mph | NC | BTC | R | BTC,R | MTC,R | |----------|------------------|------------------|------------------|---------------|---|-------|-------| |**MTC** | bR - cMMTC - Q | bR - cMMTC - cD + bG -Q | bR - cMMTC + bG -Q | bR - cMMTC - Q | bR - cMMTC + bG - Q | bR - cMMTC - Q | bR - cMMTC -Q | |**Mph** | - cG - cMMph - 0.01 * Q | bG - cG - cMMph - 0.01 * Q | bG - cG - cMMph - 0.01 * Q | -cG - cMMph - 0.01 * Q | bG - cG - cMMph- 0.01 * Q | -cG - cMMph - 0.01 * Q | - cG - cMMph - 0.01 * Q | |**NC** | - cG - 0.01 * Q | bG - cG - 0.01 * Q | bG - cG - cS - 0.01 * Q | - cG - cS - 0.01 * Q | bG - cG - cS - 0.01 * Q | - cG - cS - 0.01 * Q | - cG - 0.01 * Q | |**BTC** | bR - Q | bR + bG - cD - Q | bR + bG - cS - Q | bR - cS - Q | bR + bG - cS -Q | bR - cS - Q | bR - Q | |**R** | - cG | bG - cG | bG - cG - cS | - cG - cS | bG - cG - cS | - cG - cS | - cG | -cG | |**BTC,R** | bR | bR + bG - cD | bR + bG - cS | bR - cS | bR + bG - cS | bR - cS | bR | |**MTC,R** | bR - cMMTC | bR - cMMTC - cD + bG | bR - cMMTC + bG | bR - cMMTC | bR - cMMTC + bG | bR - cMMTC | bR - cMMTC| Table:(\#tab:payoff3) Payoff matrix adapted from Barton et al., 2018, ‘Modeling of breast cancer through evolutionary game theory’, Involve, a Journal of Mathematics, 11(4), 541-548; https://doi.org/10.2140/involve.2018.11.541 . Overall, when the concentrations of the cells are ǪNC, ǪMph, ǪBTC, ǪMTC, ǪR, ǪBTC,R and ǪMTC,R, the net benefits (benefits minus the costs) to each cell type are: * W(NC) = bG([NC] + [Mph] + [R]) - cG - cS([NC] + [BTC] + [R] + [BTC,R]) - 0.01*Q * W(Mph) = bG([NC] + [Mph] + [R]) - cG - cMMph - 0.001*Q * W(BTC) = bR + bG([NC] + [Mph] + [R]) - cS([NC] + [Mph] + [R] + [BTC,R]) - cD[Mph] - Q * W(MTC) = bR + bG([NC] + [Mph] + [R]) - cMMTC - cD[Mph] - Q * W(R) = bG ([NC] + [Mph] + [R]) - cG - cS ([NC] + [BTC] + [R] + [BTC,R]) * W(BTC,R) = bR + bG([NC] + [Mph] + [R]) - cS([NC] + [Mph] + [R] + [BTC,R]) - cD[Mph] * W(MTC,R) = bR + bG([NC] + [Mph] + [R]) - cMMTC - cD[Mph] Now, we will define a function to create the data frame of frequency-dependent fitnesses to allow modelling several situations. As in the previous model, we will consider the NC cell type as the WT and will assume that Mph, BTC and MTC cells are all derived from WT by a single mutation, as previously described. Likewise, we consider that the chemotherapy-resistant normal cells (R) are derived from a single mutation in a gene, say, R. Furthermore, we will assume that the two chemotherapy-resistant cancer cells (BTC,R and MTC,R) are all derived from WT by two different mutations. {r breastCQfit1} create_fe <- function(cG, bG, cS, cMMph, cMMTC, bR, cD, Q, gt = c("WT", "BTC", "R", "MTC", "Mph", "BTC,R", "MTC,R")) { data.frame(Genotype = gt, Fitness = c( paste0("1 + ", bG, "(f_ + f_R + f_Mph) - ", cG, " - ", cS, "(f_ + f_BTC + f_R + f_BTC_R) -", "0.01*", Q), paste0("1 + ", bR, " + ", bG, "(f_ + f_R + f_Mph) - ", cS, " (f_ + f_BTC + f_R + f_BTC_R) -", cD , " * f_Mph -", Q), paste0("1 + ", bG, "(f_ + f_R + f_Mph) - ", cG, " - ", cS, "(f_ + f_BTC + f_R + f_BTC_R)"), paste0("1 + ", bR, " + ", bG, " *(f_ + f_R + f_Mph) -", cMMTC, " - ", cD , " * f_Mph -", Q), paste0("1 + ", bG, "(f_ + f_R + f_Mph) - ", cG, " - ", cMMph, "- 0.01*",Q), paste0("1 + ", bR, " + ", bG, "(f_ + f_R + f_Mph) - ", cS, " (f_ + f_BTC + f_R + f_BTC_R) -", cD , " * f_Mph"), paste0("1 + ", bR, " + ", bG, " *(f_ + f_R + f_Mph) -", cMMTC, " - ", cD , " * f_Mph") ), stringsAsFactors = FALSE) }  We verify that we recover Table \@ref(tab:payoff3) : {r breastCQcheck} create_fe("cG", "bG","cS", "cMMph", "cMMTC", "bR", "cD", "Q")  We check once again that we have correctly specified the different parameters executing evalAllGenotypes. We are trying the same case than in the previous example, having wild-type cells, macrophages and both cancer cells. But in this case, we are introducing the parameter “Q” (chemotherapy), with a value of 5. {r breastCQ2a} evalAllGenotypes(allFitnessEffects(genotFitness = create_fe(2,5,1,0.8,1,1,9,5), frequencyDependentFitness = TRUE, frequencyType = "rel"), spPopSizes = c(WT = 1000, BTC = 100, R = 0, MTC = 100, Mph = 1000, "BTC, R" = 0, "MTC, R" = 0))  As we can see, BTC and MTC have a fitness of 0, so the will not proliferate. But cancer cells mutants with a double mutation (BTC, R and MTC, R) are resistant to chemotherapy, so they can still grow. This is what we were expecting to happen, so we started with the simulation. Now, we create the allFitnessEffects object and do the simulation using the McFL model. In this case, we specify gene-specific mutations rates, so we can model a more realistic scenario where the appearence of chemotherapy-resistant cells is hindered. Once again, we simulate different situations by changing the values of the different parameters. ### Absence of chemotherapy {#cancerwoQ} In the first scenario, we simulate a situation where no chemotherapy is applied. In this condition, there is a very low R mutation rate, which hampers the proliferation of chemotherapy-resistant cells. A fast appearance of macrophages is observed, as well as non-resistant tumor cells. As there is no chemoterapy treatment, the fitness of non-resistant tumor cells is favoured against macrophages, leading to the appearance of cancer, where BTC cells show the greatest fitness due to the mobility cost of MTC cells. {r cancerwoQ1} afe_3_a <- allFitnessEffects( genotFitness = create_fe(2, 5, 1, 0.8, 1, 1, 9, 0), frequencyDependentFitness = TRUE, frequencyType = "rel") #Set mutation rates muvar2 <- c("Mph" = 1e-2, "BTC" = 1e-3, "MTC"=1e-3, "R" = 1e-7) set.seed(2) s_3_a <- oncoSimulIndiv(afe_3_a, model = "McFL", onlyCancer = FALSE, finalTime = 20, mu = muvar2, initSize = 10000, keepPhylog = TRUE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s_3_a, show = "genotypes", type = "line", col = c("black", "green", "red", "blue", "pink", "orange", "brown"))  ### Chemotherapy with low R mutation rate {#cancerwQlRm} In the second scenario, we perform a simulation including chemotherapy as a treatment. However, here we maintain a low R mutation rate, hampering once again the appearance of chemotherapy-resistant cells. This situation can be reflecting the application of a combination chemotherapy that reduces or limits the appearance of resistance. We observe that the fitness of wild-type cells and macrophages increases rapidly and remains elevated, while tumor cells undergo some proliferation at first, but it remains under control over time thanks to the negative effect on them of chemotherapy. {r cancerwQlRm1} afe_3_a <- allFitnessEffects( genotFitness = create_fe(2, 5, 1, 0.8, 1, 1, 9, 2), frequencyDependentFitness = TRUE, frequencyType = "rel") muvar2 <- c("Mph" = 1e-2, "BTC" = 1e-3, "MTC"=1e-3, "R" = 1e-7) set.seed(2) s_3_a <- oncoSimulIndiv(afe_3_a, model = "McFL", onlyCancer = FALSE, finalTime = 20, mu = muvar2, initSize = 10000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s_3_a, show = "genotypes", type = "line", col = c("black", "green", "red", "blue", "pink", "orange", "brown"))  ### Chemotherapy with considerable R mutation rate {#cancerwQHRm} Finally, we simulate a scenario in the presence of chemotherapy as a treatment and also a considerable R mutation rate. This would allow the appearance of chemotherapy-resistant cells. This simulation reflects the situation of using chemotherapy treatments against which tumor cells develop resistance. Here, we observe a similar fitness evolution of wild-type cells and macrophages to the previous example, rapidly increasing their population and remaining elevated for a period of time. The proliferation of non-resistant tumor cells is also maintained under acceptable levels thanks to the effect of chemotherapy. However, due to the increased R mutation rate, chemotherapy-resistant cells begin to appear in low levels, until the fitness of chemotherapy-resistant benign tumor cells stats to increase considerably, leading to the disappearance of the other cell types and allowing the development of a non-metastatic cancer. {r cancerwQHRm1} afe_3_a <- allFitnessEffects( genotFitness = create_fe(2, 5, 1, 0.8, 1, 1, 9, 2), frequencyDependentFitness = TRUE, frequencyType = "rel") muvar2 <- c("Mph" = 1e-2, "BTC" = 1e-3, "MTC"=1e-3, "R" = 1e-5) set.seed(2) s_3_a <- oncoSimulIndiv(afe_3_a, model = "McFL", onlyCancer = FALSE, finalTime = 20, ## short for speed; increase for "real" mu = muvar2, initSize = 10000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) plot(s_3_a, show = "genotypes", type = "line", col = c("black", "green", "red", "blue", "pink", "orange", "brown"))  \clearpage # Simulating therapeutic interventions that depend on time {#timefdf} In this section we show some examples using the time dependent functionality; with it, fitness can be made to depend on T, the current time defined in the simulation. These examples were originally prepared by Niklas Endres, Rafael Barrero Rodríguez, Rosalía Palomino Cabrera and Silvia Talavera Marcos, as an exercisse for the course Programming and Statistics with R (Master's Degree in Bioinformatics and Computational Biology, Universidad Autónoma de Madrid), course 2019-20; Niklas Endres had the idea of accessing T from exprTk. This first example is an artificial simulation, but it shows how the fitness of a genotype can suddenly increase at a certain given timepoint. {r timefdf1} ## Fitness definition fl <- data.frame( Genotype = c("WT", "A", "B"), Fitness = c("1", #WT "if (T>50) 1.5; else 0;", #A "0*f_") , #B stringsAsFactors = FALSE ) fe <- allFitnessEffects(genotFitness = fl, frequencyDependentFitness = TRUE, frequencyType = "rel") ## Evaluate the fitness before and after the specified currentTime evalAllGenotypes(fe, spPopSizes = c(100, 100, 100)) evalAllGenotypes(fe, spPopSizes = c(100, 100, 100), currentTime = 80) ## Simulation sim <- oncoSimulIndiv(fe, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 0.01, initSize = 5000, keepPhylog = FALSE, seed = NULL, errorHitMaxTries = FALSE, errorHitWallTime = FALSE) ## Plot the results plot(sim, show = "genotypes")  ## Adaptive control of competitive release and chemotherapeutic resistance {#adapChemo} The code structure of the previous example can be used, for instance, to simulate the effect of different chemotherapy treatment protocols. An example of using these game theory concepts is the adaptive theory. The primary goal is to maximize the time of tumor control by using the tumor cells that are sensitive to treatment as agents that can supress the proliferation of the resistant cells. Thus, a significant residual populations of tumor cells can be under control to inhibit the growth of cells that otherwise cannot control: killed vs resistant. Newton and Ma @PhysRevE built simulations for a tumor consisting in two types of cells: resistant to chemotherapy and sensitive to chemotherapy. The idea is to promote competition among tumor cells in order to prevent tumor growth. To do this, they developed a **three-component Prisoner's Dilemma scenario** including healthy (**H**) cells as well as chemoresistant (**R**) and chemosensitive (**S**) cancer cells. Healthy cells are cooperators, while cancer cells are defectors. This is the system's payoff matrix: {r adapChemo1} a <- 1; b <- 0.5; c <- 0.5 ## a b c d <- 1; e <- 1.25; f <- 0.7 ## d e f g <- 0.975; h <- -0.5; i <- 0.75 ## g h i payoff_m <- matrix(c(a,b,c,d,e,f,g,h,i), ncol=3, byrow=TRUE) colnames(payoff_m) <- c("Healthy", "Chemo-sensitive", "Chemo-resistant") rownames(payoff_m) <- c("Healthy", "Chemo-sensitive", "Chemo-resistant") print(payoff_m <- as.table(payoff_m))  The numerical values in the matrix are selected to satisfy the following theoretical constraints: g > a > i > c; d > a > e > b; f > i > e > h and d > g (cost to resistance). Thus, the fitness definitions for the three types of cells could be written as in the following data frame: {r adapChemo2} print( df <- data.frame( CellType = c("H", "S", "R"), Fitness = c("F(H) = ax(H) + bx(S) + cx(R)", #Healthy "F(S) = dx(H) + ex(S) + fx(R)", #Sensitive "F(R) = gx(H) + hx(S) + ix(R)")), #Resistant row.names = FALSE )  In summary: * The fitness of H cells is lower than the chemosensitive cells. * Without any therapy, S cells have a higher fitness value than R cells, because of the cost to resistance * In the presence of therapy, R cells take over the S cells One of the challenges is to optimize the drug dosage intervals. In practice, this would mean to infer the growth rates of the different cell types from a frequent monitoring of the tumor environment. With OncoSimulR is possible to try out different intervals on simulations of the collected data. ### Scenario without chemotherapy {#scenChemo} First of all, we can simulate the growth of a tumor from H cells without any treatment. We can consider that R tumor cells are generated from S and WT cells. Thus, as we expected, we can observe in the simulation results that S cells grow (tumor) and R cells cannot subsist because of their fitness disadvantage: the cost of being resistant. {r scenChemo1} set.seed(2) RNGkind("L'Ecuyer-CMRG") ## Coefficients # Healthy Sensitive Resistant a=3; b=1.5; c=1.5 # Healthy d=4; e=5; f=2.8 # Sensitive g=3.9; h=-2; i=2.2 # Resistant # Here we divide coefficients to reduce the amount of cells obtained in the simulation. # We have divided a, b and c by 3, and d, e and i by 4. # Healthy Sensitive Resistant a <- 1; b <- 0.5; c <- 0.5 # Healthy d <- 1; e <- 1.25; f <- 0.7 # Sensitive g <- 0.975; h <- -0.5; i <- 0.75 # Resistant ## Fitness definition players <- data.frame(Genotype = c("WT","S","R","S,R"), Fitness = c(paste0(a, "*f_+", b, "*f_S+", c, "*f_S_R"), #WT paste0(d,"*f_+",e,"*f_S+",f,"*f_S_R"), #S "0", #R paste0(g,"*f_+",h,"*f_S+",i,"*f_S_R")), #S,R stringsAsFactors = FALSE) game <- allFitnessEffects(genotFitness = players, frequencyDependentFitness = TRUE, frequencyType = "rel") ## Plot the first scenario eag <- evalAllGenotypes(game, spPopSizes = c(10,1,0,10))[c(1, 3, 4),] plot(eag) ## Simulation gamesimul <- oncoSimulIndiv(game, model = "McFL", onlyCancer = FALSE, finalTime = 40, mu = 0.01, initSize = 5000, keepPhylog = FALSE, seed = NULL) ## Plot 2 plot(gamesimul, show = "genotypes", type = "line", col = c("black", "green", "red"), ylim = c(20, 50000)) plot(gamesimul, show = "genotypes")  ### Scenario with continuous chemotherapy: fixed dose {#fixedChemo} For this simulation, we add the effect of chemotherapy as a fixed coefficient (**drug_eff**), representing a fixed dose. The dose is delivered only when a tumor has grown up, so we perform the drug effect after starting the simulation. For this, we apply the time funcionality used in the first section of this chapter. {r fixedChemo1} # Effect of drug on fitness sensible tumor cells drug_eff <- 0.01 wt_fitness <- paste0(a, "*f_+", b, "*f_S+", c, "*f_S_R") sens_fitness <- paste0(d, "*f_+", e, "*f_S+", f, "*f_S_R") res_fitness <- paste0(g, "*f_+", h, "*f_S+", i, "*f_S_R") players_1 <- data.frame(Genotype = c("WT", "S", "R", "S, R"), Fitness = c(wt_fitness, #WT paste0("if (T>50) ", drug_eff, "*(",sens_fitness, ")","; else ", sens_fitness, ";"), #S "0", #R res_fitness), #S,R stringsAsFactors = FALSE) period_1 <- allFitnessEffects(genotFitness = players_1, frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(2) final_time <- 170 ## for speed simul_period_1 <- oncoSimulIndiv(period_1, model = "McFL", onlyCancer = FALSE, finalTime = final_time, mu = 0.01, initSize = 5000, keepPhylog = FALSE, seed = NULL) # ylim has been adapted to number of cells plot(simul_period_1, show = "genotypes", type = "line", col = c("black", "green", "red"), ylim = c(20, 300000), thinData = TRUE) ## plot(simul_period_1, show = "genotypes", ylim = c(20, 12000))  As expected, the simulation results show how sensitive cells suddenly decrease when the current time of the simulation reach a value of 50, which is the consequence of the chemotherapy. In this regard, the code illustrates how sensitive cells fitness is multiplied by _drug_eff_ variable after 50 units of time, and then resistant cells start to grow exponentially until reaching an equilibrium where chemoterapy does not affect them anymore. With this example, we can show how chemotherapy usage could be counterproductive under certain situations, especially in those cases in which resistant tumor cells are more aggressive than sensitive cells. ### Scenario with switching doses of chemotherapy {#switchChemo} The original model by Newton and Ma @PhysRevE includes chemotherapeutic dosage as a time-dependent controller. The main idea is to increase or decrease the dose according to a periodic cancer growth in order to avoid the fixation of both sensitive and resistant cells, and keep the tumor trajectory enclosed in a loop. The model developed by this group is a is a cubic nonlinear system based on Hamiltonian orbits. They use time-dependent chemotherapeutic parameters _w_, whose values are different in each one of the several and carefully chosen intervals that depends on _C(t)_, which is the chemo-concentration parameter. For simplicity’s sake, we will just define the fitness of sensitive cells as dependent on a sine time function. During this simulation, we will see in our results small oscilations doses that keep sensitive cells population at a minimum value and the R cells progress is prevented. {r switchChemo1} set.seed(2) RNGkind("L'Ecuyer-CMRG") # Healthy Sensitive Resistant a <- 1; b <- 0.5; c <- 0.5 # Healthy d <- 1; e <- 1.25; f <- 0.7 # Sensitive g <- 0.975; h <- -0.5; i <- 0.75 # Resistant wt_fitness <- paste0(a, "*f_+", b, "*f_S+", c, "*f_S_R") sens_fitness <- paste0(d, "*f_+", e, "*f_S+", f, "*f_S_R") res_fitness <- paste0(g, "*f_+", h, "*f_S+", i, "*f_S_R") fitness_df <-data.frame(Genotype = c("WT", "S", "R", "S, R"), Fitness = c(wt_fitness, #WT paste0("if (T>50) (sin(T+2)/10) * (", sens_fitness,")", "; else ", sens_fitness, ";"), #S "0", #R res_fitness), #S,R stringsAsFactors = FALSE) afe <- allFitnessEffects(genotFitness = fitness_df, frequencyDependentFitness = TRUE, frequencyType = "rel") switching_sim <- oncoSimulIndiv(afe, model = "McFL", onlyCancer = FALSE, finalTime = 100, mu = 0.01, initSize = 5000, keepPhylog = FALSE, seed = NULL) plot(switching_sim, show = "genotypes", type = "line", col = c("black", "green", "red"), ylim = c(20, 200000)) ## plot(switching_sim, show = "genotypes", ylim = c(20, 1000))  ## Growth factors as chemotherapy target {#gfChemo} It has been reported in the literature and verified in the above simulations, that resistance acquisition is almost unavoidable. A new approach to avoid this evolutionary adaptation, proposes to change the chemotherapy target, from the cell subclones to the growing factors (GF) they produce. These molecules, which are secreted to the medium by **cooperators**, help to grow their own subclone types besides the GF **defectors**. Thus, the fitness of the whole population increases and the tumor grows. An attended side effect of this type of treatment is the emergence of cooperators that overproduce GF. This will increase their fitness and reduce the impact of GF sequestering agents. However, it would also increase the cost of its production, which will decrease this benefitial impact. @Archetti2013 develops a series of formulas to relate the impact of cooperation in tumor composition and fitness of subclones, which they divide as cooperators and defectors. Although GFs are not always distributed homogeneously, we will assume they do in the following simulations for the sake of simplicity. Attending to the theoretical foundations mentioned, we will create a cooperation scenario, including wild-type healthy cells (**WT**) and tumour cells, which are cooperators (**C**), defectors (**D**) and overproducers (**P**). The system payoff matrix is the following: {r gfChemo1} # WT Cooperators Defectors Overproducers a <- 1; b <- 0.5; c <- 0.5; m <- 0.75 ## a b c m d <- 1; e <- 1.25; f <- 0.7; o <- 0.185 ## d e f o g <- 1; h <- 1.5; i <- 0.5; p <- 2.5 ## g h i p j <- 0.8; k <- 1; l <- 0.5; q <- 1.5 ## j k l q payoff_m <- matrix(c(a,b,c,m,d,e,f,o,g,h,i,p,j,k,l,q), ncol=4, byrow=TRUE) colnames(payoff_m) <- c("WT", "Cooperators", "Defectors", "Overproducers") rownames(payoff_m) <- c("WT", "Cooperators", "Defectors", "Overproducers") print(payoff_m <- as.table(payoff_m))  The fitness definitions for the four types of cells would be the following: {r gfChemo2} print( df <- data.frame( CellType = c("WT", "C", "D", "P"), Fitness = c("F(WT) = ax(WT) + bx(C) + cx(D) + mx(P)", "F(C) = dx(WT) + ex(C) + fx(D) + ox(P)", "F(D) = gx(WT) + hx(C) + ix(D) + px(P)", "F(P) = jx(WT) + kc(C) + lx(D) + qx(P)")), row.names = FALSE )  Ordered by decreasing fitness: In summary: * The fitness of WT cells is lower than the tumour cells. * Without any therapy, C cells fitness is higher than P cells, so the overproducers will not overtake them. * D subclones benefit from the high concentration of cooperators (C or P). ### Scenario without chemotherapy {#scenGF} First, we will study the fitness of the subclones types based on hypothetical frequencies. Then, we will simulate the growth of the tumor without any treatment. For this, we are considering that C cells are the original tumor cells and they can mutate and lose by deletion the GF gene (D cells grow) or duplicate it (P cells grow). {r scenGF1} set.seed(2) RNGkind("L'Ecuyer-CMRG") ## Coefficients ## New coefficients for the interaction with overproducing sensitive: # WT COOPERATOR DEFECTOR OVERPRODUCER a <- 1; b <- 0.5; c <- 0.5; m <- 0.75 # WT wt_fitness <- paste0(a, "*f_+", b, "*f_C+", c, "*f_C_D+", m, "*f_C_P") d <- 1; e <- 1.25; f <- 0.7; o <- 1.875 # Cooperator coop_fitness <- paste0(d, "*f_+", e, "*f_C+", f, "*f_C_D+", o, "*f_C_P") g <- 1; h <- 1.5; i <- 0.5; p <- 2.5 # Defector def_fitness <- paste0(g, "*f_+", h, "*f_C+", i, "*f_C_D+", p, "*f_C_P") j <- 0.8; k <- 1; l <- 0.5; q <- 1.5 # Cooperator overproducing over_fitness <- paste0(j, "*f_+", k, "*f_C+", l, "*f_C_D+", q, "*f_C_P") ## No-chemotherapy ## Fitness definition coop_no <- data.frame(Genotype = c("WT", "C", "D", "P", "C,D", "C,P", "D,P", "C,D,P"), Fitness = c( wt_fitness, #WT coop_fitness, #S "0", #D "0", #P def_fitness, #S,D over_fitness, #S,P "0", #D,P "0" #C,D,P ), stringsAsFactors = FALSE) game_no <- allFitnessEffects(genotFitness = coop_no, frequencyDependentFitness = TRUE, frequencyType = "rel") ## First plot eag <- evalAllGenotypes(game_no, spPopSizes = c(WT = 10, C = 10, D = 0, P = 0, "C, D" = 10, "C, P" = 1, "D, P" = 0, "C, D, P" = 0))[c(1, 2, 5, 6),] plot(eag) ## Simulation gamesimul_no <- oncoSimulIndiv(game_no, model = "McFL", onlyCancer = FALSE, finalTime = 35, mu = 0.01, initSize = 5000, keepPhylog = FALSE, seed = NULL) ## Second plot plot(gamesimul_no, show = "genotypes", type = "line", col = c("blue", "red", "green", "purple"), ylim = c(20, 50000), thinData = TRUE) # Third plot ## plot(gamesimul_no, show = "genotypes")  The resulting plots show that D cells are highly benefited by the second most common subclone activity (C cells), which is a cooperator. On the other hand, subclone P has a lower fitness value because of the GF cost. However, as we can see in the first plot, a small number of clones remain and survive. ### Scenario with GF as target for chemotherapy {#scenGFChemo} In this simulation, we will add the drug effect (at time 50) to the fitness of each subclone. We assume that this will cause a reduction of the fitness by the level of GF dependency for each subclone. We now introduce some constants to make it more accurate. As cooperators will keep producing GF, they will be less affected by the sequestration of this molecule, so their coefficients will be greater than 1. In addition, P also will be less affected since its production of GF is greater, so its coefficient will be greater than the C one (1.5 > 1.1). On the other hand, as D is a defector, it will be more affected by the treatment, so its coefficient will set to 0.9, smaller than 1. {r scenGFChemo1} ## Chemotherapy - GF Impairing # Effect of drug on GF availability # This term is multiplied by the fitness, and reduces the GF available drug_eff <- 0.25 coop_fix <- data.frame(Genotype = c("WT", "C", "D", "P", "C,D", "C,P", "D,P", "C,D,P"), Fitness = c( wt_fitness, #WT paste0("if (T>50) ", drug_eff, "* 1.2 *(", coop_fitness, ")", "; else ", coop_fitness, ";"), #C "0", #D "0", #P paste0("if (T>50) ", drug_eff, "*(", def_fitness, ")", "; else ", def_fitness, ";"), #C,D paste0("if (T>50) ", drug_eff, "* 1.5 * (", over_fitness, ")", "; else ", over_fitness, ";"), #C,P ** "0", #D,P "0" #C,D,P ), stringsAsFactors = FALSE) ## ** The drug effect is 1.5 times the original because of the overproduction of GF and the ## full availability of this molecule inside the producing subclone. period_fix <- allFitnessEffects(genotFitness = coop_fix, frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(2) final_time <- 30 ## you'd want this longer; short for speed of vignette simul_period_fix <- oncoSimulIndiv(period_fix, model = "McFL", onlyCancer = FALSE, finalTime = final_time, mu = 0.01, initSize = 5000, keepPhylog = FALSE, seed = NULL) # First plot plot(simul_period_fix, show = "genotypes", type = "line", col = c("blue", "red", "green", "purple"), ylim = c(20, 50000), thinData = TRUE) # Second plot ## plot(simul_period_fix, show = "genotypes", ylim = c(20, 8000))  As expected by Archetti and Pienta @archetti2019, the tumour will be biased towards P mutant. Even if its fitness is lower than C because of its overproduction of GF, it will assure its survival and proliferation when chemotherapy is applied. As a result of this, D does not completely disappear, but reduces dramatically its number. ## Examples using time dependent frequency definition {#exTime} Here in this chapter we will comment some others approaches that can have this funcionality: increasing or decreasing the fitness as therapeutic interventions, or slow down the collapse of a subpopulation of cells. ### Increasing fitness at a certain timepoint {#exTime1} It is possible to increase the fitness value by using T functionality. In the following example we can see how fitness value in genotypes A and B increases when the simulation time reaches a specific value. Since we have used the exponential model, that is the reason why we observe some delay between the specified time and when A or B populations start to grow. {r exTimeInc} dfT1 <- data.frame(Genotype = c("WT", "A", "B"), Fitness = c("1", "if (T>50) 1 + 2.35*f_; else 0.50;", "if (T>200) 1 + 0.45*(f_ + f_1); else 0.50;"), stringsAsFactors = FALSE) afeT1 <- allFitnessEffects(genotFitness = dfT1, frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(1) simT1 <- oncoSimulIndiv(afeT1, model = "Exp", mu = 1e-5, initSize = 1000, finalTime = 500, onlyCancer = FALSE, seed = NULL) plot(simT1, show = "genotypes", type = "line")  We can check if the fitness values have increased by evaluating the genotypes in the simulation time intervals. {r exTimeInc1} evalAllGenotypes(afeT1, spPopSizes = c(10,10,10), currentTime = 49)[c(2,3), ] evalAllGenotypes(afeT1, spPopSizes = c(10,10,10), currentTime = 51)[c(2,3), ] evalAllGenotypes(afeT1, spPopSizes = c(10,10,10), currentTime = 201)[c(2,3), ]  ### Intervention at a certain point to stop subpopulation growth {#exTime2} On the other hand, besides using T functionality to create time intervals, we can also use it as an intervention. In the following example we have used the functionality to increase the fitness value of genotype A, and suddenly decreases it as an intervention, where B population takes advantage to grow, since its fitness is greater now. When the intervention elapses, we can see how A population starts to grow again and outcompetes with wild-type population whose fitness does not change during the simulation. {r exTimeDec} dfT2 <- data.frame(Genotype = c("WT", "A", "B"), Fitness = c( "1", "if (T>0 and T<50) 0; else if (T>200 and T<300) 0.05; else 1 + 0.35*f_;", "0.8 + 0.45*(f_)" ), stringsAsFactors = FALSE) afeT2 <- allFitnessEffects(genotFitness = dfT2, frequencyDependentFitness = TRUE, frequencyType = "rel") set.seed(2) simT2 <- oncoSimulIndiv(afeT2, model = "McFL", mu = 1e-5, initSize = 5000, finalTime = 450, onlyCancer = FALSE, seed = NULL) plot(simT2, show = "genotypes", thinData = TRUE) ## plot(simT2, show = "genotypes", type = "line", thinData = TRUE)  In this case, just like above, we can evaluate the fitness in each time interval and observe how fitness is differente in each one of them. {r examplesTDec1} evalAllGenotypes(afeT2, spPopSizes = c(10,10,10), currentTime = 49)[c(2,3), ] evalAllGenotypes(afeT2, spPopSizes = c(10,10,10), currentTime = 51)[c(2,3), ] evalAllGenotypes(afeT2, spPopSizes = c(10,10,10), currentTime = 201)[c(2,3), ] evalAllGenotypes(afeT2, spPopSizes = c(10,10,10), currentTime = 301)[c(2,3), ]  ### Intervention to slow down collapsing populations {#exTime3} We can use time dependent frequency functionality to slow down a collapsing population by doing an intervention at a certain time interval. In this case, we observe that genotype B has previously a higher fitness than genotype A (as long as the number of cells is greater than 10), but at certain point we can reduce its fitness in order to make A grow and reach B. However, after the time interval, B recovers its initial fitness again and overtakes A, but eventually collapses due to there are no more A's around. This could be a way to slow down the collapse of a population when there is a size dependency between them. {r examplesTCol} dfT3 <- data.frame(Genotype = c("WT", "A", "B"), Fitness = c( "1", "1 + 0.2 * (n_2 > 10)", "if (T>50 and T<80) 0.80; else 0.9 + 0.4 * (n_1 > 10)"), stringsAsFactors = FALSE) afeT3 <- allFitnessEffects(genotFitness = dfT3, frequencyDependentFitness = TRUE, frequencyType = "abs") set.seed(2) simT3 <- oncoSimulIndiv(afeT3, model = "McFLD", mu = 1e-4, initSize = 5000, finalTime = 500, onlyCancer = FALSE, seed = NULL, errorHitWallTime = FALSE, errorHitMaxTries = FALSE) plot(simT3, show = "genotypes", type = "line")  We evaluate the fitness before and after genotype B has a higher and lower fitness respectively, and finally ends up collapsing because the condition of "n_1 > 10" is no longer accomplished. {r examplesTCol1} evalAllGenotypes(afeT3, spPopSizes = c(10,10,10), currentTime = 30)[c(2,3), ] evalAllGenotypes(afeT3, spPopSizes = c(11,11,11), currentTime = 79)[c(2,3), ] evalAllGenotypes(afeT3, spPopSizes = c(11,11,11), currentTime = 81)[c(2,3), ]  \clearpage # Measures of evolutionary predictability and genotype diversity {#evolpredszend} Several measures of evolutionary predictability have been proposed in the literature (see, e.g., @szendro_predictability_2013 and references therein). We provide two, Lines of Descent (LOD) and Path of the Maximum (POM), following @szendro_predictability_2013; we also provide a simple measure of diversity of the actual genotypes sampled. In @szendro_predictability_2013 "(...) paths defined as the time ordered sets of genotypes that at some time contain the largest subpopulation" are called "Path of the Maximum" (POM) (see their p. 572). In our case, POM are obtained by finding the clone with largest population size whenever we sample and, thus, the POMs will be affected by how often we sample (argument sampleEvery), since we are running a continuous time process. @szendro_predictability_2013 also define Lines of Descent (LODs) which "(...) represent the lineages that arrive at the most populated genotype at the final time". In that same page (572) they provide the details on how the LODs are obtained. Starting with version 2.9.2 of OncoSimulR I only provide an implementation where a single LOD per simulation is returned, with the same meaning as in @szendro_predictability_2013. To briefly show some output, we will use again the \@ref(pancreas) example. {r lod_pom_ex} pancr <- allFitnessEffects( data.frame(parent = c("Root", rep("KRAS", 4), "SMAD4", "CDNK2A", "TP53", "TP53", "MLL3"), child = c("KRAS","SMAD4", "CDNK2A", "TP53", "MLL3", rep("PXDN", 3), rep("TGFBR2", 2)), s = 0.05, sh = -0.3, typeDep = "MN")) pancr16 <- oncoSimulPop(16, pancr, model = "Exp", mc.cores = 2) ## Look a the first POM str(POM(pancr16)[1:3]) LOD(pancr16)[1:2] ## The diversity of LOD (lod_single) and POM might or might not ## be identical diversityPOM(POM(pancr16)) diversityLOD(LOD(pancr16)) ## Show the genotypes and their diversity (which might, or might ## not, differ from the diversity of LOD and POM) sampledGenotypes(samplePop(pancr16))  Beware, however, that if you use multiple initial mutants (section \@ref(minitmut)) the LOD function will probably not do what you want. It is not even clear that the LOD is well defined in this case. We are working on this. \clearpage # Generating random DAGs for restrictions {#simo} You might want to randomly generate DAGs like those often found in the literature on Oncogenetic trees et al. Function simOGraph might help here. {r} ## No seed fixed, so reruns will give different DAGs. (a1 <- simOGraph(10)) library(graph) ## for simple plotting plot(as(a1, "graphNEL"))  Once you obtain the adjacency matrices, it is for now up to you to convert them into appropriate posets or fitnessEffects objects. Why this function? I searched for, and could not find any that did what I wanted, in particular bounding the number of parents, being able to specify the approximate depth^[Where depth is defined in the usual way to mean smallest number of nodes ---or edges--- to traverse to get from the bottom to the top of the DAG.] of the graph, and optionally being able to have DAGs where no node is connected to another both directly (an edge between the two) and indirectly (there is a path between the two through other nodes). So I wrote my own code. The code is fairly simple to understand (all in file generate-random-trees.R). I would not be surprised if this way of generating random graphs has been proposed and named before; please let me know, best if with a reference. Should we remove direct connections if there are indirect? Or, should we set removeDirectIndirect = TRUE? Setting removeDirectIndirect = TRUE is basically asking for the [transitive reduction](https://en.wikipedia.org/wiki/Transitive_reduction) of the generated DAG. Except for @Farahani2013 and @ramazzotti_capri_2015, none of the DAGs I've seen in the context of CBNs, Oncogenetic trees, etc, include both direct and indirect connections between nodes. If these exist, reasoning about the model can be harder. For example, with CBN (AND or CMPN or monotone relationships) adding a direct connection makes no difference iff we assume that the relationships encoded in the DAG are fully respected (e.g., all$s_h = -\infty$). But it can make a difference if we allow for deviations from the monotonicity, specially if we only check for the satisfaction of the presence of the immediate ancestors. And things get even trickier if we combine XOR with AND. Thus, I strongly suggest you leave the default removeDirectIndirect = TRUE. If you change it, you should double check that the fitnesses of the possible genotypes are what you expect. In fact, I would suggest that, to be sure you get what you think you should get, you convert the fitness from the DAG to a fitness table, and pass that to the simulations, and this requires using non-exposed user functions; to give you an idea, this could work (but you've been warned: this is dangerous!) {r simographindirect, eval=FALSE,echo=TRUE} g2 <- simOGraph(4, out = "rT", removeDirectIndirect = FALSE) fe_from_d <- allFitnessEffects(g2) fitness_d <- evalAllGenotypes(fe_from_d) fe_from_t <- allFitnessEffects(genotFitness = OncoSimulR:::allGenotypes_to_matrix(fitness_d)) ## Compare fitness_d (fitness_t <- evalAllGenotypes(fe_from_t)) identical(fitness_d, fitness_t) ## ... but to be safe use fe_from_t as the fitnessEffects object for simulations  \clearpage # FAQ, odds and ends ## What we mean by "clone"; and "I want clones disregarding passengers" {#meaningclone} In this vignette we often use "clone" or "genotype" interchangeably. A clone denotes a set of cells that have identical genotypes. So if you are using a fitness specification with four genes (i.e., your genome has only four loci), there can be up to$16 = 2^4$different genotypes or clones. Any two entities that differ in the genotype are different clones. And this applies regardless of whether or not you declare that some genes (loci) are drivers or not. So if you have four genes, it does not matter whether only the first or all four are regarded as drivers; you will always have at most 16 different clones or 16 different genotypes. Of course you can arrive at the same clone/genotype by different routes. Just think about loci A and B in our four-loci genome, and how you can end up with a cell with both A and B mutated. Analogously, if you have 100 genes, 10 drivers and 90 passengers, you can have up to$2^{100}$different clones or genotypes. Sure, one cell might have driver A mutated and passenger B mutated, and another cell might have driver A mutated and passenger C mutated. So if you only look at drivers you might be tempted to say that they are "the same clone for all practical purposes"; but they really are not the same clone as they differ in their genotype and this makes a lot of difference computationally. If you want summaries of simulations that collapse over some genes (say, some "passengers", the 90 passengers we just mentioned) look at the help for samplePop, argument geneNames. This would allow you, for instance, to look at the diversity of clones/genotypes, considering as identical those genotypes that only differ in genes you deem relevant; something similar to defining a "drivers' clone" as the set formed from the union of all sets of cells that have identical genotype with respect to only the drivers (so that in the example of "A, B" and "A, C" just mentioned both cells would be considered "the same clone" as they only differ with respect to passengers). However, this "disregard some genes" only applies to summaries of simulations once we are done simulating data. OncoSimulR will always track clones, as defined above, regardless of whether many of those clones have the same genotype if you were to only focus on driver genes; see also section \@ref(trackindivs). Labeling something as a "driver", therefore, does not affect what we mean by clone. Yes, labeling something as a driver can affect when you stop simulations if you use detectionDrivers as a stopping mechanism (see section \@ref(endsimul)). But, again, this has nothing to do with the definition of "clone". <!-- Below we will see the expression haplotype. I am hesitant to use it --> <!-- because haplotypes often have implicit the idea of having been in --> <!-- Strictly, we keep track of clones, not haplotypes as --> <!-- the haplotype refers to inheritance. But you can arrive at the same --> <!-- clone through different routes so that two cells that are the same --> <!-- clone could have originated from different immediate parents. Just --> <!-- think of the ways you can get to a cell with both genes A and B --> <!-- mutated. --> If this is all obvious to you, ignore it. I am adding it here because I've seen strange misunderstandings that eventually could be traced to the apparently multiple meanings of clone. (And to make the story complete, @Mather2012 use the expression "class" ---e.g., Algorithm 4 in the paper, Algorithm 5 in the supplementary material). ## Does OncoSimulR keep track of individuals or of clones? And how can it keep track of such large populations? {#trackindivs} OncoSimulR keeps track of clones, where a clone is a set of cells that are genetically identical (note that this means completely identical over the whole set of genes/markers you are using; see section \@ref(meaningclone)). We do not need to keep track of individual cells because, for all purposes, and since we do not consider spatial structure, two or more cells that are genetically identical are interchangeable. This means, for instance, that the computational cost of keeping a population of a single clone with 1 individual or with$10^9$individuals is exactly the same: we just keep track of the genotype and the number of cells. (Sure, it is much more likely we will see a mutation soon in a clone with$10^9$cells than in a clone with 1, but that is a different issue.) Of course, the entities that die, reproduce, and mutate are individual cells. This is of course dealt with by tracking clones (as is clearly shown by Algorithms 4 and 5 in @Mather2012). Tracking individuals, as individuals, would provide no advantage, but would increase the computational burden by many orders of magnitude. ### sampleEvery, keepPhylog, and pruning {#prune} At each sampling time (where sampleEvery determines the time units between sampling times) the abundance of all the clones with number of cells$>0$is recorded. This is the structure that at the end of the run is converted into the pops.by.time matrix. Now, some clones might arise from mutation between successive population samples but these clones might be extinct by the time we take a population sample. These clones do not appear in the pops.by.time matrix because, as we just said, they have 0 cells at the time of sampling. Of course, some of these clones might appear again later and reach a size larger than 0 at some posterior sampling time; it is at this time when this/these clone(s) will appear in the pops.by.time matrix. This pruning of clones with 0 cells can allow considerable savings in computing time (OncoSimulR needs to track the genotype of clones, their population sizes, their birth, death, and mutation rates, their next mutation time and the last time they were updated and thus it is important that we only loop over structures with information that is really needed). However, we still need to track clones as clones, not simply as classes such as "number of mutated genes". Therefore, very large genomes can represent a problem if they lead to the creation and tracking of many different clones (even if they have the same number of mutated genes), as we have seen, for instance, in section \@ref(lnum). In this case, programs that only keep track of numbers of mutated genes or of drivers, not individual clones, can of course achieve better speed. What about the genealogy? If you ask OncoSimulR to keep track of the complete parent-child relationships (keepPhylog = TRUE), you might see in the genealogy clones that are not present in pops.by.time if these are clones that never had a population size larger than 0 at any sampling time. To give an example, suppose that we will take population samples at times 0, 1, and 2. Clone A, with a population size larger than 0 at time 1, gives rise at time 1.5 to clone B; clone B then gives rise to clone C at time 1.8. Finally, suppose that at time 2 only clone C is alive. In other words, when we carry out the update of the population with Algorithm 5 from @Mather2012, clones A and B have size 0. Now, at time 1 clones B and C did not yet exist, and clone B is never alive at times 1 or 2. Thus, clone B is not present in pops.by.time. But we cannot remove clone B from our genealogy if we want to reflect the complete genealogy of C. Thus, pops.by.time will show only clones A and C (not B) but the complete genealogy will show clones A, B, C (and will show that B appeared from A at time 1.5 and C appeared from B at time 1.8). Since function plotClonePhylog offers a lot of flexibility with respect to what clones to show depending on their population sizes at different times, you can prevent being shown B, but its existence is there should you need it (see also \@ref(histlargegenes)). ## Dealing with errors in "oncoSimulPop" {#errorosp} When running OncoSimulR under Windows mclapply does not use multiple cores, and errors from oncoSimulPop are reported directly. For example: {r} ## This code will only be evaluated under Windows if(.Platform$OS.type == "windows")
try(pancrError <- oncoSimulPop(10, pancr,
initSize = 1e-5,
detectionSize = 1e7,
keepEvery = 10,
mc.cores = 2))


Under POSIX operating systems (e.g., GNU/Linux or Mac OSX)
oncoSimulPop can ran parallelized by calling
mclapply. Now, suppose you did something like

{r}
## Do not run under Windows
if(.Platform$OS.type != "windows") pancrError <- oncoSimulPop(10, pancr, initSize = 1e-5, detectionSize = 1e7, keepEvery = 10, mc.cores = 2)  The warning you are seeing tells you there was an error in the functions called by mclapply. If you check the help for mclpapply you'll see that it returns a try-error object, so we can inspect it. For instance, we could do: {r, eval=FALSE} pancrError[[1]]  But the output of this call might be easier to read: {r, eval=FALSE} pancrError[[1]][1]  And from here you could see the error that was returned by oncoSimulIndiv: initSize < 1 (which is indeed true: we pass initSize = 1e-5). ## Whole tumor sampling, genotypes, and allele counts: what gives? And what about order? {#wtsampl} You are obtaining genotypes, regardless of order. When we use "whole tumor sampling", it is the frequency of the mutations in each gene that counts, not the order. So, for instance, "c, d" and "c, d" both contribute to the counts of "c" and "d". Similarly, when we use single cell sampling, we obtain a genotype defined in terms of mutations, but there might be multiple orders that give this genotype. For example,$d >
c$and$c > d$both give you a genotype with "c" and "d" mutated, and thus in the output you can have two columns with both genes mutated. ## Doesn't the BNB algorithm require small mutation rates for it to be advantageous? {#bnbmutation} As discussed in the original paper by @Mather2012 (see also their supplementary material), the BNB algorithm can achieve considerable speed advantages relative to other algorithms especially when mutation events are rare relative to birth and death events; the larger the mutation rate, the smaller the gains compared to other algorithms. As mentioned in their supplementary material (see p.5) "Note that the 'cost' of each step in BNB is somewhat higher than in SSA [SSA is the original Gillespie's Stochastic Simulation Algorithm] since it requires generation of several random numbers as compared to only two uniform random numbers for SSA. However this cost increase is small compared with significant benefits of jumping over birth and death reactions for the case of rare mutations." Since the earliest versions, OncoSimulR has provided information to assess these issues. The output of function oncoSimulIndiv includes a list called *"other"* that itself includes two lists named *"minDMratio"* and *"minBMratio"*, the smallest ratio, over all simulations, of death rate to mutation rate or birth rate to mutation rate, respectively. As explained above, the BNB algorithm thrives when those are large. Note, though, we say "it thrives": these ratios being large is not required for the BNB algorithm to be an exact simulation algorithm; these ratios being large make BNB comparatively much faster than other algorithms. ## Can we use the BNB algorithm with state-dependent birth or death rates? {#bnbdensdep} As discussed in the original paper by @Mather2012 (see sections 2.6 and 3.2 of the paper and section E of the supplementary material), the BNB algorithm can be used as an approximate stochastic simulation algorithm "(...) with non-constant birth, death, and mutation rates by evolving the system with a BNB step restricted to a short duration t." (p. 9 in supplementary material). The justification is that "(...) the propensities for reactions can be considered approximately constant during some short interval." (p. 1234). This is the reason why, when we use McFarland's model, we set a very short sampleEvery. In addition, the output of the simulation functions contains the simple summary statistic errorMF that can be used to assess the quality of the approximation[^errorMF]. [^errorMF]: Death rates are affected by density dependence and, thus, it is on the death rates where the approximation that they are constant over a short interval plays a role. Thus, we examine how large the difference between successive death rates is. More precisely, let$A$and$C$denote two successive sampling periods, with$D_A = log(1 + N_A/K)$and$D_C= log(1 +
N_C/K)$their death rates. errorMF_size stores the largest$abs(D_C - D_A)$between any two sampling periods ever seen during a simulation. errorMF stores the largest$abs(D_C -
D_A)/D_A$. Additionally, a simple procedure to use is to run the simulations with different values of sampleEvery, say the default value of 0.025 and values that are 10, 20, and 50 times larger or smaller, and assess their effects on the output of the simulations and the errorMF statistic itself. You can check that using a sampleEvery much smaller than 0.025 rarely makes any difference in errorMF or in the simulation output (though it increases computing time significantly). And, just for the fun of it, you can also check that using huge values for sampleEvery can lead to trouble and will be manifested too in the simulation output with large and unreasonable jumps in total population sizes and sudden extinctions. Note that, as the authors point out, approximations are common with stochastic simulation algorithms when there is density dependence, but the advantage of the BNB algorithm compared to, say, most tau-leap methods is that clones of different population sizes are treated uniformly. @Mather2012 further present results from simulations comparing the BNB algorithm with the original direct SSA method and the tau-leaps (see their Fig. 5), which shows that the approximation is very accurate as soon as the interval between samples becomes reasonably short. ## Sometimes I get exceptions when running with mutator genes {#tomlinexcept} Yes, sure, the following will cause an exception; this is similar to the example used in \@ref(exmutantimut) but there is one crucial difference: {r ex-tomlin1exc} sd <- 0.1 ## fitness effect of drivers sm <- 0 ## fitness effect of mutator nd <- 20 ## number of drivers nm <- 5 ## number of mutators mut <- 50 ## mutator effect THIS IS THE DIFFERENCE fitnessGenesVector <- c(rep(sd, nd), rep(sm, nm)) names(fitnessGenesVector) <- 1:(nd + nm) mutatorGenesVector <- rep(mut, nm) names(mutatorGenesVector) <- (nd + 1):(nd + nm) ft <- allFitnessEffects(noIntGenes = fitnessGenesVector, drvNames = 1:nd) mt <- allMutatorEffects(noIntGenes = mutatorGenesVector)  Now, simulate using the fitness and mutator specification. We fix the number of drivers to cancer, and we stop when those numbers of drivers are reached. Since we only care about the time it takes to reach cancer, not the actual trajectories, we set keepEvery = NA: {r ex-tomlinexc2} ddr <- 4 set.seed(2) RNGkind("L'Ecuyer-CMRG") st <- oncoSimulPop(4, ft, muEF = mt, detectionDrivers = ddr, finalTime = NA, detectionSize = NA, detectionProb = NA, onlyCancer = TRUE, keepEvery = NA, mc.cores = 2, ## adapt to your hardware seed = NULL) ## for reproducibility ## set.seed(NULL) ## return things to their "usual state"  What happened? That you are using five mutator genes, each with an effect of multiplying by 50 the mutation rate. So the genotype with all those five genes mutated will have an increased mutation rate of$50^5 = 312500000$. If you set the mutation rate to the default of$1e-6$you have a mutation rate of 312 which makes no sense (and leads to all sorts of numerical issues down the road and an early warning). Oh, but you want to accumulate mutator effects and have some, or the early ones, have a large effects and the rest progressively smaller effects? You can do that using epistatic effects for mutator effects. ## What are good values of sampleEvery? {#whatgoodsampleevery} First, we need to differentiate between the McFarland and the exponential models. If you use the McFarland model, you should read section \@ref(bnbdensdep) but, briefly, the small default is probably a good choice. With the exponential model, however, simulations can often be much faster if sampleEvery is large. How large? As large as you can make it. sampleEvery should not be larger than your desired keepEvery, where keepEvery determines the resolution or granularity of your samples (i.e., how often you take a snapshot of the population). If you only care about the final state, then set keepEvery = NA. The other factors that affects choosing a reasonable sampleEvery are mutation rate and population size. If population growth is very fast or mutation rate very large, you need to sample frequently to avoid the "Recoverable exception ti set to DBL_MIN. Rerunning." issue (see discussion in section \@ref(popgtzx)). ## mutationPropGrowth and is mutation associated to division? With BNB mutation is actually "mutate after division": p.\ 1232 of Mather et al., 2012 explains: "(...) mutation is simply defined as the creation and subsequent departure of a single individual from the class". Thus, if we want individuals of clones/genotypes/populations that divide faster to also produce more mutants per unit time (per individual) we have to set mutationPropGrowth = TRUE. When mutationPropGrowth = FALSE, two individuals, one from a fast growing genotype, and the other from a slow growing genotype, would be "emiting" (giving rise to) different numbers of identical (non-mutated) descendants per unit time, but they would be giving rise to the same number of mutated descendants per unit time. There is an example in Mather et al, p. 1234, section 3.1.1 where "Mutation rate is proportional to growth rate (faster growing species also mutate faster)". Of course, this only makes sense in models where birth rate changes. ## What can you do with the simulations? This is up to you. In section \@ref(sample-1) we show an example where we infer an Oncogenetic tree from simulated data and in section \@ref(whatfor) we go over a varied set of scientific questions where OncoSimulR could help. \clearpage # Using v.1 posets and simulations {#v1} It is strongly recommended that you use the new (v.2) procedures for specifying fitness effects. However, the former v.1 procedures are still available, with only very minor changes to function calls. What follows below is the former vignette. You might want to use v.1 because for certain models (e.g., small number of genes, with restrictions as specified by a simple poset) simulations might be faster with v.1 (fitness evaluation is much simpler ---we are working on further improving speed). ## Specifying restrictions: posets {#poset} How to specify the restrictions is shown in the help for poset. It is often useful, to make sure you did not make any mistakes, to plot the poset. This is from the examples (we use an "L" after a number so that the numbers are integers, not doubles; we could alternatively have modified storage.mode). {r, fig.height=3} ## Node 2 and 3 depend on 1, and 4 depends on no one p1 <- cbind(c(1L, 1L, 0L), c(2L, 3L, 4L)) plotPoset(p1, addroot = TRUE)  {r, fig.height=3} ## A simple way to create a poset where no gene (in a set of 15) ## depends on any other. p4 <- cbind(0L, 15L) plotPoset(p4, addroot = TRUE)  Specifying posets is actually straightforward. For instance, we can specify the pancreatic cancer poset in @Gerstung2011 (their figure 2B, left). We specify the poset using numbers, but for nicer plotting we will use names (KRAS is 1, SMAD4 is 2, etc). This example is also in the help for poset: {r, fig.height=3} pancreaticCancerPoset <- cbind(c(1, 1, 1, 1, 2, 3, 4, 4, 5), c(2, 3, 4, 5, 6, 6, 6, 7, 7)) storage.mode(pancreaticCancerPoset) <- "integer" plotPoset(pancreaticCancerPoset, names = c("KRAS", "SMAD4", "CDNK2A", "TP53", "MLL3","PXDN", "TGFBR2"))  ## Simulating cancer progression {#simul1} We can simulate the progression in a single subject. Using an example very similar to the one in the help: {r, echo=FALSE,results='hide',error=FALSE} options(width=60)  {r} ## use poset p1101 data(examplePosets) p1101 <- examplePosets[["p1101"]] ## Bozic Model b1 <- oncoSimulIndiv(p1101, keepEvery = 15) summary(b1)  The first thing we do is make it simpler (for future examples) to use a set of restrictions. In this case, those encoded in poset p1101. Then, we run the simulations and look at a simple summary and a plot. If you want to plot the trajectories, it is better to keep more frequent samples, so you can see when clones appear: {r pb2bothx1,fig.height=5.5, fig.width=5.5} b2 <- oncoSimulIndiv(p1101, keepEvery = 1) summary(b2) plot(b2)  As we have seen before, the stacked plot here is less useful and that is why I do not evaluate that code for this vignette. {r pbssttx1,eval=FALSE} plot(b2, type = "stacked")  The following is an example where we do not care about passengers, but we want to use a different graph, and we want a few more drivers before considering cancer has been reached. And we allow it to run for longer. Note that in the McFL model detectionSize really plays no role. Note also how we pass the poset: it is the same as before, but now we directly access the poset in the list of posets. {r, echo=FALSE,eval=TRUE} set.seed(1) ## for reproducibility. Once I saw it not reach cancer.  {r} m2 <- oncoSimulIndiv(examplePosets[["p1101"]], model = "McFL", numPassengers = 0, detectionDrivers = 8, mu = 5e-7, initSize = 4000, sampleEvery = 0.025, finalTime = 25000, keepEvery = 5, detectionSize = 1e6)  (Very rarely the above run will fail to reach cancer. If that happens, execute it again.) As usual, we will plot using both a line and a stacked plot: {r m2x1,fig.width=6.5, fig.height=10} par(mfrow = c(2, 1)) plot(m2, addtot = TRUE, log = "", thinData = TRUE, thinData.keep = 0.5) plot(m2, type = "stacked", thinData = TRUE, thinData.keep = 0.5)  The default is to simulate progression until a simulation reaches cancer (i.e., only simulations that satisfy the detectionDrivers or the detectionSize will be returned). If you use the McFL model with large enough initSize this will often be the case but not if you use very small initSize. Likewise, most of the Bozic runs do not reach cancer. Lets try a few: {r} b3 <- oncoSimulIndiv(p1101, onlyCancer = FALSE) summary(b3) b4 <- oncoSimulIndiv(p1101, onlyCancer = FALSE) summary(b4)  Plot those runs: {r b3b4x1ch1, fig.width=8, fig.height=4} par(mfrow = c(1, 2)) par(cex = 0.8) ## smaller font plot(b3) plot(b4)  ### Simulating progression in several subjects To simulate the progression in a bunch of subjects (we will use only four, so as not to fill the vignette with plots) we can do, with the same settings as above: {r ch2} p1 <- oncoSimulPop(4, p1101, mc.cores = 2) par(mfrow = c(2, 2)) plot(p1, ask = FALSE)  We can also use stream and stacked plots, though they might not be as useful in this case. For the sake of keeping the vignette small, these are commented out. {r p1multx1,eval=FALSE} par(mfrow = c(2, 2)) plot(p1, type = "stream", ask = FALSE)  {r p1multstx1,eval=FALSE} par(mfrow = c(2, 2)) plot(p1, type = "stacked", ask = FALSE)  ## Sampling from a set of simulated subjects {#sample-1} You will often want to do something with the simulated data. For instance, sample the simulated data. Here we will obtain the trajectories for 100 subjects in a scenario without passengers. Then we will sample with the default options and store that as a vector of genotypes (or a matrix of subjects by genes): {r} m1 <- oncoSimulPop(100, examplePosets[["p1101"]], numPassengers = 0, mc.cores = 2)  The function samplePop samples that object, and also gives you some information about the output: {r} genotypes <- samplePop(m1)  What can you do with it? That is up to you. As an example, let us try to infer an Oncogenetic tree (and plot it) using the r CRANpkg("Oncotree") package @Oncotree after getting a quick look at the marginal frequencies of events: {r fxot1,fig.width=4, fig.height=4} colSums(genotypes)/nrow(genotypes) require(Oncotree) ot1 <- oncotree.fit(genotypes) plot(ot1)  Your run will likely differ from mine, but with the defaults (detection size of$10^8\$) it is likely that events down the tree will never
appear. You can set detectionSize = 1e9 and you will see that
events down the tree are now found in the cross-sectional sample.

Alternatively, you can use single cell sampling and that, sometimes,
recovers one or a couple more events.

{r fxot2,fig.width=4, fig.height=4}
genotypesSC <- samplePop(m1, typeSample = "single")
colSums(genotypesSC)/nrow(genotypesSC)

ot2 <- oncotree.fit(genotypesSC)
plot(ot2)


You can of course rename the columns of the output matrix to something
else if you want so the names of the nodes will reflect those potentially
more meaningful names.

\clearpage

# Session info and packages used

This is the information about the version of R and packages used:
{r}
sessionInfo()

Time to build the vignette:

{r last, echo=FALSE}
paste(difftime(Sys.time(), time0, units = "mins"), "minutes")


<!-- Time it takes to run each chunkc. Uncomment also the hook and -->
<!-- setting at beginning of vignette: search for all_times -->

<!-- {r timeit} -->
<!-- all_times -->
<!--  -->

\clearpage

# Funding

Supported by BFU2015-67302-R (MINECO/FEDER, EU) to
RDU. S. Sanchez-Carrillo partially supported by a "Beca de Colaboración" from Universidad Autónoma de Madrid (2017-2018); J. Antonio Miguel supported by PEJ-2019-AI/BMD-13961 from Comunidad de Madrid.

{r, echo=FALSE, eval=TRUE}
## reinitialize the seed
set.seed(NULL)


# References

<!-- %% remember to use bibexport to keep just the minimal bib needed -->
<!-- %% bibexport -o extracted.bib OncoSimulR.aux -->
<!-- %% rm OncoSimulR.bib -->
<!-- %% mv extracted.bib OncoSimulR.bib -->
<!-- %% and then turn URL of packages into notes -->

<!-- Local Variables: -->
<!-- fill-column: 68 -->
<!-- End: -->

<!--  LocalWords:  genotype Genotyping -->

`